<?xml version="1.0" encoding="iso-8859-1"?>
<dataroot xmlns:od="urn:schemas-microsoft-com:officedata" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://grants.nih.gov/web_services/xsd/GuideDocs_V20.xsd" generated="2012-05-23T07:08:13">

<GuideDocs>
<rowid>15394</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Support of Competitive Research (SCORE) Research Advancement Award (SC1)]]></Title>
<Purpose><![CDATA[-Purpose. This FOA provides updated guidelines for the National Institute of General Medical Sciences (NIGMS) Minority Biomedical Research Support (MBRS) Support of Competitive Research (SCORE) Program SC1 mechanism for Research Advancement Awards. 
-Mechanism of Support. The SCORE Program is a developmental program designed to increase the research competitiveness of faculty at minority-serving institutions (MSIs) and the institutions faculty research capabilities. To better achieve these objectives, three funding opportunities exist for individual investigator-initiated research awards according to their developmental level. The mechanisms used for these funding opportunities are the SC1 (PAR-08-026), SC2 (PAR-08-027) and SC3 (PAR-08-028) awards for individual investigators. Descriptions of the SC2 andSC3 mechanisms may be found at the NIGMS website, http://www.nigms.nih.gov/Minority/MBRS/. This announcement for the SC1 award outlines the investigator-initiated research project for faculty who are at the most advanced formative stages of their research career, i.e., who are engaged in state-of-the-art biomedical or behavioral research and are productive as evidenced by a steady track record of peer-reviewed publications, yet they have not had significant non-SCORE support and are planning to transition to other major external sources of support. It is the expectation of this award that by providing support to conduct competitive research and requiring participation of SC1 Principal Investigators (PI) in grantsmanship workshops and biennial PI meetings, they will be successful in securing non-SCORE external support. ]]></Purpose>
<RelNote/><ActivityCodes>SC1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-08-026.html</GuideLink>
<RelDate>2007-11-16</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-08-026.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-08-026</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>15395</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Support of Competitive Research (SCORE) Pilot Project Award (SC2)]]></Title>
<Purpose><![CDATA[-Purpose. This FOA provides updated guidelines for the National Institute of General Medical Sciences (NIGMS) Minority Biomedical Research Support (MBRS) Support of Competitive Research (SCORE) Program SC2 mechanism for Pilot Project Awards.
-Mechanism of Support. The SCORE Program is a developmental program to increase the research competitiveness of faculty at minority-serving institutions (MSIs) and the institutions faculty research capabilities. To better achieve these objectives, three funding opportunities exist for individual investigator-initiated research awards according to their developmental level. The mechanisms used for these funding opportunities are the SC1 (PAR- 08-026), SC2 and SC3 (PAR-08-028) for individual investigators. Descriptions of the SC1 and SC3 may be found at the NIGMS website, http://www.nigms.nih.gov/Minority/MBRS. This announcement for the SC2 award outlines the individual investigator-initiated pilot research project for faculty members who are in their early stages of development and are seeking to gather preliminary data or more advanced investigators interested in switching to a different research field from the one in which an individual has been engaged and published.
-Funds Available and Anticipated Number of Awards. Twenty-five to 30 SC2 awards totaling $2-2.2 million (direct costs) are expected to be made each year. The SC2 awards may not exceed $300,000 (direct costs) for the entire length of the award which may be one to three years maximum. Yearly requests need not be of the same amount but must be determined based on $25,000 module increments and may not exceed $100,000 per year. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number of applications submitted to each SCORE award mechanism as well as the scientific quality, duration, and costs of the applications received. The maximum number of individual SCORE applications/awards (combination of SC1, SC2, SC3 and, if applicable, S06 subprojects) that a single MSI may hold is 25.]]></Purpose>
<RelNote/><ActivityCodes>SC2</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-08-027.html</GuideLink>
<RelDate>2007-11-16</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-08-027.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-08-027</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>15398</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Support of Competitive Research (SCORE) Research Continuance Award (SC3)]]></Title>
<Purpose><![CDATA[-Purpose. This FOA provides updated guidelines for the National Institute of General Medical Sciences (NIGMS) Minority Biomedical Research Support (MBRS) Support of Competitive Research (SCORE) Program SC3 mechanism for Research Continuance Awards. 
-Mechanism of Support. The SCORE Program is a developmental program designed to increase the research competitiveness of faculty at the minority-serving institutions (MSIs), and the research capabilities of MSIs. To achieve these objectives, three funding opportunities exist for individual investigator-initiated research awards according to their developmental level. The mechanisms used for these funding opportunities are SC1 (PAR-08-026), SC2 (PAR-08-027) and SC3 (PAR-08-028) awards for individual investigators. Descriptions of the SC1 and SC2 mechanisms may be found at the NIGMS website, http://www.nigms.nih.gov/Minority/MBRS/. This FOA will use the SC3 grant mechanism, which is the individual investigator-initiated research continuance award for faculty members at intermediate formative stages of their research career who seek to improve their scholarly development by engaging in meritorious research projects of limited scope, and publishing in a given biomedical/behavioral area limited to the NIH mission.]]></Purpose>
<RelNote/><ActivityCodes>SC3</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-08-028.html</GuideLink>
<RelDate>2007-11-16</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-08-028.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-08-028</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16268</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21)]]></Title>
<Purpose><![CDATA[-Purpose. This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), invites grant applications from institutions and organizations that are interested in developing and testing innovative methods in cancer detection, diagnosis, and prognosis. The NCI is especially interested in research studies that focus on the development and testing of improved methods for detecting specific characteristics of cancer, which can be subsequently used for the clinical management of cancer patients or individuals who are at risk for (developing) cancer. It is important that research studies focus on the search for molecular and cellular differences between tumors, pre-malignant, or normal tissues. The studies should determine the clinical translational significance of these differences by correlation with clinical parameters, in order to answer clinical problems related to detection, diagnosis, treatment, and prognosis.
-Mechanism of Support. This FOA utilizes the NIH Exploratory/Developmental Grant (R21) mechanism. 
-Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-08-267.html</GuideLink>
<RelDate>2008-09-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-08-267.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-08-267</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16272</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Small Research Grant to Improve Health Care Quality through Health Information Technology (IT) (R03)]]></Title>
<Purpose><![CDATA[Purpose.The purpose of this Funding Opportunity Announcement (FOA) is to support a wide variety of research designs in order to improve the quality, safety, effectiveness, and efficiency of health care through the implementation and use of health IT.These designs include: small pilot and feasibility or self-contained health IT research projects; secondary data analysis of health IT research; and economic (prospective or retrospective) analyses of health IT implementation and use.Through economic analyses estimates of health IT implementation and use costs and benefits will be generated.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-08-268.html</GuideLink>
<RelDate>2008-09-25</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-11-16</LARD>
<FileName>PAR-08-268.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-08-268</DocNum>
<ExpirationDate>2012-11-17</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16273</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Exploratory and Developmental Grant to Improve Health Care Quality through Health Information Technology (IT) (R21) ]]></Title>
<Purpose><![CDATA[Purpose.The purpose of this Funding Opportunity Announcement (FOA) is to support short-term preparatory, pilot or feasibility studies that will inform larger scale real world health IT implementation and use or the conduct of more comprehensive health IT implementation research.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-08-269.html</GuideLink>
<RelDate>2008-09-25</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-11-16</LARD>
<FileName>PAR-08-269.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-08-269</DocNum>
<ExpirationDate>2012-11-17</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16542</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Health Services Research Projects (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) solicits Large Research (R01) Projects, and expresses AHRQ portfolio priority areas of interest for ongoing extramural health services research, demonstration, dissemination, and evaluation grants. 

Mechanism of Support. This FOA will use the AHRQ Research Project Grant (R01) award mechanism. 

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.Applications submitted in response to this FOA will receive the highest priority for AHRQ investigator initiated grant funds in FY09.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.

Budget and Project Period.The total costs awarded to a grant under this FOA will not exceed $500,000 annually for the entire project period.An application with a budget that exceeds $500,000 total costs per year will not be reviewed.Funding beyond the first year will be contingent upon a review and acceptance by Agency staff of the progress report.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-070.html</GuideLink>
<RelDate>2009-01-02</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[March 9, 2009, then standard dates apply]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-09-070.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-070</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16543</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Health Services Research Demonstration and Dissemination Grants (R18)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) solicits Large Research Demonstration and Dissemination (R18) Projects, and expresses AHRQ portfolio priority areas of interest for these ongoing, extramural grants. 

Mechanism of Support. This FOA will use the AHRQ Large Research Demonstration and Dissemination Grant (R18) award mechanism. 

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.

Budget and Project Period.The total costs awarded to a grant under this FOA will not exceed $500,000 annually for the entire project period.An application with a budget that exceeds $500,000 total costs per year will not be reviewed.Funding beyond the first year will be contingent upon a review and acceptance by Agency staff of the progress report.]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-071.html</GuideLink>
<RelDate>2009-01-02</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[March 9, 2009, then standard dates apply]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-09-071.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-071</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16597</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<Title><![CDATA[Short Term Career Development Award in the Environmental Health Sciences   for Established Investigators (K18)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of these short term career development awards is to allow established, well funded clinician investigators to expand research programs to answer questions relevant to the environmental health sciences, and to provide established environmental health sciences research investigators the tools to expand their efforts to translational research. 
Mechanism of Support. This FOA will utilize the NIH Career Enhancement Award (K18) mechanism. 
Funds Available and Anticipated Number of Awards. The NIEHS intends to commit a total of $500,000 per year to this funding opportunity announcement (FOA) ]]></Purpose>
<RelNote/><ActivityCodes>K18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-090.html</GuideLink>
<RelDate>2009-01-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-090.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-090</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16599</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Mentored  Clinical Scientist Research Career Development Award (K08)
]]></Title>
<Purpose><![CDATA[Purpose: The primary purpose of the AHRQ Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans.  This program represents the continuation of an AHRQ program that provides support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in health services research.  The award can be used both by individuals who propose to newly embark in heath services research training and those who had a hiatus in their research careers because of illness or family circumstances.  The award is also available to promote research workforce diversity by providing enhanced research career development opportunities.  Candidates interested in pursuing careers in patient-oriented research are eligible to apply for this award at AHRQ. ]]></Purpose>
<RelNote/><ActivityCodes>K08</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-085.html</GuideLink>
<RelDate>2009-01-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 9, 2009 is the first application due date for new K08 applications, then standard dates apply.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-09-085.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-085</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16600</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Independent Scientist Award (K02)]]></Title>
<Purpose><![CDATA[Purpose: The primary purpose of the AHRQ Independent Scientist Awards (K02) program is to foster the development of outstanding health service researchers and enable them to expand their potential to make significant contributions to their field of research.  The K02 award provides three, four, or five years of salary support and protected time for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers.  Applicants must focus their research careers on areas that would have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans.  This program represents the continuation of an AHRQ program. 
Mechanism of Support: This Funding Opportunity Announcement (FOA) will utilize the Independent Scientist Award (K02) mechanism. 
]]></Purpose>
<RelNote/><ActivityCodes>K02</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-086.html</GuideLink>
<RelDate>2009-01-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 9, 2009 is the first application due date for new K02 applications, then standard dates apply.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-09-086.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-086</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16601</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Mentored Research Scientist Research Career Development Award (K01)]]></Title>
<Purpose><![CDATA[Purpose: The primary purpose of the AHRQ Mentored Research Scientist Research Career Development Awards (K01) program is to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans.  This program represents the continuation of an AHRQ program that provides support and protected time to individuals with a research doctoral degree for an intensive, supervised research career development experience in health services research.  The K01 award can be used both by individuals who propose to newly embark in heath services research training and those who had a hiatus in their research careers because of illness or family circumstances.  The K01 award is also available to promote research workforce diversity by providing enhanced research career development opportunities. 
Mechanism of Support: This Funding Opportunity Announcement (FOA) will utilize the Mentored Research Scientist Research Career Development Award (K01) mechanism. 
]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-087.html</GuideLink>
<RelDate>2009-01-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 9, 2009 is the first application due date for new K01 applications, then standard dates apply.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-09-087.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-087</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16827</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44]) ]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and apply state-of-the-art multiplex assay technologies for measurement of multiple candidate biomarkers in small volumes of body fluid for musculoskeletal, rheumatic and skin diseases. 
Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-127.html</GuideLink>
<RelDate>2009-04-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-127.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-127</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16843</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) seek to support collaborative intervention trials in the treatment, prevention or rehabilitation of those with mental disorders and alcohol use disorders and comorbid mental disorders. Support is also provided for other collaborative clinical studies, including but not limited to mental health services research, AIDS, genetics, psychopathology, stigma, and cultural and social processes. This Funding Opportunity Announcement (FOA) should be used when two or more sites are needed to complete the study. Accordingly, the collaborating studies share a specific protocol across the sites and are organized as such in order to increase sample size, accelerate recruitment, or increase sample diversity and representation. In studies with a large number of sites, it is expected that one site will be submitted as a coordinating site for data management and/or other centralized administration. For a linked set of collaborative R01s, each site has its own Project Director/Principal Investigator and the program provides a mechanism for cross-site coordination, quality control, database management, statistical analysis, and reporting. 
Mechanism of Support. This FOA will use the NIH Collaborative Research Project Grant (Collaborative R01) award mechanism.  For each set of linked collaborative R01 applications, it is expected that each application will be coordinated and interlocked with the others as each application will contribute an essential component to the overall study. In the case of multi-site clinical trials, it is anticipated that the same protocol will be submitted by each site. However, there are likely to be elements unique to some sites (e.g., data coordination, fidelity assessment, statistical analyses). 
]]></Purpose>
<RelNote/><ActivityCodes>R01(Collab)</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-153.html</GuideLink>
<RelDate>2009-04-09</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-153.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-153</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16860</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[NIOSH Small Research Grant Program (R03) ]]></Title>
<Purpose><![CDATA[The National Institute for Occupational Safety and Health (NIOSH) within the Centers for Disease Control and Prevention (CDC) invites grant applications for research related to occupational safety and health. 

Purpose. The purpose of this grants program is to develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 

Mechanism of Support.  This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with NIOSHs R01 and R21 mechanisms which have identical scientific scope.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-138.html</GuideLink>
<RelDate>2009-04-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-138.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-138</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16861</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[NIOSH Exploratory and/or Developmental Grant Program (R21)]]></Title>
<Purpose><![CDATA[The National Institute for Occupational Safety and Health (NIOSH) within the Centers for Disease Control and Prevention (CDC) invites grant applications for research related to occupational safety and health. 

Purpose. The purpose of this grants program is to develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. 

Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with NIOSHs R01 and R03 mechanisms which have identical scientific scope.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-139.html</GuideLink>
<RelDate>2009-04-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-139.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-139</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16877</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Research on Teen Dating Violence (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages investigator-initiated research grant applications from institutions/ organizations that propose to conduct behavioral and/or biomedical research aimed at better understanding the etiologies and precursors for, reducing risk for, and incidence of, teen dating violence (TDV). Research is also sought that examines the linkages and gaps among perceptions of appropriate responses to teen dating violence from service providers, the criminal justice system, teens themselves, victims, perpetrators and bystanders. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-170, which encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-169.html</GuideLink>
<RelDate>2009-04-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-169.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-169</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16878</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Research on Teen Dating Violence (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages investigator-initiated research grant applications from institutions/ organizations that propose to conduct behavioral and/or biomedical research aimed at better understanding the etiologies and precursors for, reducing risk for, and incidence of, teen dating violence (TDV). Research is also sought that examines the linkages and gaps among perceptions of appropriate responses to teen dating violence from service providers, the criminal justice system, teens themselves, victims, perpetrators and bystanders. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-169, which encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-170.html</GuideLink>
<RelDate>2009-04-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-170.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-170</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16886</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Pilot Intervention and Services Research Grants (R34)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research on 1) the development and/or pilot testing of new or adapted interventions, 2) the adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale effectiveness trials, or 3) innovative services research directions that require preliminary testing or development. The R34 award mechanism provides resources for evaluating the feasibility, tolerability, acceptability and safety of novel approaches to improving mental health and modifying health risk behavior, and for obtaining the preliminary data needed as a pre-requisite to a larger-scale (efficacy or effectiveness) intervention or services study.  NIMH intervention and services research is aimed at preventing or ameliorating mental disorders, emotional or behavioral problems, the co-occurrence of mental, physical and substance abuse problems, HIV infections, and the functional consequences of these problems across the life span. 
Mechanism of Support. This FOA will utilize the NIMH R34 award mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-173.html</GuideLink>
<RelDate>2009-04-22</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-173.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-173</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16944</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Translational Programs in Lung Diseases (P01) 
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the NHLBI, National Institutes of Health, solicits Program Project Grant (P01) applications from institutions/organizations that will perform collaborative, translational research that moves mechanistic research to clinical applications to improve prevention, diagnosis and/or treatment of lung diseases and sleep disorders.

Mechanism of Support. This FOA will utilize the Program Project (P01) grant mechanism and will consist of at least 3 projects and 2 cores (assuming an administrative core as one of the cores).

Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-185.html</GuideLink>
<RelDate>2009-05-13</RelDate>
<IntentDate>August 25, 2009; April 25, 2010; August 25, 2010; April 25, 2011; August 25, 2011; April 26, 2012; August 25, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 25, 2009; May 25, 2010; September 25, 2010; May 25, 2011; September 25, 2011; May 26, 2012; September 25, 2012]]></AppReceiptDate>
<LARD>2012-09-25</LARD>
<FileName>PAR-09-185.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-185</DocNum>
<ExpirationDate>2012-09-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16973</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<Title><![CDATA[Ancillary Studies of Acute Kidney Injury, Chronic Kidney Disease, and End Stage Renal Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart Lung and Blood Institute (NHLBI) invite investigator-initiated research project applications for ancillary studies to ongoing or completed clinical trials, existing administrative and clinical databases and epidemiological studies of kidney disease as well as clinical trials and epidemiological studies for other diseases or populations that lend themselves to the study of acute kidney injury and chronic kidney disease. These studies may range from new analyses of existing datasets of completed studies to additional collection of data and biological specimens in ongoing investigations. The goal of these studies should be to extend our understanding of the risk factors for developing kidney disease and their associated co-morbid illnesses such as malnutrition and cardiovascular disease, factors associated with rapid decline in kidney function among persons with chronic kidney disease, and the impact of these diseases on quality of life and mental and physical functioning. Investigations of acute kidney injury, including biomarkers is also an appropriate topic for investigation. Studies ancillary to both government and non-government supported clinical trials and epidemiological studies are encouraged.  Analysis of large public access databases and other databases is also encouraged. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-196.html</GuideLink>
<RelDate>2009-05-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-196.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-196</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16975</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R03) ]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications from organizations/institutions that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-195.html</GuideLink>
<RelDate>2009-05-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-195.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-195</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16976</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Exploratory/Developmental Research Project Grant (R21) applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-09-193, that encourages applications under the R01 Research Grant mechanism, and PA-09-195, that encourages applications under the R03 Small Research Grant mechanism.. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-194.html</GuideLink>
<RelDate>2009-05-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-194.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-194</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16977</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<Title><![CDATA[Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Research Project Grant (R01) applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement.  
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-09-194, that encourages applications under the R21 Exploratory/Developmental grant mechanism, and PA-09-195, that encourages applications under the R03 Small Research Grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-193.html</GuideLink>
<RelDate>2009-05-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-05</LARD>
<FileName>PA-09-193.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-193</DocNum>
<ExpirationDate>2012-09-06</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16987</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research grant applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. 
Mechanism of Support. This FOA will utilize the NIH exploratory/developmental (R21) grant mechanism and runs in parallel an FOA of identical scientific scope, (PA-09-199) that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-200.html</GuideLink>
<RelDate>2009-06-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-200.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-200</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16988</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research grant applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. 
Mechanism of Support. This FOA uses the NIH research project R01 grant mechanism and runs in parallel with an FOA of identical scientific scope, PA-09-200 that encourages applications under the NIH Exploratory/Developmental (R21) Grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-199.html</GuideLink>
<RelDate>2009-06-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-199.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-199</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16989</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Biomarkers for Early Detection of Hematopoietic Malignancies (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies. 
Mechanism of Support. This FOA will utilize the NIH exploratory/developmental (R21) grant mechanism and runs in parallel an FOA of identical scientific scope, PA-09-197) that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-198.html</GuideLink>
<RelDate>2009-06-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-198.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-198</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16990</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Biomarkers for Early Detection of Hematopoietic Malignancies (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies.

Mechanism of Support. This FOA uses the NIH research project R01 grant mechanism and runs in parallel with an FOA of identical scientific scope, PA-09-198 that encourages applications under the NIH Exploratory/Developmental (R21) Grant mechanism. 

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-197.html</GuideLink>
<RelDate>2009-06-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-197.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-197</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16995</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Bioenergetics, Fatigability, and Activity Limitations in Aging (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Nursing Research, Office of Research on Womens Health, and the Office of Dietary Supplements encourages R21 applications proposing to study bioenergetic factors underlying increased fatigability and activity limitations in aging. Increased fatigability is a significant cause of restricted physical and cognitive activity in older adults. Alterations in bioenergeticsthe production and utilization of energy, and the regulation of these processesmay contribute significantly to increased fatigability. This FOA encourages applications that propose to 1) elucidate specific alterations in bioenergetics related to increased fatigability and activity limitations; 2) develop and evaluate improved measures of fatigability related to bioenergetics; 3) evaluate interventions for increased fatigability and activity limitations that target alterations in bioenergetics and lead to improved quality of life.     
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-190, that encourages applications under the Research Project Grant (R01) mechanism, and PA-09-192, that encourages applications under the Small Research Grant (R03) mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-191.html</GuideLink>
<RelDate>2009-06-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-191.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-191</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16996</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Bioenergetics, Fatigability, and Activity Limitations in Aging (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Aging (NIA), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Nursing Research (NINR), the Office of Research on Womens Health (ORWH), and the Office of Dietary Supplements (ODS). 
encourages Research Project Grant (R01) applications proposing to study bioenergetic factors underlying increased fatigability and activity limitations in aging. Increased fatigability is a significant cause of restricted physical and cognitive activity in older adults. Alterations in bioenergeticsthe production and utilization of energy, and the regulation of these processesmay contribute significantly to increased fatigability. This FOA encourages applications that propose to 1) elucidate specific alterations in bioenergetics related to increased fatigability and activity limitations; 2) develop and evaluate improved measures of fatigability related to bioenergetics; 3) evaluate interventions for increased fatigability and activity limitations that target alterations in bioenergetics and lead to improved quality of life.    
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-09-192, that encourages applications under the R03 Small Research Grant mechanism, and PA-09-191, that encourages applications under the R21 Exploratory/Developmental grant mechanism.   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-190.html</GuideLink>
<RelDate>2009-06-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-190.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-190</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16999</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Advances in Polycystic Kidney Disease (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) through its Division of Kidney, Urologic and Hematologic Diseases (DKUHD) invites experienced and new investigators to submit research grant applications to pursue basic and applied investigations in order to better understand the etiology and pathogenesis of Polycystic Kidney Disease (PKD), in both its autosomal dominant and autosomal recessive forms.  The intent of this funding opportunity is to intensify investigator-initiated research, to attract new investigators to the field, and to increase interdisciplinary research.  The ultimate aim is to facilitate PKD-related research studies, which will provide the basis for new therapeutic approaches. 
Mechanism of Support. This funding opportunity will utilize the (R01) grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-202.html</GuideLink>
<RelDate>2009-06-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-202.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-202</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17003</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Development and Validation of Disease Biomarkers (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),  the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Nursing Research (NINR), and the Office of Dietary Supplements (ODS) of the National Institutes of Health, will provide resources to validate candidate biomarkers for well-defined human diseases of the liver, kidney, urological tract, and digestive and hematologic systems, as well as endocrine and metabolic disorders, diabetes and its complications, and obesity, for which there are no or very few biomarkers, or for which standard biomarkers are currently prohibitively invasive or expensive. A biomarker is an indicator of a disease process, and could replace hard clinical end points as a measure of the effect of new therapies. Appropriate studies will validate candidate biomarkers in well-defined patient populations, provide new technologies to monitor biomarkers or establish reliable assays for validated markers. Progress in this area has the potential to advance translational research related to efficacy of treatments and bio-behavioral interventions. This FOA is not appropriate for biomarker discovery projects.  
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism.  Developmental/Exploratory Research (R21) applications within the scientific scope of the FOA can be submitted in response to the NIH Parent R21 PA http://grants.nih.gov/grants/guide/pa-files/PA-06-181.html. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-204.html</GuideLink>
<RelDate>2009-06-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-204.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-204</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>16994</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Bioenergetics, Fatigability, and Activity Limitations in Aging (R03)
]]></Title>
<Purpose><![CDATA[Purpose. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This FOA issued by the National Institute on Aging and the Office of Dietary Supplementssolicits Small Research Grant (R03) applications proposing to study bioenergetic factors underlying increased fatigability and activity limitations in aging. Increased fatigability is a significant cause of restricted physical and cognitive activity in older adults. Alterations in bioenergeticsthe production and utilization of energy, and the regulation of these processesmay contribute significantly to increased fatigability. This FOA encourages applications that propose to 1) elucidate specific alterations in bioenergetics related to increased fatigability and activity limitations; 2) develop and evaluate improved measures of fatigability related to bioenergetics; 3) evaluate interventions for increased fatigability and activity limitations that target alterations in bioenergetics and lead to improved quality of life.    
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-09-190, that encourages applications under the Research Project Grant (R01) mechanism, and PA-09-191, that encourages applications under the Exploratory/Developmental Research (R21) mechanism. ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-192.html</GuideLink>
<RelDate>2009-06-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-192.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-192</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17059</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[NIDDK Small Grants for Clinical Scientists to Promote Diversity in Health-Related Research (R03) ]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this funding opportunity announcement (FOA) is to provide support for clinical scientists from underrepresented racial/ethnic backgrounds, disadvantaged backgrounds or clinical scientists with disabilities to conduct small research projects in the area of diabetes, endocrinology, metabolism, digestive diseases, hepatology, obesity, nutrition, kidney, urology, or hematology. The NIDDK and the ODS recognize the need to promote diversity in the health-related workforce by increasing the number of highly trained clinical researchers from diverse backgrounds conducting research in areas of importance to the NIDDK. This FOA is aimed at New Investigators (see Section III.1.B. for definition) who hold a health professional doctoral degree or other clinical doctoral degree AND who are from a group that have been shown to be underrepresented in biomedical research (see eligible PD/PI for full definition). The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>125000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-223.html</GuideLink>
<RelDate>2009-06-26</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-223.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-223</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17067</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Program Announcement is sponsored by the NIDDK and the NICHD.  Congenital obstructive uropathy is one of the major causes of chronic kidney disease and end stage renal disease (ESRD) in infants and children. The pathogenesis of this disorder, however, remains poorly understood. Many controversies and clinical uncertainties exist in the detection, prognosis, and effective treatment strategies for this condition. The impact of early fetal detection and neonatal intervention, the long-term effects of watchful waiting and the various surgical interventions have not been well studied and documented. There is also no consensus on the indications for, or ideal timing of surgical intervention. The purpose of this funding opportunity is to address the numerous scientific and clinical uncertainties related to the development, treatment and prognosis of congenital obstructive uropathy, by encouraging and facilitating research in diverse areas. These areas include: the development of objective prognostic markers; the genetic determinants of this congenital disorder; the development of reliable animal models of the disorder; and, evaluation of the long-term effectiveness of various treatment strategies. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-226.html</GuideLink>
<RelDate>2009-07-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-226.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-226</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17070</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Individual Awards for Postdoctoral Fellows (F32) Ruth L. Kirschstein National Research Service Awards (NRSA)]]></Title>
<Purpose><![CDATA[Purpose: The purpose of this individual postdoctoral research training fellowship is to provide support to promising Fellowship Applicants with the potential to become productive, independent investigators in health services research in research areas and priorities relevant to the mission of AHRQ. 
Mechanism of Support: This funding opportunity announcement (FOA) uses the Ruth L. Kirschstein Individual Postdoctoral National Research Service Award (NRSA) mechanism (F32).  
Funds Available and Anticipated Number of Awards: The total amount to be awarded and the number of F32 fellowships awarded will depend on the quality and scientific merit of the applications received, their relevance to the program priorities of AHRQ and the availability of funds.   
]]></Purpose>
<RelNote/><ActivityCodes>F32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-229.html</GuideLink>
<RelDate>2009-07-02</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-229.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-229</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17069</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Proteomics in Auditory Developmental and Disease Processes (R01) ]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH) encourages R01 applications that focus on Proteomics in Auditory Developmental and Disease Processes. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-06-366, that encourages applications under the R21. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-228.html</GuideLink>
<RelDate>2009-07-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-228.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-228</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17011</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Calcium Oxalate Stone Diseases (R01)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to increase investigator interest in research into oxalate metabolism, transport and homeostasis, and oxalate stone diseases. This initiative encourages basic, clinical or epidemiological studies that utilize new and innovative approaches to study the diagnosis, treatment and prevention of these disorders.  
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-213.html</GuideLink>
<RelDate>2009-07-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-213.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-213</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17025</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Mechanisms Underlying the Links between Psychosocial Stress, Aging, the Brain and the Body (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages multidisciplinary and interdisciplinary research to elucidate the mechanistic links between psychosocial stress and health in aging, as well as how the aging process and age-related diseases affect the responses to psychosocial stressors.  Generally, research should be focused on (1) aging and how neural mechanisms respond to psychosocial stress and affect other body systems, (2) characterizing the behavioral, psychological and social mechanisms and pathways involved in transducing psychosocial stressors into health outcomes, (3) how stressors modulate physiological process underlying life-span, immune mechanisms, and metabolism, and (4) how psychosocial stress contributes to the development or progression of geriatric syndromes, chronic medical conditions, and disabilities in later life. Research is strongly encouraged that aims to identify appropriate targets for intervention, at any level of analysis, from societal to molecular.  Research spanning multiple levels of analysis is particularly encouraged. Research focused on oxidative stress or on environmental or physical stressors of a non-psychosocial nature is not appropriate to this FOA.      
Mechanism of Support. This FOA will utilize the R01 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-216.html</GuideLink>
<RelDate>2009-07-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-216.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-216</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17033</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[The Role of Apolipoprotein E, Lipoprotein Receptors and CNS Lipid Homeostasis in Brain Aging and Alzheimers Disease (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA encouarges multidisciplinary and interdisciplinary research to elucidate how Apolipoprotein E, lipoprotein receptors and CNS lipid homeostasis influence brain aging and the transition to neurodegeneration in Alzheimers disease (AD). The ultimate goal is to gain an in depth understanding of the mechanisms by which the Apolipoprotein E e4 allele confers increased AD risk for the purpose of advancing the overall search for efficacious AD treatments and Apolipoprotein E e4-directed therapeutics in particular. To this end we encourage research spanning multiple levels of analysis in multiple species (from mice to man).Studies aimed at identifying new therapeutic targets for the treatment of AD and other age-related neurodegenerative conditions associated with lipid neurobiology are strongly encouraged. Also of great interest are projects that aim to use lipidomics, various types of imaging and other cutting edge technologies to identify and develop early biomarkers of neurodegeneration associated lipid dyshomeostasis. 

Mechanism of Support. This FOA will utilize the R01 grant mechanism. 

Funds Available and Anticipated Number of Awards. During Fiscal Year 2010, the estimated amount of funds available to support projects under this FOA is $2,500,000.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.Given the likely range of budgets, it is anticipated that 4 to 7 awards could be made during Fiscal Year 2010.The availability of funds and the number of awards in future years will depend upon annual appropriations.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-217.html</GuideLink>
<RelDate>2009-07-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-217.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-217</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17078</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Improving Diet and Physical Activity Assessment (R01) ]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Nursing Research (NINR), and the National Institutes of Health (NIH) Office of the Director (OD) Office of Dietary Supplements (ODS), encourages innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications submitted under this FOA may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations or various age groups, including older adults; improved technology or applications of existing technology; statistical methods to assess or correct for measurement errors or biases, methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors. 

Mechanism of Support. This FOA will utilize the Research Project Grant (R01) grant mechanism runs in parallel with a FOA of identical scientific scope, PAR-09-225, that encourages applications under the NIH Exploratory/Developmental (R21) mechanism.

Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-224.html</GuideLink>
<RelDate>2009-07-09</RelDate>
<IntentDate>(new applications) September 5, 2009; May 5, 2010; January 5, 2011; September 5, 2011; May 5, 2012 (resubmission and revision applications) October 5, 2009; June 5, 2010; February 5, 2011; October 5, 2011; June 5, 2012</IntentDate>
<AppReceiptDate><![CDATA[Application Due Dates: (new applications): 10/5/2009; 6/05/2010; 2/05/2011; 10/05/2011; 06/5/2012 (alternating standard R01 receipt dates).
(renewal, resubmission, and revision applications): 11/05/2009; 7/05/2010; 3/05/2011; 11/05/2011; 7/05/2012 (alternating standard R01 receipt dates)]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-224.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-224</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17103</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Diet, Epigenetic Events, and Cancer Prevention (R01)]]></Title>
<Purpose><![CDATA[Purpose. The aim of this funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the Office of Dietary Supplements (ODS), of the National Institutes of Health (NIH), is to promote clinical and preclinical research to determine how diet and dietary factors, including dietary supplements, impact DNA methylation, histone posttranslational modification, noncoding RNA, and other epigenetic processes involved in cancer prevention and development. Another important aim of this FOA is to encourage collaborations between nutrition and epigenetic experts to study bioactive food components with cancer-preventative properties and to examine key epigenetic events in cancer processes (e.g., carcinogen metabolism, cell division, differentiation, and apoptosis) in order to begin to establish linkages between epigenetics, methylation patterns, and tumor incidences/behaviors. 
Mechanism of Support. This FOA uses the NIH research project R01 grant mechanism and runs in parallel with an FOA of identical scientific scope, PA-09-235 that encourages applications under the NIH Exploratory/Developmental (R21) Grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-234.html</GuideLink>
<RelDate>2009-07-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-234.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-234</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17104</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Diet, Epigenetic Events, and Cancer Prevention (R21)
]]></Title>
<Purpose><![CDATA[Purpose. The aim of this funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the Office of Dietary Supplements (ODS), of the National Institutes of Health (NIH), is to promote clinical and preclinical research to determine how diet and dietary factors, including dietary supplements, impact DNA methylation, histone posttranslational modification, noncoding RNA, and other epigenetic processes involved in cancer prevention and development. Another important aim of this initiative is to encourage collaborations between nutrition and epigenetic experts to study bioactive food components with cancer-preventative properties and to examine key epigenetic events in cancer processes (e.g., carcinogen metabolism, cell division, differentiation, and apoptosis) in order to begin to establish linkages between epigenetics, methylation patterns, and tumor incidences/behaviors. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-234, that encourages applications under the Research Project Grant (R01) mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-235.html</GuideLink>
<RelDate>2009-07-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-235.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-235</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17076</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Grants for Health Services Research Dissertation Program (R36)]]></Title>
<Purpose><![CDATA[Purpose: The overall goal of the AHRQ grants for Health Services Research Dissertation Program is to help ensure that a diverse pool of highly trained health services researchers is available in adequate numbers and appropriate research areas to address the research mission and priorities of AHRQ, noted below.This announcement represents the continuation of an AHRQ program that provides support to individuals who are conducting research undertaken as part of an academic program to qualify for a research doctorate degree.

Mechanism of Support: This Funding Opportunity Announcement (FOA) utilizes the dissertation research grant mechanism (R36). 

Funds Available and Anticipated Number of Awards: The total amount to be awarded and the number of awards will depend upon the quality and merit of applications received and the availability of funds. ]]></Purpose>
<RelNote/><ActivityCodes>R36</ActivityCodes>
<FA_DirectCosts>40000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-212.html</GuideLink>
<RelDate>2009-07-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 1, May 1, August 1, and November 1 annually, beginning November 1, 2009]]></AppReceiptDate>
<LARD>2012-08-01</LARD>
<FileName>PAR-09-212.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-212</DocNum>
<ExpirationDate>2012-08-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17064</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Improving Diet and Physical Activity Assessment (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Nursing Research (NINR), and the National Institutes of Health (NIH) Office of the Director (OD) Office of Dietary Supplements (ODS), encourages innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications submitted under this FOA may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations or various age groups, including children and older adults; improved technology or applications of existing technology; statistical methods to assess or correct for measurement errors or biases, methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-09-224, that encourages applications under the NIH Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-225.html</GuideLink>
<RelDate>2009-07-17</RelDate>
<IntentDate>(new applications) 09/16/2009; 05/16/2010; 01/16/2011; 09/16/2011; 05/16/2012; (renewal, resubmission, and revision applications) 10/16/2009; 06/16/2010; 02/16/2011; 10/16/2011; 06/16/2012 </IntentDate>
<AppReceiptDate><![CDATA[(new applications): 10/16/2009; 06/16/2010; 02/16/2011; 10/16/2011; 06/16/2012 (alternating standard R21 receipt dates).
 (renewal, resubmission, and revision applications): 11/16/2009; 07/16/2010; 03/16/2011; 11/16/2011; 07/16/2012 (alternating standard R21 receipt dates).
]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-225.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-225</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17075</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) ]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Office of Dietary Supplements (ODS) announce a program that provides NIDDK-supported K01, K08 and K23 recipients the opportunity to apply for Small Grant (R03) support to run concurrently with the latter years of their K award.  Through the use of this mechanism, which allows up to $50,000 direct costs per year for two years in additional research development costs, the NIDDK is seeking to enhance the capability of its K01, K08 and K23 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism. 
Funds Available and Anticipated Number of Awards. The total amount awarded and the number of awards will depend upon the quality and the number of applications received.  Funding decisions will reflect the needs, priorities and mission of the NIDDK. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-230.html</GuideLink>
<RelDate>2009-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-230.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-230</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17124</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21) ]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National institute on Drug Abuse, National Institutes of Health, encourages Research Project Grant (R01) applications to identify the role(s) that drug abuse plays in fueling the HIV/AIDS epidemic in vulnerable groups (racial/ethnic minorities, men who have sex with men, youth) in the United States and to develop effective interventions to prevent new infections and to improve the health and well-being of those living with HIV/AIDS.  It is essential to understand the factors (biological, behavioral, psychosocial, environmental, institutional, etc.) responsible for the profoundly disproportionate burden of HIV/AIDS among vulnerable groups.  This FOA will support studies to: 1) understand the contribution of drug abuse (both injection and non-injection) to the acquisition and/or transmission of HIV; 2) study disease progression and disease outcomes; 3) develop and/or improve prevention and treatment interventions; 4) address organizational, structural, and/or community level factors including social, drug-using, and sexual networks.  
Mechanism of Support. This FOA will utilize the R21  grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-236, that encourages applications under the R01 mechanism 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-237.html</GuideLink>
<RelDate>2009-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-237.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-237</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17125</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01) ]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National institute on Drug Abuse and the National Institute of Nursing Research, National Institutes of Health, encourages Research Project Grant (R01) applications to identify the role(s) that drug abuse plays in fueling the HIV/AIDS epidemic in vulnerable groups (racial/ethnic minorities, men who have sex with men, youth) in the United States and to develop effective interventions to prevent new infections and to improve the health and well-being of those living with HIV/AIDS.It is essential to understand the factors (biological, behavioral, psychosocial, environmental, institutional, etc.) responsible for the profoundly disproportionate burden of HIV/AIDS among vulnerable groups.This FOA will support studies to: 1) understand the contribution of drug abuse (both injection and non-injection) to the acquisition and/or transmission of HIV; 2) study disease progression and disease outcomes; 3) develop and/or improve prevention and treatment interventions; 4) address organizational, structural, and/or community level factors including social, drug-using, and sexual networks.

Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-237, that encourages applications under the R21 mechanism. 


Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-236.html</GuideLink>
<RelDate>2009-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-236.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-236</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17126</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis (R21)]]></Title>
<Purpose><![CDATA[Purpose.This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), invites applications aimed at the development of novel technologies for capturing, enriching, and preserving exfoliated abnormal cells from body fluids or effusions as well as methods for concentrating the tumor-derived sub-cellular material for use in biomarker studies. In body fluids, such as sputum, exfoliated tumor cells are a minor component compared to normal cells. As a result, the detection of exfoliated abnormal cells by routine cytopathology is often limited by the low number of atypical cells present in a given specimen. New enrichment methods are necessary to facilitate the detection of very low levels of exfoliated tumor cells and tumor-derived sub-cellular materials in biological fluids. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.  
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-238.html</GuideLink>
<RelDate>2009-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-238.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-238</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17127</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Behavioral Science Track Award for Rapid Transition (B/START) (R03)  ]]></Title>
<Purpose><![CDATA[Purpose. This FOA will use the NIH Small Research Grant (R03) award mechanism and seeks to facilitate the entry of beginning investigators into the field of behavioral science research related to drug abuse.   To be appropriate for a B/START award, research must be primarily focused on behavioral processes and research questions. 
The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-239.html</GuideLink>
<RelDate>2009-07-23</RelDate>
<IntentDate>Letters of intent not required for this funding opportunity</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-239.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-239</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17155</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[NIMH Career Transition Award for Intramural Investigators (K22)
]]></Title>
<Purpose><![CDATA[Purpose:  The primary goal of the NIMH Career Transition Award for Intramural Investigators (K22) program (hereafter abbreviated as the NIMH Career Transition K22) is to provide support for career intramural investigators at NIMH who aim to transition from the Division of Intramural Research Programs (DIRP) to a research position in the extramural community.  Principal investigators will have a demonstrated record of meritorious research in mental health-related fields. 
Mechanism of Support:  This Funding Opportunity Announcement (FOA) will utilize the NIH Career Transition (K22) award mechanism. The NIMH Career Transition K22 award will provide up to 3 years of support at the point of transition of the federal scientist from the DIRP at the NIMH to an extramural position. The initial (Phase 1) application will be submitted while the investigator is in a tenured or tenure-track position in the NIMH intramural laboratories.  The Phase 1 application is the document that will be submitted for peer review for scientific merit, and the outcome of the review will be the primary determinant of whether the application will be supported.  However, it is the Phase 2 application that will be awarded.  If the applicant receives a fundable score after the review of Phase 1 of the application, she/he will be notified in writing of NIMHs commitment to make an award.  The candidate will then have a period of up to 18 months to identify a suitable position in research at a domestic academic institution and negotiate a start-up package.  As soon as negotiations between the applicant and the institution are complete, the Phase 2 application must be submitted. 
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-246.html</GuideLink>
<RelDate>2009-07-31</RelDate>
<IntentDate>A letter of intent is not required for this funding opportunity</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-246.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-246</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17084</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Innovations in Biomedical Computational Science and Technology (R01) ]]></Title>
<Purpose><![CDATA[Purpose. The NIH is interested in promoting research and developments in biomedical informatics and computational biology that will support rapid progress in areas of scientific opportunity in biomedical research.  As defined here, biomedical informatics and computational biology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical computational models and simulations. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism.  This initiative is run in parallel with announcements with similar scientific scope for R21 high risk/high impact research PAR-09-219, as well as small business innovation research (SBIR) PAR-09-220 and small business technology transfer research (STTR) PAR-09-221.  
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-218.html</GuideLink>
<RelDate>2009-08-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-218.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-218</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17090</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[Innovations in Biomedical Computational Science and Technology Initiative (STTR [R41/R42])]]></Title>
<Purpose><![CDATA[Purpose This funding opportunity announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose innovative research in biomedical informatics and computational biology to promote the progress of biomedical research. There exists an expanding need to speed the progress of biomedical research through the power of computing to manage and analyze data and to model biological processes.  The NIH is interested in promoting research and developments in biomedical computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research.  As defined here biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational research including the development of structural, functional, integrative, and analytical computational models and simulations. 
Mechanism of Support.  This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with an FOA of identical scientific scope: PAR-09-220 which encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms; and with FOAs of similar scientific scope, PAR-09-219 that encourages R21 high risk/high reward research grants; and PAR-09-218 that encourages R01 regular research grants. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-221.html</GuideLink>
<RelDate>2009-08-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-221.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-221</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17091</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44])
]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose innovative research in biomedical informatics and computational biology to promote the progress of biomedical research. There exists an expanding need to speed the progress of biomedical research through the power of computing to manage and analyze data and to model biological processes.  The NIH is interested in promoting research and developments in biomedical computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research.  As defined here biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational research including the development of structural, functional, integrative, and analytical computational models and simulations. 
Mechanism of Support.  This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with an FOA of identical scientific scope: PAR-09-221 which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms; and with FOAs of similar scientific scope: PAR-09-219 that encourages R21 high risk/high reward research grants; and PAR-09-218 that encourages R01 regular research grants. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-220.html</GuideLink>
<RelDate>2009-08-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-220.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-220</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17168</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Initiative to Maximize Research Education in Genomics (R25)]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity supports two types of activities: (1) short, advanced level courses that are intended to disseminate new laboratory techniques, methods, analyses related to the mission of the NHGRI and (2) research education and training initiatives that are linked to specific NHGRI research initiatives, such as Centers of Excellence in Genomic Science (CEGS) and large-scale sequencing and database grants. 
Mechanism of Support. This FOA will use the NIH Research Education (R25) grant mechanism.  Research education and training initiatives may not be transferred from one institution to another, unless strongly justified (see Section VI.2). 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-245.html</GuideLink>
<RelDate>2009-08-06</RelDate>
<IntentDate>Thirty (30) days before application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-25</LARD>
<FileName>PAR-09-245.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-245</DocNum>
<ExpirationDate>2012-09-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17176</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity (FOA) encourages Research Project Grant (R01) applications from qualified investigators to conduct ancillary studies to major ongoing clinical research studies, including clinical trials, epidemiological studies and disease databases supported by the National Institute of Diabetes and Digestive and Kidney Diseases.  Major studies include multi-center investigations, national databases and Phase 3 clinical trials.  Examples of NIDDK-supported major clinical research studies eligible for ancillary studies may be found at http://www2.niddk.nih.gov/Research/ClinicalResearch/AncillaryStudies/ .  This FOA also encourages grant applications for ancillary studies utilizing major clinical research studies supported by other Institutes and Centers of the National Institutes of Health, other government agencies and the private sector.  However, the proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of interest of the Institute.  The scientific areas funded by the NIDDK may be found at the following website:  http://www2.niddk.nih.gov/Research/. 
Mechanism of Support. This FOA will utilize the NIH Research Project (R01) grant mechanism. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-247.html</GuideLink>
<RelDate>2009-08-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-247.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-247</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17178</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (STTR [R41/R42])]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to define the factors and mechanisms controlling the differentiation of embryonic or adult stem or progenitor cells, either in vitro or in vivo.  It is designed to stimulate new scientific advances in stem cell differentiation including technology research that may not be hypothesis driven.  The long range goal of this program is the development of methods to direct the differentiation or development of stem cells along specific cell lineages to yield replacement cells for clinical use, whether the replacement cells are formed in vitro for delivery or formed in vivo in the tissue or organ environment.   
Mechanism of Support.  This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with FOAs of identical scientific scope, PA-09-249, that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms, and PA-09-248 that encourages applications under the Exploratory/Developmental (R21) grant mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-250.html</GuideLink>
<RelDate>2009-08-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-250.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-250</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17179</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to define the factors and mechanisms controlling the differentiation of embryonic or adult stem or progenitor cells, either in vitro or in vivo.  It is designed to stimulate new scientific advances in stem cell differentiation including technology research that may not be hypothesis driven.  The long-range goal of this program is the development of methods to direct the differentiation or development of stem cells along specific cell lineages to yield replacement cells for clinical use, whether the replacement cells are formed in vitro for delivery or formed in vivo in the tissue or organ environment.  
Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with FOAs of identical scientific scope, PA-09-250, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms, and PA-09-248 that encourages applications under the Exploratory/Developmental (R21) grant mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-249.html</GuideLink>
<RelDate>2009-08-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-249.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-249</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17181</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (R21)]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) encourages Exploratory/Developmental (R21) grant applications from applicant organizations that propose to define the factors and mechanisms controlling the differentiation of embryonic or adult stem or progenitor cells, either in vitro or in vivo. It is designed to stimulate new scientific advances in stem cell differentiation including technology research that may not be hypothesis driven. The long range goal of this program is the development of methods to direct the differentiation or development of stem cells along specific cell lineages to yield replacement cells for clinical use, whether the replacement cells are formed in vitro for delivery or formed in vivo in the tissue or organ environment. 
Mechanism of Support. This FOA will utilize the Exploratory/Developmental (R21) grant mechanism, and it runs in parallel with FOAs of identical scientific scope, PA-09-249, that encourages applications under the SBIR [R43/R44] mechanism, and PA-09-250, that encourages applications under the STTR [R41/R42] mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-248.html</GuideLink>
<RelDate>2009-08-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-248.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-248</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17191</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Image-guided Drug Delivery in Cancer (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages innovative translational research in the development of quantitative in vivo imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery validation, and therapy response. This FOA will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer. Validation studies in non-human primates or large animal models and first in human studies directed towards translation of IGDD technology into the clinic will be considered appropriate for this FOA. 
Mechanism of Support. This FOA will utilize the Research Project Grant (R01) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-253.html</GuideLink>
<RelDate>2009-08-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-09-253.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-253</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17192</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[NEI Research Grant for Secondary Data Analysis (R21) ]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Eye Institute (NEI), National Institutes of Health (NIH), encourages Research Project Grant for Secondary Data Analysis  (R21) applications from institutions/organizations that propose to conduct secondary data analyses utilizing existing database resources.  Applications may be related to, but must be distinct from, the specific aims of the original data collection.  The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects, wherein numerous data collection activities are required to meet each projects specific aims.  The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a projects originally intended purpose.  Data are not limited to that collected under NEI support but these data are of highest programmatic interest.  The R21 may be used to develop new statistical methodologies or to test hypotheses using existing data.  Applicants should consider the relevance of their proposed analyses to NEI programs and priorities as described in the National Plan for Eye and Vision Research available at http://www.nei.nih.gov. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-252.html</GuideLink>
<RelDate>2009-08-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-252.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-252</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17193</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Optimization of Small Molecule Probes for the Nervous System (R21)]]></Title>
<Purpose><![CDATA[Purpose.  This FOA issued by participating institutes of the National Institutes of Health, encourages research grant applications from institutions/ organizations that propose to develop new small molecule probes for investigating biological function in the nervous system via the application of advanced medicinal chemistry and the biological testing of compounds.  Eligible investigators will have identified probe candidates via screening of small molecule collections, using in vitro assays of biological activity developed to interrogate these collections, and be able to show that the structural features of these small molecules are related to their biological activity.  Proposals should nominate small molecule probe candidates from distinct structural series for the further, iterative design and testing of analogues in structure-activity relationship studies, using in vitro assays of biological function adapted to the medium throughput screening requirements of this work.  These studies should have the goal of developing a small molecule probe possessing the attributes (eg: affinity, selectivity, activity) required for its use in future pharmacological studies proposed by the investigator.  Applicants are strongly encouraged to utilize publicly available cheminformatic capabilities for the acquisition of compounds, and semi-custom synthesis of analogues. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.  In the near future, NINDS expects to publish two additional FOAs of identical scientific scope that encourage applications under the Small Business Innovation Research (SBIR) (R43) grant mechanism and Small Business Technology Transfer (STTR) (R41) grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-251.html</GuideLink>
<RelDate>2009-08-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-251.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-251</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17196</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<Title><![CDATA[Erythropoiesis:  Components and Mechanisms (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) the National Institute of Aging (NIA), and the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, encourages investigator-initiated R01 applications that propose hypothesis-driven research using erythroid cells. The aim of this program is to support research efforts towards a complete description of the molecular and cellular components of erythropoiesis and how these components contribute to erythropoiesis. Components include genes that are expressed (transcriptome) in erythroid cells, either during development or during differentiation, and the proteins (proteome) that are translated in erythroid cells, especially with post-translational modifications or subcellular localizations that are unique to erythroid cells. A long range goal of this program is to generate a concise description of erythropoiesis that unifies genetics, molecular processes and cytokine determinants in the erythroid lineages so that new therapeutics may be developed to measure and combat anemia. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-255.html</GuideLink>
<RelDate>2009-08-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-255.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-255</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17203</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Dentist Scientist Pathway to Independence Award (K99/R00)
]]></Title>
<Purpose><![CDATA[Purpose: The primary purpose of the Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented NIH-supported independent investigators. The program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other independent research support at an earlier stage than is currently the norm.   
With this FOA, NIDCR is introducing a modified K99/R00 Pathway to Independence Award program, targeted specifically for recent DDS/PhD graduates.  The purpose of the Dentist Scientist K99/R00 award program is to ensure that dual degree dentist scientists receive sufficient mentoring and protected research time necessary to allow them to successfully transition to independent researchers.  In order to accomplish this, the mentored K99 phase is required to last for the full two year award duration.  The sponsoring institution(s) must guarantee a minimum of 75% protected research time during both the K99 and R00 award phases.  In addition, recipients may receive clinical specialty training during the R00 phase, which may be extended for up to five years.  Funding from the K99/R00 award cannot be used to support the clinical specialty training.  The R00 phase will be limited to 3 years in the event that the awardee already has clinical specialty training, or chooses not to pursue specialty training.   
Mechanism of Support: This Funding Opportunity Announcement (FOA) will utilize the NIH Pathway to Independence Award (K99/R00) mechanism. 
]]></Purpose>
<RelNote/><ActivityCodes>K99/R00</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-256.html</GuideLink>
<RelDate>2009-08-14</RelDate>
<IntentDate>See Section IV3A1</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-256.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-256</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17083</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Exploratory Innovations in Biomedical Computational Science and Technology (R21) ]]></Title>
<Purpose><![CDATA[Purpose. The NIH is interested in promoting research and developments in biomedical informatics and computational biology that will support rapid progress in areas of scientific opportunity in biomedical research.  As defined here, biomedical informatics and computational biology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical computational models and simulations. 
Mechanism of Support. This FOA will utilize the R21 grant mechanism.  This FOA is intended to support exploratory biomedical informatics and computational biology researchapplications should be innovative, with high risk/high impact in new areas that are lacking preliminary data or development.  Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism.  For example, long-term projects or projects designed to increase knowledge in a well-established area will not be considered for R21 awards. This initiative is run in parallel with announcements with similar scientific scope for R01 research PAR-09-218, as well as small business innovation research (SBIR) PAR-09-220 and small business technology transfer research (STTR) PAR-09-221. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-219.html</GuideLink>
<RelDate>2009-08-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-219.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-219</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17210</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Grant Program for Large or Recurring Conferences (R13)]]></Title>
<Purpose><![CDATA[Purpose. The Agency for Healthcare Research and Quality (AHRQ), announces its continued interest in supporting conferences through its Large or Recurring Grant Program for Conference Support. AHRQ seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include: 1) Research development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed; 2) Research design and methodology - conferences where methodological and technical issues of major importance to the field of health services research are addressed or new designs and methodologies are developed; 3) Dissemination and implementation - conferences where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or, 4) Research training, infrastructure and career development -conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, or training competencies.

AHRQ is especially interested in supporting conferences that include plans for disseminating complimentary conference materials and products beyond the participants attending the event. Such strategies might include, but are not limited to, submitting articles for publication, posting information on a Web site, and seeking formal opportunities to discuss conference information with others.

Mechanism of Support. This Funding Opportunity Announcement (FOA) will use the conference grant (R13) award mechanism.

Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed conference will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of AHRQ provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications]]></Purpose>
<RelNote/><ActivityCodes>R13</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-257.html</GuideLink>
<RelDate>2009-08-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[In 2011:  February 22, June 21, and October 20; In 2012:  February 21, June 20, and October 22]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-09-257.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-257</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17073</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Small Grant Program for Conference Support (R13)]]></Title>
<Purpose><![CDATA[Purpose. The Agency for Healthcare Research and Quality (AHRQ), announces its continued interest in supporting conferences through its Small Grant Program for Conference Support. AHRQ seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include: 1) Research development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed; 2) Research design and methodology - conferences where methodological and technical issues of major importance in the field of health services research are addressed or new designs and methodologies are developed; 3) Dissemination and implementation conferences - where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or, 4) Research training, infrastructure and career development -conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, training competencies.

AHRQ is especially interested in supporting conferences that demonstrate strategies that include plans for disseminating complimentary conference materials and products beyond the participants attending the event. Such strategies might include, but are not limited to, submitting articles for publication, posting information on a Web site, and seeking formal opportunities to discuss conference information with others.

]]></Purpose>
<RelNote/><ActivityCodes>R13</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-231.html</GuideLink>
<RelDate>2009-08-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[In 2009:  October 20, December 21; In 2010: February 22, April 20, June 21, August 20, October 20, December, 20; In 2011: February 22, April 20, June 21, August 22, October 20, December 20; In 2012: February 21, April 20, June 20, August 20, and October 22]]></AppReceiptDate>
<LARD>2012-10-22</LARD>
<FileName>PA-09-231.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-231</DocNum>
<ExpirationDate>2012-10-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17225</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Research Project Grant (R01) applications that propose research on the roles of nutrition and physical activity in the development, prevention, and management of cardiovascular diseases (CVD) or pulmonary diseases.  In particular, the FOA aims to (1) improve knowledge of the contribution of diet and physical activity to these conditions and how sleep influences these relationships, (2) increase the evidence base for refining public health recommendations and clinical guidelines regarding these lifestyle behaviors, and (3) develop and test strategies to improve the adoption of these recommendations. 
Mechanism of Support. This FOA will utilize the NIH research project R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-244, that encourages applications under the R21 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-243.html</GuideLink>
<RelDate>2009-08-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-243.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-243</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17226</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Research Project Grant (R21) applications that propose research on the roles of nutrition and physical activity in the development, prevention, and management of cardiovascular diseases (CVD) or pulmonary diseases.  In particular, the FOA aims to (1) improve knowledge of the contribution of diet and physical activity to these conditions and how sleep influences these relationships, (2) increase the evidence base for refining public health recommendations and clinical guidelines regarding these lifestyle behaviors, and (3) develop and test strategies to improve the adoption of these recommendations. 
Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-243, that encourages applications under the R01 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-244.html</GuideLink>
<RelDate>2009-08-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-244.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-244</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17231</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Optimization of Small Molecule Probes for the Nervous System (STTR [R41])]]></Title>
<Purpose><![CDATA[Purpose This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop new small molecule probes for investigating biological function in the nervous system via the application of advanced medicinal chemistry and the biological testing of compounds.  Eligible SBCs will have identified probe candidates via screening of small molecule collections, using in vitro assays of biological activity developed to interrogate these collections, and be able to show that the structural features of these small molecules are related to their biological activity.  Applications should nominate small molecule probe candidates from distinct structural series for the further, iterative design and testing of analogues in structure-activity relationship studies, using in vitro assays of biological function adapted to the medium throughput screening requirements of this work.  These studies should have the goal of developing a small molecule probe possessing the attributes (eg: affinity, selectivity, activity) required for its use in future pharmacological studies proposed by the SBC.  Applicants are strongly encouraged to utilize publicly available cheminformatic capabilities for the acquisition of compounds, and semi-custom synthesis of analogues, which is required of these studies. 
Mechanism of Support.  This FOA will utilize the STTR (R41) grant mechanism for Phase I, and runs in parallel with FOAs of identical scientific scope that encourage applications under the Small Business Innovation Research (SBIR) (R43) grant mechanism (PAR-09-260, and the R21 grant mechanism (PAR-09-251). 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R41</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-259.html</GuideLink>
<RelDate>2009-08-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-259.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-259</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17232</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Optimization of Small Molecule Probes for the Nervous System (SBIR [R43])]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new small molecule probes for investigating biological function in the nervous system via the application of advanced medicinal chemistry and the biological testing of compounds.  Eligible SBCs will have identified probe candidates via screening of small molecule collections, using in vitro assays of biological activity developed to interrogate these collections, and be able to show that the structural features of these small molecules are related to their biological activity.  Applications should nominate small molecule probe candidates from distinct structural series for the further, iterative design and testing of analogues in structure-activity relationship studies, using in vitro assays of biological function adapted to the medium throughput screening requirements of this work.  These studies should have the goal of developing a small molecule probe possessing the attributes (eg: affinity, selectivity, activity) required for its use in future pharmacological studies proposed by the SBC.  Applicants are strongly encouraged to utilize publicly available cheminformatic capabilities for the acquisition of compounds, and semi-custom synthesis of analogues. 
Mechanism of Support.  This FOA will utilize the SBIR (R43) grant mechanism for Phase I, and runs in parallel with FOAs of identical scientific scope that encourage applications under the Small Business Technology Transfer (STTR) (R41) grant mechanism (PAR-09-259), and the R21 grant mechanism (PAR-09-251). 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R43</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-260.html</GuideLink>
<RelDate>2009-08-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-09-260.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-260</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17252</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Health Disparities in NIDDK Diseases (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Nursing Research (NINR) of the National Institutes of Health (NIH) seek research to understand and mitigate issues of health disparities in high priority diseases within their scope, including diabetes, obesity, nutrition-related disorders, hepatitis C, gallbladder disease, H. Pylori infection, sickle cell disease, kidney diseases, urologic diseases, hematologic diseases, metabolic, gastrointestinal, hepatic, and renal complications from infection with HIV.NINR promotes and improves the health of individuals, families, communities, and populations, supports and conducts clinical and basic research and research training on health and illness across the lifespan. 

Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the NIH Research Project Grant (R01) award mechanism.

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 

Budget and Project Period. The maximum duration requested for each individual award may not exceed 5 years.

Application Research Plan Component Length: The R01 application Research Plan component of the PHS398 may not exceed 25 pages, including tables, graphs, figures, diagrams, and charts. 

Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply.

Eligible Project Directors/Principal Investigators (PDs/PIs). Include Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-262.html</GuideLink>
<RelDate>2009-09-02</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PA-09-262.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-262</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17273</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[Ancillary Studies in Clinical Trials of CNS/PNS Disorders NINDS Accelerated Awards Program (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA is issued by the National Institute of Neurological Disorders and Stroke, National Institutes of Health. The purpose of this initiative is to encourage and facilitate ancillary studies undertaken in conjunction with on-going NINDS-funded clinical trials of neurological disorders. For a definition of ancillary studies see      http://www.ninds.nih.gov/research/clinical_research/policies/ancillary.htm. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds.  The total amount awarded and the number of grants will depend upon the quality, duration, and cost of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-09-263.html</GuideLink>
<RelDate>2009-09-17</RelDate>
<IntentDate>30 days prior to submission</IntentDate>
<AppReceiptDate><![CDATA[12/16/2009; 04/16/2010; 08/16/2010; 12/16/2010; 04/15/2011; 08/16/2011; 12/16/2011; 04/16/2012; 08/16/2012]]></AppReceiptDate>
<LARD>2012-08-16</LARD>
<FileName>PAR-09-263.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-09-263</DocNum>
<ExpirationDate>2012-08-17</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17302</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Aging (NIA) invites applications to support short term projects involving secondary analysis of existing data sets or stored biospecimens, to address clinically-related issues on aging changes influencing health across the life span, and/or on diseases and disabilities in older persons.This funding opportunity announcement (FOA) will support activities addressing specific hypotheses in clinical aging research and/or to inform the design and implementation of future epidemiologic or human intervention studies, or current geriatric practice in maintenance of health, management of disease, and prevention of disability.Existing data sets may also be used to develop and test new statistical analytical approaches.Costs for archiving of data to be made publicly available may be included in the budget, as long as the archival activities are related to the proposed secondary analyses. 

Mechanism of Support. This FOA will utilize the research project (R01) grant mechanism. 

Funds Available and Anticipated Number of Awards. The total amount to be awarded depends on the scientific merit of the applications and the funds available in NIAs general funding pool.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-09-265.html</GuideLink>
<RelDate>2009-09-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-09-265.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-09-265</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17311</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Drug Discovery for Nervous System Disorders (R01)

]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) encourages research grant applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-002 that encourages applications under the Exploratory/Development (R21) award mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-001.html</GuideLink>
<RelDate>2009-10-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-001.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-001</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17314</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Drug Discovery for Nervous System Disorders (R21)]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) encourages Exploratory/Developmental (R21) grant applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-001 that encourages applications under the Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-002.html</GuideLink>
<RelDate>2009-10-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-002.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-002</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17315</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[NHLBI Clinical Trial Pilot Studies (R34)]]></Title>
<Purpose><![CDATA[Purpose. The National Heart, Lung, and Blood Institute (NHLBI) (http://www.nhlbi.nih.gov) invites applications proposing pilot studies to obtain data that is critical for the design of robust clinical trials.This Funding Opportunity Announcement (FOA) should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial.Appropriate pilot studies might demonstrate feasibility of an intervention or an experimental design, estimate intervention parameters, or gather other data important for the design of a trial.Applicants who propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial will not be considered appropriate for to this announcement.Applications must demonstrate that the proposed pilot studies are both necessary and sufficient to permit the design of the clinical trial.During the evaluation of applications in response to this FOA, the review group will also consider the significance and potential public health impact of the full-scale clinical trial that would be proposed following the R34 award period.The NHLBI anticipates that the R34 award period will yield more competitive investigator-initiated clinical trial grant applications and more robust and successful clinical trials that evaluate interventions for the treatment or prevention of heart, lung, blood, or sleep disorders. 

Mechanism of Support. This FOA will utilize the R34 grant mechanism.

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-005.html</GuideLink>
<RelDate>2009-10-02</RelDate>
<IntentDate>30 days prior to standard application due dates</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-005.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-005</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17316</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2010, 2011 and 2012 (P50)
]]></Title>
<Purpose><![CDATA[Purpose. The National Cancer Institute (NCI), the National Institute of Dental and Craniofacial Research (NIDCR), and the National Institute of Neurological Disorders and Stroke (NINDS), at the National Institutes of Health (NIH), invite new or renewal (competing) applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). The program will fund 5-year P50 SPORE grants to support state-of-the-art investigator-initiated research that will contribute to improved detection, diagnosis, treatment, and prevention of an organ-specific cancer (or a related group of cancers). SPOREs are expected not only to conduct a wide spectrum of research activities, but also to contribute significantly to the development of specialized research COREs, improved research model systems, and collaborative research projects with other institutions. The research supported through this program must be translational in nature and must always be based upon knowledge of human biology stemming from research using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. 
Mechanism of Support. This FOA will utilize the NIH specialized center grant (P50) mechanism to fund up to approximately 10-20 new SPORE awards per year. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-003.html</GuideLink>
<RelDate>2009-10-02</RelDate>
<IntentDate>12/28/2009, 04/20/2010, 08/21/2010, 12/20/2010, 04/20/2011, 08/20/2011, 12/20/2011, 04/22/2012, 08/20/2012</IntentDate>
<AppReceiptDate><![CDATA[January 28 2010; May 20, 2010; September 21, 2010; January 20, 2011; May 20, 2011; September 20, 2011; January 20, 2012; May 22, 2012; September 20, 2012]]></AppReceiptDate>
<LARD>2012-09-20</LARD>
<FileName>PAR-10-003.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-003</DocNum>
<ExpirationDate>2012-09-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17320</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Mechanisms, Models, Measurement, and Management in Pain Research (R03)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA), Mechanisms, Models, Measurement, and Management in Pain Research, issued by the National Institute of Nursing Research (NINR), in conjunction with members of the NIH Pain Consortium as listed above, is to inform the scientific community of the pain research interests of the various Institutes and Centers (ICs) at the National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences.  Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-006, which encourages applications under the NIH R01 Research Project Grant mechanism and PA-10-007 which encourages applications under the R21 Exploratory/Developmental Grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-008.html</GuideLink>
<RelDate>2009-10-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-008.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-008</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17321</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Mechanisms, Models, Measurement, & Management in Pain Research (R21)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA), Mechanisms, Models, Measurement, and Management in Pain Research, issued by the National Institute of Nursing Research (NINR), in conjunction with members of the NIH Pain Consortium as listed above,  is to inform the scientific community of the pain research interests of the various Institutes and Centers (ICs) at the National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences.  Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-006, which encourages applications under the NIH R01 Research Project Grant mechanism and PA-10-008, which encourages applications under the R03 Small Research Grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-007.html</GuideLink>
<RelDate>2009-10-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-007.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-007</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17322</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Mechanisms, Models, Measurement, and Management in Pain Research (R01) ]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA), Mechanisms, Models, Measurement, and Management in Pain Research issued by the National Institute of Nursing Research (NINR), in conjunction with members of the NIH Pain Consortium as listed above, is to inform the scientific community of the pain research interests of the various Institutes and Centers (ICs) at the National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences.  Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-008, which encourages applications under the R03 Small Research Grant mechanism and PA-10-007, which encourages applications under the R21 Exploratory/Developmental Grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-006.html</GuideLink>
<RelDate>2009-10-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-006.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-006</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17333</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[MBRS Research Initiative for Scientific Enhancement (RISE) (R25)]]></Title>
<Purpose><![CDATA[The Minority Biomedical Research Support (MBRS) Program was created in response to a legislative mandate of increasing the participation of underrepresented (UR) minority faculty, investigators and students engaged in biomedical and behavioral research, and to broaden the opportunities for their participation in biomedical and behavioral research. To accomplish this goal, the Research Initiative for Scientific Enhancement (RISE) program provides institutional grants to establish research education programs at minority-serving institutions that will increase the preparation and skills of UR students in the biomedical and behavioral sciences as they academically advance in the pursuit of the Ph.D. degree in these fields.]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-004.html</GuideLink>
<RelDate>2009-10-09</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-004.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-004</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17336</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Bioengineering Research Grants (BRG)(R01)]]></Title>
<Purpose><![CDATA[Purpose.  Participating Institutes and Centers of the NIH invite applications for R01 awards to support Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological, bioengineering or medical research problems. The BRGs support multi-disciplinary research performed in a single laboratory or by a small number of investigators that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. A BRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with a FOA of similar scientific scope, Exploratory/Developmental Bioengineering Research Grants, PA-10-010, that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-009.html</GuideLink>
<RelDate>2009-10-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-009.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-009</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17337</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Behavioral and Integrative Treatment Development Program (R01) ]]></Title>
<Purpose><![CDATA[Purpose.The purpose of this FOA for R03s is to encourage early career investigators or investigators who are striving to make a shift in their research to propose discrete, well-defined projects that can be completed within two years with limited resources.Projects of interest fall within the research domain of behavioral, combined, sequential, or integrated (behavioral/pharmacological) (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Specific examples include: 1) Stage I pilot or feasibility studies; 2) secondary analysis of existing data; 3) small, self-contained research projects; 4) development of research assessments or methodology; and 5) development of new research technology.

Mechanism of Support. This FOA will use the NIH Small Research Grant (R03) mechanism and runs in parallel with the FOAs of identical scientific scope, PA-10-012, which encourages applications under the Research Project Grant (R01) mechanism and PA-10-013 which encourages applications under the R34 mechanism.

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-012.html</GuideLink>
<RelDate>2009-10-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-012.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-012</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17338</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Behavioral and Integrative Treatment Development Program (R03)]]></Title>
<Purpose><![CDATA[Purpose.  The purpose of this FOA for R03s is to encourage early career investigators or investigators who are striving to make a shift in their research to propose discrete, well-defined projects that can be completed within two years with limited resources.  Projects of interest fall within the research domain of behavioral, combined, sequential, or integrated (behavioral/pharmacological) (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Specific examples include: 1) Stage I pilot or feasibility studies; 2) secondary analysis of existing data; 3) small, self-contained research projects; 4) development of research assessments or methodology; and 5) development of new research technology.  
Mechanism of Support. This FOA will use the NIH Small Research Grant (R03) mechanism and runs in parallel with the FOAs of identical scientific scope, PA-10-012, which encourages applications under the Research Project Grant (R01) mechanism and PA-10-013 which encourages applications under the R34 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-011.html</GuideLink>
<RelDate>2009-10-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-011.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-011</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17339</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Exploratory/Developmental Bioengineering Research Grants (EBRG) [R21]]]></Title>
<Purpose><![CDATA[Purpose.  This Funding Opportunity Announcement (FOA) is intended to encourage innovation and high risk/impact bioengineering research in new areas.  While minimal or no preliminary data are expected to be described in the application, applications should clearly indicate the significance of the proposed work and that the proposed research and/or development is scientifically sound, that the qualifications of the investigators are appropriate, and that resources available to the investigators are adequate.  An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research.  The research proposed under this program can explore approaches and concepts new to a particular substantive area; research and development of new technologies, techniques or methods; or initial research and development of data upon which significant future research may be built. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of similar scientific scope, PA-10-009 Bioengineering Research Grants, and PAR-07-352, Bioengineering Research Partnerships. 
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-010.html</GuideLink>
<RelDate>2009-10-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-010.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-010</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17340</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Behavioral and Integrative Treatment Development Program (R34) ]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this R34 Funding Opportunity Announcement (FOA) is to advance evidence-based treatment research through  1) the development, manualization, standardization, early-stage efficacy and/or pilot testing of novel or adapted treatments and/or interventions (i.e. Stage 1 treatment research, see below), 2) the refinement, modification, adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale efficacy or effectiveness trials, or 3) novel treatment research that requires preliminary testing or development.   It is expected that research conducted via this R34 mechanism will primarily consist of Stage I treatment development research that will provide feasibility, tolerability, and acceptability information and/or pilot data for larger scale Stage II or Stage III behavioral and integrative treatment studies.  This FOA seeks to support research, as described above, within the domains of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. 
Mechanism of Support. This FOA will use the R34 mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-012, which encourages applications under the Research Project Grant (R01) mechanism, and PA-10-011 which encourages applications under the NIH Small Research Grant (R03) mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-013.html</GuideLink>
<RelDate>2009-10-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-013.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-013</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17380</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Development and Characterization of Animal Models for Aging Research (R01) ]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this announcement is to describe areas of research of particular interest to the National Institute on Aging.  This FOA seeks to promote research that develops, characterizes, refines and enhances model systems for aging research, including but not limited to animal models, cell lines, and informatics.  This FOA issued by the National Institute on Aging, National Institutes of Health, encourages Research Project Grant (R01) applications that propose to: characterize aging at the physiological, biochemical and functional levels in existing animal models, including but not limited to animal models currently used in other scientific fields that have potential to benefit aging research; develop new animal models for aging research; develop unique cell lines for aging research; use comparative biology to identify models of highest priority for aging research; or develop informatics that enhance the utilization of animals for aging research. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with another FOA of identical scientific scope, PA-10-015, that solicits applications under the Exploratory/Developmental Research Grant (R21) mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-014.html</GuideLink>
<RelDate>2009-10-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-014.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-014</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17381</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[NEI Clinical Study Planning Grant Program (R34) ]]></Title>
<Purpose><![CDATA[Purpose.  The National Eye Institute (NEI) supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies.  At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the studys rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements.  This information is best conveyed in a well-documented Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity.  The Clinical Study Planning Grant is designed to facilitate activities central to the refinement of a studys protocol and procedures and the development of a detailed MOP. The NEI Clinical Study Planning Grant may be used to support the development of a MOP, as well as to conduct preliminary studies to refine study procedures and/or assess recruitment potential.  The Clinical Study Planning Grant is applicable to both epidemiologic and clinical trial research studies. 
Mechanism of Support. This FOA will utilize the Clinical Study Planning Grant Program for Clinical Trials (R34) mechanism  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
Budget and Project Period.  The total project period may not exceed two years.  Direct costs are limited to $150,000 per year. 
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-017.html</GuideLink>
<RelDate>2009-10-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-017.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-017</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17384</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Development and Characterization of Animal Models for Aging Research (R21)  ]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this announcement is to describe areas of research of particular interest to the National Institute on Aging. This FOA seeks to promote research that develops, characterizes, refines and enhances model systems for aging research, including but not limited to animal models, cell lines, and informatics.This FOA issued by the National Institute on Aging, National Institutes of Health, encourages Research Project Grant (R01) applications that propose to: characterize aging at the physiological, biochemical and functional levels in existing animal models, including but not limited to animal models currently used in other scientific fields that have potential to benefit aging research; develop new animal models for aging research; develop unique cell lines for aging research; use comparative biology to identify models of highest priority for aging research; or develop informatics that enhance the utilization of animals for aging research.

Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-014, that encourages applications under the R01 mechanism.

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-015.html</GuideLink>
<RelDate>2009-10-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-015.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-015</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17386</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI) invite applications to support the innovative analysis of existing social science and behavioral data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, and other drug), HIV risk behaviors, related disorders, prevention and treatment of these behaviors, and health service utilization including quality, access, and costs.   NIDA and NCI encourage coordinated analyses of substance abuse research data that are in public use or that are privately held by a principal investigator.  The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its effort to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this announcement. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism. 
Funds Available and Anticipated Number of Awards. NIDA has set aside approximately $2 million to fund 5-8 grants through this FOA for FY2010. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-018.html</GuideLink>
<RelDate>2009-10-30</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-018.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-018</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17396</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Drug Abuse Dissertation Research: Epidemiology, Prevention, Treatment, Services, and/or Women and Sex/Gender Differences (R36)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of drug abuse doctoral dissertation research in epidemiology, prevention, treatment, services, and/or women and sex/gender differences. 
Mechanism of Support. This FOA will utilize the NIH Dissertation Award (R36) grant mechanism. For information on training opportunities, please visit NIDAs Research Training Opportunities Website (http://www.nida.nih.gov/ResearchTraining/Traininghome.html). 
 Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R36</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-020.html</GuideLink>
<RelDate>2009-11-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-020.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-020</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17404</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Partnerships in Implementing Patient Safety II (R18)
]]></Title>
<Purpose><![CDATA[Purpose.  The purpose of this Funding Opportunity (FOA) is to support Research Demonstration and Dissemination (R18) grant applications from organizations that will implement safe practice interventions that demonstrate evidence of reducing or eliminating medical errors, risks, hazards, and harms associated with the process of health care. These 24 month implementation projects will inform AHRQ, providers, patients, payers, policy makers, and the public about how safe practice interventions can be successfully implemented in diverse health care settings and lead to safer and better health care for all Americans.  This FOA follows the release of an earlier FOA in 2005 that resulted in the release of successful implementation projects and toolkits available to the public.  Background information on the earlier FOA can be found at http://grants1.nih.gov/grants/guide/FOA-files/FOA-HS-05-012.html.  Examples of and Information on projects from the initial Partnerships in Implementing Patient Safety FOA can be found at http://www.ahrq.gov/qual/pips/. 
Mechanism of Support. This FOA will utilize the AHRQ Research Demonstration and Dissemination Projects (R18) award mechanism. The individual researcher sponsored by each organizational grantee will be solely responsible for planning, directing, and executing his or her proposed projects. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-022.html</GuideLink>
<RelDate>2009-11-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-022.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-022</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17405</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[AIDS-Science Track Award for Research Transition (R03) ]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) by the National Institute on Drug Abuse seeks to facilitate the entry of both newly independent and early career investigators to the area of drug abuse research on HIV/AIDS. This FOA, AIDS--Science Track Award for Research Transition (A-START), encourages Small Research Grant (R03) applications to support research projects on drug abuse and HIV/AIDS that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.  
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism. 
Funds Available and Anticipated Number of Awards. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-021.html</GuideLink>
<RelDate>2009-11-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Standard dates not applicable.

AIDS Application Due Date(s):  September 7, 2010, September 7, 2011 and September 7, 2012 ]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-10-021.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-021</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17420</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Obesity Policy Research: Evaluation and Measures (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), 
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Eunice Kennedy Shriver National  Institute of Child Health and Human Development (NICHD),
Office of Behavioral and Social Sciences Research (OBSSR), NIH, and the National Center for Chronic Disease Prevention and Health Promotion, CDC, encourages Research Project Grant (R01) applications that propose to: (1) conduct evaluation research on obesity-related natural experiments (defined here as community and other population-level public policy interventions that may affect diet and physical activity behavior), and/or (2) develop and/or validate relevant community-level measures (instruments and methodologies to assess the food and physical activity environments at the community level). The overarching goal of this FOA is to inform public policy and research relevant to (1) diet and physical activity behavior, and (2) weight and health outcomes of Americans. 
Mechanism of Support. This FOA will utilize the research project (R01) grant mechanism, and runs in parallel with two other FOAs of identical scientific scope, PA-10-028  and PA-10-029 that encourage applications under the NIH Exploratory/Developmental (R21) and NIH Small Research (R03) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-027.html</GuideLink>
<RelDate>2009-11-16</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-027.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-027</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17421</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research applications  from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). Applications that are focused on the identification and characterization of prognostic/diagnostic markers are not appropriate for this FOA.  
Mechanism of Support. This FOA will utilize the research project (R01) grant mechanism, and runs in parallel with a FOA of identical scientific scope, PA-10-026 that encourages applications under the NIH Exploratory/Developmental (R21) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-025.html</GuideLink>
<RelDate>2009-11-16</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-025.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-025</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17424</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Obesity Policy Research: Evaluation and Measures (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), Eunice Kennedy Shriver National  Institute of Child Health and Human Development (NICHD),National Institutes of Health, and the National Center for Chronic Disease Prevention and Health Promotion, CDC, encourages Small Research Grant (R03) applications that propose to: (1) conduct evaluation research on obesity-related natural experiments (defined here as community and other population-level public policy interventions that may affect diet and physical activity behavior), and/or (2) develop and/or validate relevant community-level measures (instruments and methodologies to assess the food and physical activity environments at the community level). The overarching goal of this FOA is to inform public policy relevant to diet and physical activity behavior, and weight and health outcomes of Americans. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the Small Research Grant (R03) mechanism, and runs in parallel with two other FOAs of identical scientific scope, PA-10-027 and PA-10-028 that encourage applications under the NIH Research Project (R01) and NIH Exploratory/Developmental (R21) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-029.html</GuideLink>
<RelDate>2009-11-16</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-029.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-029</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17425</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Obesity Policy Research: Evaluation and Measures (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),Office of Behavioral and Social Sciences Research (OBSSR), NIH, and the National Center for Chronic Disease Prevention and Health Promotion, CDC, encourages Exploratory/Developmental Grant (R21) applications that propose to: (1) conduct evaluation research on obesity-related natural experiments (defined here as community and other population-level public policy interventions that may affect diet and physical activity behavior), and/or (2) develop and/or validate relevant community-level measures (instruments and methodologies to assess the food and physical activity environments at the community level). The overarching goal of this FOA is to inform public policy and research relevant to (1) diet and physical activity behavior, and (2) weight and health outcomes of Americans. The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. 
Mechanism of Support. This FOA will utilize the exploratory/developmental (R21) grant mechanism, and runs in parallel with two other FOAs of identical scientific scope, PA-10-027 and PA-10-029 that encourage applications under the NIH research project (R01) and NIH Small Grant (R03) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-028.html</GuideLink>
<RelDate>2009-11-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-028.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-028</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17426</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research applications  from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). Applications that are focused on the identification and characterization of prognostic/diagnostic markers are not appropriate for this FOA.  
Mechanism of Support.  This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-025  that encourages applications under the NIH research project grants (R01). 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-026.html</GuideLink>
<RelDate>2009-11-16</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-026.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-026</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17435</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award [R21/R33])
]]></Title>
<Purpose><![CDATA[Purpose.  This Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. 
Mechanism of Support.  This FOA will use the NIH Exploratory/Developmental Phased Innovation Grant (R21/R33) award mechanism and runs in parallel with FOA of identical scientific scope, PA-10-023, that encourages applications under the NIH Exploratory/Developmental Grant (R21) award mechanism and PA-08-137 that seeks applications using the Small Business Innovation Research (SBIR [R43/R44]) award mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-024.html</GuideLink>
<RelDate>2009-11-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-024.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-024</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17419</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21)
]]></Title>
<Purpose><![CDATA[Purpose.  This Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-024, that encourages applications under the NIH Exploratory/Developmental Phased Innovation (R21/R33) award mechanism and PA-08-137 that seeks applications using the Small Business Innovation Research (SBIR [R43/R44]) award mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-023.html</GuideLink>
<RelDate>2009-11-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-023.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-023</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17438</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Epigenetic Approaches in Cancer Epidemiology (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research applications that propose to evaluate profiles of methylation, histone modifications and micro RNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. 
Mechanism of Support. This FOA will utilize the research project (R01) grant mechanism, and runs in parallel with a FOA of identical scientific scope, PA-10-032 that encourages applications under the NIH Exploratory/Developmental (R21) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-031.html</GuideLink>
<RelDate>2009-11-24</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-031.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-031</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17439</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), and the Office of Dietary Supplements (ODS), of the National Institutes of Health (NIH), invites research applications to enhance our understanding about the dynamic interrelationship that exists between bioactive food components (and/or combinations thereof) and cancer prevention. Although much evidence exists that dietary components are linked to cancer prevention, the interactions among dietary bioactive compounds and food combinations remains under-investigated. Applications are encouraged to consider either multiple dietary bioactive components, intact foods or multiple foods utilizing physiologically relevant concentrations of the agents. New genetic technologies may be employed to study the impact of dietary components on complex cellular and molecular networks, as part of the effort to better understand the basis for the multifaceted interactions of food components with cancer prevention mechanisms. Specifically, applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to prioritize molecular targets of dietary components are highly encouraged. The sites of action that may be evaluated include carcinogen metabolism, DNA repair, cell proliferation, apoptosis, differentiation, hormonal regulation, energetics, inflammation, and/or angiogenesis. In addition, applications should either evaluate multiple molecular targets within a cancer process or multiple processes in order to prioritize which process(es) is/are most involved in bringing about a phenotypic change. It is hoped that advances in this area may assist in optimizing cancer prevention while minimizing potential toxicity due to food components. The resulting information will help define which foods or food components should be considered in isolation or in combination when developing dietary strategies to reduce cancer risk and/or modify tumor behavior. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-035.html</GuideLink>
<RelDate>2009-11-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-035.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-035</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17432</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Epigenetic Approaches in Cancer Epidemiology (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research applications that propose to evaluate profiles of methylation, histone modifications and micro RNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-031 that encourages applications under the NIH research project grants (R01). 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-032.html</GuideLink>
<RelDate>2009-11-24</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-032.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-032</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17441</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Selected Topics in Transfusion Medicine (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) encourages research grant applications from investigators who propose to study topics that will determine blood banking and transfusion practice. The National Heart, Lung, and Blood Institute (NHLBI) is responsible for supporting research in blood banking and transfusion medicine. This research aimed at improving the safety and availability of the blood supply and the practice of transfusion medicine is critical to public health since about five million patients receive blood transfusions every year in the U.S.  Since blood transfusions pose infectious and non-infectious risks to recipients, it is important to understand the determinants of transfusion-associated adverse events and how best to minimize transfusion risks. It is also crucial to maintain an adequate blood supply by minimizing the risks associated with the donation process and developing enhanced recruitment and retention programs. 
Mechanism of Support. This FOA will use the NIH Research Project (R01) grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-033 that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
Budget and Project Period.  The total project period for an application submitted in response to this funding opportunity may not exceed five years. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-034.html</GuideLink>
<RelDate>2009-11-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 5, 2012 (new), March 5, 2012 (resubmission, revision), May 7, 2012 (AIDS), October 5, 2012 (new), November 5, 2012 (resubmission, revision), January 7, 2013 (AIDS)]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-034.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-034</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17442</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Selected Topics in Transfusion Medicine (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), encourages research grant applications from investigators who propose to study topics that will determine blood banking and transfusion practice. The National Heart, Lung, and Blood Institute (NHLBI) is responsible for supporting research in blood banking and transfusion medicine. This research aimed at improving the safety and availability of the blood supply and the practice of transfusion medicine is critical to public health since about five million patients receive blood transfusions every year in the U.S.  Since blood transfusions pose infectious and non-infectious risks to recipients, it is important to understand the determinants of transfusion-associated adverse events and how best to minimize transfusion risks. It is also crucial to maintain an adequate blood supply by minimizing the risks associated with the donation process and developing enhanced recruitment and retention programs. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-034 which encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-033.html</GuideLink>
<RelDate>2009-11-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 16, 2012 (new), March 16, 2012 (resubmission, revision) May 7, 2012 (AIDS), October 16, 2012 (new), November 16, 2012 (resubmission, revision), January 7, 2013 (AIDS)]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-033.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-033</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17453</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Dissemination and Implementation Research in Health (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, and refine effective and efficient methods, structures, and strategies to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment, and quality of life improvement services into public health and clinical practice settings. 
Mechanism of Support. This FOA will use the NIH Research Project Grant (R01) award mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-039 and PAR-10-040, which encourage applications under the Small Grant (R03) and the Exploratory/Developmental Grant (R21) award mechanisms. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-038.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>30 days prior to anticipated receipt date. </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-038.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-038</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17458</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Dissemination and Implementation Research in Health (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, and refine effective and efficient methods, structures, and strategies to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment, and quality of life improvement services into public health and clinical practice settings. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-038 and PAR-10-039, which encourage applications under the NIH Research Project Grant (R01) and NIH Small Grant (R03) award mechanisms. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-040.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>30 days prior to anticipated receipt date. </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-040.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-040</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17459</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Dissemination and Implementation Research in Health (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, and refine effective and efficient methods, structures, and strategies to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment, and quality of life improvement services into public health and clinical practice settings. 
Mechanism of Support. This FOA will use the NIH Small Research Grant (R03) award mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-038 and PAR-10-040, which solicit applications under the Research Project Grant (R01) and the Exploratory/Developmental Grant (R21) award mechanisms. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-039.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>30 days prior to anticipated receipt date </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-039.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-039</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17461</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Critical Illness and Injury in Aging (R21)

]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Exploratory/Developmental research grant applications proposing to study mechanisms and management of critical illness and injury in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. 
Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental grant mechanism (R21) and runs in parallel with a FOA of identical scientific scope, PA-10-042, that encourages applications under the R01 Research Project grant mechanism, and PA-10-043, that encourages applications under the R03 Small Research grant mechanism.  This FOA also runs in parallel with an FOA of similar scientific scope, PA-10-045, which encourages applications under the R34 clinical trial planning grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-044.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-044.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-044</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17462</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Critical Illness and Injury in Aging (R03)]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Small Research Project Grant (R03) applications proposing to study mechanisms and management of critical illness and injury in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. 
Mechanism of Support. This FOA will utilize the NIH Small Research grant mechanism (R03) and runs in parallel with a FOA of identical scientific scope, PA-10-042, that encourages applications under the R01 Research Project grant mechanism, and PA-10-044, that encourages applications under the R21 Exploratory/Developmental grant mechanism. This FOA also runs in parallel with an FOA of similar scientific scope, PA-10-045, which encourages applications under the R34 clinical trial planning grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-043.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-043.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-043</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17463</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Critical Illness and Injury in Aging (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Research Project Grant (R01) applications proposing to study mechanisms and management of critical illness and injury, including trauma and neurotrauma, in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-044, that encourages applications under the R21 Exploratory/Developmental grant mechanism, PA-10-043, that encourages applications under the R03 Small Research grant mechanism.  This FOA also runs in parallel with an FOA of similar scientific scope, PA-10-045, which encourages applications under the R34 clinical trial planning grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-042.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-042.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-042</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17464</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Small Research Grants for Data Analysis and Statistical Methodology applied to Genome-wide Data (R03)]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) will support meritorious research projects that involve secondary data analyses or development of statistical methodology using existing genome-wide data, relevant to human dental or craniofacial conditions or traits.   
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism. 
Funds Available and Anticipated Number of Awards. The total amount awarded will depend on the scientific merit of applications and the funds available in NIDCRs general funding pool. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-041.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-041.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-041</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17471</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Clinical Trial Planning Grants for Critical Illness and Injury in Aging (R34)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Aging encourages Clinical Trial Planning Grant (R34) applications to develop research protocols for Phase III and IV clinical trials related to critical illness and injury in aging. The planning grant mechanism is intended to permit early peer review of the rationale and design of the proposed Phase III or IV clinical trial, and to support development of a research team, tools for data management and research oversight, recruitment strategies, detailed protocol and Manual of Procedures (MOP), and other essential components necessary for a competitive clinical trial application. This FOA is NOT designed for collecting preliminary data or conducting pilot studies in support of the scientific rationale for a clinical trial. 
Mechanism of Support. This FOA will utilize the Clinical Trial Planning Grant (R34) mechanism and runs in parallel with PA-10-042, that encourages applications under the R01 Research Project grant mechanism, PA-10-043, that encourages applications under the R03 Small Research Grant mechanism, and PA-10-044, that encourages applications under the R21 Exploratory/Developmental grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-045.html</GuideLink>
<RelDate>2009-12-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-045.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-045</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17484</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Stimulating Hematology Investigation:  New Endeavors (SHINE) (R01)
]]></Title>
<Purpose><![CDATA[Purpose.  The Stimulating Hematology Investigation:  New Endeavors (SHINE) program is intended to promote innovative, high quality hematology research relevant to the mission of The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).  In the SHINE program, NIDDK invites investigator-initiated research project grant applications in specific areas of basic and translational hematology research where needs and opportunities for progress are particularly timely.  Specific research topic areas supported by the SHINE program, as outlined below, will change over time and be up-dated annually through the NIH Guide to Grants and Contracts. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism. 
Funds Available and Anticipated Number of Awards.  $1,250,000 has been set aside in fiscal year 2010 to make approximately 3  4 awards issued under this FOA in addition to those funded within NIDDK regular funding policies.  In subsequent years, the amount available will be contingent upon the availability of funds and will be announced in Notices published in the NIH Guide to Grants and Contracts.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-046.html</GuideLink>
<RelDate>2009-12-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAS-10-046.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-046</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17489</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<Title><![CDATA[Development of Multifunctional Drug and Gene Delivery Systems (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Biomedical Imaging and Bioengineering and the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose the engineering of novel, multifunctional drug and gene delivery systems that can target therapies to particular cells and intracellular compartments and can monitor delivery and determine therapeutic efficacy through the integration of advanced imaging and/or sensing technologies into the delivery system.  Applications should propose to develop at least one prototype system by the end of the project period.  Applications that are submitted to this FOA should include investigators from both the drug/gene delivery and imaging fields.  Applicants are strongly encouraged to use the Multi-PD/PI model to meet the imaging and drug/gene delivery expertise. 
Mechanism of Support. This FOA utilizes the NIH R01 research grant award mechanism.  
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-048.html</GuideLink>
<RelDate>2009-12-07</RelDate>
<IntentDate>30 days before Application Due Dates</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-048.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-048</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17497</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Clinical Research Center Grant (P50)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and amelioration of human communication disorders. The NIDCD believes that most research within its mission areas can be best accomplished via the investigator-initiated individual research grant (R01, R21, R03, R15) and the research core center grant (P30) mechanisms. There are special circumstances in clinical research however, that warrant use of the P50 mechanism to support clinical research. For this announcement, Clinical Research is defined as research involving individuals with communication disorders or data/tissues from individuals with a communication disorder. Examples of such research include but are not limited to, studies of the prevention, pathogenesis, pathophysiology, diagnosis, treatment, management or epidemiology of a disease or disorder of hearing, balance, smell, taste, voice, speech, or language. 
Mechanism of Support. This FOA will utilize the P50 grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.  
]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>1500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-047.html</GuideLink>
<RelDate>2009-12-09</RelDate>
<IntentDate>30 days before planned application submission date</IntentDate>
<AppReceiptDate><![CDATA[February 1, 2010, June 1, 2010, October 1, 2010; February 1, 2011, June 1, 2011, September 30, 2011; February 1, 2012, June 1, 2012 and October 1, 2012.]]></AppReceiptDate>
<LARD>2012-10-01</LARD>
<FileName>PAR-10-047.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-047</DocNum>
<ExpirationDate>2012-10-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17502</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), is issued by the National Institutes of Healths National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Office of Behavioral and Social Sciences Research (OBSSR), and the Centers of Disease Control and Preventions National Center for Chronic Disease Prevention and Health Promotion (CDC). The FOA encourages Research Project Grant (R01) applications that propose to: (1) foster multidisciplinary research that will evaluate how policies (federal, state and school district levels) can influence school physical activity and nutrition environments, youths obesogenic behaviors (e.g., nutrition and physical activity behaviors), and weight outcomes; (2) understand how schools are implementing these policies and examine multi-level influences on adoption and implementation at various levels (e.g., federal, state, school district, and school); and (3) understand the synergistic or counteractive effect of school nutrition and physical activity polices on the home and community environment and body weight. 
Mechanism of Support. This FOA will utilize the research project (R01) grant mechanism, and runs in parallel with two other FOAs of identical scientific scope, PA-10-053  and PA-10-054 that encourage applications under the NIH Exploratory/Developmental (R21) and NIH Small Research (R03) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
Budget and Project Period. The total project period for an application submitted in response to this funding opportunity may not exceed 5 years. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-052.html</GuideLink>
<RelDate>2009-12-10</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-052.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-052</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17506</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes (R03)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), is issued by the National Institutes of Healths National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Office of Behavioral and Social Sciences Research (OBSSR), and the Centers of Disease Control and Preventions National Center for Chronic Disease Prevention and Health Promotion (CDC). The FOA encourages Research Project Grant (R03) applications that propose to: (1) foster multidisciplinary research that will evaluate how policies (federal, state and school district levels) can influence school physical activity and nutrition environments, youths obesogenic behaviors (e.g., nutrition and physical activity behaviors), and weight outcomes; (2) understand how schools are implementing these policies and examine multi-level influences on adoption and implementation at various levels (e.g. federal, state, school district, and school); and (3) understand the synergistic or counteractive effect of school nutrition and physical activity polices on the home and community environment and body weight. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA runs parallel with two other FOAs of similar scientific scope PA-10-052  and PA-10-053; these encourage applications under the NIH Exploratory/Developmental (R01) and NIH Small Research (R21) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-054.html</GuideLink>
<RelDate>2009-12-10</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-054.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-054</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17507</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[School Nutrition and Physical Activity Policies, Obesogenic Behaviors and Weight Outcomes (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), is issued by the National Institutes of Healths National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Office of Behavioral and Social Sciences Research (OBSSR), and the Centers of Disease Control and Preventions National Center for Chronic Disease Prevention and Health Promotion (CDC). The FOA encourages Research Project Grant (R21) applications that propose to: (1) foster multidisciplinary research that will evaluate how policies (federal, state and school district levels) can influence school physical activity and nutrition environments, youths obesogenic behaviors (e.g., nutrition and physical activity behaviors), and weight outcomes; (2) understand how schools are implementing these policies and examine multi-level influences on adoption and implementation at various levels (e.g. federal, state, school district, and school); and (3) understand the synergistic or counteractive effect of school nutrition and physical activity polices on the home and community environment and body weight. The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. 
Mechanism of Support. This FOA will utilize the exploratory/developmental (R21) grant mechanism, and runs in parallel with two other FOAs of identical scientific scope, PA-10-052 and PA-10-054 that encourage applications under the NIH research project (R01) and NIH Small Grant (R03) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-053.html</GuideLink>
<RelDate>2009-12-10</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-053.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-053</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17529</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Small Grant Program (R03)]]></Title>
<Purpose><![CDATA[Purpose. The NIDCD Small Grant Program (R03) is intended to support basic and clinical research of scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD:hearing, balance/vestibular, smell, taste, voice, speech, or language. The NIDCD R03 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD R03 is for the PD/PI to obtain sufficient preliminary data for a subsequent R01. 

Mechanism of Support. This FOA will utilize the R03 grant award mechanism. 

Funds Available and Anticipated Number of Awards. Since the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-055.html</GuideLink>
<RelDate>2009-12-16</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[February 24, 2010, June 29, 2010, and October 29, 2010, February 24, 2011, June 29, 2011, and October 31, 2011, February 24, 2012, June 29, 2012, October 31, 2012]]></AppReceiptDate>
<LARD>2012-10-31</LARD>
<FileName>PAR-10-055.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-055</DocNum>
<ExpirationDate>2012-11-01</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17562</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<Title><![CDATA[NIH Support for Conferences and Scientific Meetings (Parent R13/U13)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of the NIH Research Conference Grant Program (R13 and U13) is to support high quality conferences/scientific meetings that are relevant to the scientific mission of the NIH and to the public health.  A conference/scientific meeting is defined as a gathering, symposium, seminar, scientific meeting, workshop or any other organized, formal meeting where persons assemble to coordinate, exchange, and disseminate information or to explore or clarify a defined subject, problem, or area of knowledge.  Each NIH Institute and Center (IC) has a scientific purview and different program goals and initiatives that evolve over time.  Prior to preparing an application, it is critical that all applicants consult the appropriate IC representative listed in the R13/U13 Website (http://grants.nih.gov/grants/funding/r13/) to obtain current information about IC specific program priorities and policies. This action is of utmost importance because applications with marginal or no relevance to the participating Institutes, Centers, or Offices will not be accepted for review or possible funding.   Advance permission to submit an application must be requested early in the process and no later than 6 weeks before the application submission date.  The letter from the NIH documenting advance permission must be included in the Cover Letter component of this application.  In addition, applicants are encouraged to consult the Frequently Asked Questions Website for more detailed information about this program: http://grants.nih.gov/grants/funding/r13/index.htm.  
Mechanism of Support. This FOA will utilize the NIH Conference grant (R13) and conference cooperative agreement (U13) award mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R13,U13</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-071.html</GuideLink>
<RelDate>2010-01-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-071.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-071</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17563</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Technology Development for High-Throughput Structural Biology Research  (P01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute of General Medical Sciences (NIGMS), National Institutes of Health, encourages grant applications from institutions/organizations that propose to develop novel technologies and methodologies underpinning high-throughput structural biology. Applications for new ideas and approaches for protein production and structure determination for classes of challenging proteins are appropriate. Projects related to high-throughput structure determination by X-ray crystallography and NMR, as well as projects addressing other constituent tasks of structural biology, including structural genomics, are relevant to this FOA. Applications should focus on methods development to solve challenging proteins that are not currently amenable to high-throughput structural biology.  These challenging proteins include, but are not limited to, membrane proteins, small protein complexes, and proteins from human and other higher eukaryotes. 
Mechanism of Support. This FOA will utilize the P01 research grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-073, that encourages applications under the R01 mechanism. The program project grant mechanism is designed to support research in which the funding of several interdependent projects as a group offers significant scientific advantages over support of these same projects as individual regular research grants. 
Funds Available and Anticipated Number of Awards. The total amount to be awarded depends on the scientific merit of applications and the funds available in NIGMSs general funding pool. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications. 
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-074.html</GuideLink>
<RelDate>2010-01-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-074.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-074</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17564</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Technology Development for High-Throughput Structural Biology Research  (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute of General Medical Sciences (NIGMS), National Institutes of Health, encourages grant applications from institutions/organizations that propose to develop novel technologies and methodologies underpinning high-throughput structural biology. Applications for new ideas and approaches for protein production and structure determination for classes of challenging proteins are appropriate. Projects related to high-throughput structure determination by X-ray crystallography and NMR, as well as projects addressing other constituent tasks of structural biology, including structural genomics, are relevant to this FOA. Applications should focus on methods development to solve challenging proteins that are not currently amenable to high-throughput structural biology.  These challenging proteins include, but are not limited to, membrane proteins, small protein complexes, and proteins from human and other higher eukaryotes. 
Mechanism of Support. This FOA will utilize the R01 research grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-074, that encourages applications under the P01 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-073.html</GuideLink>
<RelDate>2010-01-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-073.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-073</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17565</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Mechanism for Time-Sensitive Drug Abuse Research (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH). The FOA is intended to support substance abuse prevention and treatment services research in rapidly evolving areas (e.g., changes in service systems, health care financing, policy, natural/man-made disasters, etc) where opportunities for empirical study are, by their very nature, only available through expedited review and award of support. There are three distinguishing features of an eligible study: 1) the study's scientific value and feasibility are clear, 2) rapid review and funding are required in order for the scientific question to be answered, and 3) the knowledge gained from the study is time-sensitive and seeking funding through the regular NIH cycle of review and award would result in a missed opportunity to conduct the research. It should be clear that the research question offers an uncommon and scientifically significant research opportunity that could only become available if the project is initiated with minimum delay.   
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with a FOA of identical scientific scope, PAR-07-345 that encourages applications under the Exploratory/Developmental Research Grant Award (R21) mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-072.html</GuideLink>
<RelDate>2010-01-04</RelDate>
<IntentDate>4 weeks prior to planned submission date</IntentDate>
<AppReceiptDate><![CDATA[Application Submission/Receipt Date(s):  March 9, 2010, June 9, 2010, September 10, 2010 December  9, 2010, March 9, 2011, June 9, 2011, September 9, 2011, December 9, 2011, March 9, 2012, June 8, 2012, September 10, 2012, December 10, 2012]]></AppReceiptDate>
<LARD>2012-12-10</LARD>
<FileName>PAR-10-072.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-072</DocNum>
<ExpirationDate>2012-12-11</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17569</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Technology Development for Protein Modeling (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute of General Medical Sciences (NIGMS), National Institutes of Health, encourages grant applications from institutions/organizations that propose to develop novel technologies that will significantly improve the accuracy of comparative modeling methods for protein structure prediction. 
Mechanism of Support. This FOA will utilize the R01 research grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-075, that encourages applications under the P01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-076.html</GuideLink>
<RelDate>2010-01-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-076.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-076</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17570</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Technology Development for Protein Modeling (P01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute of General Medical Sciences (NIGMS), National Institutes of Health, encourages grant applications from institutions/organizations that propose to develop novel technologies that will significantly improve the accuracy of comparative modeling methods for protein structure prediction. 
Mechanism of Support. This FOA will utilize the P01 research grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-076, that encourages applications under the R01 mechanism. The program project grant mechanism is designed to support research in which the funding of several interdependent projects as a group offers significant scientific advantages over support of these same projects as individual regular research grants. 
Funds Available and Anticipated Number of Awards. The total amount to be awarded depends on the scientific merit of applications and the funds available in NIGMSs general funding pool. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications. 
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-075.html</GuideLink>
<RelDate>2010-01-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-075.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-075</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17577</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Proteomics in Auditory Developmental and Disease Processes (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) supersedes the previous National Institute on Deafness and Other Communication Disorders (NIDCD) program announcement, Proteomics in Auditory Developmental and Disease Processes (PA-06-366). 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific identical scientific scope that uses the R01 mechanism, PA-09-228, http://grants.nih.gov/grants/guide/pa-files/PA-09-228.html. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-078.html</GuideLink>
<RelDate>2010-01-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-078.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-078</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17578</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Research Core Centers (P30)  ]]></Title>
<Purpose><![CDATA[Purpose. The NIDCD P30 Core Center grant contains one or more research-serving cores, providing centralized resources and facilities for funded R01 research projects. Although no funds are provided for direct support of research projects, a P30 helps to integrate and promote research in existing funded projects, and may include multi-disciplinary and regional collaborations. A Core Center must be an identifiable organizational unit either within a single grantee institution or representing a consortium of cooperating institutions (e.g., geographic or web-based). The Center may serve as an intellectual hub to stimulate cooperative research, to increase the effectiveness, capabilities or productivity of current research, and/or to promote new research directions through collaborations. Individual research cores of the Core Center may provide for sharing technical expertise or centralizing labor-intensive tasks common among several investigators (PD/PIs); staffing, training and maintenance of shared equipment or resources, including tools or staffing to enhance activities such as recruitment databases for clinical projects; or problem-solving through innovative technical solutions using the most current methodologies. NIDCD P30 funds do not provide patient services, or support unfunded pilot studies, or facilitate research other than for funded user projects, unless directly related to advancing the potential of the Core Center itself.  A P30 may provide benefits to other core centers or the larger community through sharing data or technology. 
Mechanism of Support. This FOA will utilize the P30 grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-077.html</GuideLink>
<RelDate>2010-01-06</RelDate>
<IntentDate>30 days before application receipt dates</IntentDate>
<AppReceiptDate><![CDATA[March 8, 2010, June 1, 2010, October 1, 2010, February 1, 2011, June 1, 2011, September 30, 2011, February 1, 2012, June 1, 2012, October 1, 2012 
]]></AppReceiptDate>
<LARD>2012-10-01</LARD>
<FileName>PAR-10-077.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-077</DocNum>
<ExpirationDate>2012-10-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17579</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Image-Guided Cancer Interventions (SBIR [R43/R44])
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the development and clinical validation of systems for image-guided interventions (IGIs) for cancer. Specifically, the goals of this program are to provide support for: the development and optimization of fully integrated cancer imaging, monitoring, and therapy systems; the validation of integrated image-guided intervention (IGI) systems through clinical evaluations; the development of multiple prototype integrated IGI systems as required for multisite clinical evaluations; and partnerships among small business, large business, and academic clinical centers, as well as small business joint ventures, in order to reach the research goals.      
Mechanism of Support. This FOA will use the Small Business Innovation Research (SBIR) program (R43/R44) grant mechanism(s) for Phase I, Phase II, and Fast-Track applications and runs in parallel with an FOA of identical scientific intent, PA-10-080 that encourages applications under the Small Business Technology Transfer (STTR) program (R41/R42) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-079.html</GuideLink>
<RelDate>2010-01-06</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-079.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-079</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17584</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop technologies and approaches (i.e., novel ways to use new or existing technologies) that will enable researchers to study the structure and/or function of brain localized G-protein coupled receptor proteins (GPCRs) and/or potentially identify novel selective and specific agonists/antagonists to these receptor subtypes, with a focus on mental health function or dysfunction, including HIV-related neurocognitive disorders.  Technologies and approaches aimed at known receptor subtypes or orphan receptors would be of potential interest to NIMH. 
Mechanism of Support. This FOA will utilize the SBIR (R43/R44) award mechanisms for Phase I, Phase II, and Fast-Track applications. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-081.html</GuideLink>
<RelDate>2010-01-07</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-081.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-081</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17585</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Image-Guided Cancer Interventions (STTR [R41/R42])]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the development and clinical validation of systems for image-guided interventions (IGIs) for cancer. Specifically, the goals of this program are to provide support for: the development and optimization of fully integrated cancer imaging, monitoring, and therapy systems; the validation of integrated image-guided intervention (IGI) systems through clinical evaluations; the development of multiple prototype integrated IGI systems as required for multisite clinical evaluations; and partnerships among small business, large business, and academic clinical centers, as well as small business joint ventures, in order to reach the research goals. 
Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-079 that encourages applications under the Small Business Innovation Research (SBIR) program (R43/R44) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-080.html</GuideLink>
<RelDate>2010-01-07</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-080.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-080</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17602</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<Title><![CDATA[Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21)

]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) is intended to support research in which an unpredictable opportunity has arisen to collect human or animal biosample baseline or exposure data (e.g., following natural or made-made disasters, health care policy changes; etc). The distinctive element of the project should be the need for empirical study for a situation that was not foreseeable and is achievable only if begun within a short time frame. The R21 mechanism is intended to encourage new exploratory and developmental research projects, and applications submitted to this FOA would be expected to conduct innovative research that will lay the foundation for improved population studies concerning the effect of environmental agents on health. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-083, that  encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-084.html</GuideLink>
<RelDate>2010-01-14</RelDate>
<IntentDate>March 5, 2010, April 6, 2010, May 6, 2010, June 4, 2010, July 6, 2010, August 6, 2010, September 7, 2010, October 6, 2010, November 5, 2010, January 6, 2011, February 4, 2011, March 4, 2011, April 6, 2011, May 6, 2011, June 7, 2011, July 6, 2011, August 5, 2011, September 7, 2011, October 6, 2011, November 7, 2011, January 6, 2012, February 7, 2012, March 6, 2012, April 6, 2012, May 7, 2012, June 6, 2012, July 6, 2012, August 6, 2012, September 6, 2012, October 5, 2012, November 6, 2012, January 8, 2013, February 6, 2013</IntentDate>
<AppReceiptDate><![CDATA[March 19, 2010, April 20, 2010, May 20, 2010, June 18, 2010, July 20, 2010, August 20, 2010, September 21 2010, October 20, 2010, November 19, 2010,  January 20, 2011, February 18, 2011, March 21, 2011, April 20, 2011, May 20, 2011, June 21, 2011, July 20, 2011, August 19, 2011, September 21, 2011, October 20, 2011, November 21, 2011, January 20, 2012, February 21, 2012, March 20, 2012, April 20, 2012, May 21, 2012, June 20, 2012, July 20, 2012, August 20, 2012, September 20, 2012, October 19, 2012, November 20, 2012, January 22, 2013, February 20, 2013]]></AppReceiptDate>
<LARD>2013-02-20</LARD>
<FileName>PAR-10-084.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-084</DocNum>
<ExpirationDate>2013-02-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17603</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<Title><![CDATA[Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) is intended to support research in which an unpredictable opportunity has arisen to collect human or animal biosample baseline or exposure data (e.g., following natural or made-made disasters, health care policy changes; etc). The distinctive element of the project should be the need for empirical study for a situation that was not foreseeable and is achievable only if begun within a short time frame. 
Review by the Initial Review Group and National Advisory Environmental Health Sciences Council (NAEHSC) will be expedited so an award for a successful competing application can be processed in a shorter period of time than is typical. The entire cycle from submission to award  when appropriate - is expected to be within 6 months. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-084, that encourages applications under the NIH Exploratory/Developmental (R21) grant mechanism. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-083.html</GuideLink>
<RelDate>2010-01-14</RelDate>
<IntentDate>March 5, 2010, April 6, 2010, May 6, 2010, June 4, 2010, July 6, 2010, August 6, 2010, September 7, 2010, October 6, 2010, November 5, 2010, January 6, 2011, February 4, 2011, March 4, 2011, April 6, 2011, May 6, 2011, June 7, 2011, July 6, 2011, August 5, 2011, September 7, 2011, October 6, 2011, November 7, 2011, January 6, 2012, February 7, 2012, March 6, 2012, April 6, 2012, May 7, 2012, June 6, 2012, July 6, 2012, August 6, 2012, September 6, 2012, October 5, 2012, November 6, 2012, January 8, 2013, February 6, 2013</IntentDate>
<AppReceiptDate><![CDATA[March 19, 2010, April 20, 2010, May 20, 2010, June 18, 2010, July 20, 2010, August 20, 2010, September 21, 2010, October 20, 2010, November 19, 2010, January 20, 2011, February 18, 2011, March 18, 2011, April 20, 2011, May 20, 2011, June 21, 2011, July 20, 2011, August 19, 2011, September 21, 2011, October 20, 2011, November 21, 2011, January 20, 2012 , February 21, 2012, March 20, 2012, April 20, 2012, May 21, 2012, June 20, 2012, July 20, 2012, August 20, 2012, September 20, 2012, October 19, 2012, November 20, 2012, January 22, 2013, February 20, 2013]]></AppReceiptDate>
<LARD>2013-02-20</LARD>
<FileName>PAR-10-083.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-083</DocNum>
<ExpirationDate>2013-02-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17618</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Prevention and Management of Healthcare Associated Infections (R18)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity is to fund extramural health services research, demonstration, dissemination, and evaluation grants that propose to prevent and more effectively manage healthcare associated infections (HAIs).  The FOA contained herein sets a multi-year research framework, based on the distillation of existing, peer-reviewed research, case studies, the Department of Health and Human Services 2009 National Action Plan on Healthcare-associated Infections, and qualitative information resulting from a series of listening sessions that occurred in selected cities across the United States in 2009.1

HAIs are infections that patients acquire during the course of receiving treatment for other conditions within any healthcare setting.  HAIs exact a significant toll on human life, are among the leading causes of preventable death in the United States, and accounted for an estimated 1.7 million infections and 99,000 associated deaths in 2002.2   In addition to the substantial human suffering caused by HAIs, the financial burden attributable to such infections is staggering.  It is estimated that HAIs result in $28 to $33 billion in excess healthcare costs each year.  

Research priorities for this FOA are the: 1) development, implementation and demonstration of the prevention and management of HAIs, along with the determination of the costs of such interventions; 2) determination of the efficacy, effectiveness, and costs of preventative interventions; 3) population-level studies on the patient risk factors, clinical presentation, sources, and disease genotypes of antibiotic-resistant organisms that can result in perceived HAIs.  The scientific and practical knowledge to be achieved through these research and demonstration efforts will identify the practical and cost-effective approaches to preventing and managing HAIs.

]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-089.html</GuideLink>
<RelDate>2010-01-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-089.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-089</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17647</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[ Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement is to provide a vehicle for submitting grant applications for investigator-initiated multi-site Phase II or Phase III randomized, controlled clinical trials. The trials may address any research question related to the mission and goals of NHLBI and may test clinical or behavioral interventions. Investigators should consult the NHLBIs Guidelines for Investigator Initiated Clinical Trials (http://www.nhlbi.nih.gov/funding/policies/clinical.htm) for more detailed instructions and information about multi-site clinical trial grant applications. Additional information about the mission, strategic plan and research interests of the NHLBI can be found at NHLBIs website (http://www.nhlbi.nih.gov/index.htm). 
This Funding Opportunity Announcement is not intended for support of single-center studies or multi-center observational studies that are not testing an intervention. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Awards may be converted by NHLBI to cooperative agreements (U01). 
]]></Purpose>
<RelNote/><ActivityCodes>R01(Collab)</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-096.html</GuideLink>
<RelDate>2010-01-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-096.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-096</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17658</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Research on Alcohol and HIV/AIDS (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is intended to appeal to a broad audience of alcohol and HIV/AIDS researchers, including alcohol researchers with no prior experience in HIV/AIDS research, but with a keen appreciation for the relationship between problem drinking and HIV/AIDS and a strong interest in acquiring such experience; HIV/AIDS researchers with no prior alcohol research experience who realize the importance of more intensive alcohol interventions to improving clinical outcomes among HIV+ individuals; and those with prior research experience in the area of co-occurring HIV/AIDS and alcohol and other substance abuse. Given the breadth of research objectives included in this announcement, potential applicants are encouraged to carefully review all sections of the announcement for research opportunities. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the R03 grant mechanism and runs in parallel with an FOA of identical scientific scope, PA-10-103 , that encourages applications under R01 and PA-10-105 , that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-104.html</GuideLink>
<RelDate>2010-02-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-104.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-104</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17667</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Scientific Meetings for Creating Interdisciplinary Research Teams (R13)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Research Conference Grant (R13) applications from institutions and organizations that propose to develop interdisciplinary research teams. Teams must include investigators from the social and/or behavioral sciences, and may include the life and/or physical sciences.  The goal is to broaden the scope of investigation into scientific problems, yield fresh and possibly unexpected insights, and increase the sophistication of theoretical, methodological, and analytical approaches by integrating the analytical strengths of two or more disparate scientific disciplines while addressing gaps in terminology, approach, and methodology.  This program will allow investigators from multiple disciplines to hold meetings in order to provide the foundation for developing interdisciplinary research projects. 
Mechanism of Support. This FOA will utilize the R13 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R13</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-106.html</GuideLink>
<RelDate>2010-02-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-106.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-106</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17668</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Research on Alcohol and HIV/AIDS (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is intended to appeal to a broad audience of alcohol and HIV/AIDS researchers, including alcohol researchers with no prior experience in HIV/AIDS research, but with a keen appreciation for the relationship between problem drinking and HIV/AIDS and a strong interest in acquiring such experience; HIV/AIDS researchers with no prior alcohol research experience who realize the importance of more intensive alcohol interventions to improving clinical outcomes among HIV+ individuals; and those with prior research experience in the area of co-occurring HIV/AIDS and alcohol and other substance abuse. The primary objectives for this announcement are to increase research : 1) to characterize the relative importance of reducing alcohol misuse in the prevention of acquisition and transmission of HIV in order to identify and apply appropriate alcohol and HIV interventions as public health measures,  2) to more fully understand and prevent the progression of HIV disease in the presence of continued alcohol exposure  and 3) to develop operational research frameworks for addressing the occurrence and persistence of infections in high-risk populations (e.g. minority women, young gay men, etc.), and translate  findings  these targeted populations. Given the breadth of research objectives included in this announcement, potential applicants are encouraged to carefully review all sections of the announcement for research opportunities.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-103.html</GuideLink>
<RelDate>2010-02-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-103.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-103</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17669</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Research on Alcohol and HIV/AIDS (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is intended to appeal to a broad audience of alcohol and HIV/AIDS researchers, including alcohol researchers with no prior experience in HIV/AIDS research, but with a keen appreciation for the relationship between problem drinking and HIV/AIDS and a strong interest in acquiring such experience; HIV/AIDS researchers with no prior alcohol research experience who realize the importance of more intensive alcohol interventions to improving clinical outcomes among HIV+ individuals; and those with prior research experience in the area of co-occurring HIV/AIDS and alcohol and other substance abuse. Given the breadth of research objectives included in this announcement, potential applicants are encouraged to carefully review all sections of the announcement for research opportunities. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-103, that encourages applications under the R01 mechanism and PA-10-104 that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-105.html</GuideLink>
<RelDate>2010-02-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-105.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-105</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17713</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Grants for Research in Glomerular Diseases (R01)]]></Title>
<Purpose><![CDATA[Purpose. The Division of Kidney, Urologic and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications from new or established investigators to pursue exploratory investigations of glomerular disease, which would foster development of new ideas enhancing the understanding of disease detection, pathogenesis, pre-emption and/ or treatment. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-113.html</GuideLink>
<RelDate>2010-02-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-113.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-113</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17729</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)]]></Title>
<Purpose><![CDATA[Purpose. Scientific cooperation between India and the U.S. has taken place under a variety of bilateral umbrella agreements, including the Indo-U.S. Science and Technology (SandT) Sub-Commission, the Gandhi-Reagan SandT Initiative, the U.S.-India Fund, and the current SandT Cooperation Agreement.  Building upon these agreements and initiatives, representatives of the United States and the Government of India signed a Memorandum of Understanding on July, 9 1987 implementing the Indo-U.S. Vaccine Action Program (VAP) in order to expand collaborative vaccine research.  The goal of the VAP is to support collaborative vaccine-related research projects that ultimately reduce the burden of infectious diseases of importance in India, the U.S., the South Asian region and globally. Applications are encouraged from organizations/institutions that propose to conduct vaccine-related research through well-established collaborations with Indian investigators on the following: dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis.  Basic, translational, clinical, or epidemiological vaccine research may be proposed. Clinical trials will not be supported by this initiative. 
Mechanism of Support. This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications, which will provide U.S. dollar support of vaccine-related research in India and the United States and augment current VAP activities.  Investigators from U.S. and Indian institutions are eligible to apply. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-115.html</GuideLink>
<RelDate>2010-02-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-115.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-115</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17737</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[New Approaches to Arrhythmia Detection and Treatment (SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[Purpose.  This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to improve our ability to detect, prevent, and treat all forms of cardiac arrhythmias.  This initiative encourages SBCs to develop improved diagnostic and therapeutic tools, products, or devices for cardiac arrhythmia monitoring, detection and treatment. 
Mechanism of Support.  This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-118, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-117.html</GuideLink>
<RelDate>2010-03-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-117.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-117</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17738</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[New Approaches to Arrhythmia Detection and Treatment (STTR [R41/R42])]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to improve our ability to detect, prevent, and treat all forms of cardiac arrhythmias.  This initiative encourages SBCs to develop improved diagnostic and therapeutic tools, products, or devices for cardiac arrhythmia monitoring, detection and treatment. 
Mechanism of Support.  This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-117,that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-118.html</GuideLink>
<RelDate>2010-03-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-118.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-118</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17743</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Service Award (NRSA) Institutional Research Training Grant (T34)]]></Title>
<Purpose><![CDATA[Purpose: The National Institute of General Medical Sciences (NIGMS) will award Minority Access to Research Careers (MARC) Undergraduate Student Training in Academic Research (U-STAR) National Research Service Act (NRSA) Training grants to eligible institutions as a means of supporting undergraduate academic and research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nations biomedical and behavioral research agenda.  The MARC U-STAR program is designed to have a significant impact on the health-related research needs of the Nation by providing support  to students underrepresented in the biomedical and behavioral sciences and improving their preparation for highly selective Ph.D. level training and future careers.  The program supports efforts to strengthen the science/math course curricula, pedagogical skills of faculty, and biomedical research training at institutions with significant enrollments of students from underrepresented groups. 
Mechanism of Support:  This Funding Opportunity Announcement (FOA) will utilize the Ruth L. Kirschstein National Research Service Award (NRSA) Prebaccalaureate Institutional Academic and Research Training Grant (T34). 
Funds Available and Anticipated Number of Awards: Because the nature and scope of the proposed research training will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>T34</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-119.html</GuideLink>
<RelDate>2010-03-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[May 25, 2010, 2011, 2012]]></AppReceiptDate>
<LARD>2012-05-25</LARD>
<FileName>PAR-10-119.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-119</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17747</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCRR]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<Title><![CDATA[SHIFT Award: Small Businesses Helping Investigators to Fuel the Translation of Scientific Discoveries  [SBIR: R43/R44]]]></Title>
<Purpose><![CDATA[Purpose. The primary objectives of the SHIFT SBIR initiative are: (1) to foster research that is translational in nature and (2) to transform academic scientific discoveries into commercial products and services.  Academic researchers can be a driving force for new products and services in a small business concern (SBC).  A major feature of the SHIFT program includes the requirement for an investigator who is primarily employed by a United States research institution at the time of application to transition to a small business concern (SBC) and be primarily employed (more than 50% time) by the SBC by or at the time of award.  A SHIFT SBIR grant enables an SBC to increase both its scientific research staff and its core competencies.  The Project Director/Principal Investigator (PD/PI) may also facilitate SBC licensing of intellectual property (IP) from the PD/PIs prior academic institutions, promote collaboration opportunities with academic investigators, and enable better access to academic resources. 
Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications.  
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-122.html</GuideLink>
<RelDate>2010-03-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2013-01-07</LARD>
<FileName>PA-10-122.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-122</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17752</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Advanced Technology SBIR (NIAID-AT-SBIR [R43/R44])
]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for advanced technology projects that require a longer award period and greater award amount than those routinely allowed under the SBIR program.  For this FOA, "advanced technology" is defined as a clearly identified product or service that requires approval of the Food and Drug Administration (FDA) and is within the mission of NIAID.  An example of a clearly identified product is a research project focused on a lead compound for an AIDS drug.  A research project focused on developing an assay to identify lead compounds does not have a clearly identified product and would not be appropriate for this FOA.  Only applications meeting the above advanced technology definition should be submitted in response to this FOA. Applications in response to this FOA should not contain human clinical trials. NIAID Policy currently only allows investigator initiated clinical trials to be submitted using the R34 mechanism.  Information on this process can be found at the following site:  http://funding.niaid.nih.gov/ncn/clinical/R34.htm. 
Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-124, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-123.html</GuideLink>
<RelDate>2010-03-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-123.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-123</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17755</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Advanced Technology STTR (NIAID-AT-STTR [R41/R42])
]]></Title>
<Purpose><![CDATA[Purpose. Add This funding opportunity announcement (FOA) encourages Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) for advanced technology projects that require a longer award period and greater award amount than those routinely allowed under the SBIR program.  For this FOA, "advanced technology" is defined as a clearly identified product or service that requires approval of the Food and Drug Administration (FDA) and is within the mission of NIAID.  An example of a clearly identified product is a research project focused on a lead compound for an AIDS drug.  A research project focused on developing an assay to identify lead compounds does not have a clearly identified product and would not be appropriate for this FOA.  Only applications meeting the above advanced technology definition should be submitted in response to this FOA.  Applications in response to this FOA should not contain human clinical trials.  NIAID Policy currently only allows investigator initiated clinical trials to be submitted using the R34 mechanism.  Information on this process can be found at the following site:  http://funding.niaid.nih.gov/ncn/clinical/R34.htm.  
Mechanism of Support.  This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and and Fast-Track and runs in parallel with a FOA of identical scientific scope, PA-10-123, that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-124.html</GuideLink>
<RelDate>2010-03-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-124.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-124</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17760</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Collaborative Research for Molecular and Genomic Studies of Behavior in Animal Models (R01) 
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA), issued by the National Institute of General Medical Sciences (NIGMS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, is to facilitate collaborative research, involving behavioral scientists and investigators with expertise in molecular biology and/or genomics, which addresses questions about the mechanisms of behavior in animal models. Applications from multiple PIs are encouraged. 
Mechanism of Support. This FOA will utilize the R01 mechanism, 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-125.html</GuideLink>
<RelDate>2010-03-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-125.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-125</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17662</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Collaborative Clinical Trials in Drug Abuse (Collaborative R01)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Drug Abuse (NIDA) seeks to increase the clinical collaboration of investigators between multiple clinical research groups, while simultaneously facilitating the study of outcome measures and/or patient populations that require larger numbers of subjects than any single site can reasonable enroll. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism.  
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01(Collab)</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-099.html</GuideLink>
<RelDate>2010-03-08</RelDate>
<IntentDate>30 days before planned application submission date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-099.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-099</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17763</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ODP]]></PartIC>
<Title><![CDATA[Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R21)

]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung and Blood Institute (NHLBI), the Office of Behavioral and Social Sciences Research (OBSSR) and the Office of Disease Prevention (ODP), National Institutes of Health, invites exploratory pilot/feasibility study and small clinical trial (R21) applications from institutions/organizations that propose to test novel home or family based interventions for the prevention or management of overweight in infancy and early childhood. Tested interventions can use behavioral (including dietary and physical activity), environmental, or other relevant approaches.  Applications should focus on infants and young children (to age six years) and emphasize the role of home environment and the influence of family/extended family members and parents (including guardians/substantial care-providers) within the childs home environment.  The direct goal of this initiative is to fund research that will advance knowledge for innovative approaches to the prevention or management of overweight in children less than 6 years of age, with potential for future research clinical trial applications either in the home or linked to a community setting.  Research should consider the role of families in the initiation, support, and reinforcement of fundamental food and beverage consumption, physical activity practices, and sedentary behaviors.  In addition it is of interest to elucidate various underlying behavioral determinants that are crucial to initiate or sustain changes in behaviors that impact energy balance.  Research designs may include linkages with other settings (e.g., daycare, pre-school, or other community venues) or other care providers (e.g., health care providers or teachers) but must include infants or children less than age six years as the primary study participant along with parents, and/or other family members residing with the child.  The overarching goal is to identify interventions that influence parent and child behaviors that contribute to inappropriate weight gain, and thereby improve subsequent health status in childhood, adolescence, and adulthood for which overweight is a known risk factor.      
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-128.html</GuideLink>
<RelDate>2010-03-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-128.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-128</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17764</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R01)

]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung and Blood Institute (NHLBI), and the Office of Behavioral and Social Science Research (OBSSR), National Institutes of Health, invites Research Project Grant (R01) applications from institutions/organizations that propose randomized clinical trials testing novel home- or family-based interventions for the prevention or management of overweight in infancy and early childhood. Tested interventions can use behavioral (including dietary and physical activity), environmental, or other relevant approaches.  Applications should focus on infants and young children (to age six years) and emphasize the role of home environment and the influence of family/extended family members and parents (including guardians/substantial care-providers) within the childs home environment.  The direct goal of this initiative is to fund research that will advance knowledge for innovative approaches to the prevention or management of overweight in children less than 6 years of age, with potential for future translation to applications either in the home or linked to a community setting.  Research should consider the familial mechanisms of behavior such as the role of families in the initiation, support, and reinforcement of fundamental food and beverage consumption, physical activity practices, and sedentary behaviors.  In addition it is of interest to elucidate various underlying behavioral determinants that are crucial to initiate or sustain changes in behaviors that impact energy balance.  Research designs may include linkages with other settings (e.g., daycare, pre-school, or other community venues) or other care providers (e.g., health care providers or teachers) but must include infants or children less than age six years as the primary study participant along with parents, and/or other family members residing with the child.  The overarching goal is to identify interventions that influence parent and child behaviors that contribute to inappropriate weight gain, and thereby improve subsequent health status in childhood, adolescence, and adulthood for which overweight is a known risk factor. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-127.html</GuideLink>
<RelDate>2010-03-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-127.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-127</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17768</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Drug Abuse Aspects of HIV/AIDS (R21) 
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), encourages Exploratory Developmental Research Grant (R21) applications for early and conceptual stages of research on drug abuse aspects of HIV/AIDS, including research on drug-related risk behaviors, addiction and HIV disease, and drug use/HIV-related comorbidities and consequences. Proposals are needed to identify and predict changes in the epidemiology of HIV/AIDS among injection and non-injection drug users and among their sexual partners, to develop and test primary and secondary drug abuse and HIV prevention and treatment interventions, to improve HIV testing, counseling, and treatment services for those living with HIV/AIDS, and to address basic mechanisms involved in HIV infection and AIDS pathogenesis in the context of drug abuse and addiction.  
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-129 that encourages applications under the R01 and PA-10-131 that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-130.html</GuideLink>
<RelDate>2010-03-11</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-130.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-130</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17769</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[Mentored Research Scientist Development Award (K01)]]></Title>
<Purpose><![CDATA[The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC) invites grant applications for research career development related to occupational safety and health.  The goal of the NIOSH research program is to support research that is relevant and of high quality, and that will have an impact in reducing occupational disease and injury. This program is intended to contribute to this goal by facilitating the preparation of the next generation of occupational safety and health researchers and educators.  Emphasis for funding is placed on projects that specifically address the priority goals of the NIOSH National Occupational Research Agenda (NORA) which is described at http://www.cdc.gov/niosh/programs/. This industrial sector-based agenda has been developed to focus resources on priority problems that significantly impact the illness and injury burden on United States (US) workers.  Research training supported by this announcement may include a wide range of training modalities reflecting the diverse approaches needed to effectively address occupational safety and health problems effectively.]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-132.html</GuideLink>
<RelDate>2010-03-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-132.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-132</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17771</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Drug Abuse Aspects of HIV/AIDS (R03)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), encourages Small Grant (R03) applications for pilot or feasibility studies, secondary data analysis, and small, self-contained research projects on drug abuse aspects of HIV/AIDS, including research on drug-related risk behaviors, addiction and HIV disease, and drug use/HIV-related comorbidities and consequences. Proposals are needed to identify and predict changes in the epidemiology of HIV/AIDS among injection and non-injection drug users and among their sexual partners, to develop and test primary and secondary drug abuse and HIV prevention and treatment interventions, to improve HIV testing, counseling, and treatment services for those living with HIV/AIDS, and to address basic mechanisms involved in HIV infection and AIDS pathogenesis in the context of drug abuse and addiction. 
 Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-10-129 that encourages applications under the R01 and PA-10-130 that encourages applications under thr R21 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-131.html</GuideLink>
<RelDate>2010-03-11</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-131.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-131</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17772</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Drug Abuse Aspects of HIV/AIDS (R01) 
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), encourages Research Project Grant (R01) applications to examine the drug abuse aspects of HIV/AIDS, including research on drug-related risk behaviors, addiction and HIV disease, and drug use/HIV-related comorbidities and consequences. Proposals are needed to identify and predict changes in the epidemiology of HIV/AIDS among injection and non-injection drug users and among their sexual partners, to develop and test primary and secondary drug abuse and HIV prevention and treatment interventions, to improve HIV testing, counseling, and treatment services for those living with HIV/AIDS, and to address basic mechanisms involved in HIV infection and AIDS pathogenesis in the context of drug abuse and addiction.   
Mechanism of Support. This FOA will utilize the R01 grant mechanism, and runs in parallel with a FOA of identical scientific scope, PA-10-130, that encourages applications under the R21 and PA-10-131 that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-129.html</GuideLink>
<RelDate>2010-03-11</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-129.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-129</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17779</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[Understanding and Promoting Health Literacy (R21)]]></Title>
<Purpose><![CDATA[Purpose. The ultimate goal of this program announcement is to encourage empirical research on health literacy concepts, theory and interventions as these relate to the U.S. Department of Health and Human Services public health priorities that are outlined in its HealthierUS and Healthy People initiative.  Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions. 
Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-133 that encourages applications under the R01 grant mechanism, and PAR-10-134, that encourages applications under the R03 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-135.html</GuideLink>
<RelDate>2010-03-12</RelDate>
<IntentDate>Due 30 days before application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-135.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-135</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17780</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[Understanding and Promoting Health Literacy (R01)]]></Title>
<Purpose><![CDATA[Purpose. The ultimate goal of this program announcement is to encourage empirical research on health literacy concepts, theory and interventions as these relate to the U.S. Department of Health and Human Services public health priorities that are outlined in its Healthy People initiative.  Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-134 that encourages applications under the R03 grant mechanism, and PAR-10-135, that encouragess applications under the R21 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-133.html</GuideLink>
<RelDate>2010-03-12</RelDate>
<IntentDate>30 days before application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-133.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-133</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17781</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[ODP]]></PartIC>
<Title><![CDATA[Understanding and Promoting Health Literacy (R03)]]></Title>
<Purpose><![CDATA[Purpose. The ultimate goal of this program announcement is to encourage empirical research on health literacy concepts, theory and interventions as these relate to the U.S. Department of Health and Human Services public health priorities that are outlined in its HealthierUS and Healthy People initiative.  Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions. 
Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-133 that encouragess applications under the R01 grant mechanism, and PAR-10-135, that encouragess applications under the R21 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-134.html</GuideLink>
<RelDate>2010-03-12</RelDate>
<IntentDate>30 days before application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-134.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-134</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17789</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[Development of Animal Models and Related Biological Materials For Research (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) issued by NCRR, National Institutes of Health, encourages research grant applications from institutions/ organizations that propose to develop, characterize or improve animal models for human disease or to improve diagnosis and control diseases of laboratory animals that may interfere with research.  Models to be considered must be applicable to the research interests of two or more categorical NIH Institutes/Centers.  Investigators considering applying are strongly encouraged to consult with NCRR program staff as early as possible to be advised whether this FOA is appropriate.  Proposals to develop models that would not have broad applications, but would apply only to a specific disease or category of research, should be proposed to the appropriate categorical institute of the National Institutes of Health (NIH), e.g., models or model systems with primary focus on cancer or heart diseases should contact those categorical institutes at NIH to discuss alternative funding opportunities.  
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-138.html</GuideLink>
<RelDate>2010-03-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-138.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-138</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17670</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, encourages Research Project Grant (R01) applications that propose to study biological processes involving the cellular organelles in alcohol-induced tissue injury. Excessive alcohol consumption can damage many organ systems including the liver, heart, pancreas, brain, and lung.  However, the mechanisms for these injuries are currently not fully understood.  Cellular organelles play an important role in cellular functions and are significantly involved in alcohol-induced tissue injury.  Thus, studies of alcohols effects on the structure and function of cellular organelles are critical to better understand the mechanisms of alcohol-induced injuries and to develop new strategies for their diagnosis and treatment.  The purpose of this FOA is to: (1) better understand how acute or chronic alcohol consumption affects the structure and function of cellular organelles, and in turn, how these changes contribute to alcohol-induced injury; (2) investigate how variations of proteins in cellular organelles, or their regulation and function, including cellular signaling pathways, contribute to an individuals response to acute or chronic alcohol intake and alcohol-induced tissue injury; (3) develop potential biomarkers for prognosis and diagnosis of tissue injury, or identify new targets for therapeutic interventions.  This FOA aims to foster the utilization of innovative experimental design and emerging technologies, such as genomics, proteomics, metabolomics, bioinformatics, as well as novel microscopic imaging techniques that illuminate functions in intact cells and tissues, to generate new mechanistic and clinical insights into alcohol-induced tissue injuries. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-086, that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards.  The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Although the financial plans of NIAAA provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-085.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-085.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-085</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17659</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol Use Disorders: Treatment, Services Research, and Recovery (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Exploratory/Developmental (R21) grant applications from institutions/organizations that utilize innovative approaches to research on: behavioral and pharmacological treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and/or on the phenomenon of recovery from alcohol use disorders.  
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with two FOAs of identical scientific scope:  PA-10-100 that encourages applications under the R01 mechanism and PA-10-101 that encourages applications under the R03 mechanism.   
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-102.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-102.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-102</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17660</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol Use Disorders:  Treatment, Services Research, and Recovery (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages grant applications from institutions/organizations that propose to support  research on behavioral and pharmacological treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with two FOAs of identical scientific scope: PA-10-100 that encourages applications under the R01 mechanism and PA-10-102 that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-101.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-101.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-101</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17661</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol Use Disorders: Treatment, Services Research, and Recovery (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages grant applications from institutions/organizations that propose to support  research on behavioral and pharmacological treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders.   
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with two FOAs of identical scientific scope:  PA-10-102 that encourages applications under the R21 mechanism and PA-10-101 that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-100.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-100.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-100</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17630</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Stress Pathways in Alcohol Induced Organ Injury and Protection (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, encourages Research Project Grant (R21) applications that propose studying the role of cellular stress responses, the cytoplasmic classical stress response or heat shock response (HSR) and the endoplasmic reticulum (ER) stress, in alcohol-induced tissue injury and tissue protection. While excessive alcohol use causes organ damage, moderate alcohol consumption may be beneficial. The underlying molecular mechanisms for this apparent dichotomy of alcohols harmful and salutary effects are currently not fully understood. Alcohol induces cellular stress pathways in the cytoplasm and in the endoplasmic reticulum that may significantly be involved in alcohol-induced tissue injury or mediate tissue protection depending on the quantity, frequency, duration, and temporal pattern of drinking. Hence, studies of the effects of alcohol on cellular stress pathways are critical to understand the mechanisms of alcohol-induced injuries or protection to develop new strategies for prevention, diagnosis and treatment. The purpose of this FOA is to: (1) acquire insight into how acute or chronic alcohol consumption affects cellular stress pathways and in turn, how these changes contribute to alcohol-induced injury/protection; (2) investigate how alcohol induced stress responses mediate cell survival and death signaling pathways at macromolecular, organelle, cellular and organism level contributing to alcohol-induced tissue injury/protection; (3) develop potential stress related biomarkers for prognosis, diagnosis of tissue injury/protection, furthermore identify new targets for their therapeutic interventions. Utilizing innovative experimental design and emerging technologies, such as deep sequencing, genomics, proteomics, metabolomics, bioinformatics, and novel imaging techniques these investigations are expected to provide a more comprehensive understanding of how alcohol affects the evolutionally conserved stress pathways and elucidate their roles in tissue injuries and repair 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-093, that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-094.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-094.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-094</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17631</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Stress Pathways in Alcohol Induced Organ Injury and Protection (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, encourages Research Project Grant (R01) applications that propose studying the role of cellular stress responses, the cytoplasmic classical stress response or heat shock response (HSR) and the endoplasmic reticulum (ER) stress, in alcohol-induced tissue injury and tissue protection. While excessive alcohol use causes organ damage, moderate alcohol consumption may be beneficial. The underlying molecular mechanisms for this apparent dichotomy of alcohols harmful and salutary effects are currently not fully understood. Alcohol induces cellular stress pathways in the cytoplasm and in the endoplasmic reticulum that may significantly be involved in alcohol-induced tissue injury or mediate tissue protection depending on the quantity, frequency, duration, and temporal pattern of drinking. Hence, studies of the effects of alcohol on cellular stress pathways are critical to understand the mechanisms of alcohol-induced injuries or protection to develop new strategies for prevention, diagnosis and treatment. The purpose of this FOA is to: (1) acquire insight into how acute or chronic alcohol consumption affects cellular stress pathways and in turn, how these changes contribute to alcohol-induced injury/protection; (2) investigate how alcohol induced stress responses mediate cell survival and death signaling pathways at macromolecular, organelle, cellular and organism level contributing to alcohol-induced tissue injury/protection; (3) develop potential stress related biomarkers for prognosis, diagnosis of tissue injury/protection, furthermore identify new targets for their therapeutic interventions. Utilizing innovative experimental design and emerging technologies, such as deep sequencing, genomics, proteomics, metabolomics, bioinformatics, and novel imaging techniques these investigations are expected to provide a more comprehensive understanding of how alcohol affects the evolutionally conserved stress pathways and elucidate their roles in tissue injuries and repair. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01)grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-094, that encourages applications under the under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-093.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-093.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-093</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17616</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), encourages exploratory research on the role of nutrition in cancer prevention. Specifically, this FOA seeks to promote cancer prevention research to identify and characterize molecular targets for bioactive food components. For the purpose of this FOA, a bioactive food component is defined as a dietary constituent that has a health benefit by altering one or more cellular processes when provided in quantities over and beyond that needed for basic nutrition. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-088.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-088.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-088</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17601</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, encourages Research Project Grant (R01) applications that propose to study biological processes involving the cellular organelles in alcohol-induced tissue injury. Excessive alcohol consumption can damage many organ systems including the liver, heart, pancreas, brain, and lung.  However, the mechanisms for these injuries are currently not fully understood.  Cellular organelles play an important role in cellular functions and are significantly involved in alcohol-induced tissue injury.  Thus, studies of alcohols effects on the structure and function of cellular organelles are critical to better understand the mechanisms of alcohol-induced injuries and to develop new strategies for their diagnosis and treatment.  The purpose of this FOA is to: (1) better understand how acute or chronic alcohol consumption affects the structure and function of cellular organelles, and in turn, how these changes contribute to alcohol-induced injury; (2) investigate how variations of proteins in cellular organelles, or their regulation and function, including cellular signaling pathways, contribute to an individuals response to acute or chronic alcohol intake and alcohol-induced tissue injury; (3) develop potential biomarkers for prognosis and diagnosis of tissue injury, or identify new targets for therapeutic interventions.  This FOA aims to foster the utilization of innovative experimental design and emerging technologies, such as genomics, proteomics, metabolomics, bioinformatics, as well as novel microscopic imaging techniques that illuminate functions in intact cells and tissues, to generate new mechanistic and clinical insights into alcohol-induced tissue injuries. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-085, that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-086.html</GuideLink>
<RelDate>2010-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-086.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-086</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17786</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R01)]]></Title>
<Purpose><![CDATA[Purpose. To encourage behavioral and social science research on the causes and solutions to health and disabilities disparities in the U. S. population. Health disparities between, on the one hand, racial/ethnic populations, lower socioeconomic classes, and rural residents and, on the other hand, the overall U.S. population are major public health concerns. Emphasis is placed on research in and among three broad areas of action: 1) public policy, 2) health care, and 3) disease/disability prevention. Particular attention is given to reducing health gaps among groups. Proposals that utilize an interdisciplinary approach, investigate multiple levels of analysis, incorporate a life-course perspective, and/or employ innovative methods such as system science or community-based participatory research are particularly encouraged. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-137, that encourages applications under the R21. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-136.html</GuideLink>
<RelDate>2010-03-18</RelDate>
<IntentDate>August 14, 2010, December 11, 2010, April 11, 2011, August 14, 2011, December 11, 2011, April 11, 2012, August 14, 2012, December 14, 2012, April 11, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 14, 2010, January 11, 2011, May 11, 2011, September 14, 2011, January 11, 2012, May 11, 2012, September 14, 2012, January 14, 2013, May 11, 2013]]></AppReceiptDate>
<LARD>2013-05-11</LARD>
<FileName>PAR-10-136.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-136</DocNum>
<ExpirationDate>2013-05-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17802</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[ODP]]></PartIC>
<Title><![CDATA[Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R21)
]]></Title>
<Purpose><![CDATA[Purpose. To encourage behavioral and social science research on the causes and solutions to health and disabilities disparities in the U. S. population. Health disparities between, on the one hand, racial/ethnic populations, lower socioeconomic classes, and rural residents and, on the other hand, the overall U.S. population are major public health concerns. Emphasis is placed on research in and among three broad areas of action: 1) Public policy, 2) health care, and 3) disease/disability prevention. Particular attention is given to reducing health gaps among groups. Proposals that utilize an interdisciplinary approach, investigate multiple levels of analysis, incorporate a life-course perspective, and/or employ innovative methods such as system science or community-based participatory research are particularly encouraged. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-136, that encourages applications under the R01. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-137.html</GuideLink>
<RelDate>2010-03-18</RelDate>
<IntentDate>August 14, 2010, December 11, 2010, April 11, 2011, August 14, 2011, December 11, 2011, April 11, 2012, August 14, 2012, December 14, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 14, 2010, January 11, 2011, May 11, 2011, September 14, 2011, January 11, 2012, May 11, 2012, September 14, 2012, January 14, 2013, May 11, 2013]]></AppReceiptDate>
<LARD>2013-05-11</LARD>
<FileName>PAR-10-137.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-137</DocNum>
<ExpirationDate>2013-05-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17808</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Exploratory/Developmental Projects in Translational Research for Resistant Epilepsy and Epileptogenesis (R21)]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA), from the National Institute of Neurological Disorders and Stroke (NINDS) encourages applications for projects intended to complete preliminary steps in the pipeline for the preclinical development of therapeutics to cure epilepsy, prevent the emergence of epilepsy following brain injury (including status epilepticus, traumatic brain injury, stroke, encephalitis, or other injury) or in other high-risk groups, or to better treat individuals with intractable epilepsy.  Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required for therapy development can be supported in this program. This program excludes clinical research, basic research, and studies of disease mechanisms. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism  and runs in parallel with a FOA of identical scientific scope, PAR-10-144, that encourages applications under the Cooperative Agreement (U01) mechanism. 
Funds Available and Anticipated Number of Awards. The NINDS funding plan for this FOA will support up to $900,000 total costs, which is sufficient for at least one new application per year for 3 years.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-143.html</GuideLink>
<RelDate>2010-03-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-143.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-143</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17819</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Small Grants on Primary Immunodeficiency Diseases (R03)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases.  The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA.   
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PAS-10-148, that encourages applications under the R21grant mechanism. 
Funds Available and Anticipated Number of Awards. It is anticipated that approximately $150,000 will be available under this FOA and that 2 new awards will be made each fiscal year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-147.html</GuideLink>
<RelDate>2010-03-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-147.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-147</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17820</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support innovative exploratory/developmental investigations in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for, primary immunodeficiency diseases. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in this field are encouraged to apply to this FOA. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-147, that encourages applications under the R03 small grant mechanism. 
Funds Available and Anticipated Number of Awards.   It is anticipated that approximately $650,000 will be available under this FOA and that 2 new awards will be made each fiscal year.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-148.html</GuideLink>
<RelDate>2010-03-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAS-10-148.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-148</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17825</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Grants for Alzheimers Disease Drug Discovery (R21)
]]></Title>
<Purpose><![CDATA[Purpose. The goal of this FOA is to advance the discovery of new, efficacious therapies for the treatment, delay of progression, or prevention of Alzheimers disease (AD), mild cognitive impairment (MCI) and age-related cognitive decline. This FOA encourages the early stages of drug discovery necessary to identify promising disease-modifying therapies as well as treatments aimed at ameliorating the cognitive and neuropsychiatric/behavioral symptoms characteristic of Alzheimers disease.   Studies aimed at the discovery and testing of therapies directed at a variety of established as well as novel therapeutic targets are encouraged. The goal is not to duplicate or compete with pharmaceutical companies but to encourage the process of discovering new, innovative, and effective therapeutics for the prevention and treatment of the cognitive impairment and behavioral symptoms associated with Alzheimer's disease 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism.     
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-151.html</GuideLink>
<RelDate>2010-03-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAS-10-151.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-151</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17833</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Diet Composition and Energy Balance (R01)]]></Title>
<Purpose><![CDATA[Purpose. The goal of this funding opportunity announcement (FOA) is to invite Research Project Grant (R01) applications investigating the role of diet composition in energy balance, including studies in both animals and humans. Both short and longer-term studies are encouraged, ranging from basic studies investigating the impact of micro-or macronutrient composition on appetite, metabolism, and energy expenditure through clinical studies evaluating the efficacy of diets differing in micro- or macronutrient composition, absorption, dietary variety, or energy density for weight loss or weight maintenance. 
Mechanism of Support. This FOA will utilize the Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-152.html</GuideLink>
<RelDate>2010-03-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-152.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-152</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17834</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<Title><![CDATA[NIBIB Biomedical Technology Resource Centers (P41)

]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), encourages grant applications for Biomedical Technology Resource Centers (BTRCs) that are funded using the P41 mechanism.  BTRCs conduct research and development on new technologies that are driven by the needs of basic, translational, and clinical researchers.  BTRCs also make their technologies available, train members of the research community in the use of the technologies, and disseminate these technologies broadly. 
Mechanism of Support. This FOA will utilize the P41 grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.  The total amount awarded and the number of awards will depend upon the number, quality, duration and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P41</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-153.html</GuideLink>
<RelDate>2010-03-25</RelDate>
<IntentDate>30 days before each receipt date</IntentDate>
<AppReceiptDate/><LARD>2013-05-07</LARD>
<FileName>PAR-10-153.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-153</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17836</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Paul Calabresi Career Development Award for Clinical Oncology (K12)]]></Title>
<Purpose><![CDATA[Purpose: This funding opportunity announcement (FOA) issued by the National Cancer Institute (NCI) encourages applications for institutional research career development (K12) programs from applicant organizations that propose to promote the training and career development of translational and clinical trials researchers. The purpose of the Paul Calabresi Career Development Award in Clinical Oncology (PCACO) K12 (NIH Institutional Research Career Development K12 grant mechanism) is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s) and basic research scientists (Ph.D.s. or equivalents) who are trained to design and administer hypothesis-based pilot/Phase I, Phase II, and Phase III cancer therapeutic clinical trials in team research settings. A PCACO can support the research career development of clinicians only (single-track program) or clinicians and Ph.D. basic research scientists (dual-track program). Clinical and basic research scientists will collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train laboratory-based scientists whose research will be primarily focused upon the use of animal or other model systems.  
Mechanism of Support: This FOA will use the NIH Institutional Research Career Development K12 grant mechanism. K12 programs may not be transferred from one institution to another (See section VI.2). 
Funds Available and Anticipated Number of Awards: The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Awards are renewable. 
]]></Purpose>
<RelNote/><ActivityCodes>K12</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-155.html</GuideLink>
<RelDate>2010-03-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[June 10, 2010; June 10, 2011; June 11, 2012]]></AppReceiptDate>
<LARD>2012-06-11</LARD>
<FileName>PAR-10-155.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-155</DocNum>
<ExpirationDate>2012-06-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17839</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Research on Autism and Autism Spectrum Disorders (R21)]]></Title>
<Purpose><![CDATA[Purpose.  This funding opportunity announcement (FOA) encourages research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD).  Basic, clinical, and applied studies are encouraged. This FOA is intended to support the broad research goals of the Strategic Plan for ASD Research (http://iacc.hhs.gov/reports/2009/iacc-strategic-plan-for-autism-spectrum-disorder-research-jan26.shtml).  The R21 grant mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects.  These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on biomedical, behavioral, or clinical research. 
Mechanism of Support.  This FOA will utilize the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-158 and PA-10-159, which encourage applications under the R01 and R03 mechanisms, respectively. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-160.html</GuideLink>
<RelDate>2010-03-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-160.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-160</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17840</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Research On Autism And Autism Spectrum Disorders (R03)]]></Title>
<Purpose><![CDATA[Purpose.  This funding opportunity announcement (FOA) encourages research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD).  Basic, clinical, and applied studies are encouraged. This FOA is intended to support the broad research goals of the Strategic Plan for ASD Research (http://iacc.hhs.gov/reports/2009/iacc-strategic-plan-for-autism-spectrum-disorder-research-jan26.shtml).  The R03 award mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.  The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support.  This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with two FOAs of identical scientific scope, PA-10-158 and PA-10-160, which encourage applications under the R01 and R21 mechanisms, respectively.  
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-159.html</GuideLink>
<RelDate>2010-03-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-159.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-159</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17841</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Research on Autism and Autism Spectrum Disorders (R01)
]]></Title>
<Purpose><![CDATA[Purpose.  This funding opportunity announcement (FOA) encourages research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD).  Basic, clinical, and applied studies are encouraged. This FOA is intended to support the broad research goals of the Strategic Plan for ASD Research (http://iacc.hhs.gov/reports/2009/iacc-strategic-plan-for-autism-spectrum-disorder-research-jan26.shtml). 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with two FOAs of identical scientific scope, PA-10-159 and PA-10-160, which encourage applications under the R03 and R21 mechanisms, respectively. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-158.html</GuideLink>
<RelDate>2010-03-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-158.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-158</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17843</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Research Opportunities on Spasmodic Dysphonia (R01)]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) issued by the National Institute on Deafness and Other Communication Disorders (NIDCD) invites innovative collaborative research project grant applications (R01) designed to improve our understanding of the pathogenesis and pathophysiology of spasmodic dysphonia (SD) for its prevention and improved treatment.  This FOA invites basic, translational and clinical studies to accelerate research into promising therapeutic approaches for spasmodic dysphonia and to stimulate progress in spasmodic dysphonia research through encouraging and facilitating transdisciplinary interactions.   
Mechanism of Support. This FOA will utilize the R01 Research Project Grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-156 that invites applications under the R21 Research Project Grant mechanism.  
Funds Available and Anticipated Number of Awards. This FOA does not have set-aside funds.  The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-157.html</GuideLink>
<RelDate>2010-03-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-157.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-157</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17844</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Research Opportunities on Spasmodic Dysphonia (R21) ]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) issued by the National Institute on Deafness and Other Communication Disorders (NIDCD) invites innovative collaborative research project grant applications (R01) designed to improve our understanding of the pathogenesis & pathophysiology of spasmodic dysphonia (SD) for its prevention and improved treatment.  This FOA invites basic, translational and clinical studies to accelerate research into promising therapeutic approaches for spasmodic dysphonia and to stimulate progress in spasmodic dysphonia research through encouraging and facilitating transdisciplinary interactions.    
Mechanism of Support. This FOA will utilize the R21 Research Project Grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-157 that invites applications under the R01 Research Project Grant mechanism.  
Funds Available and Anticipated Number of Awards. This FOA does not have set-aside funds.  The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-156.html</GuideLink>
<RelDate>2010-03-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-156.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-156</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17823</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Research Career Enhancement Award for Established Investigators (K18)]]></Title>
<Purpose><![CDATA[Purpose: The purpose of the NIDCD Research Career Enhancement Award for Established Investigators (K18) program is to enable established, proven investigators to augment or redirect their research programs through the acquisition of new research skills to answer questions relevant to the hearing, balance, smell, taste, voice, speech and language sciences. 
Mechanism of Support: This Funding Opportunity Announcement (FOA) will utilize the NIH Career Enhancement Award (K18) mechanism. 
Funds Available and Anticipated Number of Awards: The total amount to be awarded by the NIDCD and the number of awards will depend upon the quality and merit of applications received and the availability of funds.  The NIDCD intends to commit up to $500,000 per year to this FOA. 
]]></Purpose>
<RelNote/><ActivityCodes>K18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-162.html</GuideLink>
<RelDate>2010-03-30</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-162.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-162</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17821</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Bioengineering Nanotechnology Initiative (SBIR [R43/R44])
]]></Title>
<Purpose><![CDATA[Purpose. Nanotechnology is the understanding and control of matter at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications. Encompassing nanoscale science, engineering, and technology, nanotechnology involves imaging, measuring, modeling, and manipulating matter at this length scale. The purpose of this trans-NIH Funding Opportunity Announcement (FOA) is to stimulate Small Business Innovation Research (SBIR) grant applications that employ nanotechnology to enable the development of diagnostics and interventions for treating diseases. 
Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-149, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Future year amounts will depend on annual appropriations. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-150.html</GuideLink>
<RelDate>2010-04-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-150.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-150</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17822</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Bioengineering Nanotechnology Initiative (STTR [R41/R42])]]></Title>
<Purpose><![CDATA[Purpose. Nanotechnology is the understanding and control of matter at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications. Encompassing nanoscale science, engineering, and technology, nanotechnology involves imaging, measuring, modeling, and manipulating matter at this length scale. The purpose of this trans-NIH Funding Opportunity Announcement (FOA) is to stimulate Small Business Technology Transfer (STTR) grant applications that employ nanotechnology to enable the development of diagnostics and interventions for treating diseases. 
Mechanism of Support.  This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-150, that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Future year amounts will depend on annual appropriations. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-149.html</GuideLink>
<RelDate>2010-04-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-149.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-149</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17857</rowid>
<PrimaryIC><![CDATA[NCCAM]]></PrimaryIC>
<Title><![CDATA[Preliminary Clinical Studies in Preparation for Large Interventional Trials of Complementary and Alternative Medicine (CAM) Therapies (R34)]]></Title>
<Purpose><![CDATA[Purpose. The goal of this FOA, issued by the National Center for Complementary and Alternative Medicine, is to support early phase clinical research and development on high priority CAM interventions.  This mechanism is intended to support the development of methodology and the preliminary data needed for planning and design of subsequent, larger randomized clinical trials, cluster randomized trials or cohort studies. This mechanism is not appropriate for support of randomized clinical trials to test or determine efficacy. It is appropriate for development of preliminary studies that will contribute to the design of either efficacy or real-world effectiveness studies. 
Mechanism of Support. This FOA will utilize the R34 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-163.html</GuideLink>
<RelDate>2010-04-06</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-163.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-163</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17866</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Identification and Characterization of Molecular Targets Within the mTOR Pathway With Potential to Impact Healthspan and Lifespan (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Aging and the National Cancer Institute encourages grant applications focused on: 1) identifying novel targets within the mTOR (mammalian target of rapamycin) signaling network, the manipulation of which has the potential to promote healthy aging, i.e. extend health span in the aged (NIA interest); and 2) identifying and characterizing dietary constituents that modulate the mTOR pathway and promote cancer prevention (NCI interest).  Identification and characterization of targets can utilize a wide range of approaches, including medicinal chemistry, in vitro assays, and studies in lower organisms or mammalian models. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-164.html</GuideLink>
<RelDate>2010-04-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-17</LARD>
<FileName>PA-10-164.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-164</DocNum>
<ExpirationDate>2013-05-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17869</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[National Cancer Institute (NCI) Cancer Education and Career Development Program (R25)]]></Title>
<Purpose><![CDATA[Purpose:   This Funding Opportunity Announcement (FOA) represents the continuation of the Cancer Education and Career Development Program (CECDP) established by the National Cancer Institute (NCI), of the National Institutes of Health (NIH). The purpose of the CECDP is to support the development and implementation of institutional curriculum-dependent predoctoral/postdoctoral programs in the areas of cancer prevention and control, behavioral and population sciences research, nutrition, epidemiology, and/ or biostatistics. 
Mechanism of Support: This FOA will use the NIH Research Education (R25) grant mechanism.  Research education programs may not be transferred from one institution to another, unless strongly justified (see Section VI.2). 
Funds Available and Anticipated Number of Awards: Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-165.html</GuideLink>
<RelDate>2010-04-12</RelDate>
<IntentDate>A letter of intent is not required for this grant mechanism</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-165.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-165</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17872</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Small Research Grant Program (R03) ]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Research Grant (R03) applications, and expresses AHRQ portfolio priority areas of interest for ongoing small research projects.  The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and, development of new research technology. 
Mechanism of Support. This FOA will use the AHRQ Small Research Grant (R03) mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-168.html</GuideLink>
<RelDate>2010-04-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-03-16</LARD>
<FileName>PAR-10-168.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-168</DocNum>
<ExpirationDate>2014-03-17</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17883</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Institutional Training for a Dental and Craniofacial Research Workforce (T90/R90)
]]></Title>
<Purpose><![CDATA[Purpose: The National Institute of Dental and Craniofacial Research (NIDCR) will award T90/R90 grants to eligible institutions that are committed to supporting predoctoral and postdoctoral research training as a means to help ensure that a diverse and highly trained workforce is available to address the Nations health related needs in dental, oral, and craniofacial research.  This NIDCR program is designed in recognition of the need to develop a cadre of highly qualified independent scientists who can successfully address basic, behavioral, and clinical research questions to improve oral, dental and craniofacial health. Trainees are required to pursue full-time research training.  Priority will be given to programs that present plans and evidence that they will train dentist scientists either as predoctoral dual degree dentist scientists, dentists receiving PhD training or dentists training in a postdoctoral research experience. 
Mechanism of Support:  This Funding Opportunity Announcement (FOA) will use the T90/R90 mechanism that includes linked research training and education programs.  Applicants will submit a single unified grant application and, if selected for funding, two separate awards will be issued: a T90 (Research Training award) and an R90 (Research Education award), which are based on distinct research training and education-related funding authorities.  Each application must include a combination of the following full-time training programs: (1) a Ruth L. Kirschstein National Research Service Award (NRSA) institutional predoctoral and/or postdoctoral training component (T90), and (2) a non-NRSA institutional postdoctoral research component for non-citizen dentists (R90. 
NOTE:  NIDCR has also issued a companion T32 Institutional Training Program Funding Opportunity Announcement (PAR-10-171).   Institutions who do not wish to offer an education component to provide postdoctoral training to foreign-trained dentists who do not meet NRSA eligibility requirements should apply using that announcement.  An institution may not submit applications in response to both announcements. 
]]></Purpose>
<RelNote/><ActivityCodes>T90,R90</ActivityCodes>
<FA_DirectCosts>800000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-170.html</GuideLink>
<RelDate>2010-04-16</RelDate>
<IntentDate>August 25, 2010, 2011, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 25, 2010, 2011, 2012

AIDS Application Submission Date: January 7, 2011, 2012, 2013 ]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-170.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-170</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17884</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) 
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the Cancer Imaging and Radiation Research Programs of the National Cancer Institute (NCI), National Institutes of Health (NIH), encourages applications from research partnerships formed by academic and industrial investigators to accelerate the translation of either animal or human in vivo imaging, image guided, and/or spectroscopic systems and methods designed to solve targeted cancer problems for cancer research, clinical trials, and/or clinical practice. The partners on each application will establish an inter-disciplinary, multi-institutional research team to work in a strategic alliance to implement a coherent strategy to develop and translate the proposed system or methods with potential for significant impact on preclinical, single, or multisite clinical studies. Partnerships must include at least one lead academic and one lead industrial organization large or small among their numbers. For either preclinical or clinical research, funding may be requested for limited additional copies of prototype systems and methods in order to optimize and validate them across different platforms and/or research sites. Each partnership is encouraged to plan to solve its choice of targeted cancer problem within the five year funding period. This FOA supports clinical trials that emphasize optimization and validation of the performance of imaging systems, including devices, agents and/or methods.  It will not support commercial production. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism.  
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-169.html</GuideLink>
<RelDate>2010-04-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-169.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-169</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17885</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental and Craniofacial Research Workforce (T32)
]]></Title>
<Purpose><![CDATA[Purpose: The National Institute of Dental and Craniofacial Research (NIDCR) will award T32 Institutional Training grants to eligible institutions that are committed to supporting predoctoral and postdoctoral research training as a means to help ensure that a diverse and highly trained workforce is available to address the Nations health related needs in dental, oral, and craniofacial research.  This NIDCR program is designed in recognition of the need to develop a cadre of highly qualified independent scientists who can successfully address basic, behavioral, and clinical research questions to improve oral, dental and craniofacial health. Trainees are required to pursue full-time research training.  Priority will be given to programs that present plans and evidence that they will train dentist scientists either as predoctoral dual degree dentist scientists, dentists receiving PhD training or dentists training in a postdoctoral research experience. 
Mechanism of Support:  This Funding Opportunity Announcement (FOA) will utilize the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32). 
NOTE:  NIDCR has also issued a companion T90/R90 Institutional Training Program Funding Opportunity Announcement (PAR-10-170).   Institutions who wish to offer an education component to provide postdoctoral training to foreign-trained dentists who do not meet NRSA eligibility requirements should apply using that announcement.  An institution may not submit applications in response to both announcements. 
]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>800000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-171.html</GuideLink>
<RelDate>2010-04-16</RelDate>
<IntentDate>August 25, 2010, 2011, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 25, 2010, 2011, 2012 
AIDS Application Submission Date: January 7, 2011, 2012, 2013 ]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-171.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-171</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17890</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[NIDA Research Education Program for Clinical Researchers and Clinicians (R25)]]></Title>
<Purpose><![CDATA[Purpose: The NIDA Research Education Program will support research education and training for those in clinically focused careers. Participants (those receiving the research education and training) should be training for careers as clinical researchers, clinicians/service providers, or optimally, a combination of the two. This mechanism may not be used for support of non-research related clinical training. In addition, applicant organizations may only propose research education experiences at the following levels of professional career development: medical/graduate student, postdoctoral fellow, medical resident, and/or independent scientist. Research education and training activities may be in any topic area related to substance use/abuse/addiction; however, the following are examples of particular relevance to this FOA: etiology; clinical assessment and diagnostics; treatment; prevention; health services; clinical neuroscience; medical consequences of drug abuse; and pre-clinical research as it pertains to translational research. Interdisciplinary research education is encouraged and may include co-morbid conditions and consequences of drug use such as HIV/AIDS. Education partnerships and collaborations are also encouraged. 
Mechanism of Support: This FOA will use the NIH Research Education (R25) grant mechanism.  Research education programs may not be transferred from one institution to another, unless strongly justified (see Section VI.2). 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research education program will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-173.html</GuideLink>
<RelDate>2010-04-20</RelDate>
<IntentDate>30 days prior to the application submission date</IntentDate>
<AppReceiptDate><![CDATA[May 25, 2010, May 25, 2011, and May 25, 2012 

AIDS Application Submission Date(s): September 7, 2010, September 7, 2011, and September 7, 2012]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-10-173.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-173</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17904</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<Title><![CDATA[Advanced Tools and Technologies for Deep Brain Stimulation (STTR [R41/R42])]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. 
Mechanism of Support.  This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-176 which encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-175.html</GuideLink>
<RelDate>2010-04-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-175.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-175</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17905</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<Title><![CDATA[Advanced Tools and Technologies for Deep Brain Stimulation (SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. 
Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-175, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-176.html</GuideLink>
<RelDate>2010-04-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-176.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-176</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17906</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12)
]]></Title>
<Purpose><![CDATA[Purpose: The goal of NIH-supported career development programs is to help ensure that a diverse pool of highly trained scientists is available in adequate numbers and in appropriate research areas to address the Nations biomedical, behavioral, and clinical research needs. This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (scholars) leading to research independence in the area of drug abuse and addiction. Candidates selected for support as scholars must hold a clinical or research doctorate and can commit a minimum of 9 person-months (equivalent to 75% of full-time professional effort) conducting clinical research and career development activities associated with the proposed program.  
Mechanism of Support: This FOA will use the NIH Institutional Research Career Development K12 grant mechanism.  K12 programs may not be transferred from one institution to another. (See section VI.2.) 
Funds Available and Anticipated Number of Awards: Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>K12</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-177.html</GuideLink>
<RelDate>2010-04-27</RelDate>
<IntentDate>A letter of intent is not required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-177.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-177</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17909</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<Title><![CDATA[Aging Studies in the Pulmonary System (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Aging (NIA) and the National Heart Lung and Blood Institute (NHLBI) invite research project grant applications that explore age-associated changes in pulmonary physiology, pathology and function, and their relationship to respiratory conditions and diseases that occur commonly in older populations. The goal of this FOA is to support basic, clinical and translational research to address physiological mechanisms underlying progressive functional declines in the pulmonary system. This research will likely enhance our basic understanding of molecular and cellular aspects of pulmonary aging, which may translate into improvements in the prevention and management of pulmonary diseases in older persons. Projects involving in vitro studies, animal models, and/or human subjects are of significant interest to NIA and NHLBI. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-179.html</GuideLink>
<RelDate>2010-04-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-179.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-179</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17911</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages grant  applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT U54 program is to develop new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping.  They include traditional chemical warfare nerve agents such as sarin and VX, and toxic industrial chemicals and pesticides such as cyanide, chlorine, parathion, and sodium fluoroacetate.  The scope of the research to be supported includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy, through Investigational New Drug (IND) submission and Phase 1 clinical trials when appropriate.  Each new CounterACT Research Center of Excellence will be composed of an administrative core, scientifically related research and development subprojects, and scientific cores if needed and justified.  Applicants must demonstrate that the formation of an interdisciplinary Center will produce a synergistic research environment that allows each project to share the creative strengths and resources of the others.  Research and development plans must include milestones that create discrete go or no-go decision points in a progressive translational study plan.    

Mechanism of Support. This FOA will utilize the Specialized Center Cooperative Agreement (U54) grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-180 that encourages applications under the Research Project Cooperative Agreements (U01) program. 
Funds Available and Anticipated Number of Awards.   The participating Institutes intend to commit an average of $6 million per year in Fiscal Years 2011, 2012, and 2013 to fund new and/or competing renewal awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-181.html</GuideLink>
<RelDate>2010-04-29</RelDate>
<IntentDate>August 14 2010; August 14, 2011; August 14, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 14, 2010; September 14, 2011; September 14, 2012
]]></AppReceiptDate>
<LARD>2012-09-14</LARD>
<FileName>PAR-10-181.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-181</DocNum>
<ExpirationDate>2012-09-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17914</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[CHDI]]></PartIC>
<Title><![CDATA[Validation of Novel Therapeutic Targets for Huntingtons Disease (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Neurological Disorders and Stroke (NINDS) invites research project grant (R01) applications aimed at validating novel molecular targets for disease-modifying therapeutic intervention in Huntingtons disease. This FOA is for support of new projects, and not the continuation of projects that have already been initiated with NIH funding. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. $4,500,000 has been set aside in fiscal year 2011 for support of 3 to 4 R01 research projects (assuming average direct costs of $250,000 per year and an average length of four years) in addition to those funded within NINDS regular funding policies.  In subsequent years, the amount available will be contingent upon the availability of funds and will be announced in Notices published in the NIH Guide to Grants and Contracts. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-183.html</GuideLink>
<RelDate>2010-04-30</RelDate>
<IntentDate>30 days prior to anticipated due date. </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAS-10-183.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-183</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17923</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[Occupational Safety and Health Research (R01)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this funding opportunity announcement (FOA) is to develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. 
Mechanism of Support. This FOA will utilize the Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>400000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-188.html</GuideLink>
<RelDate>2010-05-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-188.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-188</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17924</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Clinical Trial Implementation Grant (R01)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) is to invite applications that propose implementation of investigator-initiated non-high-risk clinical trials.  The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/.)  Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (R01) Grant application. 
Mechanism of Support. This FOA will utilize the NIH research project (R01) award mechanism and runs in parallel with two related FOAs, PAR-10-185 and PAR-10-186, that invite applications that propose planning of investigator-initiated clinical trials and implementation of high-risk investigator-initiated clinical trials, respectively.  Pre-approval by the NIAID is required for submission of an application under all three FOAs. 
Funds Available and Anticipated Number of Awards. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.  ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-184.html</GuideLink>
<RelDate>2010-05-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[July 22, 2010, September 13, 2010, January 13, 2011, May 13, 2011, September 13, 2011, January 13, 2012, May 14, 2012, September 13, 2012, January 14, 2013]]></AppReceiptDate>
<LARD>2013-01-14</LARD>
<FileName>PAR-10-184.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-184</DocNum>
<ExpirationDate>2013-01-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17926</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Clinical Trial Planning Grant (R34)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications that propose the complete planning, design, and preparation of documentation necessary for implementation of investigator-initiated clinical trials.  The trials must be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/.)  
Mechanism of Support. This FOA will utilize the NIH clinical trial planning (R34) grant mechanism and runs in parallel with two related FOAs, PAR-10-184 and PAR-10-186, that invite applications that propose implementation of non-high-risk and high-risk investigator-initiated clinical trials, respectively.  Pre-approval by the NIAID is required for submission of an application under all three FOAs. 
Funds Available and Anticipated Number of Awards. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-185.html</GuideLink>
<RelDate>2010-05-05</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[July 22, 2010, September 13, 2010, January 13, 2011, May 13, 2011, September 13, 2011, January 13, 2012, May 14, 2012, September 13, 2012, January 14, 2013]]></AppReceiptDate>
<LARD>2013-01-14</LARD>
<FileName>PAR-10-185.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-185</DocNum>
<ExpirationDate>2013-01-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17933</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[NIDA Research "Center of Excellence" Grant Program (P50)]]></Title>
<Purpose><![CDATA[Purpose. This FOA is to provide support for research Centers that conduct drug abuse and addiction research in any area of NIDAs mission, that have outstanding innovative science, that are multidisciplinary, thematically integrated, synergistic, and that serve as national resource(s) to provide educational and outreach activities to drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research fields. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are required. The P50 Center of Excellence is expected to support the education, training, and mentoring of new investigators who would be given meaningful roles to play in the Center projects.  NIDA Centers are expected to share their findings, their data and their resources, and to serve as national research resources in the drug abuse research field. 
Mechanism of Support. This FOA will utilize the Research Center of Excellence Grant (P50) mechanism.  There should be evidence that the presence of a Center structure is essential for the accomplishment of the research activities. 
Funds Available and Anticipated Number of Awards. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-189.html</GuideLink>
<RelDate>2010-05-07</RelDate>
<IntentDate>August 25, 2010, August 25, 2011, August 25, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 25, 2010, September 25, 2011, September 25, 2012

AIDS Application Submission Dates(s): January 7, 2011, January 7, 2012, January 7, 2013]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-189.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-189</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17941</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R01)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to invite investigator-initiated applications that address basic, clinical, translational, epidemiological and/or behavioral research on vulvodynia and related symptom-based conditions.  The goal of the initiative is to facilitate new research on diagnostic, prevention, and therapeutic approaches to vulvodynia, a chronic pelvic pain condition in women.  An expected outcome will be to provide findings useful for development of future prevention or treatment strategies.  It is anticipated that these studies will increase our understanding of the pathophysiology, biologic and behavioral risk factors, natural history, and genetics of vulvodynia. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-191, which encourages applications under the R03 Small Research Grant mechanism and PAR-10-192, which encourages applications under the R21 Exploratory/Developmental Grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-190.html</GuideLink>
<RelDate>2010-05-07</RelDate>
<IntentDate>August 20, 2010, August 20, 2011, August 20, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 21, 2010, September 21, 2011, September 21, 2012]]></AppReceiptDate>
<LARD>2012-09-21</LARD>
<FileName>PAR-10-190.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-190</DocNum>
<ExpirationDate>2012-09-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17942</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R03)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to invite investigator-initiated applications that address basic, clinical, translational, epidemiological and/or behavioral research on vulvodynia and related symptom-based conditions.  The goal of the initiative is to facilitate new research on diagnostic, prevention, and therapeutic approaches to vulvodynia, a chronic pelvic pain condition in women.  An expected outcome will be to provide findings useful for development of future prevention or treatment strategies.  It is anticipated that these studies will increase our understanding of the pathophysiology, biologic and behavioral risk factors, natural history, and genetics of vulvodynia. The R03 grant mechanism is intended to support small research projects that can be carried out in a short period of time with limited resources.   
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PAR-10-192, which encourages applications under the R21 Exploratory/Developmental Grant mechanism and PAR-10-190, which encourages applications under the R01 Research Grant mechanism. 
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-191.html</GuideLink>
<RelDate>2010-05-07</RelDate>
<IntentDate>August 20, 2010, August 20, 2011, August 20, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 21, 2010, September 21, 2011, September 21, 2012]]></AppReceiptDate>
<LARD>2012-09-21</LARD>
<FileName>PAR-10-191.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-191</DocNum>
<ExpirationDate>2012-09-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17943</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R21)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to invite investigator-initiated applications that address basic, clinical, translational, epidemiological and/or behavioral research on vulvodynia and related symptom-based conditions.  The goal of the initiative is to facilitate new research on diagnostic, prevention, and therapeutic approaches to vulvodynia, a chronic pelvic pain condition in women.  An expected outcome will be to provide findings useful for development of future prevention or treatment strategies.  It is anticipated that these studies will increase our understanding of the pathophysiology, biologic and behavioral risk factors, natural history, and genetics of vulvodynia. By using the R21 grant mechanism, the NIH seeks to foster the introduction of novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-190, that encourage applications under the R01 traditional research grant mechanism, and PAR-10-191 that encourage applications under the R03 Small Research Grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-192.html</GuideLink>
<RelDate>2010-05-07</RelDate>
<IntentDate>August 20, 2010, August 20, 2011, August 20, 2012 </IntentDate>
<AppReceiptDate><![CDATA[September 21, 2010, September 21, 2011, September 21, 2012]]></AppReceiptDate>
<LARD>2012-09-21</LARD>
<FileName>PAR-10-192.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-192</DocNum>
<ExpirationDate>2012-09-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17950</rowid>
<PrimaryIC><![CDATA[NLM]]></PrimaryIC>
<Title><![CDATA[NLM Independent Career Development Award for Biomedical Informatics (K22)]]></Title>
<Purpose><![CDATA[Purpose: The purpose of the NLM Independent Career Development Award for Biomedical Informatics (K22) program is to facilitate the transition of investigators from the mentored to the independent stage of their careers by providing "protected time" for newly independent investigators to develop and receive support for their initial research programs. The award applies to biomedical informaticians who are pursuing research in clinical informatics, public health informatics or translational informatics. Preference will be given to candidates who received their informatics training at one of NLMs university-based training programs in biomedical informatics.  
Mechanism of Support: This Funding Opportunity Announcement (FOA) will utilize the NIH Career Transition Award (K22) mechanism. 
Funds Available and Anticipated Number of Awards: The total amount to be awarded by the NLM and the number of awards will depend upon the quality and merit of applications received and the availability of funds.  NLM anticipates making 3-5 new K22 awards per year.  
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-195.html</GuideLink>
<RelDate>2010-05-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-195.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-195</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17951</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Centers of Biomedical Research Excellence (COBRE) Phase III: Transitional Centers [P30]
]]></Title>
<Purpose><![CDATA[Purpose. The National Center for Research Resources (NCRR) of the NIH invites applications for COBRE infrastructure support grants.  The objectives of this FOA are to continue support of infrastructure at Centers of Biomedical Research Excellence (COBRE) that have received 10 years of funding from NCRR. This FOA is supported through the Institutional Development Award (IDeA) Program at the National Center for Research Resources (NCRR) of NIH.  
Mechanism of Support. This FOA will utilize the NIH center core grant mechanism (P30). 
Funds Available and Anticipated Number of Awards. The NCRR intends to commit approximately $15 million in fiscal year (FY) 2011 to support this program.  It is anticipated that up to 15 applications will be funded in response to this FOA.  Although the financial plans of the NCRR provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>750000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-196.html</GuideLink>
<RelDate>2010-05-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[July 20, 2010, July 20, 2011. and July 20, 2012 ]]></AppReceiptDate>
<LARD>2012-07-20</LARD>
<FileName>PAR-10-196.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-196</DocNum>
<ExpirationDate>2012-07-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17953</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Program in Systems Biology of Developmental Biology & Birth Defects(T32) 
]]></Title>
<Purpose><![CDATA[Purpose: The National Institutes of Health (NIH) awards Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible institutions as the primary means of supporting predoctoral and postdoctoral research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nations biomedical, behavioral and clinical research agenda.  The primary objective of the T32 program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages applications for predoctoral NRSA T32s to provide research training in systems biology of developmental biology and/or structural birth defects research. 
Mechanism of Support:  This Funding Opportunity Announcement (FOA) will utilize the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32). 
Funds Available and Anticipated Number of Awards: Because the nature and scope of the proposed research training will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-193.html</GuideLink>
<RelDate>2010-05-11</RelDate>
<IntentDate>June 14, 2010, April 25, 2011, April 25, 2012</IntentDate>
<AppReceiptDate><![CDATA[July 13, 2010, May 25, 2011, May 25, 2012]]></AppReceiptDate>
<LARD>2012-05-25</LARD>
<FileName>PAR-10-193.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-193</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17954</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Predoctoral and Postdoctoral Training Program in Reproductive, Obstetric, Perinatal and Pediatric Epidemiology and Pharmacoepidemiology (T32)
]]></Title>
<Purpose><![CDATA[Purpose: The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible institutions as the primary means of supporting predoctoral and postdoctoral research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nations biomedical, behavioral and clinical research agenda.  The primary objective of the T32 program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation.   This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), solicits grant applications from institutions/ organizations for the predoctoral and postdoctoral training program in reproductive, obstetric, perinatal and pediatric epidemiology and pharmacoepidemiology. This program supports broad and fundamental, early stage graduate research training and postdoctoral training in reproductive, obstetric, perinatal, and pediatric epidemiology as well as pharmacoepidemiology via institutional training grants. 
Mechanism of Support:  This FOA will utilize the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32). 
Funds Available and Anticipated Number of Awards: Because the nature and scope of the proposed research training will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-194.html</GuideLink>
<RelDate>2010-05-12</RelDate>
<IntentDate>June 14, 2010, April 25, 2011, April 25, 2012</IntentDate>
<AppReceiptDate><![CDATA[July 13, 2010, May 25, 2011, May 25, 2012
]]></AppReceiptDate>
<LARD>2012-05-25</LARD>
<FileName>PAR-10-194.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-194</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17969</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Exploratory Clinical Trials (R01)
]]></Title>
<Purpose><![CDATA[Purpose.  The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for submitting grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS).  The trials must address research questions related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or surgical, behavioral or rehabilitation therapies.  Information about the mission, strategic plans and research interests of the NINDS can be found at the NINDS website (http:\\www.ninds.nih.gov). 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds.  The total amount awarded and the number of awards will depend upon the impact, quality, number, duration, and cost of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-199.html</GuideLink>
<RelDate>2010-05-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-10-199.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-199</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17973</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[NIDDK Multi-Center Clinical Study Implementation Planning Grants (U34)
]]></Title>
<Purpose><![CDATA[Purpose. NIDDK supports investigator-initiated, multi-center (three or more sites) clinical studies exclusively through a two-part process that includes an implementation planning (U34) grant. The U34 planning grant is designed to: (1) permit early peer review of the rationale for the proposed clinical study; (2) permit assessment of the design and protocol of the proposed study; (3) provide support for the development of documents needed for the conduct of the study, including a manual of operations and (4) support the development of other essential elements required for the conduct of a clinical study. Completion of the required products of a U34 grant is a prerequisite for submission of a multi-center clinical study cooperative agreement (U01) application, which will support the actual conduct of the study. Pre-approval from NIDDK will be required for submission of an U34 application. 
Mechanism of Support. This FOA will utilize the U34 grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>U34</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-197.html</GuideLink>
<RelDate>2010-05-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[August 10, 2010; November 15, 2010; June 28, 2011; March 15, 2012; November 15, 2012;and June 28, 2013]]></AppReceiptDate>
<LARD>2013-06-28</LARD>
<FileName>PAR-10-197.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-197</DocNum>
<ExpirationDate>2013-06-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17982</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[The Central Processing of Taste Information (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations studying the role of the central nervous system in the processing of taste information and the perception of taste quality. The purpose of this FOA is to foster basic and clinical research on the central mechanisms underlying the perception of taste quality. A broad range of experimental approaches is encouraged. The NIDCD encourages applications from investigators who are conducting research outside the field of gustation and who are using methodological approaches that have not been typically applied to but which would greatly promote scientific progress within the field. The NIDCD also encourages applications from new investigators in the early stages of establishing an independent research program. 
Mechanism of Support. This FOA will utilize the Research Project Grant (R01) award mechanism 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-201.html</GuideLink>
<RelDate>2010-05-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-10-201.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-201</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17984</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Centers of Excellence in Genomic Science (CEGS) (P50) 
]]></Title>
<Purpose><![CDATA[Purpose. The Centers of Excellence in Genomic Sciences (CEGS) program establishes academic Centers for advanced genome research. Each CEGS grant supports a multi-investigator, interdisciplinary team to develop innovative genomic approaches to address a particular biological problem. A CEGS project will address a critical issue in genomic science, proposing a solution that would be a very substantial advance. Thus, the research conducted at these Centers will entail substantial risk, balanced by outstanding scientific and management plans and very high potential payoff. A CEGS will focus on the development of novel technological or computational methods for the production or analysis of comprehensive data sets, or on a particular genome-scale biological problem, or on other ways to develop and use genomic approaches for understanding biological systems. Exploiting its outstanding scientific plan and team, each CEGS will nurture genomic science at its institution by facilitating the interaction of investigators from different disciplines, and by providing training of new investigators will expand the pool of professional genomics scientists and engineers. Applicants to the CEGS program are required to submit a parallel application to the Initiative to Maximize Research Education in Genomics (R25)http://grants.nih.gov/grants/guide/pa-files/PAR-09-245.html  
Mechanism of Support. This FOA will utilize the Specialized P50 Center grant mechanism. 
Funds Available and Anticipated Number of Awards. NHGRI and NIMH anticipate supporting approximately ten CEGS P50 projects at any one time. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the high-quality applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-202.html</GuideLink>
<RelDate>2010-05-20</RelDate>
<IntentDate>June 21, 2010, April 25, 2011; April 25, 2012 </IntentDate>
<AppReceiptDate><![CDATA[July 21, 2010, May 25, 2011; May 25, 2012
]]></AppReceiptDate>
<LARD>2012-05-25</LARD>
<FileName>PAR-10-202.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-202</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>17987</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Postdoctoral Research Training for Obstetricians and Gynecologists (T32)]]></Title>
<Purpose><![CDATA[Purpose:  The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible institutions as the primary means of supporting predoctoral and postdoctoral research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nations biomedical, behavioral and clinical research agenda.  The primary objective of the T32 program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will award T32 programs is to prepare qualified obstetricians and gynecologists to assume leadership roles related to the Nations biomedical, behavioral and clinical research agenda through a training program composed of a collaboration between a department of obstetrics and gynecology and a department of epidemiology, biostatistics, or preventive medicine (or equivalent).  This initiative will increase the cadre of obstetrician gynecologists with good epidemiologic and clinical trials training to better carry out future clinical and translational research. 
Mechanism of Support:  This Funding Opportunity Announcement (FOA) will utilize the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32). 
Funds Available and Anticipated Number of Awards: Because the nature and scope of the proposed research training will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-203.html</GuideLink>
<RelDate>2010-05-21</RelDate>
<IntentDate>June 28, 2010, April 25, 2011, April 25, 2012</IntentDate>
<AppReceiptDate><![CDATA[July 28, 2010, May 25, 2011, May 25, 2012]]></AppReceiptDate>
<LARD>2012-05-25</LARD>
<FileName>PAR-10-203.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-203</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18000</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[NIH Blueprint for Neuroscience Research Competitive Revisions for Studies Focused on Neuropathic Pain or Neural Plasticity to Promote Collaborative Pain Research (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA is issued as an initiative of the NIH Blueprint for Neuroscience Research.  The Neuroscience Blueprint is a collaborative framework through which 16 NIH Institutes, Centers and Offices jointly support neuroscience-related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders (for further information, see http://neuroscienceblueprint.nih.gov/). The goal of this FOA is to facilitate the partnering of pain scientists and non-pain neuroscientists from the field of neural plasticity to capture insights and expertise from disciplines where transitions from health to disease have been extensively examined. An expected outcome of this FOA will be the formation of partnerships between pain researchers and non-pain neuroscientists to develop new collaborations focused on understanding the maladaptive neuroplastic changes that occur during the transition from acute to chronic pain. It is anticipated that these initial collaborations will lead to new applications for highly innovative projects centered on similar studies of the transition from acute to chronic pain. The purpose of this FOA is to encourage the submission of competitive revision applications that propose a collaborative, one year pilot study or a new specific aim associated with an active NIH grant. The parent grant may be focused on pain or on neural plasticity outside the area of pain. 
Mechanism of Support. This FOA will utilize the Competitive Revision grant mechanism for R01 applications. 
Funds Available and Anticipated Number of Awards. The participating Neuroscience Blueprint Institutes intend to commit at least $375,000 in 2011 (and at least an additional $375,000 per year in 2012 and 2013 to fund approximately 5-6 Competitive Revisions in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>75000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-204.html</GuideLink>
<RelDate>2010-05-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[September 28, 2010; September 28, 2011; September 28, 2012 
]]></AppReceiptDate>
<LARD>2012-09-28</LARD>
<FileName>PAR-10-204.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-204</DocNum>
<ExpirationDate>2012-09-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18003</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[NCRR Science Education Partnership Award (SEPA) (R25)
]]></Title>
<Purpose><![CDATA[Purpose. NCRR encourages applications to its SEPA program for the development and evaluation of innovative research education programs to improve PreK-12 research career opportunities and the community's understanding of the health science advances supported by the National Institutes of Health (NIH)-funded clinical and basic research.  SEPA encourages dynamic partnerships between biomedical and clinical researchers and PreK-12 teachers and schools and other interested organizations. Particular importance will be given to applications that target PreK-12 and/or ISE/media topics that may not be addressed by existing curriculum, community-based or ISE/media activities. 
Mechanism of Support. This FOA will use the NIH Research Education (R25) grant mechanism.  
Funds Available and Anticipated Number of Awards.  NCRR is providing approximately $3 million dollars per year to support this funding opportunity.  NCRR intends to fund approximately 10 new awards per year in FY 2011  2013 in response to this PAR.     
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-206.html</GuideLink>
<RelDate>2010-05-24</RelDate>
<IntentDate>June 28, 2010 May 22, 2011, May 22, 2012</IntentDate>
<AppReceiptDate><![CDATA[July 28, 2010, , June 22, 2011, June 22, 2012]]></AppReceiptDate>
<LARD>2012-06-22</LARD>
<FileName>PAR-10-206.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-206</DocNum>
<ExpirationDate>2012-06-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18011</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[NEI Clinical Vision Research (U10)]]></Title>
<Purpose><![CDATA[Purpose.  The National Eye Institute (NEI) supports investigator-initiated clinical vision research projects, including clinical trials and large-scale epidemiologic studies in vision research.  The intent of this funding opportunity announcement is to provide a framework for applicants proposing clinical vision research projects, including clinical trials and epidemiological studies.    
Mechanism of Support. This FOA will utilize the  National Institutes of Health (NIH) cooperative agreement (U10) grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>U10</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-207.html</GuideLink>
<RelDate>2010-05-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-207.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-207</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18017</rowid>
<PrimaryIC><![CDATA[NCCAM]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Biology of Manual Therapies (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by National Center for Complementary and Alternative Medicine (NCCAM) and the National Cancer Institute (NCI), at the National Institutes of Health (NIH), encourages research grant applications (R01) from institutions/organizations that propose to investigate the basic science and mechanisms of action underlying the biomechanical, immunological, endocrinological and/or neurophysiological consequences of manual therapies, such as spinal manipulation, mobilization and massage therapy. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-210, that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-209.html</GuideLink>
<RelDate>2010-05-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-10-209.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-209</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18018</rowid>
<PrimaryIC><![CDATA[NCCAM]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Biology of Manual Therapies (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Center for Complementary and Alternative Medicine (NCCAM) and the National Cancer Institute (NCI) at the National Institutes of Health (NIH) encourages research grant applications (R21) from institutions/organizations that propose to investigate the basic science and mechanisms of action underlying the biomechanical, immunological, endocrinological and/or neurophysiological consequences of manual therapies, such as spinal manipulation, mobilization and massage therapy. 
Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-209, that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-210.html</GuideLink>
<RelDate>2010-05-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-10-210.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-210</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18040</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Development of Assays for High-Throughput screening for use in Probe and Pre-therapeutic Discovery (R01)
]]></Title>
<Purpose><![CDATA[Purpose.  This FOA issued by the NIDDK, NCI, NHLBI, NIA, NIAAA, NIAID, NIDR, NIGMS and NIMH of the National Institutes of Health,encourages Research Project Grant (R01) applications from institutions/organizations that propose the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to its mission with the intent of using them to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads. The NIH launched a Molecular Libraries and Imaging initiative as part of the NIH Roadmap for Medical Research to establish a network of HTS screening centers which provide access to a large compound library, robotics to carry out the assays, and informatics to interpret the results (http://mli.nih.gov/mli/). This FOA seeks to establish a stream of scientifically and technologically outstanding assays for screening by these and other academic centers. Assays may involve targets indirectly related to disease, but which might provide insight into the biology of relevant diseases. Other targets might be associated with rare and neglected diseases, an area of increasing focus for the NIH (http://www.nih.gov/news/health/may2009/nhgri-20.htm). Assays should be relevant to the scope of the research for at least one of the sponsoring NIH Institutes. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-213.html</GuideLink>
<RelDate>2010-06-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-213.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-213</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18049</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Novel NeuroAIDS Therapeutics: Integrated Preclinical/Clinical Program (P01) ]]></Title>
<Purpose><![CDATA[Purpose. The aim of this Funding Opportunity Announcement (FOA) issued by the National Institute of Mental Health (NIMH), National Institutes of Health (NIH), is to support research focused on accelerating basic and translational scientific discoveries with a plan to advance drug therapeutics for HIV-Associated Neurocognitive Disorders (HAND).  Recent clinical observations indicate that over 50% of HIV infected patients manifest HAND despite receiving highly active antiretroviral therapy (HAART).  These clinical observations inform the need to obtain a better understanding of HAND and to develop novel therapeutic drug candidates to prevent or interfere with progression of HAND.  Applicants are invited to develop a multidisciplinary program with a minimum of three highly integrated research projects and one Administrative Core focused on research and development of novel therapeutics for HAND.  At least one component (research project) may be derived from industry (i.e., pharmaceutical, chemical, bioengineering or biotechnological companies).  A Scientific Advisory Panel (SAP) for each award under this FOA will be constituted within 6 months of the award. 
Mechanism of Support. This FOA will utilize the NIH Program Project (P01) award mechanism. 
Funds Available and Anticipated Number of Awards.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. 
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-216.html</GuideLink>
<RelDate>2010-06-16</RelDate>
<IntentDate>August 7, 2010; August 7, 2011; August 7, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 7, 2010; September 7, 2011; September 7, 2012
]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-10-216.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-216</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18053</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[Occupational Safety and Health Education and Research Centers (T42)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute for Occupational Safety and Health (NIOSH)/ Centers for Disease Control and Prevention (CDC) invites grant applications for Education and Research Centers (ERC) that are focused on occupational safety and health training and research training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the principal means for meeting this mandate. ERCs are academic institutions that provide interdisciplinary graduate training and continuing education in the core occupational safety and health areas of industrial hygiene (IH), occupational health nursing (OHN), occupational medicine residency (OMR), occupational safety (OS), as well as other closely related occupational safety and health (OSH) fields. Research and research training are integral components of ERCs, thus ERC scientists conduct peer reviewed, investigator initiated research on issues related to the National Occupational Research Agenda (NORA). The NIOSH homepage provides a full description of occupational safety and health program areas, http://www.cdc.gov/niosh/homepage.html. The ERCs also serve as regional resource centers for industry, labor, government, and the public. 
Mechanism of Support. This FOA uses the T42 mechanism for the support of ERCs. 
Funds Available and Anticipated Number of Awards. The total amount of funds to be awarded under this program is approximately $20 million dollars per year for new competing applications, competing renewal applications, and continuing awards. The number of awards for this program is between 12 and 20 depending on the quality of the applications and funds available. Each year the number of new competing and competing renewal awards will vary between one and ten depending on the number of awards that have ended. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. ]]></Purpose>
<RelNote/><ActivityCodes>T42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-217.html</GuideLink>
<RelDate>2010-06-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[September 10 2010; August 15, 2011; August 14, 2012; August 14, 2013; August 14, 2014]]></AppReceiptDate>
<LARD>2014-08-14</LARD>
<FileName>PAR-10-217.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-217</DocNum>
<ExpirationDate>2014-08-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18062</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[NIDA Core Center of Excellence Grant Program (P30) ]]></Title>
<Purpose><![CDATA[Purpose. NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are required. A P30 should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to support the education, training, and mentoring of new investigators, and share findings, data and their resources. ]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-220.html</GuideLink>
<RelDate>2010-06-22</RelDate>
<IntentDate>September 27, 2010, August 25, 2011, August 25, 2012</IntentDate>
<AppReceiptDate><![CDATA[October 27,  2010, September 25, 2011, September 25, 2012 ;
AIDS Application Submission Dates(s): January 7, 2011, January 7, 2012, January 7, 2013]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-220.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-220</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18081</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Biophysical and Biomechanical Aspects of Embryonic Development (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),National Institute of Biomedical Imaging and Bioengineering (NIBIB) (http://www.nibib.nih.gov), National Institute of General Medical Sciences (NIGMS), (http://www.nigms.nih.gov/), and  National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov), encourages Research Project Grant (R01) applications from Institutes/ organizations that propose to advance our knowledge in the area of the physics and mechanics of embryonic development. Applicants must propose hypothesis-driven developmental research with the prospect of gaining new and critical information about tissue mechanics relevant to vertebrate development and understanding the basis for developmental disorders. Investigators are encouraged to explore approaches and concepts new to the area of developmental tissue mechanics; and use newly developed techniques superior to the ones currently used in the field. It should be noted that applications using the NIH R01 grant mechanism will require sufficient preliminary data to substantiate the validity of the proposed research and feasibility of new technologies or tools. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) mechanism and runs in parallel with a FOA of similar scientific scope, PAR-10-222 that encourages applications under the NIH Exploratory/Developmental (R21) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-221.html</GuideLink>
<RelDate>2010-06-25</RelDate>
<IntentDate>August 20, 2010, August 20, 2011, August 20 2012</IntentDate>
<AppReceiptDate><![CDATA[September 20, 2010, September 20, 2011, September 20, 2012]]></AppReceiptDate>
<LARD>2012-09-20</LARD>
<FileName>PAR-10-221.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-221</DocNum>
<ExpirationDate>2012-09-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18082</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<Title><![CDATA[Biophysical and Biomechanical Aspects of Embryonic Development (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Biomedical Imaging and Bioengineering (NIBIB) (http://www.nibib.nih.gov), and  National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov), is intended to encourage innovative and high risk/impact research in the area of physics/mechanics of embryonic development to be explored in model organisms. The research proposed under this program can explore approaches and concepts new to the area of developmental tissue mechanics; research and development of new technologies; or initial research and development of data upon which significant future research may be built. The focus of this FOA is to promote research aimed at generating new and critical information about tissue mechanics relevant to vertebrate development and understanding the basis for developmental disorders. While minimal or no preliminary data are expected to be described, applications should clearly indicate the significance of the proposed work and that the proposed research and/or development is scientifically sound, that the qualifications of the investigators are appropriate, and that resources available to the investigators are adequate. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope,  PAR-10-221, that encourages applications under the NIH Research Project Grant (R01) mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-222.html</GuideLink>
<RelDate>2010-06-25</RelDate>
<IntentDate>August 20, 2010, August 20, 2011, August 20 2012</IntentDate>
<AppReceiptDate><![CDATA[September 20, 2010, September 20, 2011, September 20, 2012]]></AppReceiptDate>
<LARD>2012-09-20</LARD>
<FileName>PAR-10-222.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-222</DocNum>
<ExpirationDate>2012-09-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18089</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[NEI Center Core Grants for Vision Research (P30) ]]></Title>
<Purpose><![CDATA[Purpose.  An NEI P30 Center Core Grant combines one or more research modules for a group of R01 investigators to enhance their research, consolidate resources, avoid duplication of efforts, and/or contribute to cost effectiveness by providing a service with lower cost or higher quality than could be attempted for independent projects by several individual PIs.  Shared resources and facilities that are accessible to a group of independently funded investigators lead to greater productivity for the separate projects, and can provide instrumentation and facilities that are too costly to be maintained by an individual investigator.  The design and purpose of each P30 Center Core Grant may vary in how it serves its users.  This program is designed to enhance an institution's environment and capability to conduct vision research and to facilitate collaborative studies of the visual system and its disorders. 
Mechanism of Support. This FOA will utilize the P30 Center Core Grant mechanism 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-223.html</GuideLink>
<RelDate>2010-06-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[September 27, 2010, 2011, 2012
]]></AppReceiptDate>
<LARD>2012-09-27</LARD>
<FileName>PAR-10-223.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-223</DocNum>
<ExpirationDate>2012-09-28</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18091</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Pre-application for a Biomedical Technology Research Center (X02)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Center for Research Resources, National Institutes of Health encourages pre-applications for national Biomedical Technology Research Centers (BTRCs).  These Centers conduct research and development on new technology and new/improved instruments driven by the needs of basic, translational, and clinical researchers.  The BTRCs are charged to make their technologies available, to train members of the research community in the use of the technologies, and to disseminate both the technologies and the Centers experimental results broadly.  A detailed description of the required components of a BTRC can be found in PAR-10-225.  Pre-applications are the first step in order to submit a full BTRC application for a new Center.  Existing Centers are not required to submit a pre-application.  No formal awards will be made under this announcement.  
Mechanism of Support. This FOA will utilize the X02 grant mechanism and runs in parallel with an FOA of similar scientific scope, PAR-10-225 , that describes full applications under the P41 mechanism.  Submitting an X02 pre-application is the first step when submitting a new BTRC application using the P41 mechanism.  Applicants must read both FOAs. 
Funds Available and Anticipated Number of Awards. No awards will be made in response to this FOA.  Authors of Pre-applications  under this FOA that are found meritorious and programmatically relevant will be notified of the opportunity to submit a full application for a new Biomedical Technology Research Center.]]></Purpose>
<RelNote/><ActivityCodes>X02</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-224.html</GuideLink>
<RelDate>2010-06-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[December 14, 2010; May 11, 2011; December 13, 2011; May 11, 2012; December 13, 2012 ]]></AppReceiptDate>
<LARD>2012-12-13</LARD>
<FileName>PAR-10-224.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-224</DocNum>
<ExpirationDate>2012-12-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18092</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Biomedical Technology Research Center (P41)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Center for Research Resources (NCRR), National Institutes of Health (NIH), encourages grant applications for national Biomedical Technology Research Centers. These Centers conduct research and development on new technologies and new/improved instruments driven by the needs of basic, translational, and clinical researchers. The Centers are charged to make their technologies available, to train members of the research community in the use of the technologies, and to disseminate these technologies and the Centers experimental results broadly. New applicants are strongly encouraged to submit a pre-application in response to PAR-10-224 . The pre-application process provides feedback regarding appropriateness for this program and competitiveness of a potential application. 
Mechanism of Support. This FOA will utilize the P41 grant mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-224, that allows pre-applications under the X02 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P41</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-225.html</GuideLink>
<RelDate>2010-06-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-225.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-225</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18093</rowid>
<PrimaryIC><![CDATA[ORWH]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NCMHD]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Advancing Novel Science in Womens Health Research (ANSWHR) (R21)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this Funding Opportunity Announcement (FOA), issued by the Office of Research on Womens Health (ORWH) and co-sponsoring NIH institutes and centers (ICs), is to promote innovative, interdisciplinary research that will advance new concepts in womens health research and the study of sex/gender differences. Recent research reports have established the importance of studying issues specific to women, including the scientific and clinical importance of analyzing data separately for females and males.  ORWH is particularly interested in encouraging extramural investigators to undertake new interdisciplinary research to advance studies on how sex and gender factors affect women's health; however, applications in all areas of womens health and/or sex/gender research are invited.   
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism. 
Funds Available and Anticipated Number of Awards. It is anticipated that $4 million will be available for FY 2011. The total amount awarded and the number of awards will depend upon the number, quality, and costs of the applications received.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-226.html</GuideLink>
<RelDate>2010-07-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[October 16, 2010; October 16, 2011, October 16, 2012 for new applications; November 16, 2010; November 16, 2011; November 16, 2012 for resubmission applications]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAS-10-226.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-226</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18111</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Science Education Drug Abuse Partnership Award (R25)]]></Title>
<Purpose><![CDATA[Purpose: This funding opportunity announcement (FOA) encourages Science Education (R25) grant applications to fund the development and evaluation of innovative model programs and materials for enhancing knowledge and understanding of neuroscience and the neurobiological mechanisms of drug abuse and addiction among K-12 students, the general public, health care practitioners, museums, media experts, and other educational groups. The award provides support for the formation of partnerships between scientists and educators, media experts, community leaders, and other interested organizations for the development and evaluation of programs and materials that will enhance knowledge and understanding of science related to drug abuse. The intended focus is on topics not well addressed in existing efforts by educational, community, or media activities. 
Mechanism of Support: This FOA will use the NIH Research Education (R25) grant mechanism.  Research education programs may not be transferred from one institution to another, unless strongly justified (see Section VI.2). 
Funds Available and Anticipated Number of Awards. Funds Available and Anticipated Number of Awards:  For this funding opportunity, budgets up to $250,000 direct costs/year and time periods up to 4 years may be requested. Awards issued under this FOA are contingent upon the availability of funds and the submission of sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-227.html</GuideLink>
<RelDate>2010-07-09</RelDate>
<IntentDate>A letter of intent is not required.</IntentDate>
<AppReceiptDate><![CDATA[May 25, 2011, May 25, 2012, May 25, 2013]]></AppReceiptDate>
<LARD>2013-05-25</LARD>
<FileName>PAR-10-227.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-227</DocNum>
<ExpirationDate>2013-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18114</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Structural Biology of Membrane Proteins (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by NIGMS, as well as NCI, NIA, NIDCD, NIDDK, NIDA, NIEHS and NHLBI, National institutes of Health, encourages grant applications from institutions/organizations that propose to develop research and methods to enhance the rate of membrane protein structure determination and to determine specific membrane protein structures.  Innovative methods for expression, oligomerization, solubilization, stabilization, purification, characterization, crystallization, isotopic labeling, and structure determination of unique and biologically significant membrane proteins by x-ray diffraction, nuclear magnetic resonance (NMR), electron microscopy, mass spectrometry, and other biophysical techniques are encouraged.  Projects that will lead in the near term to determining the structures of biologically important membrane proteins are also encouraged.  Responding to this FOA, rather than the regular investigator-initiated Research Project Grant (R01) FOA, will help NIH staff track interest and progress of research in this scientific area. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-228.html</GuideLink>
<RelDate>2010-07-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-228.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-228</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18141</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<PartIC><![CDATA[OPD]]></PartIC>
<Title><![CDATA[Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)]]></Title>
<Purpose><![CDATA[Purpose. The goal of FDA's OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy.  FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application's Background and Significance section documentation to support the estimated prevalence of the orphan disease or condition and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development. 
Mechanism of Support. This FOA will utilize the research project (R01) grant. All awards will be subject to all policies and requirements that govern the research grant programs of the PHS as incorporated in the HHS Grants Policy Statement, dated January 1, 2007 (http://www.hhs.gov/grantsnet/adminis/gpd/index.htm), including the provisions of 42 CFR Part 52 and 45 CFR Parts 74 and 92. The regulations issued under Executive Order 12372 do not apply to this program. The NIH modular grant program does not apply to this FDA grant program. All funded studies are subject to the requirements of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 331 et seq.) and regulations issued under it and to applicable Department of Health and Human Services (HHS) statutes and regulations.  All grant awards are subject to applicable requirements for clinical investigations imposed by sections 505, 512, and 515 of the act, section 351 of the PHS Act, and regulations issued under any of these sections. 
Funds Available and Anticipated Number of Awards. Of the estimated FY 2012 funding ($14.1 million), approximately $10 million will fund non-competing continuation awards, and approximately $4.1 million will fund 5 to 12 new awards, subject to availability of funds. It is anticipated that funding for the number of non-competing continuation awards and new awards in FY 2013 will be similar to FY 2012. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-11-001.html</GuideLink>
<RelDate>2010-07-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 2, 2011; February 1, 2012
Resubmission Due Date(s): October 14, 2011 and October 15, 2012]]></AppReceiptDate>
<LARD>2012-10-15</LARD>
<FileName>RFA-FD-11-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-11-001</DocNum>
<ExpirationDate>2012-10-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18154</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Innovative Therapies and Tools for Screenable Disorders in Newborns (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Deafness and Other Communication Disorders (NIDCD) encourages Research Project Grant (R01) applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future.  In this FOA, a high priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.   
Mechanism of Support. This FOA will utilize the R01 funding mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-10-231 and PAR-10-232 that encourage applications under the R03 and R21 mechanisms (FOA numbers/URLs). 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-230.html</GuideLink>
<RelDate>2010-07-19</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-230.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-230</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18155</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Innovative Therapies and Tools for Screenable Disorders in Newborns (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages Small Research Project Grant (R03) applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future.  In this FOA, a high priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-10-230 and PAR-10-232, that encourage applications under the R01, R21 mechanisms (FOA numbers/URLs). 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-231.html</GuideLink>
<RelDate>2010-07-19</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-231.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-231</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18156</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<Title><![CDATA[Innovative Therapies and Tools for Screenable Disorders in Newborns (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and National Institute on Deafness and Other Communication Disorders (NIDCD) encourages Research Project Grant (R21) applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future.  In this FOA, a high priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.  
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-10-230 and PAR-10-231, that encourage applications under the R01 and R03 mechanisms. 
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-232.html</GuideLink>
<RelDate>2010-07-19</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-15</LARD>
<FileName>PAR-10-232.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-232</DocNum>
<ExpirationDate>2013-09-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18160</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<Title><![CDATA[National Institute of Biomedical Imaging and Bioengineering Program Project (P01) Applications 
]]></Title>
<Purpose><![CDATA[Purpose. This FOA, issued by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Insitutes of Health, encourages investigator-initiated Program Project Grant (P01) applications from institutions/organizations in the broad areas of biomedical imaging and bioengineering enabled by relevant areas of the physical sciences, engineering, computer sciences, information science, and the medical and life sciences.  P01 grants are to support broad-based multidisciplinary research programs, which have a well-defined major objective or central theme, but which are addressing a range of imaging or bioengineering questions in contrast to the traditional research project (R01).  Proposed program projects may address any of the broad areas of imaging and bioengineering research supported by the Institute. A description of the NIBIB scientific program areas can be found at http://www.nibib1.nih.gov/Research/ProgramAreas.    
Mechanism of Support. This FOA supports the NIH Program Project (P01) grant mechanism.  The P01 mechanism is designed for research in which the funding of several independent projects as a group offers significant scientific advantages over support of the same projects as individual research grants.  An NIBIB P01 application requires a minimum of three interrelated research projects and the component projects must share a common central theme, focus, and overall objective. 
Funds Available and Anticipated Number of Awards.   Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-233.html</GuideLink>
<RelDate>2010-07-20</RelDate>
<IntentDate>30 days before the receipt date</IntentDate>
<AppReceiptDate/><LARD>2013-05-25</LARD>
<FileName>PAR-10-233.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-233</DocNum>
<ExpirationDate>2013-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18163</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Bioengineering Research Partnerships (BRP)[R01]]]></Title>
<Purpose><![CDATA[Purpose.  Participating Institutes and Centers (ICs) of the National Institutes of Health (NIH) invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological, clinical or biomedical research problems. In the context of this program, a partnership is a multi-disciplinary research team, that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. The partnership must operate according to a clear leadership plan and include appropriate bioengineering or allied quantitative sciences in combination with biomedical and/or clinical components. BRPs may propose, within a 12-page research strategy section, design-directed, developmental, discovery-driven, or hypothesis-driven research at universities, national laboratories, medical schools, large or small businesses, or other public and private entities or combinations of these entities, and will be evaluated against expanded review criteria. It is expected that a BRP will have a well-defined goal or deliverable that will be achieved in a 5-10 year timeframe based on objective milestones specified in the initial application. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
Budget and Project Period.  Because the ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-234.html</GuideLink>
<RelDate>2010-07-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-234.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-234</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18166</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NCMHD]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Climate Change and Health: Assessing and Modeling Population Vulnerability to Climate Change (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is being issued by the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) with participation from the following NIH components: FIC, NCI, NCMHD NHLBI, NIA, NIBIB, NICHD, NLM and OBSSR.  This FOA encourages research applications to examine the differential risk factors of populations that lead to or are associated with increased vulnerability to exposures, diseases and other adverse health outcomes related to climate change. Applications may involve either applied research studies that address specific hypotheses about risk factors or population characteristics associated with increased vulnerability, or research projects to develop general models or methods for identifying and characterizing population vulnerability to climate change.  The ultimate goal of this research program is to help inform climate change adaptation and public health interventions to reduce current and future vulnerability of various populations to the health effects of climate change.  Applications are anticipated to involve a multidisciplinary research team, including experts in health sciences and climatology as well as geography, modeling, statistics, demography, and social and behavioral sciences as appropriate.  In addition, partnerships with community-based or advocacy organizations, public health officials, urban planners and others are encouraged. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism.    
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-235.html</GuideLink>
<RelDate>2010-07-21</RelDate>
<IntentDate>August 28, 2010; April 24, 2011; April 24, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 28, 2010; May 24, 2011; May 24, 2012]]></AppReceiptDate>
<LARD>2012-05-24</LARD>
<FileName>PAR-10-235.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-235</DocNum>
<ExpirationDate>2012-05-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18170</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Health Promotion Among Racial and Ethnic Minority Males (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental (R21) grant applications from applicants that propose to stimulate and expand research in the health of minority men. Specifically, this initiative is intended to: 1) enhance our understanding of the numerous factors (e.g., sociodemographic, community, societal, personal) influencing the health promoting behaviors of racial and ethnic minority males and their subpopulations across the life cycle, and 2) encourage applications focusing on the development and testing of culturally and linguistically appropriate health-promoting interventions designed to reduce health disparities among racially and ethnically diverse males and their subpopulations age 21 and older.   
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism  and runs in parallel with a FOA of identical scientific scope,  PA-10-236 , that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-237.html</GuideLink>
<RelDate>2010-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-237.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-237</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18171</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Health Promotion Among Racial and Ethnic Minority Males (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages  Research Project (R01) grant applications from applicants that propose to stimulate and expand research in the health of minority men. Specifically, this initiative is intended to: 1) enhance our understanding of the numerous factors (e.g., sociodemographic, community, societal, personal) influencing the health promoting behaviors of racial and ethnic minority males and their subpopulations across the life cycle, and 2) encourage applications focusing on the development and testing of culturally and linguistically appropriate health-promoting interventions designed to reduce health disparities among racially and ethnically diverse males and their subpopulations age 21 and older. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope,  PA-10-237 , that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-236.html</GuideLink>
<RelDate>2010-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-236.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-236</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18176</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<Title><![CDATA[Ancillary Studies to the ACCORD Clinical Trial or the ACCORD Follow-on Study (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart Lung and Blood Institute and National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/ organizations that propose studies that either explore mechanisms of outcomes or other clinical measures using the stored biospecimens from the Action to Control Cardiovascular Disease (ACCORD) participants, or that propose studies to collect new observational data in the ACCORD follow-up study.  
Mechanism of Support. This FOA will utilize the Research Project (R01) grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-238.html</GuideLink>
<RelDate>2010-07-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[December 7, 2010, September 28, 2011, September 28, 2012 ]]></AppReceiptDate>
<LARD>2012-09-28</LARD>
<FileName>PAR-10-238.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-238</DocNum>
<ExpirationDate>2012-09-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18189</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Nutrition and Alcohol-Related Health Outcomes (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the National Cancer Institute (NCI), National Institutes of Health (NIH), encourages research grant applications from institutions/organizations that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol dependence and psychiatric co-morbidities, chronic and acute diseases, and organ function and damage. Study designs may include biomedical research, epidemiologic approaches, and intervention studies. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-239 and PA-10-240, that encourages applications under the R01 and R03 mechanisms, respectively. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-241.html</GuideLink>
<RelDate>2010-07-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-241.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-241</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18190</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Nutrition and Alcohol-Related Health Outcomes (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, encourages Small Research Grant (R03) applications from institutions/organizations that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol dependence and psychiatric co-morbidities, chronic and acute diseases, and organ function and damage. Study designs may include biomedical research, epidemiologic approaches, and intervention studies.The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-10-239 and PA-10-241 that encourages applications under the R01 and R21 mechanisms, respectively. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-240.html</GuideLink>
<RelDate>2010-07-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-240.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-240</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18191</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Nutrition and Alcohol-Related Health Outcomes (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Cancer Institute (NCI) encourages Research Grant (R01) applications from institutions/organizations that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol dependence and psychiatric co-morbidities, chronic and acute diseases, and organ function and damage. Study designs may include biomedical research, epidemiologic approaches, and intervention studies. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-10-240 and PA-10-241 that encourages applications under the R03 and R21 mechanisms, respectively. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-239.html</GuideLink>
<RelDate>2010-07-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-239.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-239</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18197</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, encourages research grant applications from institutions/ organizations that propose to investigate the effectiveness of structural interventions that reduce the risk of HIV/AIDS transmission by changing the environment of alcohol use. Although a variety of structural and environmental interventions have been employed successfully to reduce other drinking-related problems, there has been relatively little research that extends such efforts into the realm of HIV/AIDS risk reduction. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-242, that encourages applications under the R01 grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-243.html</GuideLink>
<RelDate>2010-08-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-243.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-243</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18198</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R01)

]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, encourages RO1 research grant applications from institutions/ organizations that propose to investigate the effectiveness of structural interventions that reduce the risk of HIV/AIDS transmission by changing the environment of alcohol use. Although a variety of structural and environmental interventions have been employed successfully to reduce other drinking-related problems, there has been relatively little research that extends such efforts into the realm of HIV/AIDS risk reduction. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-243, that encourages applications under the R21 grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-242.html</GuideLink>
<RelDate>2010-08-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-10-242.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-242</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18199</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[NICHD Program Project Grant (P01) 
]]></Title>
<Purpose><![CDATA[Purpose.  This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) encourages innovative, multidisciplinary, interactive, and synergistic program project grant applications from institutions/organizations that propose to conduct research on reproductive, developmental, behavioral, social, and rehabilitative processes that determine the health or functioning of newborns, infants, children, adults, families, and populations.  The purpose of the P01 mechanism is to encourage investigation of complex problems relevant to NlCHD's mission and to facilitate economy of effort, space, and equipment. Under appropriate circumstances, the collaborative research effort of a program project can accelerate the acquisition of knowledge more effectively than a simple aggregate of research projects without thematic integration. 
Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. 
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-245.html</GuideLink>
<RelDate>2010-08-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-245.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-245</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18207</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[NIDA Program Project Grant Applications (P01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), is to provide support for applications from institutions/organizations that propose broadly based investigative efforts with a well defined central focus or object to address critical issues in drug abuse and addiction involving neuroscience, behavior, prevention, treatment, epidemiology, etiology, health services, HIV/AIDS or other drug abuse-related research areas. 
Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism.  There should be evidence that a program project grant is essential for the accomplishment of the research activities. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-244.html</GuideLink>
<RelDate>2010-08-03</RelDate>
<IntentDate>August 25, 2010</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-244.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-244</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18209</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Strategies for Treatment of Young Adults with Alcohol Use Disorders (R03)

]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25.  Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment.  The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PAS-10-246, that encourages applications under the R01 mechanisms and PAS-10-248 that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the submission of a sufficient number of meritorious applications. NIAAA has set aside $1.5 million in total cost for fiscal year 2011, and expects that a total of up to six awards will be made for this and companions FOAs. The total amount awarded and the number of awards will depend upon the quality, duration and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-247.html</GuideLink>
<RelDate>2010-08-04</RelDate>
<IntentDate>Not more than 30 days before receipt date</IntentDate>
<AppReceiptDate/><LARD>2013-09-07</LARD>
<FileName>PAS-10-247.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-247</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18210</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Strategies for Treatment of Young Adults with Alcohol Use Disorders (R01)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25.  Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment.  
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with two FOAs of identical scientific scope, PAS-10-247 that encourages applications under the R03 mechanism and PAS-10-248 that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the submission of a sufficient number of meritorious applications. NIAAA has set aside $1.5 million in total cost for fiscal year 2011, and expects that a total of up to six awards will be made for this and companions FOAs. The total amount awarded and the number of awards will depend upon the quality, duration and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-246.html</GuideLink>
<RelDate>2010-08-04</RelDate>
<IntentDate>Not more than 30 days before receipt date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAS-10-246.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-246</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18212</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Research Project Grants (R21) applications from institutions/organizations that propose to study the roles and underlying mechanisms of endocannabinoid signaling in alcohol preference, consumption, intoxication and alcohol use disorders, and to explore endocannabinoid signaling system as potential targets for alcohol pharmacotherapy. With increasing knowledge of the function of eCBs in the developing and adult brain and recent behavioral and pharmacological evidence linking alcohol and eCB signaling system, there is now great potential to explore the role of eCB signaling system in alcohol-related behaviors and alcohol use disorders.  Studies supported with this FOA will help to gain knowledge about the role and underlying mechanisms of eCB signaling in alcohol preference and consumption; the interactions of acute and chronic alcohol exposure with eCBs at synapses; the effects of such interactions on short- and long-term synaptic plasticity; the role of eCB signaling in the development and maturation of the central nervous system; and the eCB signaling system in fetal alcohol spectrum disorders. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope,  PA-10-249, that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-250.html</GuideLink>
<RelDate>2010-08-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-250.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-250</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18213</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R01)

]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Research Project Grants (R01) applications from institutions/organizations that propose to study the roles and underlying mechanisms of endocannabinoid signaling in alcohol preference, consumption, intoxication and alcohol use disorders, and to explore endocannabinoid signaling system as potential targets for alcohol pharmacotherapy. With increasing knowledge of the function of eCBs in the developing and adult brain and recent behavioral and pharmacological evidence linking alcohol and eCB signaling system, there is now great potential to explore the role of eCB signaling system in alcohol-related behaviors and alcohol use disorders.  Studies supported with this FOA will help to gain knowledge about the role and underlying mechanisms of eCB signaling in alcohol preference and consumption; the interactions of acute and chronic alcohol exposure with eCBs at synapses; the effects of such interactions on short- and long-term synaptic plasticity; the role of eCB signaling in the development and maturation of the central nervous system; and the eCB signaling system in fetal alcohol spectrum disorders. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-250, that encourages applications under the R21 mechanism (URL). 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-249.html</GuideLink>
<RelDate>2010-08-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-249.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-249</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18214</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Strategies for Treatment of Young Adults with Alcohol Use Disorders (R21)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25.  Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment.  
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism  and runs in parallel with two FOAs of identical scientific scope, PAS-10-246, that encourages applications under the R01 mechanism and PAS-10-247 that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the submission of a sufficient number of meritorious applications. NIAAA has set aside $1.5 million in total cost for fiscal year 2011, and expects that a total of up to six awards will be made for this and companions FOAs. The total amount awarded and the number of awards will depend upon the quality, duration and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-248.html</GuideLink>
<RelDate>2010-08-04</RelDate>
<IntentDate>more than 30 days before receipt date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAS-10-248.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-248</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18219</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Treatment of Co-Occurring Alcohol Use Disorders and Depression/Anxiety Disorders (R21)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), invites applications to support research on the treatment of individuals with co-occurring alcohol use disorders and depression/anxiety. Anxiety disorders include generalized anxiety disorder, social phobia, and posttraumatic stress disorder.   The scope of interest includes innovative pharmacological and behavioral treatments based on biological, psychological, behavioral, and social/cultural models of etiology and treatment of comorbid alcohol use disorders and depression/anxiety.  In addition, this FOA accepts Comparative and Effectiveness Research applications which compares two or more different existing treatments in this comorbid population. This FOA is limited to depression and anxiety because of the high prevalence of these psychiatric disorders in individuals with alcohol use disorders. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope,  PAS-10-251, that encourages applications under the R01 mechanisms 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the submission of a sufficient number of meritorious applications. NIAAA has set aside $1.5 million in total cost for fiscal year 2011, and expects that a total of up to six awards will be made for this and companions FOAs. The total amount awarded and the number of awards will depend upon the quality, duration and costs of the applications received 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-252.html</GuideLink>
<RelDate>2010-08-05</RelDate>
<IntentDate>Not more than 30 days berore due date</IntentDate>
<AppReceiptDate/><LARD>2013-09-07</LARD>
<FileName>PAS-10-252.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-252</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18211</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Treatment of Co-Occurring Alcohol Use Disorders and Depression/Anxiety Disorders (R01)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), invites applications to support research on the treatment of individuals with co-occurring alcohol use disorders and depression/anxiety. Anxiety disorders include generalized anxiety disorder, social phobia, and posttraumatic stress disorder.   The scope of interest includes innovative pharmacological and behavioral treatments based on biological, psychological, behavioral, and social/cultural models of etiology and treatment of comorbid alcohol use disorders and depression/anxiety.  In addition, this FOA accepts Comparative and Effectiveness Research applications which compare two or more different existing treatments in this comorbid population. This FOA is limited to depression and anxiety because of the high prevalence of these psychiatric disorders in individuals with alcohol use disorders.   
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, PAS-10-252, that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the submission of a sufficient number of meritorious applications. NIAAA has set aside $1.5 million in total cost for fiscal year 2011, and expects that a total of up to six awards will be made for this and companions FOAs. The total amount awarded and the number of awards will depend upon the quality, duration and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-251.html</GuideLink>
<RelDate>2010-08-05</RelDate>
<IntentDate>Not more than 30 days before due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAS-10-251.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-251</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18235</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Research on Hearing Health Care (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA, issued by the National Institute on Deafness and Other Communication Disorders, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations to support research leading to accessible and affordable hearing health care (HHC).  The overarching emphasis is on the acquisition of knowledge that can be rapidly translated into new or enhanced approaches for access, assessment or interventions with a goal to delivering better hearing health care outcomes. Applications should seek quality approaches that are effective, affordable and deliverable to those who need them as well as implementable and sustainable in settings beyond the research environment.    
Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-254, that encourages applications under the R21 mechanism .    
Funds Available and Anticipated Number of Awards. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-253.html</GuideLink>
<RelDate>2010-08-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-253.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-253</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18236</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Research on Hearing Health Care (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA, issued by the National Institute on Deafness and Other Communication Disorders, National Institutes of Health, encourages Exploratory/Developmental Research Grant (R21) applications from institutions/organizations to support research leading to accessible and affordable hearing health care (HHC).  The overarching emphasis is on the acquisition of knowledge that can be rapidly translated into new or enhanced approaches for access, assessment or interventions with a goal to delivering better hearing health care outcomes. Applications should seek quality approaches that are effective, affordable and deliverable to those who need them as well as implementable and sustainable in settings beyond the research environment.  
Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-253, that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. The total amount awarded and the anticipated number of awards will depend upon the quality, duration and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-254.html</GuideLink>
<RelDate>2010-08-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-254.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-254</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18231</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)

]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) issued by the Fogarty International Center (FIC), together with the Office of Dietary Supplements (OD/ODS), the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), the National Institute on Aging (NIA), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Environmental Health Sciences (NIEHS), encourages applications for the Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) D43 program for collaborative research training between institutions in the U.S. and low-and middle-income countries (LMIC), defined by the World Bank classification system. The proposed institutional research training program is expected to sustainably strengthen the research capacity of the LMIC institutions, and to train in-country experts to conduct research on chronic, non-communicable diseases and disorders across the lifespan, with the ultimate goal of implementing evidence-based interventions relevant to their countries.   
Mechanism of Support: This FOA will use the NIH Institutional Research Training D43 grant mechanism.  Training programs may not be transferred from one institution to another. (See section VI.2.) 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed international research training program will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.   
]]></Purpose>
<RelNote/><ActivityCodes>D43</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-257.html</GuideLink>
<RelDate>2010-08-10</RelDate>
<IntentDate>October 2 2010, August 21, 2011, August 21, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 2, 2010, September 21, 2011, September 21, 2012]]></AppReceiptDate>
<LARD>2012-09-21</LARD>
<FileName>PAR-10-257.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-257</DocNum>
<ExpirationDate>2012-09-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18232</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health, encourages Exploratory/Developmental Research Project Grants (R21) applications from institutions/organizations that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism   and runs in parallel with a FOA of identical scientific scope,  PA-10-255 , that encourages applications under the R01 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-256.html</GuideLink>
<RelDate>2010-08-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2013-09-07</LARD>
<FileName>PA-10-256.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-256</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18233</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R01)

]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Research Project grants (R01) applications from institutions/organizations that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. 
Mechanism of Support. This FOA will utilize the Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-10-256 , that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-255.html</GuideLink>
<RelDate>2010-08-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-255.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-255</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18254</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Neurobiology of Migraine (R01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is a program announcement (PA) issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Dental and Craniofacial Research (NIDCR), and National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). It encourages R01 grant applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development.   
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with a FOA of identical scientific scope,  PA-10-259, that encourages applications under the NIH Exploratory/Developmental (R21) mechanism.  
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-258.html</GuideLink>
<RelDate>2010-08-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-258.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-258</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18255</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Neurobiology of Migraine (R21)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is a program announcement (PA) issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Environmental Health Sciences (NIEHS), and Office of Research on Womens Health, National Institutes of Health (NIH). It encourages R21 grant applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development.   
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope,  PA-10-258, that encourages applications under the NIH Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-259.html</GuideLink>
<RelDate>2010-08-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-259.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-259</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18260</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<Title><![CDATA[Global Infectious Disease Research Training Program (D43)]]></Title>
<Purpose><![CDATA[Purpose. The Fogarty International Center (FIC) encourages renewal and new applications for the Global Infectious Disease Research Training Program. The application must propose a collaborative research training program that will strengthen the capacity of institutions in low-and middle-income countries (LMIC), defined by the World Bank classification system, to conduct infectious disease (excluding HIV/AIDS) research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, widespread co-infections of HIV/AIDS patients or infections associated with non-communicable disease conditions of poverty in developing countries (see the FIC Strategic Plan http://www.fic.nih.gov/about/plan/strategicplan_08-12.htm  and Global Health Initiative http://www.theglobalhealthinitiative.org/).  
Mechanism of Support. This FOA will utilize the D43 grant mechanism.  
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research education program will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received as well as the availability of funds.  
]]></Purpose>
<RelNote/><ActivityCodes>D43</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-260.html</GuideLink>
<RelDate>2010-08-13</RelDate>
<IntentDate>April 21, 2012, April 21, 2013</IntentDate>
<AppReceiptDate><![CDATA[May 21, 2012, May 21, 2013]]></AppReceiptDate>
<LARD>2013-05-21</LARD>
<FileName>PAR-10-260.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-260</DocNum>
<ExpirationDate>2013-05-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18264</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Limited Pilot for NIGMS Legacy Community-Wide Scientific Resources (R24)]]></Title>
<Purpose><![CDATA[Purpose. The purpose of this limited pilot funding opportunity issued by NIGMS, NIH is to allow applications for continued support of important legacy resources developed as a result of NIGMS-supported research activities that are not being renewed under the original initiatives, because an initiative is expiring or an award is not renewable due to a fixed duration of funding specified in the initiative.  A resource is a non-hypothesis-driven activity to provide data, materials, tools, or services that are essential to making the most timely, high quality, and cost-efficient progress in a field.  Additionally, a resource should be available to all investigators for clear purposes that are known.  NIGMS will consider funding (or providing partial support) for resources that are central to its mission, not supportable by other institutes/centers initiatives, and not yet self-sustaining or commercializable.  A resource must show great potential for having high value to a community of researchers that the institute supports with its granting programs.  This funding opportunity is designed only to support continuation of existing resources, not to develop new ones.  The support requested must be for funding of maintenance activities only, and not for research activities.  Because this is a limited pilot, awardees should be aware that support may not continue beyond the funding period.       
Mechanism of Support. This FOA will utilize the R24 grant mechanism. 
Funds Available and Anticipated Number of Awards. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-261.html</GuideLink>
<RelDate>2010-08-16</RelDate>
<IntentDate>September 26, 2010, September 26, 2011, September 26, 2012</IntentDate>
<AppReceiptDate><![CDATA[October 26, 2010, October 26, 2011, October 26, 2012
]]></AppReceiptDate>
<LARD>2012-10-26</LARD>
<FileName>PAR-10-261.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-261</DocNum>
<ExpirationDate>2012-10-27</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18268</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<Title><![CDATA[Planning Grant for Global Infectious Disease Research Training Program (D71)
]]></Title>
<Purpose><![CDATA[Purpose. The Fogarty International Center (FIC), encourages new applications for planning grants in the Global Infectious Disease Research Training Program (GID), The application must propose a plan to develop the components necessary for an international research training program application to submit in response to the D43 FOA for the Global Infectious Disease Research Training Program (GID),. In developing an application for a planning grant, applicants need to be aware of the objectives and special requirements of this program defined in the Global Infectious Disease Research Training Program (GID) (D43),(PAR-10-260) Funding Opportunity Announcement (FOA)  The  Global Infectious Disease Research Training Program (GID) supports research training that will strengthen the capacity of institutions in low-and middle-income countries (LMIC), defined by the World Bank classification system, to conduct infectious disease (excluding HIV/AIDS) research. FIC will support planning grants for research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, widespread co-infections of HIV/AIDS patients or infections associated with non-communicable disease conditions of poverty in developing countries (see the FIC Strategic Plan http://www.fic.nih.gov/about/plan/strategicplan_08-12.htm  and the Global Health Initiative http://www.theglobalhealthinitiative.org/.) The planning grant application should be developed and implemented collaboratively with all designated participating institutions.   ]]></Purpose>
<RelNote/><ActivityCodes>D71</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-262.html</GuideLink>
<RelDate>2010-08-17</RelDate>
<IntentDate>April 21, 2012, April 21, 2013</IntentDate>
<AppReceiptDate><![CDATA[May 21, 2012, May 21, 2013]]></AppReceiptDate>
<LARD>2013-05-21</LARD>
<FileName>PAR-10-262.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-262</DocNum>
<ExpirationDate>2013-05-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18283</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<Title><![CDATA[Asthma in Older Adults (R03)
]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. Different types of projects may be supported by this mechanism, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope,  PA -10-263, that encourages applications under the R01 research grant mechanism, and PA-10-264, that encourages applications under the R21 exploratory/developmental mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-265.html</GuideLink>
<RelDate>2010-08-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-265.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-265</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18284</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<Title><![CDATA[Asthma in Older Adults (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA encourages Exploratory/Developmental Grant (R21) applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope,  PA-10-263, that encourages applications under the R01 research grant mechanism, and PA-10-265, that encourages applications under the R03 small research grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-264.html</GuideLink>
<RelDate>2010-08-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-264.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-264</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18285</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<Title><![CDATA[Asthma in Older Adults (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Aging, the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) encourages Research Project Grant (R01) applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. 
Mechanism of Support. This FOA will utilize the R01 research grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-265, that encourages applications under the R03 small research grant mechanism, and  PA-10-264, that encourages applications under the R21 exploratory/developmental grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-263.html</GuideLink>
<RelDate>2010-08-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-263.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-263</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18287</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[NIMH Research Education Grants (R25)]]></Title>
<Purpose><![CDATA[Purpose: This funding opportunity announcement (FOA) issued by the National Institute of Mental Health (NIMH) encourages Research Education Grant (R25) applications from Institutions/Organizations that propose creative and innovative research educational programs to facilitate the development of a cadre of investigators in appropriate scientific areas to fulfill the objectives of the NIMH Strategic Plan (http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml).The interests of the NIMH are broad, spanning from basic neuroscience, human genetics/genomics and translational research to interventions and mental health services research across the lifespan. While not limited to the categories and examples provided below, the NIMH is particularly interested in innovative R25 applications that propose to develop short courses or workshops, research mentoring networks, activities during medical school and/or residency that encourage the development of research-oriented physician-scientists, or that combine didactic instruction with ongoing mentoring and research opportunities. 

Mechanism of Support: This FOA will use the NIH Research Education (R25) award mechanism. Research education programs may not be transferred from one institution to another, unless strongly justified (see Section VI.2). 

Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research education program will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received.

Budget and Project Period: The total project period for an application submitted in response to this FOA may not exceed five years. The direct costs are limited to $250,000 annually. All personnel costs (including administrative and clerical costs, as well as salaries of the PD/PI and other investigators/faculty) associated with directing, coordinating, administering, and implementing the program should be justified and reasonable. Personnel costs cannot exceed 25 percent of the requested directs costs annually.]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-267.html</GuideLink>
<RelDate>2010-08-20</RelDate>
<IntentDate>30 days before the submission date</IntentDate>
<AppReceiptDate><![CDATA[October 19, 2010, then September 25 annually for new, resubmission, renewal, and revision applications]]></AppReceiptDate>
<LARD>2012-09-25</LARD>
<FileName>PAR-10-267.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-267</DocNum>
<ExpirationDate>2012-09-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18288</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Neuroscience Research on Drug Abuse (R01)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/ organizations that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. 

Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-269, that encourages applications under the R21 mechanism, and PA-10-270 that encourages applications under the R03 mechanism. 

Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 

Budget and Project Period.Costs appropriate for the project and a project duration of up to five years may be requested.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-268.html</GuideLink>
<RelDate>2010-08-20</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-268.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-268</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18289</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Neuroscience Research on Drug Abuse (R21)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), encourages research grant applications from institutions/ organizations that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction. This research may be conducted using model systems, animals, and/or humans. The Exploratory/Developmental Grant (R21) mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. 

Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-268, that encourages applications under the R01 mechanism, and PA-10-270 that encourages applications under the R03 mechanism

Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, quality, duration, and costs of the applications received.

Budget and Project Period.The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-269.html</GuideLink>
<RelDate>2010-08-20</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-269.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-269</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18290</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Neuroscience Research on Drug Abuse (R03)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages research grant R03 applications from institutions/ organizations that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.Preliminary data are not required for an R03. 

Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-269, that encourages applications under the R21 mechanism, and PA-10-268 that encourages applications under the R01 mechanism. 

Funds Available and Anticipated Number of Awards. Because the R03 is a small grant mechanism, it is anticipated that the nature and scope of the proposed research will be limited. The number of awards will depend upon the quality and alignment with NIDAs programmatic priorities of the applications received. 

Budget and Project Period.Budgets for direct costs of up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-270.html</GuideLink>
<RelDate>2010-08-20</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-270.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-270</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18295</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Investigator Initiated Program Project Applications (P01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites submission of investigator-initiated Program Project (P01) applications.The proposed programs may address scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases. Each P01 application submitted in response to this FOA must include at least two related research projects that share a common central theme, focus, and/or overall objective.

Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. 

Funds Available and Anticipated Number of Awards.The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. 

Budget and Project Period. Applicants may request support for up to 5 years. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Application Research Strategy Length: The Research Strategy sections of the Overall Program and of each individual Research Project may not exceed 12 pages, and the Core Services Strategy sectionfor the individual Cores may not exceed 6 pages, including tables, graphs, figures, diagrams, and charts.SeeTable of Page Limits.]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-271.html</GuideLink>
<RelDate>2010-08-20</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-271.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-271</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18296</rowid>
<PrimaryIC><![CDATA[NCCAM]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Mechanistic Research on CAM Natural Products (R01) ]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Center for Complementary and Alternative Medicine (NCCAM) in collaboration with the Office of Dietary Supplements (ODS), at the National Institutes of Health, invites Research Project Grant (R01) applications to study the potential mechanisms of action of promising CAM natural products (NPs). Natural products are widely used by Americans for health purposes. Knowledge about the active components, their molecular and cellular targets, as well as  markers of potential beneficial or harmful biological effects are critical pieces of preliminary information needed to insure maximally informative clinical efficacy studies on these products. Research on the development of improved methodology for the isolation and characterization of constituents of natural products and on their determination in the natural matrix will also be supported under this initiative. 
Mechanism of Support. This FOA will utilize the R01 award mechanism. 
Funds Available and Anticipated Number of Awards. NIH participants are contributing $8.1 million in total to this FOA. The total amount to be awarded in the first year is approximately $1.625 million (total costs). Approximately 2-4 awards are anticipated. The total amount to be awarded in the second and third year is approximately $3.25 million (total costs). Approximately 5-7 awards are anticipated per year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-11-001.html</GuideLink>
<RelDate>2010-08-23</RelDate>
<IntentDate>November 1, 2010, February 1, 2011, September 30, 2011, February 1, 2012, September 30, 2012</IntentDate>
<AppReceiptDate><![CDATA[December 1, 2010, March 1, 2011, November 1, 2011, March 1, 2012, November 1, 2012]]></AppReceiptDate>
<LARD>2012-11-01</LARD>
<FileName>RFA-AT-11-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AT-11-001</DocNum>
<ExpirationDate>2012-11-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18303</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Clinically Relevant Comparative Effectiveness of Alcoholism Treatments (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages grant applications from institutions/organizations that propose to support research on the comparative effectiveness in typical clinical settings of pharmacologic and behavioral treatments for alcohol use disorders given patient characteristics, and the organizational, financial, and management factors that facilitate or inhibit the delivery of evidence-based services for alcohol use disorders, The overall goal is to inform clinical decision-making  that will enhance treatment outcomes and reduce harms associated with interventions for alcohol use disorders. 
Mechanism of Support. This FOA will utilize the R01 grant mechanism 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the submission of a sufficient number of meritorious applications. NIAAA has set aside $ 1.5 million in total cost for fiscal year 2011, and expects that a total of up to six awards will be made. The total amount awarded and the number of awards will depend upon the quality, duration and costs of the applications received.   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-273.html</GuideLink>
<RelDate>2010-08-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAS-10-273.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-273</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18304</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[NIOSH Support for Conferences and Scientific Meetings (R13)]]></Title>
<Purpose><![CDATA[Purpose: The purpose of the NIOSH Research Conference Grant Program (R13) is to support high quality conferences/scientific meetings that are relevant to its scientific mission and to the public health. A conference/scientific meeting is defined as a gathering, symposium, seminar, scientific meeting, workshop or any other organized, formal meeting where persons assemble to coordinate, exchange, and disseminate information or to explore or clarify a defined subject, problem, or area of knowledge. Applications for training only events will not be considered under this announcement. 
Mechanism of Support: This funding opportunity announcement (FOA) will use the HHS conference grant (R13) award mechanism. 
Funds Available and Anticipated Number of Awards:  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>R13</ActivityCodes>
<FA_DirectCosts>20000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-272.html</GuideLink>
<RelDate>2010-08-25</RelDate>
<IntentDate>Sixty calendar days in advance of standard Application</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-10-272.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-272</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18307</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Small Grant Program for New Investigators (R03)]]></Title>
<Purpose><![CDATA[Purpose. This NIDCR Small Grant Program for New Investigators supports basic and clinical research of scientists who are in the early stages of establishing an independent research career in oral, dental, and craniofacial research. This R03 grant mechanism supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent Investigator-initiated Research Project Grant (R01) application. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received. Awards will also be contingent upon availability of funds and programmatic priorities. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-275.html</GuideLink>
<RelDate>2010-08-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-275.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-275</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18309</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM)  NIDA (R21/R33) 

]]></Title>
<Purpose><![CDATA[Purpose. The National Institute on Drug Abuse (NIDA), through the issuance of this program announcement, with set aside funds (PAS), invites Phased Innovation (R21/R33) grant applications from new-to-NIH investigators into basic chemistry research applied to drug abuse and addiction.  NIDA invites newly independent investigators and investigators who have not had previous NIH funding to submit applications for research projects related to NIDAs mission. 
Mechanism of Support. This FOA will utilize the Exploratory/Developmental Phased Innovation (R21/R33) grant mechanism. Applicants will submit a single application organized into two phases, beginning with discussion of the R21 phase followed by discussion of the R33 phase. Applicants using only the R21 mechanism or only the R33 mechanism will not be considered. 
Funds Available and Anticipated Number of Awards. NIDA intends to commit approximately $1,500,000 in FY 2011 to fund 6 to 8 grants. Funding will be based on scientific and technical merit, program priorities, and availability of funds. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award also will vary. ]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-10-274.html</GuideLink>
<RelDate>2010-08-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAS-10-274.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-10-274</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18324</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Revolutionary Genome Sequencing Technologies  The $1000 Genome (SBIR  [R43/R44])
]]></Title>
<Purpose><![CDATA[Purpose. The National Human Genome Research Institute (NHGRI) solicits Small Business Innovation Research (SBIR [R43/R44]) grant applications to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing.  The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000.  Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components.  Exploration of methods other than those currently being pursued as potential $1,000 genome technologies are encouraged.  High-risk/high-payoff proposals are appropriate to achieve the goals of this FOA by approximately 2014. 
Mechanism of Support.  This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with FOAs of identical scientific scope, RFA-HG-10-012 and RFA-HG-10-013, which solicit applications under the R01 and R21 grant mechanisms. 
Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 25 projects awarded as a result of this announcement is $2.5 million for fiscal year 2011. Future year amounts will depend on annual appropriations. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-10-014.html</GuideLink>
<RelDate>2010-08-27</RelDate>
<IntentDate>October 1, 2010; September 18, 2011; September 17, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 1, 2010, 2010; October 18, 2011; October 17, 2012]]></AppReceiptDate>
<LARD>2012-10-17</LARD>
<FileName>RFA-HG-10-014.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-10-014</DocNum>
<ExpirationDate>2012-10-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18325</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Revolutionary Genome Sequencing Technologies  The $1000 Genome (R21) 
]]></Title>
<Purpose><![CDATA[Purpose. The National Human Genome Research Institute (NHGRI) solicits R21 grant applications to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing.  The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000.  Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components.  Exploration of methods other than those currently being pursued as potential $1,000 genome technologies are encouraged.  High-risk/high-payoff proposals are appropriate to achieve the goals of this FOA by approximately 2014. 
Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Research (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, RFA-HG-10-012 and RFA-HG-10-014, that encourage applications under the R01 and R43/R44 mechanisms. 
Funds Available and Anticipated Number of Awards. Contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications, the NHGRI may make 2-7 awards and may award $2 million total costs in each of FY2011, FY 2012, and FY 2013 in response to this FOA. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-10-013.html</GuideLink>
<RelDate>2010-08-27</RelDate>
<IntentDate>September 19, 2010; September 18, 2011; September 17, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 1, 2010; October 18, 2011; October 17, 2012]]></AppReceiptDate>
<LARD>2012-10-17</LARD>
<FileName>RFA-HG-10-013.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-10-013</DocNum>
<ExpirationDate>2012-10-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18326</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Revolutionary Genome Sequencing Technologies  The $1000 Genome (R01)]]></Title>
<Purpose><![CDATA[Purpose. The National Human Genome Research Institute (NHGRI) solicits R01 grant applications to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing.  The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000.  Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components.  Exploration of methods other than those currently being pursued as potential $1,000 genome technologies are encouraged.  High-risk/high-payoff applications are appropriate to achieve the goals of this FOA by approximately 2014. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with FOAs of identical scientific scope, RFA-HG-10-013 and RFA-HG-10-014, that encourage applications under the R21 and R43/R44 mechanisms, respectively. 
Funds Available and Anticipated Number of Awards. Contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications, the NHGRI may make 2-7 awards and may award $5 million total costs in each of FY2011, FY 2012, and FY 2013 in response to this FOA. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-10-012.html</GuideLink>
<RelDate>2010-08-27</RelDate>
<IntentDate>September 19, 2010; September 18, 2011; September 17, 2012</IntentDate>
<AppReceiptDate><![CDATA[October 19, 2010; October 18, 2011; October 17, 2012]]></AppReceiptDate>
<LARD>2012-10-17</LARD>
<FileName>RFA-HG-10-012.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-10-012</DocNum>
<ExpirationDate>2012-10-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18337</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[USDA]]></PartIC>
<Title><![CDATA[Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Species (R01) ]]></Title>
<Purpose><![CDATA[Purpose. This interagency Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Food and Agriculture (USDA-NIFA) is to invite the submission of grant proposals that utilize agriculturally important domestic species to improve human health through the advancement of basic and translational research deemed highly relevant to both agricultural and biomedical research.  This initiative is designed to facilitate and encourage comparative medicine research studies through the careful selection and refinement of farm animal models that mimic human developmental, physiological and etiological processes to better understand disease origins and improve assisted reproduction efficiencies.  The anticipated outcomes include both the elucidation of fundamental information relevant for the improvement of human health and an increase in food animal production and improvement in animal health and product quality.  It is envisioned that each proposal will address mission-relevant areas of both agencies.  
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  The total amount awarded and the number of awards will depend upon the number, quality, duration and costs of the applications received.  It is the intention of the NIH and USDA-NIFA to independently fund proposals. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-276.html</GuideLink>
<RelDate>2010-09-02</RelDate>
<IntentDate>October 3, 2010, August 20, 2011, August 20 2012 </IntentDate>
<AppReceiptDate><![CDATA[November 3 , 2010, September 20, 2011, September 20, 2012]]></AppReceiptDate>
<LARD>2012-09-20</LARD>
<FileName>PAR-10-276.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-276</DocNum>
<ExpirationDate>2012-09-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18345</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Planning Grant for Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Planning Award (NCD-LIFESPAN) (D71)

]]></Title>
<Purpose><![CDATA[Purpose: The Fogarty International Center (FIC), together with the Office of Dietary Supplements (OD/ODS) encourages new applications for the: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Planning Award (NCD-LIFESPAN) (D71). The application must propose a plan to develop the components necessary for the(D43)  application,  including the objectives and special requirements as defined in the Chronic, Non-Communicable Diseases and Disorders Across the Lifespan:  Fogarty International Research Training Award (NCD-LIFESPAN) (D43) FOA .The NCD-LIFESPAN D43 program supports research training that will strengthen the capacity of institutions in low-and middle-income countries (LMIC), defined by the World Bank classification system, to conduct non-communicable disease (NCD) research.  The planning grant application should be developed and implemented collaboratively with all designated participating institutions.   
Mechanism of Support. This FOA will utilize the International Training Program Planning Grant (D71) grant mechanism.  
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research training program will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>D71</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-277.html</GuideLink>
<RelDate>2010-09-07</RelDate>
<IntentDate>October 4, 2010, August 21, 2011, August 21, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 4, 2010, September 21, 2011, September 21, 2012]]></AppReceiptDate>
<LARD>2012-09-21</LARD>
<FileName>PAR-10-277.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-277</DocNum>
<ExpirationDate>2012-09-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18371</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[NEI Translational Research Program on Therapy for Visual Disorders (R24) ]]></Title>
<Purpose><![CDATA[Purpose.  The National Eye Institute (NEI) supports multidisciplinary research focusing on the development of novel therapies to treat  visual diseases and disorders. The rapid and efficient translation of innovative laboratory research findings into clinical development frequently requires a comprehensive and highly integrated approach involving collaborative teams of scientists and clinicians with expertise in multiple disciplines.  Such a collaborative approach is particularly appropriate for research focused on pathways that will likely be targeted by biological intervention, such as gene therapy, cell-based therapy, pharmacological approaches. The intention of this program is to make resources available to scientists from several disciplines to form research teams to address scientific and technical questions that would be beyond the capabilities of any one research group. Each project should have a well-defined end-point, achievable within a five-year time frame, of developing a specific treatment for a specific disease.  The steps toward this end-point should be clearly delineated in a series of milestones that support the development of a therapeutic approach, which can then be tested in a clinical trial.  
Mechanism of Support. This FOA will utilize the  National Institutes of Health (NIH) R24 Research Resources Grant award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-281.html</GuideLink>
<RelDate>2010-09-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[January 25, 2011, 2012, 2013 
]]></AppReceiptDate>
<LARD>2013-01-25</LARD>
<FileName>PAR-10-281.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-281</DocNum>
<ExpirationDate>2013-01-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18378</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[Pilot and Feasibility Clinical Research Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)

]]></Title>
<Purpose><![CDATA[Purpose. This FOA, issued by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health, encourages exploratory/developmental clinical research related to the prevention or treatment of arthritis and musculoskeletal and skin diseases, conditions, and/or injuries. The Pilot and Feasibility Clinical Research Grants Program is designed to allow initiation of exploratory, short-term clinical studies, so that new ideas may be investigated without stringent requirements for preliminary data. The short-term studies should focus on research questions that are likely to gather critical preliminary data in support of a future, planned clinical trial.  They can include testing new or prevention strategies, a new intervention, or unique combinations of therapies.  A high priority is the use of such studies to help stimulate the translation of promising research developments from the laboratory into clinical practice.  
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, number, quality, duration, and cost of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-282.html</GuideLink>
<RelDate>2010-09-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Nov 18, 2010, March 1, 2011, July 1, 2011; Nov 1, 2011, March 1, 2012, July 2, 2012; Nov 1, 2012, March 1, 2013,  July 1, 2013]]></AppReceiptDate>
<LARD>2013-07-01</LARD>
<FileName>PAR-10-282.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-282</DocNum>
<ExpirationDate>2013-07-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18384</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[National Institute on Aging: Revision Requests for Active Program Projects (P01) 
]]></Title>
<Purpose><![CDATA[The National Institute on Aging invites Revision applications (formerly called competing supplements) to ongoing NIA-supported Program Projects (P01) in order to expand the scope of the existing award. Revision applications should include expansion of (an) existing, or proposal of (a) new subproject or projects. Revision applications may not request support beyond the project end date of the Parent P01 award.   ]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-284.html</GuideLink>
<RelDate>2010-09-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-284.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-284</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18385</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR [U43/U44])
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. 
Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>U43,U44</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-286.html</GuideLink>
<RelDate>2010-09-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[December 7, 2010; March 10, 2011; July 7, 2011; November 10, 2011; March 8, 2012; July 9, 2012; November 8, 2012; March 8, 2013; July 8, 2013]]></AppReceiptDate>
<LARD>2013-07-08</LARD>
<FileName>PAR-10-286.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-286</DocNum>
<ExpirationDate>2013-07-09</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18386</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[NHLBI Program Project Applications (P01)]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Heart, Lung, and Blood Institute (NHLBI) continues the long standing program project program detailed at http://www.nhlbi.nih.gov/funding/resmech.htm and invites submission of investigator-initiated Program Project (P01) applications.  The proposed programs may address scientific areas relevant to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders.  Each P01 application submitted in response to this FOA must include at least three related research projects that share a common central theme, focus, and/or overall objective.  
Mechanism of Support. This FOA will utilize the NIH Program Project (P01) grant mechanism. 
Funds Available and Anticipated Number of Awards.  The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-285.html</GuideLink>
<RelDate>2010-09-21</RelDate>
<IntentDate>September 21, 2010</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-285.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-285</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18399</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[Occupational Safety and Health Training Project Grants (T03)
]]></Title>
<Purpose><![CDATA[Purpose. The National Institute for Occupational Safety and Health (NIOSH)/ Centers for Disease Control and Prevention (CDC) invites grant applications for Training Project Grants (TPG) that are focused on occupational safety and health training and on research training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act of 1970 (Pub. L. 91-596, 84 Stat. 1590), and the TPGs are one of the principal means for meeting this mandate. TPGs are programs at institutions that provide training in the core occupational safety and health areas of industrial hygiene (IH), occupational health nursing (OHN), occupational medicine residency (OMR), occupational safety (OS), as well as other closely related occupational safety and health (OSH) fields. Applicants proposing training programs in allied disciplines closely related to OSH must contact the program administrator identified in this announcement to discuss the concept and its relevance to OSH training program priorities. The NIOSH homepage provides a full description of occupational safety and health program areas, http://www.cdc.gov/niosh/programshtml. 
Mechanism of Support. The type of training awards supported by this FOA is the T03 (Combined Undergraduate and Graduate Training Programs) award mechanisms, which is for the support of TPGs. 
Funds Available and Anticipated Number of Awards.   The total amount of funds to be awarded under this program is approximately $3 million per year for new competing applications, competing renewal applications, and continuing awards. The number of awards for this program will be between 20 and 30 depending on the quality of the applications and funds available. Each year the number of new competing and competing renewal awards will vary between one and ten depending on the number of awards that have ended. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>T03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-288.html</GuideLink>
<RelDate>2010-09-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[December 17, 2010; August 24, 2011; August 24, 2012; August 23, 2013; August 24, 2014]]></AppReceiptDate>
<LARD>2014-08-24</LARD>
<FileName>PAR-10-288.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-288</DocNum>
<ExpirationDate>2014-08-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18400</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[Resource Related Research Projects for Development of Animal Models and Related Materials (R24) 

]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Center for Research Resources (NCRR) (National Institutes of Health) encourages Resource Related Research Project  grant applications (R24) aimed at developing, characterizing or improving animal models of human diseases or improving diagnosis and control of diseases of laboratory animals.  This FOA applies only to R24 grant applications for potential support by the Division of Comparative Medicine, NCRR.  The animal models and related materials to be developed must address the research interests of two or more of the categorical NIH Institutes and Centers.  In addition, projects that predominantly address the research interests of one NIH Institute or Center, but that are peripherally related to the research interests of other Institutes and Centers will not be considered appropriate for  this Program Announcement. An example of an inappapropriate  request is one exclusively involving an animal model of cancer.  
Mechanism of Support. This FOA will utilize the R24 grant mechanism 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary, but will not exceed 4 years. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-10-289.html</GuideLink>
<RelDate>2010-09-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-10-289.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-10-289</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18403</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<Title><![CDATA[Research on Malignancies in the Context of HIV/AIDS (R01)
]]></Title>
<Purpose><![CDATA[ This funding opportunity announcement (FOA) issued by NCI and NIDCR, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/ organizations that propose to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR seek to encourage research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both AIDS-defining and non-AIDS defining malignancies in diverse populations in the context of an underlying HIV infection. This FOA invites research efforts that will: (i) provide information on the clinical outcomes of such cancers in the HIV-infected population; and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-290.html</GuideLink>
<RelDate>2010-09-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-290.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-290</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18404</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<Title><![CDATA[Research on Malignancies in the Context of HIV/AIDS (R21)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) issued by NCI and NIDCR, National Institutes of Health, encourages Research Project Grant (R21) applications from institutions/ organizations that propose to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR seek to encourage research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both AIDS-defining and non-AIDS defining malignancies in diverse populations in the context of an underlying HIV infection. This FOA invites research efforts that will: (i) provide information on the clinical outcomes of such cancers in the HIV-infected population; and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-10-291.html</GuideLink>
<RelDate>2010-09-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PA-10-291.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-10-291</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18416</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[Animal and Biological Material Resource Centers (P40) 
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Center for Research Resources (NCRR), National Institutes of Health (NIH), encourages grant applications for national Animal Model, and Animal and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals, as well as other resources such as reagents, cultures (cells, tissues, and organs) and genetic stocks that serve the biomedical research community at large.  The resource centers for Animal Models or Animal and Biological Materials collect, maintain, characterize, and distribute defined strains of animals and/or related biological materials to biomedical researchers in a variety of research areas on a local, regional, and national basis. This funding opportunity is designed to both support continuation of existing resources, and to develop new ones when appropriate.  Prior to preparing an application, it is critical that all applicants consult with NCRR Program staff to be advised on appropriateness of the intended resource plans for this program, competitiveness of a potential application and NCRR program priorities.
]]></Purpose>
<RelNote/><ActivityCodes>P40</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-001.html</GuideLink>
<RelDate>2010-10-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-11-001.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-001</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18420</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[NIMH Research Education Programs for HIV/AIDS Research (R25)]]></Title>
<Purpose><![CDATA[Purpose.  This funding opportunity announcement (FOA) issued by the National Institute of Mental Health encourages Research Education Grant (R25) applications from Institutions/Organizations that propose creative and innovative research education programs to facilitate the development of a cadre of investigators in appropriate scientific areas to fulfill the  mental health relevant objectives as defined by the  Office of Aids Research (OAR) Annual Strategic Plan.  The NIMH expects all programs to foster the participation of individuals from racial and ethnic groups underrepresented in biomedical and behavioral research, individuals with disabilities, individuals from disadvantaged backgrounds, and women. 
Mechanism of Support.  This FOA will use the NIH Research Education (R25) award mechanism.  Research education programs may not be transferred from one institution to another, unless strongly justified (see Section VI.2). 
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research education program will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-002.html</GuideLink>
<RelDate>2010-10-04</RelDate>
<IntentDate>30 days before the submission date</IntentDate>
<AppReceiptDate/><LARD>2013-01-07</LARD>
<FileName>PAR-11-002.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-002</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18433</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01) 
]]></Title>
<Purpose><![CDATA[The NIDCD is encouraging applications which translate basic research findings into clinical tools for better human health in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. The intent of this Funding Opportunity Announcement (FOA) is to provide a new avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders.  Multi-institutional, multi-disciplinary, and academic-industrial collaborations studies are encouraged.  This FOA is not intended for outcome studies, the extension of ongoing clinical research studies, the optimization of current clinical protocols, or pre-translational studies.  Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-003.html</GuideLink>
<RelDate>2010-10-08</RelDate>
<IntentDate>January 22, 2011; September 21, 2011, May 22, 2012, January 22, 2013 and September 22, 2013</IntentDate>
<AppReceiptDate><![CDATA[February 22, 2011; October 21, 2011, June 22, 2012, February 22, 2013 and October 22, 2013., by 5:00 PM local time of applicant organization. 
]]></AppReceiptDate>
<LARD>2013-10-22</LARD>
<FileName>PAR-11-003.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-003</DocNum>
<ExpirationDate>2013-10-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18435</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Research Grants for Translating Basic Research into Clinical Tools (R21)]]></Title>
<Purpose><![CDATA[The NIDCD is encouraging applications which translate basic research findings into clinical tools for better human health in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. The intent of this Funding Opportunity Announcement (FOA) is to provide a new avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders.  Multi-institutional, multi-disciplinary, and academic-industrial collaborations studies are encouraged.  This FOA is not intended for outcome studies, the extension of ongoing clinical research studies, the optimization of current clinical protocols, or pre-translational studies.  Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-004.html</GuideLink>
<RelDate>2010-10-08</RelDate>
<IntentDate>January 22, 2011; September 21, 2011, May 22, 2012, January 22, 2013 and September 22, 2013</IntentDate>
<AppReceiptDate><![CDATA[February 22, 2011; October 21, 2011, June 22, 2012, February 22, 2013 and October 22, 2013, by 5:00 PM local time of applicant organization. 
]]></AppReceiptDate>
<LARD>2013-10-22</LARD>
<FileName>PAR-11-004.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-004</DocNum>
<ExpirationDate>2013-10-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18436</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites new or renewal (competing) applications for P30 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas -- laboratory, clinical, and population-based research -- and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused on laboratory research, clinical research, population science research, or some combination of these components. The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through the P30 grant mechanism are expected: to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community. 
Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the NIH center grant (P30) mechanism. 
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-005.html</GuideLink>
<RelDate>2010-10-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[November 9, 2010, after which Standard dates apply]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-11-005.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-005</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18443</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<Title><![CDATA[Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23)
]]></Title>
<Purpose><![CDATA[Purpose.  The purpose of this Mentored Patient-Oriented Research Career Development Award (K23) is to provide salary and protected time (up to five years for this award) to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research.  Each Research Career Development Award must be tailored to meet the individual needs of the candidate.  The Translational Scholar Awards in Pharmacogenomics and Personalized Medicine program is intended to address the scarcity of investigators cross-trained in both clinical research core competencies and modern methods required to address pharmacogenomics research problems in patient populations.  Dual mentors from the Clinical and Translational Science Awards consortium and the Pharmacogenomics Research Network are required. 
Mechanism of Support. This FOA will utilize the NIH Research Career Development Award K23 award mechanism. 
Funds Available and Anticipated Number of Awards. For this funding opportunity, the total amount to be awarded will be up to $1.5 M and the anticipated number of awards will be approximately six in FY2012.  The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received.   
]]></Purpose>
<RelNote/><ActivityCodes>K23</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-009.html</GuideLink>
<RelDate>2010-10-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-009.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-009</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18450</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) 
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) encourages applications to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged.  This FOA for R03 applications is intended to support pilot and feasibility studies; small, self-contained research projects; development of research methodology; and development of new research technology that can be carried out in a short period of time with limited resources.  In no cases, should research involving animals be proposed.  Such research would be considered non-responsive to this or the companion R21 and R01 FOAs. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award and runs in parallel with FOAs of identical scientific scope, PA-11-006 , that encourages applications under the R01 mechanisms and PA-11-007 that encourages applications under the R21 mechanism. 
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-008.html</GuideLink>
<RelDate>2010-10-19</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-008.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-008</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18451</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21)
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) for R21 applications encourages exploratory, descriptive or hypothesis-generating research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged.  In no cases, should research involving animals be proposed.  Such research would be considered non-responsive to this or the companion R01 and R03 FOAs . 
 Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-11-006, that encourages applications under the R01 and PA-11-008 that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-007.html</GuideLink>
<RelDate>2010-10-19</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-007.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-007</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18452</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) 
]]></Title>
<Purpose><![CDATA[Purpose. This Funding Opportunity Announcement (FOA) is intended to stimulate model-driven research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged. This FOA for R01 applications solicits empirical, hypothesis-driven, confirmatory research and modeling approaches. Exploratory, descriptive or hypothesis-generating research are more appropriate for the complementary FOAs using the R21 or R03 mechanisms.  In no cases, should research involving animals be proposed.  Such research would be considered non-responsive to this or the companion R21 and R03 FOAs.   
Mechanism of Support. This FOA will utilize the R01  grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-11-007, that encourages applications under the R21 mechanism and PA-11-008 that encourages applications under the R03 mechanism.   
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-006.html</GuideLink>
<RelDate>2010-10-19</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-006.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-006</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18455</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Diversity Research Education Grants in Neuroscience (R25)]]></Title>
<Purpose><![CDATA[The purpose of the FOA is to invite applications for Diversity Research Education grants whose goals are to support the development and/or implementation of programs to: (1) increase the number of Ph.D.-level research scientists from diverse backgrounds including graduate, post-doctoral and/or junior-faculty career levels; and (2) advance the careers of the participants to the next step in their education. Funding support for the R25 Diversity Research Education Programs should lead to increased recruitment, mentoring, education and retention of researchers from diverse backgrounds in the neuroscience scientific workforce.]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-010.html</GuideLink>
<RelDate>2010-10-22</RelDate>
<IntentDate>30 days prior to application due date</IntentDate>
<AppReceiptDate><![CDATA[January 25, 2011, 2012, 2013.]]></AppReceiptDate>
<LARD>2013-01-25</LARD>
<FileName>PAR-11-010.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-010</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18463</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[HIV Infection of the Central Nervous System (R01)]]></Title>
<Purpose><![CDATA[The National Institute of Mental Health (NIMH), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), and the National Institute of Neurological Disorders and Stroke (NINDS) invite research grant applications focused on defining the pathogenic mechanisms involved in Human Immunodeficiency Virus (HIV)-1 Associated Neurocognitive Disorders (HAND) and identifying therapeutic strategies to treat and prevent the neurobehavioral and neurological effects of HIV-1 on the central nervous system (CNS). Applications ranging from basic research to clinical diagnosis and treatment in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-014.html</GuideLink>
<RelDate>2010-10-26</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-014.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-014</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18466</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol marketing and youth drinking (R01)
]]></Title>
<Purpose><![CDATA[ This FOA issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages grant applications from institutions/ organizations that propose to investigate the factors that mediate and moderate the impact of alcohol advertising and other alcohol promotions on youth drinking.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-015.html</GuideLink>
<RelDate>2010-10-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-015.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-015</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18475</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Epidemiology and Prevention in Alcohol Research (R21)
]]></Title>
<Purpose><![CDATA[ The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.
 ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-018.html</GuideLink>
<RelDate>2010-10-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-018.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-018</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18476</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Epidemiology and Prevention in Alcohol Research (R03)
]]></Title>
<Purpose><![CDATA[ The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.    
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-017.html</GuideLink>
<RelDate>2010-10-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-017.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-017</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18477</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Epidemiology and Prevention in Alcohol Research (R01) 
]]></Title>
<Purpose><![CDATA[The National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-016.html</GuideLink>
<RelDate>2010-10-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-016.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-016</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18493</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Centers Program for Research on HIV/AIDS and Mental Health (P30)]]></Title>
<Purpose><![CDATA[The National Institute of Mental Healths (NIMH) Division of AIDS (DAR) encourages applications for Center Core grants (P30) to support either HIV/AIDS Research Centers (ARC) or Developmental ARCs (D-ARC). The ARC/D-ARC Program is intended to provide infrastructural support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. It intends to support innovative, interdisciplinary research in several areas, including basic, applied, clinical, translational, and implementation science. The ARC/D-ARC program gives priority to institutions that receive significant levels of funding from NIMH and other NIH Institutes or Centers.
]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-019.html</GuideLink>
<RelDate>2010-11-05</RelDate>
<IntentDate>December 7, 2010</IntentDate>
<AppReceiptDate><![CDATA[January 7, 2011; September 7, 2011; September 7, 2012,;September 7, 2013 
 
AIDS Application Due Date(s) January 7, 2011 (for renewals and resubmissions only), September 7 annually, thereafter.
 
]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-11-019.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-019</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18497</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Technologies for Healthy Independent Living (R01)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD National Institute of Nursing Research (NINR), and the Office of Research on Womens Health (ORWH) encourages Research Project Grant (R01) applications for research and development of technologies that monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way.  These systems are expected to integrate, process, analyze, communicate, and present data so that the individuals are engaged and empowered in their own healthcare with reduced burden to care providers. The development of these technology systems has the potential to significantly improve the quality of life for people with disabilities, people aging with mild impairments, as well as individuals with chronic conditions.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-020.html</GuideLink>
<RelDate>2010-11-05</RelDate>
<IntentDate>December 19, 2010</IntentDate>
<AppReceiptDate><![CDATA[January 19, 2011; May 19, 2011; September 19, 2011; January 19, 2012; May 18, 2012; September 19, 2012; January 18, 2013; May 17, 2013; September 19, 2013, by 5:00 PM local time of applicant organization. 
]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-020.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-020</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18500</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[Centers for Agricultural Disease and Injury Research, Education, and Prevention (U54)]]></Title>
<Purpose><![CDATA[Purpose. NIOSH is encouraging applications from qualified organizations for Centers of Excellence in Agricultural Disease and Injury Research, Education, and Prevention (Ag Centers). These centers will conduct high quality research and help translate scientific discoveries into practical applications to improve worker safety and health. Ag Centers are expected to have a high caliber of scientific and technical competency, be forward looking, and provide regional leadership in the development and delivery of relevant interventions to improve Ag health and safety. Center structure should take advantage of diverse scientific resources and focus on local, regional and national issues. Center functions should include developing holistic approaches that link prevention, intervention, translation, outreach, education, and evaluation. The implementation of innovative, evidence-based solutions that address important agricultural safety and health problems in a collaborative manner is expected. While a specific Center theme is not required, applicants must concisely describe the mission, structure, function and service area of the proposed Center. Supporting information on major issues, priority focus areas, and essential gaps/needs must be concise, complete, timely and clearly tied to the basis for the proposed Center. ]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>1300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-022.html</GuideLink>
<RelDate>2010-11-05</RelDate>
<IntentDate>January 4, 2011; November 2, 2011; November 4, 2012</IntentDate>
<AppReceiptDate><![CDATA[February 4, 2011; December 2, 2011; December 4, 2012]]></AppReceiptDate>
<LARD>2012-12-04</LARD>
<FileName>PAR-11-022.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-022</DocNum>
<ExpirationDate>2012-12-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18502</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Design and Development of Novel Technologies for Healthy Independent Living (R21) 
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),  National Institute of Nursing Research (NINR), and the Office of Research on Womens Health (ORWH) encourages Exploratory/ Developmental Research Project (R21) applications for design and development of novel technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way.  These may be novel sensor or monitoring systems, home-use point-of-care devices, home or mobile therapy or rehabilitation tools, or information systems and should have the goal of fostering healthy and independent living.  The development of such technologies has the potential to significantly improve the quality of life for people with disabilities, people aging with mild impairments, as well as individuals with chronic conditions.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-021.html</GuideLink>
<RelDate>2010-11-05</RelDate>
<IntentDate>December 19, 2010</IntentDate>
<AppReceiptDate><![CDATA[January 19, 2011; May 19, 2011; September 19, 2011; January 19, 2012; May 18, 2012; September 19, 2012; January 18, 2013; May 17, 2013; September 19, 2013, by 5:00 PM local time of applicant organization. 
 ]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-021.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-021</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18505</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)]]></Title>
<Purpose><![CDATA[This FOA encourages applications for research projects that identify and/or validate chromosomal loci and variations in genes that are associated with vulnerability to addiction and that inform the likelihood of responsiveness to treatment.  Applications that propose to examine intermediate phenotypes or endophenotypes to assess the molecular genetics of drug addiction, addiction vulnerability and/or their associated co-morbidities and how they are related to drug addiction are especially encouraged.  Also encouraged are genetic as well as computational and large-scale genomic approaches, which may include but are not limited to linkage, linkage disequilibrium, case-control or family-based studies, and integration of data from other databases that may supplement substance abuse genetics and genomics data.  Data may be collected from the general population, special populations, recent admixed populations, and/or animal models.  Investigators are encouraged to include, as a component of their project and as appropriate, gene x gene interactions, gene x environment interactions, gene x environment x development interactions, pharmacogenetics, and non-human models.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-026.html</GuideLink>
<RelDate>2010-11-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-026.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-026</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18508</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Advances in Patient Safety through Simulation Research (R18)
]]></Title>
<Purpose><![CDATA[Purpose. The Agency for Healthcare Research and Quality (AHRQ) is interested in funding a diverse set of projects that develop, test and evaluate various simulation approaches for the purpose of improving the safe delivery of health care.  Simulation in health care predominately is a training technique that exposes individuals and teams to realistic clinical challenges through the use of mannequins, task trainers, virtual reality, standardized patients or other forms, and allows participants to experience in real-time the consequences of their decisions and actions.  The principal advantage of simulation is that it provides a safe environment for health care practitioners to acquire valuable experience without putting patients at risk.  Simulation also can be used as a test-bed to improve clinical processes and to identify failure modes or other areas of concern in new procedures and technologies that might otherwise be unanticipated and serve as threats to patient safety.  Applications that address a variety of simulation techniques, clinical settings, provider groups, priority populations, patient conditions, and threats to safety are welcomed.  
Mechanism of Support. This FOA will use the AHRQ Research Demonstration and Dissemination Projects (R18) grant mechanism.  The individual researcher, sponsored by his or her organization, will be solely responsible for planning, directing, and executing the proposed project. 
]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-024.html</GuideLink>
<RelDate>2010-11-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-01-07</LARD>
<FileName>PAR-11-024.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-024</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18503</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[ The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01)
 ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by NIDA encourages Research Project Grant (R01) applications from institutions/organizations that propose to study the development of the frontal and prefrontal cortices, together with the subcortical areas of the limbic system, that play significant roles in mediating emotional and motivated behavior.  This initiative is designed to support the basic neuroscience research into the fundamental mechanisms of development of the frontal and prefrontal cortices, as well as the midbrain and basal forebrain structures that mediate a number of functions related to drug abuse and psychiatric disorders including:  the euphoric properties of drugs, actions of psychotherapeutic agents, and memory, cognitive and emotional functions.  An additional major goal of this initiative is to understand how exposure to drugs of abuse affects the cellular and molecular mechanisms underlying nervous system development of circuits implicated in drug reward and addiction. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-027.html</GuideLink>
<RelDate>2010-11-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-027.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-027</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18516</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<Title><![CDATA[Collaborative Studies on The Central Nervous System and Glycemia (R01)
]]></Title>
<Purpose><![CDATA[Purpose. This FOA, issued by NINDS and NIDDK, promotes new interdisciplinary collaborations by researchers in neuroscience and in diabetes/metabolism to further understanding of the mechanisms by which the CNS controls glucose levels and the consequences to the CNS of derangements in these mechanisms. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01)  award mechanism.   
Funds Available and Anticipated Number of Awards. A maximum of $750,000 in first year direct costs is available with the anticipation that two to three new R01 awards will be made per year for the 3-year duration of this FOA. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-11-029.html</GuideLink>
<RelDate>2010-11-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-01-07</LARD>
<FileName>PAS-11-029.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-11-029</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18517</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Continued Development and Maintenance of Software (R01)

]]></Title>
<Purpose><![CDATA[Purpose. Biomedical research laboratories increasingly undertake a software development project to solve a problem of interest specifically related to that laboratory. These software packages sometimes become useful to a much broader community of users that can include translational and clinical researchers. The goal of this program announcement is to support the continued development, maintenance, testing and evaluation of existing software. The proposed work should apply best practices and proven methods for software design, construction, and implementation to extend the applicability of existing biomedical informatics/computational biology software to a broader biomedical research community. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-028.html</GuideLink>
<RelDate>2010-11-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-028.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-028</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18521</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Limited Competition: Brain Disorders in the Developing World:  Research Across the Lifespan (R01)) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages grant applications proposing the conduct of innovative, collaborative research and research training projects, between High Income country (HIC) and low- to middle-income country (LMIC) scientists, on nervous system function and disorders throughout life, relevant to LMICs. The collaborative research programs are expected to contribute to the long-term goals of building sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, treatment and prevention strategies.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-030.html</GuideLink>
<RelDate>2010-11-12</RelDate>
<IntentDate>December 10, 2010, December 10, 2011, December 10, 2012 AIDS Related Applications:  March 11, 2011, March 11, 2012, March 11, 2013</IntentDate>
<AppReceiptDate><![CDATA[January 10, 2011, January 10, 2012, January 10, 2013, by 5:00 PM local time of applicant organization. 
April 11, 2011, April 11, 2012, April 11, 2013, by 5:00 PM local time of applicant organization. 
 ]]></AppReceiptDate>
<LARD>2013-04-11</LARD>
<FileName>PAR-11-030.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-030</DocNum>
<ExpirationDate>2013-04-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18523</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Brain Disorders in the Developing World: Research Across the Lifespan (R21) 
]]></Title>
<Purpose><![CDATA[ This Funding Opportunity Announcement (FOA) encourages exploratory/developmental planning grant applications proposing the development of innovative, collaborative research and research training projects, between high income country (HIC) and low- to middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs. The planning grants are expected to lead to full research programs which contribute to the long-term goals of building sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, prevention, and treatment strategies.
 ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-031.html</GuideLink>
<RelDate>2010-11-12</RelDate>
<IntentDate>December 10, 2010, December 10, 2011, December 10, 2012 AIDS Related Applications: March 11, 2011, March 11, 2012, March 11, 2013</IntentDate>
<AppReceiptDate><![CDATA[January 10, 2010, January 10, 2011, January 10, 2012, by 5:00 PM local time of applicant organization. 
April 11, 2011, April 11, 2012, April 11, 2013 
]]></AppReceiptDate>
<LARD>2013-04-11</LARD>
<FileName>PAR-11-031.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-031</DocNum>
<ExpirationDate>2013-04-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18526</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R03)

]]></Title>
<Purpose><![CDATA[Purpose. Genetic and genomic studies have identified genes and gene variants that potentially modulate the fundamental biological mechanisms underpinning addictive processes.  Discovery of these genes/variants, while extremely valuable, is only a first step in understanding molecular mechanisms of addiction.  This Funding Opportunity Announcement encourages basic functional genomic research in two areas:  1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. 
The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-11-033, that encourages applications under the R01 mechanism and PA-11-034  that encourages applications under the R21 mechanism. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-035.html</GuideLink>
<RelDate>2010-11-16</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-035.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-035</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18527</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R21)]]></Title>
<Purpose><![CDATA[Purpose. Genetic and genomic studies have identified genes and gene variants that potentially modulate the fundamental biological mechanisms underpinning addictive processes.  Discovery of these genes/variants, while extremely valuable, is only a first step in understanding molecular mechanisms of addiction.  This Funding Opportunity Announcement encourages basic functional genomic research in two areas:  1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism    and runs in parallel with FOAs of identical scientific scope, PA-11-033, that encourages applications under the R01 mechanism and PA-11-035  that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-034.html</GuideLink>
<RelDate>2010-11-16</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-034.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-034</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18528</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R01)]]></Title>
<Purpose><![CDATA[Purpose.  Genetic and genomic studies have identified genes and gene variants that potentially modulate the fundamental biological mechanisms underpinning addictive processes.  Discovery of these genes/variants, while extremely valuable, is only a first step in understanding molecular mechanisms of addiction. This Funding Opportunity Announcement encourages basic functional genomic research in two areas:  1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. 
Mechanism of Support. This FOA will utilize the R01 mechanism and runs in parallel with FOAs of identical scientific scope,  PA-11-034 , that encourages applications under the R21 mechanism and PA-11-035  that encourages applications under the R03 mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-033.html</GuideLink>
<RelDate>2010-11-16</RelDate>
<IntentDate>Not Required</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-033.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-033</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18536</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) 
]]></Title>
<Purpose><![CDATA[This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/ organizations addressing preclinical research in model organisms of neurodevelopmental disorders. Applications responsive to this FOA will propose to develop, validate, and/or calibrate outcome measures, surrogate markers, and biomarkers in model organisms that can inform and effectively translate to human clinical trials for individuals with intellectual and developmental disabilities (IDD). In addition, applications may propose to conduct rigorous, controlled and standardized preclinical animal trials designed for safety, toxicity, and efficacy prediction or to perform an independent validation of efficacy in animals prior to human clinical trials. The goal of this FOA is to accelerate and improve the preclinical testing of candidate treatments and therapeutic compounds in order to move promising new drug therapies into clinical trials. Potential applicants may be interested in the FOA Outcome measures for use in treatment trials of individuals with intellectual and developmental disabilities issued simultaneously with this FOA.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-038.html</GuideLink>
<RelDate>2010-11-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-11-038.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-038</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18538</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Understanding and Treating Co-Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R01)]]></Title>
<Purpose><![CDATA[ This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages research project grant (R01, R03, R21) applications from institutions/organizations that propose to focus investigator-initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-039.html</GuideLink>
<RelDate>2010-11-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-039.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-039</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18539</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Understanding and Treating Co-Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R03)
]]></Title>
<Purpose><![CDATA[ This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages Small Research Grant (R03) applications from institutions/organizations that propose to focus investigator-initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence.  The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
 ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-040.html</GuideLink>
<RelDate>2010-11-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-040.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-040</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18540</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[ Understanding and Treating Co-Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R21) 
 ]]></Title>
<Purpose><![CDATA[ This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages research project grant (R01, R03, R21) applications from institutions/organizations that propose to focus investigator initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence. 
 ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-041.html</GuideLink>
<RelDate>2010-11-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-041.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-041</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18548</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[NIDDK Program Project Applications (P01)
]]></Title>
<Purpose><![CDATA[ This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites submission of investigator-initiated Program Project Applications. The proposed programs should address scientific areas relevant to the NIDDK mission including diabetes, endocrine and metabolic diseases, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat and cure these diseases, including clinical research. A description of NIDDK scientific program areas can be found at http://www2.niddk.nih.gov/Funding/default.htm.
 ]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-043.html</GuideLink>
<RelDate>2010-11-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-043.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-043</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18551</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01)
]]></Title>
<Purpose><![CDATA[This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), encourages Research Project Grant (R01) applications from institutions/organizations that propose to develop, validate, and/or calibrate informative outcome measures for use in clinical trials for individuals with intellectual and developmental disabilities (IDD). This funding opportunity will address a significant need in the field, one that is especially apparent in efforts to develop pharmacological treatments for these populations. This solicitation will focus ongoing clinical and translational research on a neglected area essential for therapy and pharmacological treatment development. Potential applicants may be interested in FOA (PAR-11-038) Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) issued simultaneously with this FOA.   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-045.html</GuideLink>
<RelDate>2010-11-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-11-045.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-045</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18552</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Indo-US Collaborative Program on Low-Cost Medical Devices (R03)

]]></Title>
<Purpose><![CDATA[Purpose.  The purpose of this program is to encourage collaborative research and/or technology development between scientists and engineers in the United States and India. This FOA issued by National Institute of Biomedical Imaging and Bioengineering (NIBIB) (http://www.nibib.nih.gov) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (http://www.nichd.nih.gov), National Institutes of Health, encourages Small Research Grant (R03) applications for its program on the collaborative development of low-cost medical devices; the Republic of India and the United States of America are inviting collaborative research projects involving U.S. and Indian investigators to develop new, low cost, appropriate diagnostic and therapeutic medical technologies for low-resource settings. Appropriate medical technologies are those that are useable, cost effective, sustainable, and effective in meeting a significant clinical need in a low-resource setting.  Collaborations should be aimed at the development, translation and use of medical technologies that can significantly impact underserved populations within the United States and/or India.  Within this context grantees can apply for grants to: 
Develop devices and technologies within the mission of National Institute of Biomedical Imaging and Bioengineering and the Eunice Kennedy Shriver National Institute of Child Health and Human Development that are appropriate for low-resource settings; 
Reengineer or accelerate the translation of medical devices and technologies for low-resource applications; and 
Reengineer and expand the potential applications of existing medical devices for low-resource settings. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-044.html</GuideLink>
<RelDate>2010-11-23</RelDate>
<IntentDate>December 26, 2010</IntentDate>
<AppReceiptDate><![CDATA[January 26, 2011, May 24, 2011, September 23, 2011, January 24, 2012, May 24, 2012, September 24, 2012, January 24, 2013]]></AppReceiptDate>
<LARD>2013-01-24</LARD>
<FileName>PAR-11-044.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-044</DocNum>
<ExpirationDate>2013-01-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18554</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[NEI Genomic Research Grant on Integrative Data Analysis for Vision Research (R01) 
]]></Title>
<Purpose><![CDATA[ This Funding Opportunity Announcement (FOA) issued by the National Eye Institute (NEI), National Institutes of Health (NIH), encourages the submission of applications proposing integrative and in-depth analyses of existing large-scale genetic and genomic data sets relevant to the NEI mission, as well as the development of novel bioinformatics approaches and innovative computational tools to interpret these data sets.  Applicants are particularly encouraged to propose integrative analysis of existing large-scale, high-throughput data sets generated by utilizing advanced genomic technologies and combined analysis of multiple data sets obtained with other high dimensional technologies such as imaging, if feasible.  This FOA will not support the collection of additional data; only existing data sets may be used.    
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-EY-11-001.html</GuideLink>
<RelDate>2010-11-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[May 18, 2011, 2012, 2013]]></AppReceiptDate>
<LARD>2013-05-18</LARD>
<FileName>RFA-EY-11-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-EY-11-001</DocNum>
<ExpirationDate>2013-05-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18561</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<Title><![CDATA[Limited Competition: NIH Competing Revision Awards for Creating Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)(R01)
]]></Title>
<Purpose><![CDATA[The purpose of the ViCTER program is to foster and promote transdisciplinary collaborations and/or translational research efforts among basic (technology and mechanism oriented), clinical (patient-oriented) and population-based researchers and other individuals with expertise relevant to environmental health who have come together in common interest around a particular environmental stressor(s) of interest. For the purposes of this FOA, transdisciplinary research is defined as the use of cross-disciplinary methods, insights, and research approaches that would not have occurred with a traditional uni-disciplinary investigation and translational research is defined as research that stimulates the bidirectional flow of information across the spectrum of in vitro, lower animal models, higher animal models, human population or clinical-based research in order to provide data useful for the prevention and intervention of human disease.   

The goal of the Consortia Program is to support the exchange of knowledge and resources among collaborators to carry out small high-risk, high-reward transdisciplinary and/or translational research projects with the potential to lead to sustained collaborative efforts addressing key issues to improve human health in those areas where environmental factors are known or expected to influence the development or progression of disease.  Each virtual consortium will consist of an NIEHS-funded researcher (lead applicant), who will serve as the Principal Investigator (PI) and overall coordinator of the consortia, and two new collaborators.  The Competing Revision application should include one to two new specific aims for the current NIEHS-funded research project and one to two specific aims from each of the new collaborators that will expand the scope of the current project with the goal of making the research more transdisciplinary and/or translational. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-046.html</GuideLink>
<RelDate>2010-11-29</RelDate>
<IntentDate>January 22, 2011, January 22, 2012, January 22, 2013</IntentDate>
<AppReceiptDate><![CDATA[February 22, 2011, February 22, 2012, February 22, 2013 ]]></AppReceiptDate>
<LARD>2013-02-22</LARD>
<FileName>PAR-11-046.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-046</DocNum>
<ExpirationDate>2013-02-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18563</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03)
 ]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women.  Both human and animal model studies are sought.    ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-049.html</GuideLink>
<RelDate>2010-11-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-049.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-049</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18564</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21)
 ]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women.  Both human and animal model studies are sought.   ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-048.html</GuideLink>
<RelDate>2010-11-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-048.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-048</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18565</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) 
 ]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women.  Both human and animal model studies are sought.     ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-047.html</GuideLink>
<RelDate>2010-11-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-047.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-047</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18570</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[ NIH Summer Research Experience Programs (R25) 
 ]]></Title>
<Purpose><![CDATA[The purpose of the NIH Summer Research Experience Program (referred to as the Summer Research Program) is to provide a high quality research experience for high school and college students and for science teachers during the summer academic break.  The NIH expects that such programs will: help attract young students to careers in science; provide opportunities for college students to gain valuable research experience to help prepare them for graduate school; and enhance the skills of science teachers and enable them to more effectively communicate the nature of the scientific process to their students.  The programs would also contribute to enhancing overall science literacy.  Summer Research Programs that expand and complement existing summer educational and training programs are encouraged.  Not all participating Institutes and Centers (ICs) support all aspects of this program.  Therefore, prospective applicants should contact staff at the relevant IC (see Section VII) to discuss their proposed program.
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-050.html</GuideLink>
<RelDate>2010-12-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 1, 2011; August 1, 2011; August 1, 2012
AIDS Dates: February 1, 2011, September 8, 2011 and September 6, 2012]]></AppReceiptDate>
<LARD>2012-09-06</LARD>
<FileName>PAR-11-050.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-050</DocNum>
<ExpirationDate>2012-09-07</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18571</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Studies in Neonatal Hypoglycemia (R01)

]]></Title>
<Purpose><![CDATA[Purpose.  This funding opportunity announcement (FOA) is issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to encourage Research Project Grant (R01) applications from institutions and organizations to propose studies related to basic, applied and translational research in neonatal hypoglycemia. While much progress has been made in understanding the causes and mechanisms of altered neonatal glucose homeostasis, major gaps remain. Through this FOA, the NICHD is hoping to fill-in such knowledge gaps, which may lead to better monitoring and treatment strategies for altered neonatal glucose homeostasis. 
Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism, and runs in parallel with FOAs of identical scientific scope, PA-11-054 and PA-11-055 , that encourage applications under the NIH Small Research Grant (R03) and NIH Exploratory/Developmental Research Grant (R21) award mechanisms. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-053.html</GuideLink>
<RelDate>2010-12-02</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-053.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-053</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18572</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Mechanisms of Adverse Drug Reactions in Children (R03)
]]></Title>
<Purpose><![CDATA[ This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages Small Research Grant (R03) applications from organizations/institutions that propose to study the molecular, cellular and genetic mechanisms involved in the production of adverse drug reactions in children. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.
 ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-052.html</GuideLink>
<RelDate>2010-12-02</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-11-052.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-052</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18573</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Mechanisms of Adverse Drug Reactions in Children (R01)
]]></Title>
<Purpose><![CDATA[This FOA encourages projects that enhance the state-of-the-science on the molecular and cellular, genetic and epigenetic mechanisms involved in the production of adverse drug reactions in children. The objective of this announcement includes research on the role of ontogeny and the characterization of pharmacogenetic and developmental variations of drug metabolizing enzymes (DMEs), transporters, ion channels, receptors and signaling pathways that are responsible for drug toxicity in the pediatric population.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-051.html</GuideLink>
<RelDate>2010-12-02</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-051.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-051</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18575</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Studies in Neonatal Hypoglycemia (R21)
]]></Title>
<Purpose><![CDATA[Purpose: This funding opportunity announcement (FOA) is issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to encourage Research Project Grant (R21) applications from institutions and organizations to propose studies related to basic, applied and translational research in neonatal hypoglycemia. While much progress has been made in understanding the causes and mechanisms of altered neonatal glucose homeostasis, major gaps remain. Through this FOA, the NICHD is hoping to fill-in such knowledge gaps, which may lead to better monitoring and treatment strategies for altered neonatal glucose homeostasis. 
Mechanism of Support. This FOA will use the NIH Exploratory/Developmental Research Grant (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-11-053  and PA-11-054 , that encourage applications under the NIH Research Project Grant (R01) and NIH Small Research Grant (R03) award mechanisms. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-055.html</GuideLink>
<RelDate>2010-12-02</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-055.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-055</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18576</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Studies in Neonatal Hypoglycemia (R03)

]]></Title>
<Purpose><![CDATA[Purpose. This funding opportunity announcement (FOA) is issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to encourage Small Research Project Grant (R03) applications from institutions and organizations to propose studies related to the basic, applied and translational research in neonatal hypoglycemia. While much progress has been made in understanding the causes and mechanisms of altered neonatal glucose homeostasis, major gaps remain. Through this FOA, the NICHD is hoping to fill-in such knowledge gaps, which may lead to better monitoring, diagnosis and treatment strategies in newborn infants with altered neonatal glucose homeostasis. 
Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism  and runs in parallel with FOAs of identical scientific scope, PA-11-053  and PA-11-055 , that encourage applications under the NIH Research Project Grant (R01) and NIH Exploratory/Developmental Research Grant (R21) award mechanisms.   
Funds Available and Anticipated Number of Awards.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-054.html</GuideLink>
<RelDate>2010-12-02</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-054.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-054</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18580</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Resource Related Research Projects for AIDS, Allergy, Immunology and Transplantation (R24)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites submission of investigator-initiated Resource-Related Research Projects (R24) applications.These applications are limited to the research priorities of the Division of AIDS (DAIDS), and the Division of Allergy, Immunology and Transplantation (DAIT). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified.Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID. It is anticipated that the request for resource support through the R24 mechanism will occur on an infrequent basis and only in circumstances where other mechanisms of support from the NIAID are not appropriate.

The proposed applications must address scientific areas relevant to the specific parts of the NIAID mission including the biology, pathogenesis, and host response to HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and research to develop vaccines, therapeutics, and diagnostics to prevent and treat HIV, immune-mediated, and allergic diseases.]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-056.html</GuideLink>
<RelDate>2010-12-03</RelDate>
<IntentDate>30 days prior to standard receipt dates</IntentDate>
<AppReceiptDate><![CDATA[February 3, 2011, after this date, Standard dates will apply.]]></AppReceiptDate>
<LARD>2013-01-08</LARD>
<FileName>PAR-11-056.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-056</DocNum>
<ExpirationDate>2013-01-09</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18583</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Developmental Pharmacology (R01)]]></Title>
<Purpose><![CDATA[This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI), National Institute of General Medical Sciences (NIGMS), National Institute of Mental Health (NIMH), and National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), encourages Research Project Grant (R01) applications from institutions/ organizations that propose to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>499999</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-057.html</GuideLink>
<RelDate>2010-12-03</RelDate>
<IntentDate>30 days prior to the application due date </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-057.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-057</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18584</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Developmental Pharmacology (R03)]]></Title>
<Purpose><![CDATA[The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI), National Institute of Environmental Health Sciences (NIEHS),National Institutes of Health (NIH) invite grant applications for research related to developmental pharmacology. A major aim of this FOIA is to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-058.html</GuideLink>
<RelDate>2010-12-03</RelDate>
<IntentDate>30 days before application receipt date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-058.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-058</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18585</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Developmental Pharmacology (R21)]]></Title>
<Purpose><![CDATA[The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and participating Institutes within the National Institutes of Health (NIH) invite grant applications for research related to developmental pharmacology. To encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity acrossdevelopmental periods from fetal life to adolescence.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-059.html</GuideLink>
<RelDate>2010-12-03</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-059.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-059</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18587</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)]]></Title>
<Purpose><![CDATA[Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Resource-Related Research Project Grant (R24) applications from institutions that serve economically disadvantaged students andcommunities.Applications should propose to develop or strengthen the drug abuse research infrastructure at the institution and foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research. 

Mechanism of Support. This FOA will utilize the Resource-Related Research Projects (R24) grant mechanism.

Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $350,000 in directcosts per year and time periods up to 5 years may be requested.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards supported will depend upon the mechanism number, quality, duration, and cost of the applications received. 

Budget and Project Period.Budgets for direct costs of up to $350,000 per year and project duration of up to 5 years may be requested.]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>350000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-060.html</GuideLink>
<RelDate>2010-12-06</RelDate>
<IntentDate>August 9, 2011, December 9, 2011, August 10, 2012, December 10, 2012, August 10, 2013 </IntentDate>
<AppReceiptDate><![CDATA[September 9, 2011, January 10, 2012, September 10, 2012, January 10, 2013, September 9, 2013]]></AppReceiptDate>
<LARD>2013-09-09</LARD>
<FileName>PAR-11-060.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-060</DocNum>
<ExpirationDate>2013-09-10</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18599</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Translating Basic Behavioral and Social Science Discoveries into Interventions to Improve Health-Related Behaviors (R01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is being issued by the Office of Behavioral and Social Sciences Research (OBSSR), with participation from the National Cancer Institute (NCI), National Center for Complementary and Alternative Medicine (NCCAM)), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Alcohol Abuse and Alcoholism (NIAAA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Diabetes and Digestive and Kidney Diseases, (NIDDK), National Institute on Drug Abuse (NIDA), Office of Research on Women's Health (ORWH).This FOA seeks highly innovative Research Project Grant (R01) applications that propose to translate findings from basic research on human behavior into effective clinical, community, or population-based behavioral interventions to improve health.Specifically, this FOA will support interdisciplinary teams of basic and applied biological, behavioral and/or social science researchers in developing and refining novel behavioral interventions with high potential impact to improve health-promoting behaviors (e.g., healthy dietary intake, sun safety, physical activity, or adherence to medical regimens), and/or reduce problem health behaviors (e.g., smoking, tanning or physical activity or alcohol or substance use, abuse or dependence).]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-063.html</GuideLink>
<RelDate>2010-12-07</RelDate>
<IntentDate>January 5, 2010</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-063.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-063</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18601</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[ Neuroimmune Mechanisms Of Alcohol Related Disorders (R21)
 ]]></Title>
<Purpose><![CDATA[This FOA issued by National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Research Project Grant (R21) applications from institutions/organizations that propose to study the neuroimmune mechanisms of alcohol related disorders. Studies using animal models and post-mortem human alcoholic brains suggest that alcohol exposure has a significant impact on the neuroimmune system in the brain. However, it remains unclear how the altered neuroimmune factors contribute to brain and behavioral changes associated with alcohol exposure. Emerging data indicate that neuroimmune molecules are expressed in neurons and glia, and play an important role in modulating synaptic function, neurodevelopment, and neuroendocrine function. These neuromodulatory properties, together with their essential roles in neuroinflammation, provide a new frame work to understand the role of neuroimmune factors in mediating neuroadaptation, neurodegeneration, and behavioral disorders due to alcohol exposure. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-065.html</GuideLink>
<RelDate>2010-12-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-065.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-065</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18602</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Neuroimmune Mechanisms Of Alcohol Related Disorders (R01)
]]></Title>
<Purpose><![CDATA[ This FOA issued by National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Research Project Grant (R01) applications from institutions/organizations that propose study the neuroimmune mechanisms of alcohol related disorders. Studies using animal models and post-mortem human alcoholic brains suggest that alcohol exposure has a significant impact on the neuroimmune system in the brain. However, it remains unclear how the altered neuroimmune factors contribute to brain and behavioral changes associated with alcohol exposure. Emerging data indicate that neuroimmune molecules are expressed in neurons and glia, and play an important role in modulating synaptic function, neurodevelopment, and neuroendocrine function. These neuromodulatory properties, together with their essential roles in neuroinflammation, provide a new frame work to understand the role of neuroimmune factors in mediating neuroadaptation, neurodegeneration, and behavioral disorders due to alcohol exposure. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-064.html</GuideLink>
<RelDate>2010-12-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-064.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-064</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18603</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Research Into The Impact Of Economic Fluctuations On Alcohol Consumption, Drinking Patterns, And Prevention And Treatment Of Problem Drinking And Related Problems (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Exploratory/Developmental Research Grant (R21) applications from institutions/ organizations that propose to investigate the impact of national or local economic fluctuations on alcohol consumption, alcohol drinking patterns, and the prevention and treatment of problem drinking.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-062.html</GuideLink>
<RelDate>2010-12-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-062.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-062</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18604</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Research Into The Impact Of Economic Fluctuations On Alcohol Consumption, Drinking Patterns, And Prevention And Treatment Of Problem Drinking And Related Problems (R01)
]]></Title>
<Purpose><![CDATA[ This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), encourages Research Project Grant (R01) applications from institutions/ organizations that propose to investigate the impact of national or local economic fluctuations on alcohol consumption,  alcohol drinking patterns, and the prevention and treatment of problem drinking.     
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-061.html</GuideLink>
<RelDate>2010-12-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-061.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-061</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18612</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[NIA Program Project Applications (P01)]]></Title>
<Purpose><![CDATA[The National Institute on Aging invites the submission of investigator-initiated  program project (P01) applications. The applications may address scientific areas relevant to the NIA mission.    Each P01 submitted in response to this FOA must include at least three related research projects that share a common central theme, focus, and/overall objective.
 ]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-066.html</GuideLink>
<RelDate>2010-12-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[January 25, 2011, January 25, 2012, January 25, 2013; May 25, 2011, May 25, 2012, May 25, 2013
AIDS: May 7, 2011, May 7, 2012, May 7, 2013 and September 7, 2011, September 7, 2012, September 7, 2013]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-11-066.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-066</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18613</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), encourages Exploratory/Developmental Grant (R21) applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments.

]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-074.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-074.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-074</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18614</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), encourages Research Project Grant (R01) applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-073.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-073.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-073</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18615</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Chronic Illness Self-Management in Children and Adolescents (R21)
]]></Title>
<Purpose><![CDATA[ The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Child Health and Human Development (NICHD), and the National Heart, Lung, and Blood Institute (NHLBI) is to encourage research to improve self-management and quality of life in children and adolescents with chronic illnesses.Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. Studies of chronic mental illness or serious cognitive disability are beyond the scope of this FOA. 
 ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-072.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-072.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-072</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18616</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Chronic Illness Self-Management in Children and Adolescents (R03)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR) and the National Institute of Child Health and Human Development (NICHD) is to encourage research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. Studies of chronic mental illness or serious cognitive disability are beyond the scope of this FOA.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-071.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-071.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-071</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18617</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Chronic Illness Self-Management in Children and Adolescents (R01) 
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the National Heart, Lung, and Blood Institute (NHLBI) is to encourage research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged.  This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. Studies of chronic mental illness or serious cognitive disability are beyond the scope of this FOA. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-070.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-070.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-070</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18618</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Focal Cognitive Deficits in CNS Disorders (R21)
 ]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Institute of Child Health and Human Development (NICHD), and Office of Behavioral and Social Sciences Research (OBSSR) is to invite grant applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders.  The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness.  However, only participating ICs will provide direct grant support under this FOA.   
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-069.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-069.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-069</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18619</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Focal Cognitive Deficits in CNS Disorders (R03)
]]></Title>
<Purpose><![CDATA[ The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Institute of Child Health and Human Development (NICHD), and Office of Behavioral and Social Sciences Research (OBSSR) is to invite grant applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders.  The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness.  However, only participating ICs will provide direct grant support under this FOA. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. 
 ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-068.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-068.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-068</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18620</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Focal Cognitive Deficits in CNS Disorders (R01)
]]></Title>
<Purpose><![CDATA[ The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Institute of Child Health and Human Development (NICHD), and Office of Behavioral and Social Sciences Research (OBSSR) is to invite grant applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders.  The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness.  However, only participating ICs will provide direct grant support under this FOA.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-067.html</GuideLink>
<RelDate>2010-12-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-067.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-067</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18626</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral Fellowships in Muscular Dystrophy Research (F32)
]]></Title>
<Purpose><![CDATA[Purpose. The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) individual Postdoctoral fellowship (F32) program is to provide support to promising applicants with the potential to become productive and successful independent research investigators in scientific health-related fields relevant to the programmatic interests of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).  NIAMS is interested in supporting additional training fellowship opportunities in muscular dystrophy research.  Research supported through this funding opportunity announcement will address basic, translational or clinical studies of the muscular dystrophies, which include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. 
Mechanism of Support. This FOA will utilize the Ruth L. Kirschstein NRSA F32 award mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research training will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. 
]]></Purpose>
<RelNote/><ActivityCodes>F32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-075.html</GuideLink>
<RelDate>2010-12-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-075.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-075</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18627</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[NIH Pathway to Independence Award in Muscular Dystrophy Research (K99/R00)

]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) are interested in supporting additional career development and mentoring opportunities in muscular dystrophy research.  NIAMS and NICHD will provide career development awards to promising clinically trained applicants with the potential to become productive, independent investigators in basic, translational, and clinical research on the muscular dystrophies. This funding opportunity Announcement (FOA) is issued in recognition of the urgent need for highly skilled, interactive investigators who are able to integrate various disciplines and levels of expertise to successfully address the increasing challenges in the current research environment of the muscular dystrophies. This FOA calls for applications for mentored career development awards for clinical scientist engaged in laboratory research. It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training.  Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies.   
Mechanism of Support. This FOA will utilize the K99 grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-11-075 , PA-11-077  and  PA-11-076 , that encourage applications under the F32, K08, and K23 mechanisms. 
]]></Purpose>
<RelNote/><ActivityCodes>K99,R00</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-078.html</GuideLink>
<RelDate>2010-12-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-078.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-078</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18628</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Mentored Clinical Scientist Research Career Development Award in Muscular Dystrophy Research (K08)

]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) are interested in supporting additional career development and mentoring opportunities in muscular dystrophy research.  NIAMS and NICHD will provide career development awards to promising clinically trained applicants with the potential to become productive, independent investigators in basic, translational, and clinical research on the muscular dystropies. This FOA is issued in recognition of the urgent need for highly skilled, interactive investigators who are able to integrate various disciplines and levels of expertise to successfully address the increasing challenges in the current research environment of the muscular dystrophies. This FOA calls for applications for mentored career development awards for clinical scientist engaged in laboratory research. It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training.  Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies.  
Mechanism of Support. This FOA will utilize the K08 grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-11-075 , PA-11-076  and PA-11-078  , that encourage applications under the F32, K23, and K99 mechanisms. 
]]></Purpose>
<RelNote/><ActivityCodes>K08</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-077.html</GuideLink>
<RelDate>2010-12-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-11-12</LARD>
<FileName>PA-11-077.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-077</DocNum>
<ExpirationDate>2013-11-13</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18629</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Mentored Patient-Oriented Research Career Development Award in Muscular Dystrophy Research (K23)

]]></Title>
<Purpose><![CDATA[Purpose. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) are interested in supporting additional career development and mentoring opportunities in muscular dystrophy research.  NIAMS and NICHD will provide career development awards to promising clinically trained applicants with the potential to become productive, independent investigators in basic, translational, and clinical research on the muscular dystrophies. This funding opportunity Announcement (FOA) is issued in recognition of the urgent need for highly skilled, interactive investigators who are able to integrate various disciplines and levels of expertise to successfully address the increasing challenges in the current research environment of the muscular dystrophies. This FOA calls for applications for mentored career development awards for clinical scientist engaged in patient-oriented research (POR). It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training.  Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies.   
Mechanism of Support. This FOA will utilize the K23 grant mechanism and runs in parallel with FOAs of identical scientific scope, PA-11-075 , PA-11-077 and PA-11-078 , that encourage applications under the F32, K08, and K99 mechanisms. 
]]></Purpose>
<RelNote/><ActivityCodes>K23</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-076.html</GuideLink>
<RelDate>2010-12-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-076.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-076</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18634</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Cancer Prevention Research Small Grant Program (R03)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) is designed to enhance both basic and applied cancer prevention research. The National Cancer Institute (NCI) invites applications that propose small and time-limited projects pertinent to the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, and/or clinical prevention studies that focus on specific target organs. Proposed projects may involve basic animal and/or translational research and/or human subjects-oriented research. However, treatment related quality of life population based studies, as well as projects focused on cancer etiology, metastasis, animal model development, or treatment will not be appropriate for this FOA. New, as well as established, investigators in relevant fields and disciplines (e.g., chemoprevention, nutritional science, genetics, infectious agents, and early detection, including biomarker development and validation) are encouraged to apply for these small grants to test the feasibility of innovative ideas or carry out pilot studies. Ultimately, these small grants are expected to facilitate the development of full research projects grants.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-079.html</GuideLink>
<RelDate>2010-12-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 18, 2011; July 21, 2011; December 16, 2011; February 15, 2012; July 18, 2012; December 14, 2012; February 15, 2013; July 19, 2013; December 16, 2013]]></AppReceiptDate>
<LARD>2013-12-16</LARD>
<FileName>PAR-11-079.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-079</DocNum>
<ExpirationDate>2013-12-17</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18653</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R01) ]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose to study the underlying pathophysiology of osteonecrosis of the jaw (ONJ), identify risk factors for this condition, establish the natural history of the disease, and generate evidence for its treatment. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-082.html</GuideLink>
<RelDate>2010-12-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-082.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-082</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18662</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R21) ]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, encourages NIH Exploratory/Developmental (R21) applications from institutions/organizations that propose to study the underlying pathophysiology of osteonecrosis of the jaw (ONJ), identify risk factors for this condition, establish the natural history of the disease, and generate evidence for its treatment. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-083.html</GuideLink>
<RelDate>2010-12-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-083.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-083</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18667</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Genetic Susceptibility & Variability of Human Structural Birth Defects (R01)]]></Title>
<Purpose><![CDATA[ The purpose of this funding opportunity announcement (FOA) is to support innovative investigator-initiated R01 applications using animal models in conjunction with translational/clinical approaches that take advantage of advances in genetics, biochemistry, molecular, and developmental biology to identify the specific genetic, epigenetic, environmental, or gene/environment interactions associated with the susceptibility to and variability of structural birth defects in human populations.  Applicants funded through this FOA will join the NICHD Birth Defects Working Group and participate in annual meetings designed to provide a forum to discuss research progress, exchange ideas, share resources, and foster collaborations relevant to the goals of the NIHCD's Birth Defects Initiative.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-085.html</GuideLink>
<RelDate>2010-12-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-085.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-085</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18666</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Science Education Awards (R25)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages applications from organizations that focus on the development of science education for K-12 students. It is expected that these education programs will provide outreach to a large audience of students at a national level, directly or through their teachers, using approaches where successes can be measured. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-086.html</GuideLink>
<RelDate>2010-12-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 18, 2011 thereafter Standard dates apply]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-086.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-086</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18678</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Research on Alcohol-Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites applications to conduct research on the effects of alcohol-related public policies on health, economic, and social behaviors and outcomes. The purpose of the FOA is to advance understanding of public policy pertaining to alcohol as a tool for improving public health and welfare. The NIAAA has developed the Alcohol Policy Information System (APIS) as a resource for researchers conducting studies in this area; studies that make use of the information available through APIS are particularly encouraged. Research supported by this FOA includes, but is not necessarily limited to, studies examining the effects of alcohol-related public policies on health-related behaviors and outcomes, evaluations of public policies as tools for improving public health, and research to advance methods and measurement used in studying relationships between alcohol-related public policies and health-related behaviors and outcomes.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-089.html</GuideLink>
<RelDate>2011-01-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-089.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-089</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18679</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Research on Alcohol-Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites applications to conduct research on the effects of alcohol-related public policies on health, economic, and social behaviors and outcomes. The purpose of the FOA is to advance understanding of public policy pertaining to alcohol as a tool for improving public health and welfare. The NIAAA has developed the Alcohol Policy Information System (APIS) as a resource for researchers conducting studies in this area; studies that make use of the information available through APIS are particularly encouraged. Research supported by this FOA includes, but is not necessarily limited to, studies examining the effects of alcohol-related public policies on health-related behaviors and outcomes, evaluations of public policies as tools for improving public health, and research to advance methods and measurement used in studying relationships between alcohol-related public policies and health-related behaviors and outcomes.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-088.html</GuideLink>
<RelDate>2011-01-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-088.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-088</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18680</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Research on Alcohol-Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites applications to conduct research on the effects of alcohol-related public policies on health, economic, and social behaviors and outcomes. The purpose of the FOA is to advance understanding of public policy pertaining to alcohol as a tool for improving public health and welfare. The NIAAA has developed the Alcohol Policy Information System (APIS) as a resource for researchers conducting studies in this area; studies that make use of the information available through APIS are particularly encouraged. Research supported by this FOA includes, but is not necessarily limited to, studies examining the effects of alcohol-related public policies on health-related behaviors and outcomes, evaluations of public policies as tools for improving public health, and research to advance methods and measurement used in studying relationships between alcohol-related public policies and health-related behaviors and outcomes.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-087.html</GuideLink>
<RelDate>2011-01-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-087.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-087</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18681</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[NHLBI Investigator-Initiated Resource-Related Research Projects (R24)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the NHLBI, invites Resource-Related Research Project applications (R24) to support projects that will enhance the capabilities of ongoing basic, translational, and clinical research through the development of resources or infrastructure for use by the broader scientific community for furthering research. This FOA continues the investigator-initiated Resource-Related Research Project funding opportunity as detailed and structured in http://www.nhlbi.nih.gov/funding/policies/r24.htm.  ]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-090.html</GuideLink>
<RelDate>2011-01-04</RelDate>
<IntentDate>One month prior to the planned submission date</IntentDate>
<AppReceiptDate><![CDATA[March 3, 2011 then Standard dates apply thereafter. ]]></AppReceiptDate>
<LARD>2014-01-25</LARD>
<FileName>PAR-11-090.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-090</DocNum>
<ExpirationDate>2014-01-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18699</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Genomic Resource Grants for Community Resource Projects (U41)]]></Title>
<Purpose><![CDATA[Genomic research has had substantial impact on biomedical research, in large part because of the open sharing of data (often prior to publication) and resources with the greater research community.  To facilitate genomic research and the dissemination of its products, NHGRI supports resources that are crucial for disease studies, model organism studies, and other biomedical research.  This FOA encourages applications for the development and support of genomic resources that will be available to and valuable for the broad research community.  Such resources include (but are not limited to) informatics resources such as model organism databases and ontologies, comprehensive collections of genomic features (such as structural variants), and collections of physical resources (such as samples and cDNA clone banks).
]]></Purpose>
<RelNote/><ActivityCodes>U41</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-095.html</GuideLink>
<RelDate>2011-01-07</RelDate>
<IntentDate>The first letter of intent due date will be February 15, 2011; then letters of intent will be due one month prior to regular receipt dates.</IntentDate>
<AppReceiptDate><![CDATA[The first receipt date will be March 15, 2011; then Standard dates apply: May 25, 2011; September 25, 2011; January 25, 2012; May 25, 2012; September 25, 2012; January 25, 2013; May 25, 2013; and September 25, 2013]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-095.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-095</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18713</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Education Research in Sleep Health and Sleep-Circadian Biology (R25) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites the submission of Education Research (R25) grant applications focused on scientific advances in sleep health and circadian and sleep biology.Proposed projects may include the development of innovative education tools, platforms and programs that will transfer health information and scientific advances in sleep and circadian biology to research scientists, health care providers, educators from diverse disciplines, and to specific populations including youth, older adults, women, racial and ethnic minorities, and veterans.Projects should draw upon cutting-edge education, knowledge transfer, or social marketing models and must include analytic plans for the assessment of program efficacy and plans for adoption and sustained implementation in other settings.]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-098.html</GuideLink>
<RelDate>2011-01-13</RelDate>
<IntentDate>May 3, 2011; January 2, 2012; January 2, 2013</IntentDate>
<AppReceiptDate><![CDATA[June 2, 2011; February 2, 2012; February 1, 2013]]></AppReceiptDate>
<LARD>2013-02-01</LARD>
<FileName>PAR-11-098.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-098</DocNum>
<ExpirationDate>2013-02-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18719</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Alzheimer's Disease Pilot Clinical Trials (R01)]]></Title>
<Purpose><![CDATA[In 1999, at the direction of Congress, the National Institute on Aging (NIA), in conjunction with the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) embarked on the Alzheimer's Disease (AD) Prevention Initiative, which encompasses a number of interrelated efforts including basic, epidemiological, behavioral, and clinical research. An important part of the AD Prevention Initiative is to quicken the pace for translating basic science findings into clinical trials to evaluate treatment and prevention strategies. This funding opportunity announcement (FOA) focuses on AD pilot clinical trials while other FOAs are targeted to AD drug discovery and development. 

In this FOA the National Institute on Aging (NIA) invites qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline.

]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-100.html</GuideLink>
<RelDate>2011-01-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 18, 2011 then Standard dates apply.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-100.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-100</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18738</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<Title><![CDATA[Reducing Health Disparities Among Minority and Underserved Children (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Alcohol, Alcoholism, and Alcohol Abuse (NIAAA), and National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), solicits Research Project Grant (R01) applications from institutions/organizations that propose to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the comparative effectiveness of health promotion interventions conducted in traditional and nontraditional settings.     ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-104.html</GuideLink>
<RelDate>2011-01-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 1, 2011 thereafter Standard dates apply]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-104.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-104</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18739</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<Title><![CDATA[Reducing Health Disparities Among Minority and Underserved Children (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Alcohol, Alcoholism, and Alcohol Abuse (NIAAA), and National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), encourages Research Project Grant (R21) applications from institutions/organizations that propose to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the comparative effectiveness of health promotion interventions conducted in traditional and nontraditional settings.   ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-105.html</GuideLink>
<RelDate>2011-01-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 1, 2011, thereafter Standard dates apply]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-105.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-105</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18756</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Maximizing the Scientific Value of the NHLBI Biologic Specimen Repository:  Scientific Opportunities  (R21) ]]></Title>
<Purpose><![CDATA[ This Funding Opportunity Announcement (FOA), issued by the National Heart, Lung, and Blood Institute, solicits Exploratory/ Developmental Grant (R21) applications from  Investigators at institutions/organizations that propose to conduct research in heart, lung, and blood diseases, and blood resources using existing biospecimens stored in the NHLBI Biologic Specimen Repository (Biorepository). 
 ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-004.html</GuideLink>
<RelDate>2011-02-03</RelDate>
<IntentDate>April 4, 2011; April 4, 2012</IntentDate>
<AppReceiptDate><![CDATA[April 4, 2011; April 4, 2012
AIDS: August 17, 2011; August 17 2012]]></AppReceiptDate>
<LARD>2012-08-17</LARD>
<FileName>RFA-HL-12-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-12-004</DocNum>
<ExpirationDate>2012-08-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18757</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[International Neuroscience Fellowship (F05)]]></Title>
<Purpose><![CDATA[The goal of the International Neuroscience Fellowship (INF) is to advance the training of qualified foreign neuroscientists and clinicians at the early or mid-career level, by enhancing their basic, translational or clinical research skills in a research setting in the United States (U.S.). This program aims to strengthen the intellectual capital of neuroscience research in international institutions. Awardees are expected to pursue future independent and productive careers, which stimulate research in the neurosciences on a global scale.]]></Purpose>
<RelNote/><ActivityCodes>F05</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-106.html</GuideLink>
<RelDate>2011-02-03</RelDate>
<IntentDate>July 16, 2011, 2012</IntentDate>
<AppReceiptDate><![CDATA[August 16, 2011, 2012 ]]></AppReceiptDate>
<LARD>2012-08-16</LARD>
<FileName>PAR-11-106.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-106</DocNum>
<ExpirationDate>2012-08-17</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18763</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01)]]></Title>
<Purpose><![CDATA[This FOA is to encourage Research Project Grant (R01) applications to conduct ancillary studies to the NIDDK Intestinal Stem Cell Consortium (ISCC).  Studies will make use of consortium collaborations, techniques, and resources to accelerate research into intestinal stem cells.  The proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of interest to the Institute and commensurate with the interests and intent of the ISCC.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-107.html</GuideLink>
<RelDate>2011-02-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-11-107.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-107</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18776</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Centers for AIDS Research and Developmental Centers for AIDS Research (P30)]]></Title>
<Purpose><![CDATA[This FOA encourages applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research.  Applications are being solicited for both standard CFARs and for developmental CFARs (D-CFARs).  Standard and D-CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms.  Additionally, D-CFARs provide support to assist investigators in the development of a competitive standard CFAR.  The program emphasizes interdisciplinary collaboration, especially between basic and clinical investigators, translational research between the laboratory and the clinic, inclusion of investigators from diverse backgrounds, and inclusion of prevention and behavioral change research. ]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-108.html</GuideLink>
<RelDate>2011-02-09</RelDate>
<IntentDate>May 13, 2011, May 14, 2012 and May 14, 2013</IntentDate>
<AppReceiptDate><![CDATA[June 14, 2011, June 14, 2012 and June 14, 2013 ]]></AppReceiptDate>
<LARD>2013-06-14</LARD>
<FileName>PAR-11-108.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-108</DocNum>
<ExpirationDate>2013-06-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18781</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Grand Opportunity in Medications Development for Substance-Related Disorders (U01) ]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of medication for the treatment of Substance-Related Disorders (SRDs) by soliciting research applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. It is expected that these U01s will be short-term (funded for up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This funding mechanism will enable critical medications development studies that would not be feasible using the traditional R01 mechanism. ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>5000000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-109.html</GuideLink>
<RelDate>2011-02-09</RelDate>
<IntentDate>April 26, 2011, July 26, 2011, February 27, 2012, June 27, 2012, February 27, 2013, June 26, 2013</IntentDate>
<AppReceiptDate><![CDATA[May 26, 2011, August 26, 2011, March 27, 2012, July 27, 2012, March 27, 2013, July 26, 2013
AIDS: August 14, 2011, November 8, 2011, March 27, 2012, August 14, 2012, March 27, 2013,  August 14, 2013]]></AppReceiptDate>
<LARD>2013-08-14</LARD>
<FileName>PAR-11-109.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-109</DocNum>
<ExpirationDate>2013-08-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18783</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD and Other Dual Doctoral Degree Fellows (Parent F30)]]></Title>
<Purpose><![CDATA[ The purpose of the Ruth L. Kirschstein National Research Service Awards (Kirschstein-NRSA) is to provide support to individuals for combined MD/PhD and other dual doctoral degree training (e.g. DO/PhD, DDS/PhD, AuD/PhD). The participating Institutes award this Kirschstein-NRSA individual fellowship (F30) to qualified applicants with the potential to become productive, independent, highly trained physician-scientists and other clinician-scientists, including patient-oriented researchers in their scientific mission areas. This funding opportunity supports individual predoctoral F30 fellowships with the expectation that these training opportunities will increase the number of future investigators with both clinical knowledge and skills in basic, translational or clinical research.]]></Purpose>
<RelNote/><ActivityCodes>F30</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-110.html</GuideLink>
<RelDate>2011-02-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-110.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-110</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18784</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31)]]></Title>
<Purpose><![CDATA[ The purpose of this individual predoctoral research training fellowship is to provide support for promising doctoral candidates who will be performing dissertation research and training in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers (ICs) during the tenure of the award.
 ]]></Purpose>
<RelNote/><ActivityCodes>F31</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-111.html</GuideLink>
<RelDate>2011-02-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-111.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-111</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18785</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research (Parent F31 - Diversity)]]></Title>
<Purpose><![CDATA[The purpose of this individual predoctoral research training fellowship is to improve the diversity of the health-related research workforce by supporting the training of predoctoral students from groups that have been shown to be underrepresented. Such candidates include individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds.
]]></Purpose>
<RelNote/><ActivityCodes>F31</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-112.html</GuideLink>
<RelDate>2011-02-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-112.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-112</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18786</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (Parent F32)]]></Title>
<Purpose><![CDATA[The purpose of this individual postdoctoral research training fellowship is to provide support to promising Fellowship Applicants with the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of participating NIH Institutes and Centers.
]]></Purpose>
<RelNote/><ActivityCodes>F32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-113.html</GuideLink>
<RelDate>2011-02-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-113.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-113</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18787</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows (Parent F33)]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) awards individual senior level research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.
]]></Purpose>
<RelNote/><ActivityCodes>F33</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-114.html</GuideLink>
<RelDate>2011-02-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-114.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-114</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18789</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<Title><![CDATA[NINR Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows In Nursing Research (F31)]]></Title>
<Purpose><![CDATA[The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows in Nursing Research (F31) program is to train future generations of outstanding nurse scientists who are committed to research careers in scientific health-related fields relevant to the programmatic interests of the National Institute of Nursing Research (NINR). This FOA encourages Individual Predoctoral Fellowship (F31) applications from institutions/organizations that propose to increase the number of nurses prepared with a doctoral degree in order to meet the demands for adequately trained behavioral, biological, and biobehavioral scientists. NINR is particularly interested in facilitating the progress of students who are in research training programs for recent nursing graduates and students in BSN to PhD programs. This fellowship program will provide predoctoral training support for doctoral students. The applicant should propose a research training program and dissertation research that is consistent with the scientific mission of the NINR.  ]]></Purpose>
<RelNote/><ActivityCodes>F31</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-117.html</GuideLink>
<RelDate>2011-02-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-117.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-117</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18792</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[HIV/AIDS Testing and Follow-up Among the Underserved in the United States (R21)]]></Title>
<Purpose><![CDATA[The purpose of this initiative is to encourage research which will increase rates of HIV screening/testing and increase the number of persons who follow-up on a positive HIV screening test and receive treatment, particularly in underserved and at-risk populations within the United States. With this initiative, the ultimate goal is to decrease the rate of HIV transmission and increase the quality of life for people living with HIV/AIDS (PLWHA) by initiating diagnosis and treatment earlier. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-119.html</GuideLink>
<RelDate>2011-02-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-119.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-119</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18793</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[HIV/AIDS Testing and Follow-up Among the Underserved in the United States (R01)]]></Title>
<Purpose><![CDATA[ The purpose of this initiative is to encourage research which will increase rates of HIV screening/testing and increase the number of persons who follow-up on a positive HIV screening test and receive treatment, particularly in underserved and at-risk populations within the United States. With this initiative, the ultimate goal is to decrease the rate of HIV transmission and increase the quality of life for people living with HIV/AIDS (PLWHA) by initiating diagnosis and treatment earlier.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-118.html</GuideLink>
<RelDate>2011-02-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-118.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-118</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18794</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Research Demonstration and Dissemination Projects (R18)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites submission of investigator-initiated Research Demonstration and Dissemination Projects (R18) applications.  These applications are limited to the specific research priorities of the Division of Allergy, Immunology and Transplantation (DAIT). 

The purpose of the Research Demonstration and Dissemination Projects (R18) grant is to provide support for development, testing, and evaluation of health service activities, and to foster the application of existing knowledge for the control of categorical diseases.]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-120.html</GuideLink>
<RelDate>2011-02-11</RelDate>
<IntentDate>April 15, 2011; April 16, 2012; April 16, 2013</IntentDate>
<AppReceiptDate><![CDATA[May 16, 2011; May 16, 2012; May 16, 2013]]></AppReceiptDate>
<LARD>2013-05-16</LARD>
<FileName>PAR-11-120.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-120</DocNum>
<ExpirationDate>2013-05-17</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18796</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[Limited Competition:  Specific pathogen free macaque colonies (U42) ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to provide continuing support for specific pathogen free (SPF) macaque colonies previously funded under the auspices of RFA-RR-00-004 (http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-00-004.html).  SPF macaques are free of certain viruses that can compromise the results of AIDS-related investigations or that provide a risk to personnel who handle the animals.  Applicants must provide plans for:  a) maintaining the SPF colonies, minimally at current levels; b) distributing animals to AIDS researchers, with first priority to NIH funded investigators; c) assaying for the presence of specific viruses; d) typing animals for specific major histocompatibility complex loci; and e) financing colony operations.  ]]></Purpose>
<RelNote/><ActivityCodes>U42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-116.html</GuideLink>
<RelDate>2011-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-116.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-116</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18799</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Etiology and Pathophysiology of Sleep Disordered Breathing in Pregnancy (R01)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Nursing Research (NINR), encourages research project grant applications (R01) investigating: (1) mechanisms underlying the etiology of incident sleep disordered breathing (SDB) in pregnancy; (2) mechanisms coupling SDB to maternal heart, lung, and blood pathophysiology; (3) mechanisms through which SDB affects placental development and function and associated adverse pregnancy outcomes; and (4) mechanisms linking SDB to conditions in the intrauterine environment that result in altered fetal development and predispose offspring to obesity, metabolic, and cardiovascular disease.  The goal of this program is to identify clinically relevant mechanisms of SDB etiology and pathophysiology that will open new avenues to develop therapeutic strategies to reduce the maternal and fetal risks of SDB exposure during pregnancy.  Multi-disciplinary research teams are strongly encouraged.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-122.html</GuideLink>
<RelDate>2011-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-11-122.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-122</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18800</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<Title><![CDATA[Ribosomal Disorders and Their Role in Inherited Bone Marrow Failure Syndromes (R01)]]></Title>
<Purpose><![CDATA[is FOA issued by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases  encourages applications from institutions/organizations that propose collaborative research projects by multi-disciplinary teams to advance our understanding of molecular and cellular mechanisms underlying ribosomal dysfunction.  These research areas include effects on hematopoiesis and their role in bone marrow failure syndromes. Multi-disciplinary expertise across basic and clinical components is encouraged.  To meet the objectives of this FOA applicants are encouraged to integrate ribosomal biology with bone marrow failure to develop and characterize models of ribosomopathies.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-121.html</GuideLink>
<RelDate>2011-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-121.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-121</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18790</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[Limited Competition:  Specific pathogen free macaque colonies (U24) ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to provide continuing support for specific pathogen free (SPF) macaque colonies previously funded under the auspices of RFA-RR-02-005 (http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-02-005.html).  SPF macaques are free of certain viruses that can compromise the results of AIDS-related investigations or that provide a risk to personnel who handle the animals.  Applicants must provide plans for:  a) maintaining the SPF colonies, minimally at current levels; b) distributing animals to AIDS researchers, with first priority to NIH funded investigators; c) assaying for the presence of specific viruses; d) typing animals for specific major histocompatibility complex loci; and e) financing colony operations. ]]></Purpose>
<RelNote/><ActivityCodes>U24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-115.html</GuideLink>
<RelDate>2011-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-115.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-115</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18812</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[NHLBI Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD Fellows (F30)]]></Title>
<Purpose><![CDATA[The National Heart, Lung, and Blood Institute (NHLBI) is interested in supporting individual predoctoral fellowships for combined MD/PhD training in research areas relevant to the mission of the NHLBI.

Applications to this FOA are accepted from (a) students currently enrolled in a combined MD/PhD program and (b) current medical or graduate students seeking admission to a combined degree program. Awards to those applicants are contingent on subsequently being enrolled in a combined MD/PhD program.

]]></Purpose>
<RelNote/><ActivityCodes>F30</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-125.html</GuideLink>
<RelDate>2011-02-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-11-125.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-125</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18813</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[AOA]]></PartIC>
<Title><![CDATA[Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R01)]]></Title>
<Purpose><![CDATA[The National Institute on Aging (NIA) and the Administration on Aging (AoA) invite applications using the R01 award mechanism for translational research that moves evidence-based research findings towards the development of new interventions, programs, policies, practices, and tools that can be used by community-based organizations to help elderly individuals remain healthy and independent, and living in their own homes and communities.  The goal of this FOA is to support translational research involving collaborations between academic research centers and community-based organizations with expertise serving the elderly (such as city and state health departments, city/town leadership councils, and Area Agencies on Aging) that will enhance our understanding of practical tools, techniques, programs and policies that communities across the nation can use to more effectively respond to needs of their aging populations.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-123.html</GuideLink>
<RelDate>2011-02-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-123.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-123</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18814</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[AOA]]></PartIC>
<Title><![CDATA[ Translational Research to Help Older Adults Maintain their Health and Independence in the  Community (R21)
 ]]></Title>
<Purpose><![CDATA[The National Institute on Aging (NIA) and the Administration on Aging (AoA) invite applications using the  (R21)award mechanism for translational research that moves evidence-based research findings towards the development of new interventions, programs, policies, practices, and tools that can be used by community-based organizations to help elderly individuals remain healthy and independent, and living in their own homes and communities.  The goal of this FOA is to support translational research involving collaborations between academic research centers and community-based organizations with expertise serving the elderly (such as city and state health departments, city/town leadership councils, and Area Agencies on Aging) that will enhance our understanding of practical tools, techniques, programs and policies that communities across the nation can use to more effectively respond to needs of their aging populations.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-124.html</GuideLink>
<RelDate>2011-02-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-124.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-124</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18819</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Silvio O. Conte Centers for Basic and Translational Mental Health Research (P50) ]]></Title>
<Purpose><![CDATA[ The National Institute of Mental Health (NIMH) invites applications for Silvio O. Conte Centers for Basic or Translational Mental Health Research. The institute seeks teams of researchers working at different levels of analysis and employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions with the primary objective of: (a) advancing the state of the science in brain and behavior research that provides the foundation for understanding mental disorders relevant to mental health; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral developmental mechanisms and trajectories of psychopathology that begin in childhood and adolescence. The Conte Centers program is intended to support interdisciplinary basic and/or translational research demonstrating an extraordinary level of synergy, integration, and potential for advancing the state of the field. This program is intended only for projects that could not be achieved using other, more standard grant mechanisms. The Conte Centers program also provides an opportunity to establish interdisciplinary basic and/or translational research experiences for individuals in training. ]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-126.html</GuideLink>
<RelDate>2011-02-16</RelDate>
<IntentDate>May 23, 2011; April 25, 2012; April 25, 2013</IntentDate>
<AppReceiptDate><![CDATA[June 21, 2011; May 25, 2012; May 25, 2013]]></AppReceiptDate>
<LARD>2013-05-25</LARD>
<FileName>PAR-11-126.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-126</DocNum>
<ExpirationDate>2013-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18827</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows in MD-PhD programs (F31)]]></Title>
<Purpose><![CDATA[The purpose of this individual predoctoral research training fellowship is to provide support for promising doctoral candidates who are enrolled in combined MD-PhD programs, who will be performing dissertation research and training in scientific health-related fields relevant to the mission of the National Institute of Neurological Disorders and Stroke. 
]]></Purpose>
<RelNote/><ActivityCodes>F31</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-127.html</GuideLink>
<RelDate>2011-02-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-11-127.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-127</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18845</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Family and Interpersonal Relationships in an Aging Context (R01)]]></Title>
<Purpose><![CDATA[The National Institute on Aging invites researchers to submit innovative R01 research grant applications on aging and the family.  The objective of this research program is to expand understanding of the role of families and interpersonal relationships in the health and wellbeing of older people. This will be accomplished through increasing scientific knowledge on the effects of family and interpersonal relationships on behavioral and social processes of relevance to aging; and on how these processes change over the life course and across cohorts. A broad range of methods and approaches are encouraged.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-128.html</GuideLink>
<RelDate>2011-02-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-05-07</LARD>
<FileName>PA-11-128.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-128</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18846</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Predoctoral Fellows in PharmD/PhD Programs (F31)]]></Title>
<Purpose><![CDATA[The purpose of this individual predoctoral research training fellowship is to provide training support for promising students enrolled in a PharmD/PhD degree program who will be performing dissertation research and training in areas relevant to the missions of NIGMS, NICHD, and ODS.
]]></Purpose>
<RelNote/><ActivityCodes>F31</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-129.html</GuideLink>
<RelDate>2011-02-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-05-07</LARD>
<FileName>PA-11-129.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-129</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18847</rowid>
<PrimaryIC><![CDATA[NIMHD]]></PrimaryIC>
<Title><![CDATA[Research Centers in Minority Institutions Program (G12)]]></Title>
<Purpose><![CDATA[The purpose of the Research Centers in Minority Institutions (RCMI) Program is to expand the national capability for research in the health sciences by providing grant support to minority institutions that offer doctorate degrees in the health professions or in a health-related science.  These institutions historically have trained professionals from diverse backgrounds who provide health care to minority populations and are uniquely positioned to engage these populations in research and in the translation of research advances into culturally appropriate, measurable and sustained improvements in health outcomes.  The primary goals of the RCMI G12 Centers are to (1) develop research infrastructure to enhance institutional biomedical research capacity; (2) enable investigators to become more successful in obtaining competitive extramural support for the conduct of biomedical and/or behavioral research, particularly on diseases that disproportionately impact minority populations; and (3) foster environments conducive to professional development in the biomedical sciences.]]></Purpose>
<RelNote/><ActivityCodes>G12</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-132.html</GuideLink>
<RelDate>2011-02-25</RelDate>
<IntentDate>April 25, August 25, December 25</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-11-132.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-132</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18848</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Lab to Marketplace: Tools for Brain and Behavioral Research (SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[The NIH Blueprint for Neuroscience Research is a framework to enhance cooperative activities among the NIH Office of the Director and 15 NIH Institutes and Centers that support research on the nervous system. This Funding Opportunity Announcement (FOA) is released in affiliation with the Neuroscience Blueprint, with Institutes and Centers participating independently, and with participation by Institutes and Centers that are not part of the Blueprint. This FOA encourages the translation of technologies for brain or behavioral research from academic and other non-small business research sectors to the marketplace. Encouraged from Small Business Concerns (SBCs) are Small Business Innovation Research (SBIR) grant applications that propose to further develop, make more robust, and make more user-friendly such technologies in preparation for commercial dissemination. It is expected that this activity will require partnerships and close collaboration between the original developers of these technologies and SBCs, which may be accomplished in any of a number of ways, including the use of multiple principle investigators.]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-134.html</GuideLink>
<RelDate>2011-02-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-134.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-134</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18849</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Complex Technologies and Therapeutics Development for Mental Health Research and Practice]]></Title>
<Purpose><![CDATA[The overarching goal of the SBIR program at the National Institute of Mental Health (NIMH) is to support small businesses to develop technologies that can advance the mission of the Institute, including in basic neuroscience research relevant to mental disorders, translational and clinical research of mental disorders, clinical diagnosis or treatment of mental disorders, and dissemination of evidence-based mental health care.  This FOA encourages SBIR applications for support of research and development of particular types of complex technologies that require funding levels and durations beyond those reflected in the standard SBIR guidelines.  ]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-133.html</GuideLink>
<RelDate>2011-02-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-133.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-133</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18860</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Phase IIB Grants for Brain and Behavior Tools (R44) ]]></Title>
<Purpose><![CDATA[The NIH Blueprint for Neuroscience Research is a framework to enhance cooperative activities among the NIH Office of the Director and 15 NIH Institutes and Centers that support research on the nervous system. This Funding Opportunity Announcement (FOA) is released in affiliation with the Neuroscience Blueprint, with Institutes and Centers participating independently, and with participation by Institutes and Centers that are not part of the Blueprint. This FOA encourages Small Business Innovation Research (SBIR) grant applications that propose to continue the process of developing complex instrumentation, clinical research tools, or behavioral interventions and treatments. This FOA specifically invites applications for the competing renewal of previously funded Phase II SBIR grants to further develop the aforementioned types of technologies.
]]></Purpose>
<RelNote/><ActivityCodes>R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-135.html</GuideLink>
<RelDate>2011-02-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-135.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-135</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18877</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to stimulate the development of new model systems and/or the thorough characterization of the ovarian phenotype of existing models of fragile X associated premature ovarian insufficiency (FX-POI). New and well-characterized models of FX-POI will help us to answer fundamental questions about the role of the FMR1 repeat expansion in ovarian function and reproductive aging, and allow the field to advance into evidence based clinical research on fragile X pre-mutation carriers who are at risk for POI.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-137.html</GuideLink>
<RelDate>2011-03-09</RelDate>
<IntentDate>May 1, 2011, May 1, 2012</IntentDate>
<AppReceiptDate><![CDATA[June 1, 2011, June 1, 2012]]></AppReceiptDate>
<LARD>2012-06-01</LARD>
<FileName>PAR-11-137.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-137</DocNum>
<ExpirationDate>2012-06-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18878</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[Limited Competition:  National Primate Research Centers (P51)  ]]></Title>
<Purpose><![CDATA[This FOA issued by the National Center for Research Resources (NCRR), National Institutes of Health (NIH), encourages grant applications that support the activities of the National Primate Research Centers (NPRCs). Nonhuman primates (NHPs) are most closely related to humans, both physiologically and genetically. Therefore, NHPs are critical animal models for translational research aimed at understanding human biology, both in normal and diseased states. Proper husbandry and management of NHPs requires specialized physical and intellectual resources, which are most effectively and economically provided in centralized primate centers, the resources of which are made available to investigators on a national basis. The NPRCs provide these resources that complement and help enable the missions of the NIH Institutes and Centers, the grantees of which utilize NHPs to study specific diseases.
]]></Purpose>
<RelNote/><ActivityCodes>P51</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-136.html</GuideLink>
<RelDate>2011-03-09</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-136.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-136</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18882</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Economics of Retirement (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages research on the economic and health-related factors that influence older persons choices on labor force participation as they near typical retirement age and throughout the later stages of life.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-138.html</GuideLink>
<RelDate>2011-03-10</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt date, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-138.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-138</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18883</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Economics of Retirement (R03)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages research on the economic and health-related factors that influence older persons choices on labor force participation as they near typical retirement age and throughout the later stages of life.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-139.html</GuideLink>
<RelDate>2011-03-10</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-139.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-139</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18884</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Economics of Retirement (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages research on the economic and health-related factors that influence older persons choices on labor force participation as they near typical retirement age and throughout the later stages of life.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-140.html</GuideLink>
<RelDate>2011-03-10</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-140.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-140</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18887</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Research Opportunities in Obstetric Fistula (R01) ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage research applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula.The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate.Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum.Obstetric fistula is a critical maternal and child health issue in developing countries.Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-141.html</GuideLink>
<RelDate>2011-03-10</RelDate>
<IntentDate>May 5, 2011</IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-141.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-141</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18888</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Research Opportunities in Obstetric Fistula (R03)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage research applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula.The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate.Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum.Obstetric fistula is a critical maternal and child health issue in developing countries.Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-142.html</GuideLink>
<RelDate>2011-03-10</RelDate>
<IntentDate>May 16, 2011</IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-142.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-142</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18889</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Research Opportunities in Obstetric Fistula (R21)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage research applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula.The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate.Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum.Obstetric fistula is a critical maternal and child health issue in developing countries.Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-143.html</GuideLink>
<RelDate>2011-03-10</RelDate>
<IntentDate>May 16, 2011</IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-143.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-143</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18891</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Competitive Revision Applications for NIDCR-funded Cooperative Agreements (U01)]]></Title>
<Purpose><![CDATA[This FOA provides a mechanism for the submission of competitive revision applications for active, NIDCR-funded single project U01 awards.  The NIDCR uses the U01 Cooperative Agreement funding mechanism for a variety of projects requiring significant input from and oversight by NIDCR program staff.  Although some requests for expansion/redirection of a project can be handled administratively, more substantial changes in direction and increases in funding require peer review.]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-144.html</GuideLink>
<RelDate>2011-03-11</RelDate>
<IntentDate>April 26, 2011</IntentDate>
<AppReceiptDate><![CDATA[May 26,2011; thereafter, standard dates apply]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PAR-11-144.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-144</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18898</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[International Research in Infectious Diseases, including AIDS (R01)]]></Title>
<Purpose><![CDATA[This limited competition funding opportunity announcement (FOA) issued by the NIAID encourages Research Grant (R01) applications from organizations/institutions in eligible foreign countries that propose research related to infectious diseases that are of interest to that country. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-145.html</GuideLink>
<RelDate>2011-03-11</RelDate>
<IntentDate>30 Days prior to Application Due Date</IntentDate>
<AppReceiptDate><![CDATA[June 23 in 2011, May 23, 2012, and May 23, 2013. AIDS: August 23 in 2011, 2012, and 2013]]></AppReceiptDate>
<LARD>2013-08-23</LARD>
<FileName>PAR-11-145.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-145</DocNum>
<ExpirationDate>2013-08-24</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18902</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is designed to promote research on quantitative imaging of tumor response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making. Proposed projects should include the appropriate development and adaptation/implementation of quantitative imaging methods, protocols and software solutions/tools (using existing commercial imaging platforms and instrumentation), and their application in current and planned Phase 1-2 clinical therapy trials. No support for the clinical trials, as such, will be provided under this FOA. The proposed projects must focus on imaging-derived quantitative measurements of responses to drugs and/or radiation therapy, and/or image-guided interventions. It is anticipated that these research goals will require multidisciplinary efforts. Therefore, this FOA encourages applications from multi-disciplinary teams to include oncologists as well as clinical and basic imaging scientists. The involvement of industrial partners in the development of the quantitative imaging methods is not required, but is strongly encouraged. Awardees will form a Quantitative Imaging Network (QIN) to share ideas and approaches to validate and standardize imaging data and related imaging metadata for quantitative measurements of responses to cancer therapies.
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-150.html</GuideLink>
<RelDate>2011-03-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-150.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-150</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18903</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Nanoscience and Nanotechnology in Biology and Medicine (R21)]]></Title>
<Purpose><![CDATA[This initiative, issued by the National Institutes of Health, encourages applications from institutions/organizations that apply nanoscience and nanotechnology approaches to address problems in biology and medicine.  The purpose of this FOA is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment and management of an array of diseases and traumatic injuries.  Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes and systems based on the advancement of our understanding of biology at the nanoscale.  Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies.  Because this FOA utilizes the R21 grant mechanisms, applications that focus on novel or exploratory approaches that are risky but have potentially a high impact are encouraged as well as proposed discovery research that may lead to new areas of biomedical investigations. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-149.html</GuideLink>
<RelDate>2011-03-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-149.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-149</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18904</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Nanoscience and Nanotechnology in Biology and Medicine (R01) ]]></Title>
<Purpose><![CDATA[This initiative, issued by the National Institutes of Health, encourages applications from institutions/organizations that apply nanoscience and nanotechnology approaches to address problems in biology and medicine.  The purpose of this FOA is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment and management of an array of diseases and traumatic injuries.  Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes and systems based on the advancement of our understanding of biology at the nanoscale.  Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-148.html</GuideLink>
<RelDate>2011-03-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-148.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-148</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18908</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), encourages the submission of grant applications for support of the clinical application of multi-analyte molecular signatures derived from comprehensive molecular annotation of tumors. There is growing recognition in the clinical cancer research community that annotation of tumor specimens with data that integrates information about molecular alterations at the levels of DNA, RNA, and protein provides not only a more complete understanding of tumor biology but also provides a significant opportunity for developing new clinical tools to improve cancer treatment. Translating the knowledge gained from this molecular annotation into tools that can be used in clinical decision-making remains a major challenge. The purpose of this initiative is to build on recent demonstrations that molecular signatures correlate with important clinical parameters in cancer. The goal of this initiative is also to create publications and data sets that will be available and accessible to the scientific community in order to further the development, design, and conduct of future clinical trials (e.g., incorporation of molecular signatures into future clinical trials and large clinical validation studies) and to encourage appropriate commercialization to benefit the public health.  The NCI invites investigators to form strategic partnerships that will bring together the multi-disciplinary expertise and resources needed to determine how the information derived from comprehensive molecular analyses can be used to improve patient care and, ultimately, patient outcomes. ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>680000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-151.html</GuideLink>
<RelDate>2011-03-14</RelDate>
<IntentDate>May 15, 2011, May 15, 2012</IntentDate>
<AppReceiptDate><![CDATA[June 15, 2011, June 15, 2012]]></AppReceiptDate>
<LARD>2012-06-15</LARD>
<FileName>PAR-11-151.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-151</DocNum>
<ExpirationDate>2012-06-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18910</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<Title><![CDATA[The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), and the National Center for Complementary and Alternative Medicine, (NCCAM), at the National Institutes of Health, encourages the submission of grant applications that characterize the effects of microbially generated metabolites of dietary components on host cell biology. Specifically, this FOA seeks to characterize microbially generated metabolites and better understand their molecular mechanisms of action that affect host cell proliferative/apoptotic responses, cytokine production, inflammatory and immunomodulatory effects. This FOA will also encourage the conduct of human intervention studies that identify inter-individual variability among various racial and ethnic groups in the production of bacterial metabolites and determine their efficacy in cancer prevention. This research is necessary to better understand the role of dietary components in cancer etiology, prevention, and cancer health disparities to identify who might benefit from specific dietary recommendations and who might be placed at risk. One of the goals of this program will be to facilitate interdisciplinary collaborations among scientists engaged in nutrition, cancer prevention, cancer cell biology research, and cancer disparities research with those conducting studies with gut microorganisms. All applications must include multiple principle investigators with different areas of expertise such as microbiology, nutrition, cancer biology, analytical chemistry, or genetics. In addition, all investigators will be required to attend annual meetings with NIH personnel. Investigators may use either clinical or preclinical approaches. 
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-152.html</GuideLink>
<RelDate>2011-03-15</RelDate>
<IntentDate>October 15, 2011; October 15, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 15, 2011; November 15, 2012]]></AppReceiptDate>
<LARD>2012-11-15</LARD>
<FileName>PAR-11-152.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-152</DocNum>
<ExpirationDate>2012-11-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18911</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01)]]></Title>
<Purpose><![CDATA[The goal of this funding opportunity announcement (FOA), from the National Institute of Neurological Disorders and Stroke (NINDS) is to support preclinical development of new therapies to cure epilepsy, prevent the emergence of epilepsy following brain injury (including status epilepticus, traumatic brain injury, stroke, encephalitis, or other injury) or in other high-risk groups, or to better treat individuals with intractable epilepsy.  The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target. The program supports preclinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research, basic research, and studies of disease mechanism. This is a milestone-driven cooperative agreement program involving participation of NIH staff in the development of the project plan and monitoring of research progress. 
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>1000000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-154.html</GuideLink>
<RelDate>2011-03-15</RelDate>
<IntentDate>One month prior to application due date.</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-11-154.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-154</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18913</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<Title><![CDATA[Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages grant applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01s). The mission of the CounterACT U01 program is to develop new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping.  They include traditional chemical warfare nerve agents such as sarin and VX, and toxic industrial chemicals and pesticides such as cyanide, chlorine, parathion, and sodium fluoroacetate.  The scope of the research to be supported includes basic target and candidate identification and characterization studies, through candidate optimization and demonstration of in vivo efficacy, through Investigational New Drug (IND) submission and Phase 1 clinical trials when appropriate.  Each project must include milestones that create discrete go or no-go decision points in a progressive translational study plan.  
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-155.html</GuideLink>
<RelDate>2011-03-16</RelDate>
<IntentDate>August 14, 2011; August 14, 2012</IntentDate>
<AppReceiptDate><![CDATA[September 14, 2011; September 14, 2012]]></AppReceiptDate>
<LARD>2012-09-14</LARD>
<FileName>PAR-11-155.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-155</DocNum>
<ExpirationDate>2012-09-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18915</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[NIDDK Multi-Center Clinical Study Cooperative Agreement (U01)]]></Title>
<Purpose><![CDATA[This FOA provides for grant applications for investigator-initiated, multi-center clinical studies. NIDDK supports investigator-initiated, multi-center clinical studies through a two-part process that includes an implementation planning grant (U34; see  PAR-10-197). NIDDK will accept, peer review and consider for funding applications for investigator-initiated, multi-center clinical studies only from U34 grant awardees, except in cases where an exemption from the requirement has been given by NIDDK. Completion of the required products of a U34 grant is a prerequisite for submission of a multi-center clinical cooperative agreement (U01) application under this FOA.   
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-157.html</GuideLink>
<RelDate>2011-03-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-157.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-157</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18921</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, solicits grant applications from institutions/organizations to conduct proof-of- concept Phase II clinical trials that test a novel intervention for a lung disease or a cardiopulmonary disorder from sleep that has the potential to significantly change clinical management.  In addition, each application must include at least one basic research ancillary study tightly related to the clinical question.   
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-022.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>May 16, 2011, January 16, 2012, August 13, 2012</IntentDate>
<AppReceiptDate><![CDATA[June 15, 2011, February 15, 2012, September 13, 2012]]></AppReceiptDate>
<LARD>2012-09-13</LARD>
<FileName>RFA-HL-12-022.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-12-022</DocNum>
<ExpirationDate>2012-09-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18923</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R21)]]></Title>
<Purpose><![CDATA[This initiative issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), and
Office of Dietary Supplements (ODS), NIH, will renew a Funding Opportunity Announcements (FOA) (R21) to encourage submission of exploratory or developmental research applications on the role of nutrition and diet in the causation, prevention, and treatment of cardiomyopathies and heart failure. Mechanistic, translational, and applied interdisciplinary research applications in humans or animals are of interest. The overall goal is to develop a satisfactory science base for rational nutritional management of patients in various stages of heart failure and for preventive approaches in high-risk individuals. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-166.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-166.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-166</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18924</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R01)]]></Title>
<Purpose><![CDATA[This initiative issued by The National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), and 
Office of Dietary Supplements (ODS), NIH, will renew a Funding Opportunity Announcement (FOA) (R01) to encourage submission of investigator-initiated research applications on the role of nutrition and diet in the causation, prevention, and treatment of cardiomyopathies and heart failure. Mechanistic, translational, and applied interdisciplinary research applications with rigorous hypothesis-testing designs for projects in humans or animals are of interest. The overall goal is to develop a satisfactory science base for rational nutritional management of patients in various stages of heart failure and for preventive approaches in high-risk individuals. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-165.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-165.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-165</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18925</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages the submission of research project grant applications from institutions/organizations that proposed to: (1) improve the measurement of racial/ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; (2) to enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups: and (3) to reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States (U.S.). This R03 grant mechanism supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent Investigator-initiated Research Project Grant (R01) application. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-164.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-164.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-164</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18926</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<Title><![CDATA[The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages the submission of research project grant applications from institutions/organizations that propose to: (1) improve the measurement of racial/ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; (2) to enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups: and (3) to reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States (U.S.).
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-163.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-163.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-163</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18927</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<Title><![CDATA[The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages the submission of research project grant applications from institutions/organizations that propose to: (1) improve the measurement of racial/ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; (2) to enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups: and (3) to reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States (U.S.).
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-162.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-162.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-162</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18928</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is designed to stimulate research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-161.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-161.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-161</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18929</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<Title><![CDATA[Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is designed to stimulate research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-160.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-160.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-160</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18930</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<Title><![CDATA[Biomarkers of Infection-Associated Cancers (R21) ]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) and the National Institute of Dental and Craniofacial Research (NIDCR), of the National Institutes of Health (NIH), encourages the submission of Exploratory/Developmental Research Grant Award (R21) applications from institutions and organizations that propose to identify biomarkers for cancers where the etiology of the disease is attributed to infectious agents.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-159.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-159.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-159</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18931</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<Title><![CDATA[Biomarkers of Infection-Associated Cancers (R01) ]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) and the National Institute of Dental and Craniofacial Research (NIDCR), of the National Institutes of Health (NIH), encourages the submission of Research Project Grant (R01) applications from institutions and organizations that propose to identify biomarkers for cancers where the etiology of the disease is attributed to infectious agents.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-158.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-158.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-158</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18932</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (UM1)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), invites grant applications to provide targeted infrastructure support for the core functions of Cancer Epidemiology Cohorts (CECs) and methodological research. This infrastructure can support existing or new CECs. This FOA will support core functions for CECs currently funded through other grant mechanisms by the Epidemiology and Genetics Program (EGRP) and other components of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI).]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-167.html</GuideLink>
<RelDate>2011-03-17</RelDate>
<IntentDate>June 6, 2011, October 10, 2011, February 6, 2012, June 6, 2012, October 8, 2012, February 8, 2013, June 10, 2013, October 8, 2013</IntentDate>
<AppReceiptDate><![CDATA[July 6, 2011, November 10, 2011, March 6, 2012, July 6, 2012, November 8, 2012, March 8, 2013, July 10, 2013, November 8, 2013]]></AppReceiptDate>
<LARD>2013-11-08</LARD>
<FileName>PAR-11-167.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-167</DocNum>
<ExpirationDate>2013-11-09</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18938</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[NIAMS Multi-Center Clinical Study Implementation Planning Grants (U34) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will support planning cooperative agreements (U34) (hereafter called planning grant) for investigator-initiated clinical interventional trials. The U34 planning grant is designed to permit the necessary planning, design, and preparation of documentation prior to implementation of investigator-initiated clinical trials. Completion of the agreed upon milestones of a U34 planning grant is recommended prior to submission of a clinical trial through a cooperative agreement (UM1) application that will support the actual implementation and conduct of the study.  Consultation with NIAMS staff is strongly encouraged prior to the submission of the U34 application. The trials must be hypothesis-driven, milestone-defined, related to the research mission of the NIAMS and considered high priority by the Institute.]]></Purpose>
<RelNote/><ActivityCodes>U34</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-169.html</GuideLink>
<RelDate>2011-03-18</RelDate>
<IntentDate>30 days after publication date, August 15, 2011, December 15, 2011, April 15, 2012, August 15, 2012, December 15, 2012, , April 15, 2013, August 15, 2013, December 15, 2013 </IntentDate>
<AppReceiptDate><![CDATA[July 1, 2011, November 1, 2011, March 1, 2012, July 1, 2012, November 1, 2012, March 1, 2013, July 1, 2013, , November 1, 2013, March 1, 2014]]></AppReceiptDate>
<LARD>2014-03-01</LARD>
<FileName>PAR-11-169.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-169</DocNum>
<ExpirationDate>2014-03-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18939</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[NIAMS Clinical Study Implementation Cooperative Agreement (UM1) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (UM1) applications for implementation of investigator-initiated interventional clinical trials (all phases).  Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a (U34) planning phase (Part 1) followed by an application for the (UM1) clinical trial implementation phase (Part 2). See PAR-11-169 for information about the NIAMS Clinical Trial Planning Cooperative Agreement (U34).  Investigators who have completed all necessary pre-trial planning and preparation through other means may also apply for a NIAMS UM1.  Consultation with NIAMS staff is strongly encouraged prior to the submission of the clinical trial implementation UM1 application.  The NIAMS expects such trials to be hypothesis-driven, milestone-defined, related to the research mission of the NIAMS, and considered high priority by the Institute.  
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-168.html</GuideLink>
<RelDate>2011-03-18</RelDate>
<IntentDate>30 days after publication date, August 15, 2011, December 15, 2011, April 15, 2012, August 15, 2012, December 15, 2012, April 15, 2013, August 15, 2013, December 15, 2013</IntentDate>
<AppReceiptDate><![CDATA[July 1, 2011, November 1, 2011, March 1, 2012, July 1, 2012, November 1, 2012, March 1, 2013, July 1, 2013, , November 1, 2013, March 1, 2014 ]]></AppReceiptDate>
<LARD>2014-03-01</LARD>
<FileName>PAR-11-168.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-168</DocNum>
<ExpirationDate>2014-03-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18945</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Program Project Grant (P01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke to enable submission of program project grant applications that propose to conduct innovative, interactive research to answer significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant mechanism is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-172.html</GuideLink>
<RelDate>2011-03-22</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-172.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-172</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18947</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS PHASE III Investigator-Initiated Multi-Site Clinical Trials (U01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for submitting grant applications for investigator-initiated, multi-site, randomized, controlled Phase III clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS).The trials may address any research question related to the mission and goals of the NINDS.Information about the mission, strategic plan and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/).]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-173.html</GuideLink>
<RelDate>2011-03-22</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see annnouncement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-11-173.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-173</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18949</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[National Institute on Aging Request for Applications for an Alzheimer's Disease Genetics Data Warehouse (U24)]]></Title>
<Purpose><![CDATA[The National Institute on Aging invites applications specific to infrastructure related to storage and analysis of primary and secondary data for the genetics of Alzheimer's Disease.
]]></Purpose>
<RelNote/><ActivityCodes>U24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-175.html</GuideLink>
<RelDate>2011-03-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2012-09-07</LARD>
<FileName>PAR-11-175.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-175</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18953</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Research on Ethical Issues in Biomedical, Social, and Behavioral Research (R21) ]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support investigator-initiated Exploratory/Developmental Research Grant Award (R21) applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers.  The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness.  However, only participating ICs will provide direct grant support under this FOA.   
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-182.html</GuideLink>
<RelDate>2011-03-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-182.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-182</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18954</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Research on Ethical Issues in Biomedical, Social, and Behavioral Research (R03)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support investigator-initiated Small Research Grant Award (R03) applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social and behavioral research supported by the participating NIH Institutes/Centers.  The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness.  However, only participating ICs will provide direct grant support under this FOA.   ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-181.html</GuideLink>
<RelDate>2011-03-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-181.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-181</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18955</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<Title><![CDATA[Research on Ethical Issues in Biomedical, Social and Behavioral Research (R01)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support investigator-initiated Research Project Grant (R01) applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers.  The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness.  However, only participating ICs will provide direct grant support under this FOA. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-180.html</GuideLink>
<RelDate>2011-03-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-180.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-180</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18956</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Circadian Rhythms and Alcohol-induced Tissue Injury (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages applications that propose to conduct mechanistic studies of the circadian rhythms involved in alcohol-induced organ damage.  The circadian system comprises of a complex feedback network that involves interactions between the central nervous system and peripheral tissues.  The effects of alcohol on circadian rhythm and how alcohols action is modulated by circadian rhythms have key implications for alcohol research. The central and peripheral oscillators, either individually or together, may play an important role in alcohol-induced tissue injury.  The objective of this FOA is to understand the molecular mechanisms of alcohol-induced tissue damage that involve central and peripheral circadian rhythms, particularly their connection with metabolism and metabolic disorders. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-179.html</GuideLink>
<RelDate>2011-03-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-11-179.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-179</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18957</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Circadian Rhythms and Alcohol-induced Tissue Injury (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages applications that propose to conduct mechanistic studies of the circadian rhythms involved in alcohol-induced organ damage.  The circadian system comprises of a complex feedback network that involves interactions between the central nervous system and peripheral tissues.  The effects of alcohol on circadian rhythm and how alcohols action is modulated by circadian rhythms have key implications for alcohol research. The central and peripheral oscillators, either individually or together, may play an important role in alcohol-induced tissue injury.  The objective of this FOA is to understand the molecular mechanisms of alcohol-induced tissue damage that involve central and peripheral circadian rhythms, particularly their connection with metabolism and metabolic disorders. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-178.html</GuideLink>
<RelDate>2011-03-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PA-11-178.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-178</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18958</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Translational Research for the Development of Novel Interventions for Mental Disorders (R21/R33)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to speed the translation of emerging findings on the neuroscience of mental disorders into novel intervention approaches that will ultimately reduce symptoms and/or restore function.  This FOA provides support for up to two years (R21 phase) for preliminary, proof-of-principle studies in human participants, followed by up to 3 years of support (R33 phase) for pilot studies to assess the implementation of the intervention, and evaluate the feasibility of conducting a larger trial to assess the efficacy of the intervention.   A range of non-pharmacologic treatment approaches will be accepted, including those based on neurophysiological, cognitive, affective, and/or social neuroscience models, basic behavioral science, and neurodevelopmental models.  Applications submitted in response to this FOA must involve novel treatment targets, and/or novel and highly innovative approaches to engage and modify known targets.
]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-177.html</GuideLink>
<RelDate>2011-03-24</RelDate>
<IntentDate>30 days prior to application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-177.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-177</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18969</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Award Short-Term Institutional Research Training Grants (Parent T35)]]></Title>
<Purpose><![CDATA[ The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible institutions to develop or enhance research training opportunities for predoctoral and postdoctoral level individuals interested in careers in biomedical, behavioral and clinical research. Many of the NIH Institutes and Centers (ICs) use this grant mechanism exclusively to support intensive, short-term research training experiences for students in health professional schools during the summer. In addition, the Short-Term Institutional Research Training Grant may be used to support other types of predoctoral and postdoctoral training in focused, often emerging scientific areas relevant to the mission of the funding IC. The proposed training must be in basic, behavioral or clinical research aspects of the health-related sciences. This program is intended to encourage graduate and/or health professional students to pursue research careers by exposure to and short-term involvement in the health- related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of research..
 ]]></Purpose>
<RelNote/><ActivityCodes>T35</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-185.html</GuideLink>
<RelDate>2011-03-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-185.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-185</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18970</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Postdoctoral Research Training in Obstetric  Fetal Pharmacology (T32)]]></Title>
<Purpose><![CDATA[The purpose of this institutional research training program is to develop a cadre of diverse and highly trained academic clinical and non-clinical research scientists who will conduct basic, translational and clinical research in maternal and fetal pharmacology and therapeutics.]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-183.html</GuideLink>
<RelDate>2011-03-25</RelDate>
<IntentDate>April 25, 2011; April 25, 2012; April 25, 2013</IntentDate>
<AppReceiptDate><![CDATA[May 25, 2011; May 25, 2012;  May 25, 2013]]></AppReceiptDate>
<LARD>2013-05-25</LARD>
<FileName>PAR-11-183.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-183</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18971</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<Title><![CDATA[Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32)]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible institutions as the primary means of supporting predoctoral and postdoctoral research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nations biomedical, behavioral and clinical research agenda.  The objective of the T32 program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program supports predoctoral and postdoctoral research training programs (including those with short term research training) at domestic institutions of higher education with the T32 funding mechanism.  Note that programs solely for short-term research training should not apply to this announcement, but rather the separate (T35) NRSA Short-Term Institutional program exclusively reserved for predoctoral and/or postdoctoral level short-term research training programs (see PA-11-185).
]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-184.html</GuideLink>
<RelDate>2011-03-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-184.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-184</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18973</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Translation of Pluripotent Stem Cell Therapies for Blood Diseases (R01)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions and organizations that propose collaborative, multidisciplinary, multi-Project Director/Principal Investigator research for  the development of new technologies needed to utilize stem cells in future cell therapies to treat sickle cell disease and other blood disorders.  This initiative focuses on two key areas that are impediments to further progress: (1) development of techniques to efficiently generate hematopoietic cells by either differentiation of human pluripotent stem cells (PSC) or by cellular reprogramming to yield sufficient numbers of GMP quality cells for clinical evaluation; and (2) development of protocols that enable the efficient engraftment of hematopoietic cells derived from pluripotent stem cells or derived by cellular reprogramming.  Each multidisciplinary application will designate two or more Project Directors/Principal Investigators.  This program will be implemented in collaboration with the ongoing NHLBI Progenitor Cell Biology Consortium (http://www.progenitorcells.org/) and will add separate additional research projects.  Extensive collaboration is expected between the existing Consortium Hubs, and the new group(s) are also expected to collaborate extensively with the Consortium Hubs.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-186.html</GuideLink>
<RelDate>2011-03-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[New applications:  October 5, 2011; October 5, 2012; October 5, 2013.  Resubmission, renewal, or revision applications:  November 5, 2011; November 5, 2012; November 5, 2013. AIDS Application Due Dates: January 7, 2012; January 7, 2013; January 7, 2014.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-186.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-186</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18980</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Enhancing Zebrafish Research with Research Tools and Techniques (R01)
]]></Title>
<Purpose><![CDATA[This FOA encourages investigator-initiated applications designed to exploit the power of the zebrafish as a vertebrate model for biomedical and behavioral research.  Applications proposing to develop new research tools or techniques that are of high priority to the zebrafish community and that will advance the detection and characterization of genes, pathways, and phenotypes of interest in development and aging, organ formation, neural processes, behavior, sensory processing, physiological processes, and disease processes are welcome.  This effort stems from an NIH initiative developed by the Institutes and Centers of the Trans-NIH Zebrafish Coordinating Committee (TZCC) under the co-chairmanship of NICHD and NIDDK. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-131.html</GuideLink>
<RelDate>2011-03-30</RelDate>
<IntentDate>August 19, 2011, August 19, 2012 and August 19, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011; September 19, 2012; September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-131.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-131</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18981</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Genetic Screens to Enhance Zebrafish Research (R01)]]></Title>
<Purpose><![CDATA[This FOA encourages investigator-initiated NIH Research Project Grant (R01) applications designed to exploit the power of the zebrafish as a vertebrate model for biomedical and behavioral research.  Applications proposing to develop new genetic screens of high priority to the zebrafish community that will advance the detection and characterization of genes, pathways, and phenotypes of interest in development and aging, organ formation, neural processes, behavior, sensory processes, physiological processes, and disease processes are welcome.  In addition, applications for pilot projects seeking to adapt existing phenotypic screening to support high-throughput characterization of mutants generated by large-scale mutagenesis projects are encouraged.  This effort stems from an NIH initiative developed by the Institutes and Centers of the Trans-NIH Zebrafish Coordinating Committee (TZCC; http://www.nih.gov/science/models/zebrafish/) under the co-chairmanship of NICHD and NIDDK.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-130.html</GuideLink>
<RelDate>2011-03-30</RelDate>
<IntentDate>August 19, 2011, 2012, 2013 </IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011; September 19, 2012; September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-130.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-130</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18988</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[Support of NIAMS Program Project Grants (P01)]]></Title>
<Purpose><![CDATA[This FOA is not intended to request new (Type 1) P01 applications. As published in NOT-AR-05-007 , the NIAMS does not currently accept new P01 applications.This FOA is being issued solely for the purpose of providing a means for eligible NIAMS investigators who currently have an active, awarded Type 1P01 to apply for their second competing P01 (renewal) as described in NOT-AR-05-007.]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>1000000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-188.html</GuideLink>
<RelDate>2011-03-31</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-188.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-188</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>18994</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Program for Extramural/Intramural Alcohol Research Collaborations (U01)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity is to encourage collaboration between alcohol researchers in the extramural community and those within the NIAAA intramural research program. The objective of this Funding Opportunity Announcement is to bring together the research expertise that, as a functioning collaborative unit, will address key alcohol-based research questions that would not otherwise be possible by the same individuals working towards similar goals in isolation. The goal of the research proposed by the collaborating investigators should address questions that advance the alcohol research field with respect to issues surrounding alcohol use disorders including dependence, and the effects of alcohol on health. The NIH Intramural Scientist will be a tenured or tenure-track scientist from the NIAAA Intramural division, with whom the PD/PI has made prior contact for the collaborative project.]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-189.html</GuideLink>
<RelDate>2011-04-01</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-11-189.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-189</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19013</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<Title><![CDATA[NIH Pathway to Independence Award (Parent K99/R00)]]></Title>
<Purpose><![CDATA[The primary purpose of the Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented NIH-supported independent investigators.  The program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other independent research support at an earlier stage than is currently the norm. Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.
]]></Purpose>
<RelNote/><ActivityCodes>K99,R00</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-197.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-197.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-197</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19014</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Mentored Quantitative Research Development Award (Parent K25)]]></Title>
<Purpose><![CDATA[The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease.  The K25 award will provide support and protected time for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.  Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.
]]></Purpose>
<RelNote/><ActivityCodes>K25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-196.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-196.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-196</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19015</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Mentored Patient-Oriented Research Career Development Award (Parent K23)]]></Title>
<Purpose><![CDATA[The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research.  Individuals with a clinical degree who are interested in further career development in biomedical research that is not patient-oriented should refer to the Mentored Clinical Scientist Career Development (Parent K08) Award. Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.
]]></Purpose>
<RelNote/><ActivityCodes>K23</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-194.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-194.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-194</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19016</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Mentored Clinical Scientist Research Career Development Award (Parent K08)]]></Title>
<Purpose><![CDATA[The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation.  This program represents the continuation of a long-standing NIH program that provides support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.  Individuals with a clinical doctoral degree interested in pursuing a career in patient-oriented research should refer to the NIH Mentored Patient-Oriented Research Career Development Award (Parent K23). Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts..
]]></Purpose>
<RelNote/><ActivityCodes>K08</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-193.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-193.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-193</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19017</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Academic Career Award (Parent K07)]]></Title>
<Purpose><![CDATA[The purpose of the NIH Academic Career Award (K07) is to provide support to increase the pool of individuals with academic and research expertise to become academic researchers and to enhance the educational or research capacity at the grantee sponsoring grantee institution. The Academic Career Award supports K07 Development awards for more junior level candidates and K07 Leadership awards for more senior individuals with acknowledged scientific expertise and leadership skills. Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.
]]></Purpose>
<RelNote/><ActivityCodes>K07</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-192.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-192.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-192</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19018</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Independent Scientist Award (Parent K02)]]></Title>
<Purpose><![CDATA[The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three, four, or five years of salary support and protected time for newly independent (see IC provisions) scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate. Prospective candidates are encouraged to contact the relevant Institute or Center (IC) staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.]]></Purpose>
<RelNote/><ActivityCodes>K02</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-191.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-191.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-191</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19019</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<Title><![CDATA[Mentored Research Scientist Development Award (Parent K01)]]></Title>
<Purpose><![CDATA[The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence.Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs utilize the K01 award to increase research workforce diversity by providing enhanced research career development opportunities. Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-190.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-190.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-190</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19020</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Midcareer Investigator Award in Patient-Oriented Research (Parent K24)]]></Title>
<Purpose><![CDATA[The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates or equivalent who are typically at the Associate Professor level or the equivalent (see Section III. Eligible Individuals) for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts.
]]></Purpose>
<RelNote/><ActivityCodes>K24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-195.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-195.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-195</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19029</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Understanding Clinical Information Needs and Health Care Decision Making Processes in the Context of Health Information Technology (IT) (R01)]]></Title>
<Purpose><![CDATA[Purpose. This is a Large Research Project (R01) FOA to express AHRQs interest in funding research aimed at elucidating the nature of cognition, task distribution, and clinical work in various health care delivery settings.  Research projects funded under this FOA will address current knowledge gaps regarding our understanding of health care providers information needs and health care decision making processes, both individually and collectively, and as a health care team (composed of doctors, nurses, therapists, and administrative staff). 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-198.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-07-05</LARD>
<FileName>PA-11-198.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-198</DocNum>
<ExpirationDate>2014-07-06</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19031</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Understanding User Needs and Context to Inform Consumer Health Information Technology (IT) Design (R01)
]]></Title>
<Purpose><![CDATA[Purpose.  This is a Large Research Project (R01) FOA to express AHRQs interest in funding research projects that will build a knowledge base of individuals personal health information management (PHIM) needs and practices and the design principles related to these activities.  The increased interest in and availability of consumer health information technology (IT) applications meant to assist consumers in managing their personal health information has rapidly increased over the past decade.  Many other industries have greatly benefited from design principles that take into account user needs and context, which help designers improve the utility of information management tools among a heterogeneous population of users.  Individuals are the end users of consumer health IT; however, there is still a lack of basic research around these end users PHIM practices and needs and how these methods are influenced by a multitude of other contextual factors (e.g., care settings, demographics, motivations, user capabilities and limitations, informal caregiving networks, technology sophistication, and access to Internet) that, typically, represent a mixture of facilitators or barriers to adequate PHIM.  This FOA looks to bridge the chasm that currently exists between consumer health IT designers and the users themselves, by bolstering basic research to better understand users PHIM practices, needs, and goals as they are intrinsically shaped by an array of contextual factors. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-199.html</GuideLink>
<RelDate>2011-04-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-07-05</LARD>
<FileName>PA-11-199.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-199</DocNum>
<ExpirationDate>2014-07-06</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19043</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Research on Children in Military Families: The Impact of Parental Military Deployment and Reintegration on Child and Family Functioning (R21)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage developmental and exploratory studies on the impact of parental military deployment, combat-related stress, and reintegration with the family on child social and affective development as well as family functioning.  Intervention studies targeting the particular concerns of early childhood, middle childhood, and adolescence are also encouraged, as are the development and testing of measures to assess family functioning and child development outcomes. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-202.html</GuideLink>
<RelDate>2011-04-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-202.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-202</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19045</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Research on Children in Military Families: The Impact of Parental Military Deployment and Reintegration on Child and Family Functioning (R01)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage interdisciplinary studies on the impact of parental military deployment, combat-related stress, and reintegration with the family on child social and affective development outcomes as well as on family functioning.  Longitudinal prospective studies with diverse samples would address important gaps in the literature and are highly encouraged.  Descriptive studies addressing the particular concerns of early childhood, middle childhood and adolescence are also encouraged. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-200.html</GuideLink>
<RelDate>2011-04-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-200.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-200</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19049</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[DOE]]></PartIC>
<PartIC><![CDATA[FDA]]></PartIC>
<PartIC><![CDATA[NSF]]></PartIC>
<Title><![CDATA[Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (Interagency U01)]]></Title>
<Purpose><![CDATA[ The goal of this interagency funding opportunity announcement (FOA) is to support the development of multiscale models to accelerate biological, biomedical, behavioral, environmental and clinical research.  The NIH, DOE, FDA, and NSF recognize that to efficiently and effectively address the challenges of understanding multiscale biological and behavioral systems, researchers will need predictive, computational models that encompass multiple biological and behavioral scales.  This FOA also encourages the development of new, non-standard modeling methods and experimental approaches to facilitate multiscale modeling.  
 ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-203.html</GuideLink>
<RelDate>2011-04-15</RelDate>
<IntentDate>30 days before the Application Due Date </IntentDate>
<AppReceiptDate><![CDATA[June 17, 2011, September 27, 2011, January 31, 2012, May 31, 2012, September 27, 2012, January 31, 2013, May 31, 2013, September 27, 2013, January 31, 2014]]></AppReceiptDate>
<LARD>2014-01-31</LARD>
<FileName>PAR-11-203.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-203</DocNum>
<ExpirationDate>2014-02-01</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19063</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Early-Phase Clinical Trials for Blood Cell Therapies (R01)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions and organizations for the purpose of supporting early-phase clinical trials i.e., first-in-human, phase I, or phase II trialsto evaluate innovative and novel cell therapies to treat blood diseases and/or to improve the outcome of hematopoietic stem cell transplantations.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-204.html</GuideLink>
<RelDate>2011-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[October 5, 2011, October 5, 2012; AIDS Date: January 7, 2012, January 7, 2013 ]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-11-204.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-204</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19066</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol Education Project Grants (R25)]]></Title>
<Purpose><![CDATA[The National Institute on Alcohol Abuse and Alcoholism (NIAAA) supports research programs to advance understanding of the biological and behavioral processes involved in the development, expression, and consequences of alcoholism and other alcohol-related problems. The Institute also supports prevention, treatment, and health services research on alcohol abuse and alcoholism. A part of the NIAAA mission is the dissemination of new knowledge acquired from alcohol research to diverse audiences, including scientists, educators, clinicians, and other health and social service providers, patients and their families, professionals within the criminal justice system, and the general public. This FOA identifies the research activity on alcohol education of Health Professions that NIAAA will consider for award through  Education grants (R25). 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-205.html</GuideLink>
<RelDate>2011-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-205.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-205</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19071</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19)]]></Title>
<Purpose><![CDATA[The purpose of the National Cooperative Drug Discovery/Development Group (NCDDG) Program is to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged.
]]></Purpose>
<RelNote/><ActivityCodes>U19</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-207.html</GuideLink>
<RelDate>2011-04-22</RelDate>
<IntentDate>May 24, 2011; September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013</IntentDate>
<AppReceiptDate/><LARD>2013-02-22</LARD>
<FileName>PAR-11-207.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-207</DocNum>
<ExpirationDate>2013-02-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19072</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[National Cooperative Drug Discovery and Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1)]]></Title>
<Purpose><![CDATA[The purpose of the National Cooperative Drug Discovery/Development Group (NCDDG) Program is to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged.
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-206.html</GuideLink>
<RelDate>2011-04-22</RelDate>
<IntentDate>May 24, 2011; September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013</IntentDate>
<AppReceiptDate><![CDATA[June 24, 2011; October 24, 2011; February 24, 2012; June 22, 2012; October 22, 2012; February 22, 2013]]></AppReceiptDate>
<LARD>2013-02-22</LARD>
<FileName>PAR-11-206.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-206</DocNum>
<ExpirationDate>2013-02-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19081</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Data Concepts and Terminology Standards for Clinical Research and Drug Development (R24) ]]></Title>
<Purpose><![CDATA[The FDA Center for Drug Evaluation and Research is encouraging grant applications for programs to expedite development of data concepts and terminology to support human drug development and evaluation.  The primary objective is to support the development of non-proprietary, consensus-based, national data standards for use in clinical studies of human drugs and biologics.  Projects may focus on solutions to general data standards development and implementation challenges or on specific clinical concepts or domains where standardization is needed.
]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-209.html</GuideLink>
<RelDate>2011-04-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[June 1, 2011; November 15, 2011; June 1, 2012; November 15, 2012, June 1,2013; November 15, 2013]]></AppReceiptDate>
<LARD>2013-11-15</LARD>
<FileName>PAR-11-209.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-209</DocNum>
<ExpirationDate>2013-11-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19082</rowid>
<PrimaryIC><![CDATA[NLM]]></PrimaryIC>
<Title><![CDATA[NLM Express Research Grants in Biomedical Informatics (R01)]]></Title>
<Purpose><![CDATA[The National Library of Medicine supports research grants that advance the science of biomedical informatics. Informatics is concerned with the optimal organization, management, dissemination and use of information. Biomedical informatics can be defined as the intersection of computer and information sciences with an application domain such as health care, public health, basic biomedical research, or clinical translational research. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-208.html</GuideLink>
<RelDate>2011-04-28</RelDate>
<IntentDate>Letters of intent are not required.</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-208.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-208</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19094</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NCRR]]></PartIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<Title><![CDATA[Center for Inherited Disease Research (CIDR) High Throughput Genotyping and Sequencing Resource Access (X01)]]></Title>
<Purpose><![CDATA[CIDR high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes that contribute to human health and disease. The services provided through CIDR focus primarily on needs that cant be readily handled by individual investigator laboratories.CIDR provides the most up-to-date platforms and services. This is an NIH-wide initiative that is managed by NHGRI.Information about the current services offered can be accessed via: http://www.cidr.jhmi.edu.]]></Purpose>
<RelNote/><ActivityCodes>X01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-210.html</GuideLink>
<RelDate>2011-04-29</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Applications are accepted by continuous receipt as described in NOT-HG-09-015. See full announcement.]]></AppReceiptDate>
<LARD>2014-07-01</LARD>
<FileName>PAR-11-210.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-210</DocNum>
<ExpirationDate>2014-07-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19096</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[ Clinical Trials Planning Studies for Rare Thrombotic and Hemostatic Disorders (U34)
 ]]></Title>
<Purpose><![CDATA[This FOA issued by the National Heart, Lung, and Blood Institute invites applications to obtain critical and necessary support in the planning and development of feasible and well designed multicenter clinical trials focused on rare hemostatic and thrombotic disorders. The Clinical Trials Development Resource for Hematologic Disorders (U24) (RFA-HL-12-016) will provide guidance to investigators on trial design, biostatistics, clinical trial management, and regulatory requirements during the funding period.
]]></Purpose>
<RelNote/><ActivityCodes>U34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-023.html</GuideLink>
<RelDate>2011-05-02</RelDate>
<IntentDate>September 13, 2011, September 13, 2012, September 17, 2013</IntentDate>
<AppReceiptDate><![CDATA[October 13, 2011, October 15, 2012, October 17, 2013]]></AppReceiptDate>
<LARD>2013-10-17</LARD>
<FileName>RFA-HL-12-023.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-12-023</DocNum>
<ExpirationDate>2013-10-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19111</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R41/R42) ]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage the small business research community to submit applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to teach, motivate, visualize outcomes, and to extend the health care and learning environments for patients with obesity and diabetes.  The VR technology proposed should foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. 

Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences.  The overall goal is to develop the potential of Virtual Reality technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-024.html</GuideLink>
<RelDate>2011-05-10</RelDate>
<IntentDate>June 13, 2011 and June 11, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-11</LARD>
<FileName>RFA-HL-12-024.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-12-024</DocNum>
<ExpirationDate>2012-07-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19112</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[TATRC]]></PartIC>
<Title><![CDATA[Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R01) 
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage submission of hypothesis-testing research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes.


Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences.  The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-211.html</GuideLink>
<RelDate>2011-05-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-211.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-211</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19113</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<PartIC><![CDATA[TATRC]]></PartIC>
<Title><![CDATA[Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R21)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage submission of exploratory/developmental research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. 


Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral, and pedagogical sciences.  The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-212.html</GuideLink>
<RelDate>2011-05-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-212.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-212</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19114</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R43/R44) 
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage the small business research community to submit applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to teach, motivate, visualize outcomes, and to extend the health care and learning environments for patients with obesity and diabetes.  The VR technology proposed should foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. 

Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences.  The overall goal is to develop the potential of Virtual Reality technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-020.html</GuideLink>
<RelDate>2011-05-10</RelDate>
<IntentDate>June 13, 2011 and June 11, 2012</IntentDate>
<AppReceiptDate><![CDATA[July 11, 2011 and July 11, 2012]]></AppReceiptDate>
<LARD>2012-07-11</LARD>
<FileName>RFA-HL-12-020.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-12-020</DocNum>
<ExpirationDate>2012-07-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19128</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[NIA Limited Competition: Renewals of, and Revisions to, Existing Cooperative Agreement Awards (U01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement invites applications for renewal from current NIA-supported cooperative agreements and revision applications from current NIA supported cooperative agreements (U01 awards).
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-213.html</GuideLink>
<RelDate>2011-05-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-213.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-213</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19132</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[New Technology for Proteomics and Glycomics (STTR [R41/R42])
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) that propose the development of broadly applicable research tools that address the core technical challenges in proteomics and glycomics. This includes but is not restricted to robotics, sample preparation and pre-fractionation, analytical separations, gel and array imaging, quantitation, mass spectrometry, intelligent automated data acquisition, and improved informatics technologies. Technologies that address the unique needs of glycomics and clinical proteomics, described in Section II.I.1 (Research Objectives) are of particular interest. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-214.html</GuideLink>
<RelDate>2011-05-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-214.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-214</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19133</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Research On Hearing Health Care (R21/R33)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) issued by National Institute on Deafness and Other Communication Disorders (NIDCD) invites Exploratory/Developmental Phased Innovation (R21/R33) grant applications to support research and/or infrastructure needs leading to more accessible and affordable hearing health care (HHC).  For the purposes of the working group and this FOA, hearing health care includes assessment (including screening) and nonmedical treatment and rehabilitation of HL, including hearing aid selection and fitting and aural rehabilitation (counseling, auditory training).  The proposed research aims should lead to the delivery of better healthcare access and outcomes and be directed to solutions that are effective, affordable and deliverable to those who need them.  Outcomes research and health services research related to accessible and affordable hearing health care are also responsive to this FOA.  This FOA provides support for up to two years (R21 phase) for preliminary /development studies, followed by possible transition of up to four years of expanded research and development support (R33 phase).  The total project period for an application submitted in response to this FOA may not exceed five years.  This FOA requires measurable R21 milestones. 
]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-12-003.html</GuideLink>
<RelDate>2011-05-19</RelDate>
<IntentDate>September 30, 2011, May 29, 2012, January 28, 2013</IntentDate>
<AppReceiptDate><![CDATA[October 31, 2011, June 29, 2012, February 28, 2013]]></AppReceiptDate>
<LARD>2013-02-28</LARD>
<FileName>RFA-DC-12-003.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DC-12-003</DocNum>
<ExpirationDate>2013-03-01</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19134</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[New Technology for Proteomics and Glycomics (SBIR [R43/R44])
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) that propose the development of broadly applicable research tools that address the core technical challenges in proteomics and glycomics. This includes but is not restricted to robotics, sample preparation and pre-fractionation, analytical separations, gel and array imaging, quantitation, mass spectrometry, intelligent automated data acquisition, and improved informatics technologies. Technologies that address the unique needs of glycomics and clinical proteomics, described in Section II.I.1 (Research Objectives) are of particular interest. 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-215.html</GuideLink>
<RelDate>2011-05-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-215.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-215</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19155</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided therapy, contrast kinetic modeling, and 3-D reconstruction and other quantitative tools. As many such preliminary evaluations are early in development, this FOA will provide investigators with support for pilot (Phase I and II) cancer imaging clinical trials, including patient monitoring and laboratory studies. The imaging and Image-guided Intervention (IGI) investigations, if proven successful in these early clinical trials, can then be validated in larger studies through competitive R01 mechanisms, or through clinical trials in the Specialized Programs of Research Excellence (SPOREs), Cancer Center and/or Cooperative Groups. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-216.html</GuideLink>
<RelDate>2011-05-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[July 27, 2011; November 10, 2011; March 13, 2012; July 11, 2012; November 13, 2012; March 13, 2013; July 11, 2013; November 13, 2013; March 13, 2014]]></AppReceiptDate>
<LARD>2014-03-13</LARD>
<FileName>PAR-11-216.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-216</DocNum>
<ExpirationDate>2014-03-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19159</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Mechanistic Studies of HIV-exposed Seronegative Individuals (HESN) (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this initiative is to support mechanistic studies of individuals who are repeatedly exposed to HIV but remain seronegative (HESN), or demonstrate resistance to infection. The emphasis will be on demonstrating causality, and not simply association.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-218.html</GuideLink>
<RelDate>2011-05-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-218.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-218</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19160</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Mechanistic Studies of HIV-exposed Seronegative Individuals (HESN)(R21)]]></Title>
<Purpose><![CDATA[The purpose of this initiative is to support mechanistic studies of individuals who are repeatedly exposed to HIV but remain seronegative (HESN), or demonstrate resistance to infection. The emphasis will be on demonstrating causality, and not simply association. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-217.html</GuideLink>
<RelDate>2011-05-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-217.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-217</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19166</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (U01) applications for implementation of investigator -initiated interventional clinical trials (all phases).  This U01 FOA, which allows for the electronic submission of applications for single-site projects, compliments the previously released UM1 FOA, which permits submission of paper applications for multi-site projects.  Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a U34 planning phase (Part 1) followed by an application for the U01.  Investigators who have completed all necessary pre-trial planning and preparation through other means may also apply for a NIAMS U01.  Consultation with NIAMS staff is strongly encouraged prior to the submission of the clinical trial implementation U01 application.  The NIAMS expects such trials to be hypothesis driven, milestone-defined, related to the research mission of the NIAMS, and considered high-priority by the institute.
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-219.html</GuideLink>
<RelDate>2011-05-27</RelDate>
<IntentDate>July 1,2011, August 15, 2011, December 15, 2011, April 15, 2012, August 15, 2012, December 15, 2012, April 15, 2013, August 15, 2013, December 15, 2013</IntentDate>
<AppReceiptDate><![CDATA[August 1, 2011, November 1, 2011, March 1, 2012, July 2, 2012, November 1, 2012, March 1, 2013, July 1, 2013, November 1, 2013, March 3, 2014]]></AppReceiptDate>
<LARD>2014-03-03</LARD>
<FileName>PAR-11-219.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-219</DocNum>
<ExpirationDate>2014-03-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19174</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<Title><![CDATA[ Support of NIGMS Program Project Grants (P01)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) issued by the National Institute of General Medical Sciences encourages innovative, interactive program project grant applications from institutions/organizations that propose to conduct research which aims to solve a significant biological problem, important for the mission of NIGMS, through a collaborative approach involving outstanding scientists who might not otherwise collaborate. The program project grant mechanism is designed to support research in which the funding of several interdependent projects as a group offers significant scientific advantages over support of these same projects as individual regular research grants.
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-220.html</GuideLink>
<RelDate>2011-05-31</RelDate>
<IntentDate>May 31, 2011</IntentDate>
<AppReceiptDate/><LARD>2014-09-07</LARD>
<FileName>PAR-11-220.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-220</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19180</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Collaborative Interdisciplinary Team Science in NIDDK Research Areas (R24)
]]></Title>
<Purpose><![CDATA[Collaborative Interdisciplinary Team Science Awards will foster the application of interdisciplinary, integrative and/or paradigm-shifting approaches to address complex challenges in biomedical research relevant to the National Institute of Diabetes and Digestive and Kidney Diseases.  The NIDDK supported R24 grant mechanism is designed to apply the flexibility of the Research Resource Project Grant mechanism (R24) to accommodate many forms of approaches including discovery-based or resource-generating and hypothesis-driven or hypothesis-generating science. Information regarding the mission of NIDDK and its constituent Extramural Scientific Divisions, including Diabetes, Endocrinology and Metabolic Diseases (DEM), Digestive Diseases and Nutrition (DDN), and Kidney, Urology and Hematologic Diseases (KUH) may be found at: http://www2.niddk.nih.gov/Funding/default.htm.]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-221.html</GuideLink>
<RelDate>2011-06-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[November 15, 2011, November 15, 2012, and November 15, 2013]]></AppReceiptDate>
<LARD>2013-11-15</LARD>
<FileName>PAR-11-221.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-221</DocNum>
<ExpirationDate>2013-11-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19193</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Studies in Neonatal Resuscitation (R21) 
]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to stimulate research on a wide range of topics related to neonatal resuscitation. Possible topics may include, but are not limited to: fetal-neonatal transitional cardiovascular and pulmonary physiology, optimizing steps of resuscitation, management of third stage of labor and its effect on the fetus, resuscitation of children with malformations, and effect of resuscitation on long-term outcomes.  Proposals can include epidemiological studies, studies utilizing fetal-neonatal animal models, computer or other information-technology-based simulations or study designs, clinical observational studies, analyzes of pre-existing national or regional datasets, prospective randomized controlled trials, or any combinations thereof.  It is anticipated that the results from well conducted studies will enable translation of knowledge into evidence-based resuscitation practices ensuring a smooth neonatal transition for a healthy beginning, and lay a foundation for optimal short- and long-term outcomes for all newborn infants. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-224.html</GuideLink>
<RelDate>2011-06-08</RelDate>
<IntentDate>August 19, 2011, August 19, 2012, August 19, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011, September 19, 2012, September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-224.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-224</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19194</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Studies in Neonatal Resuscitation (R03)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to stimulate research on a wide range of topics related to neonatal resuscitation. Possible topics may include, but are not limited to: fetal-neonatal transitional cardiovascular and pulmonary physiology, optimizing steps of resuscitation, management of third stage of labor and its effect on the fetus, resuscitation of children with malformations, and effect of resuscitation on long-term outcomes.  Proposals can include epidemiological studies, studies utilizing fetal-neonatal animal models, computer or other information-technology-based simulations or study designs, clinical observational studies, analyzes of pre-existing national or regional datasets, prospective randomized controlled trials, or any combinations thereof.  It is anticipated that the results from well conducted studies will enable translation of knowledge into evidence-based resuscitation practices ensuring a smooth neonatal transition for a healthy beginning, and lay a foundation for optimal short- and long-term outcomes for all newborn infants]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-223.html</GuideLink>
<RelDate>2011-06-08</RelDate>
<IntentDate>August 19, 2011, August 19, 2012, August 19, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011, September 19, 2012, September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-223.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-223</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19195</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Studies in Neonatal Resuscitation (R01) ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to stimulate research on a wide range of topics related to neonatal resuscitation. Possible topics may include, but are not limited to: fetal-neonatal transitional cardiovascular and pulmonary physiology, optimizing steps of resuscitation, management of third stage of labor and its effect on the fetus, resuscitation of children with malformations, and effect of resuscitation on long-term outcomes.  Proposals can include epidemiological studies, studies utilizing fetal-neonatal animal models, computer or other information-technology-based simulations or study designs, clinical observational studies, analyzes of pre-existing national or regional datasets, prospective randomized controlled trials, or any combinations thereof.  It is anticipated that the results from well conducted studies will enable translation of knowledge into evidence-based resuscitation practices ensuring a smooth neonatal transition for a healthy beginning, and lay a foundation for optimal short- and long-term outcomes for all newborn infants. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-222.html</GuideLink>
<RelDate>2011-06-08</RelDate>
<IntentDate>August 19, 2011, August 19, 2012, August 19, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011, September 19, 2012, September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-222.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-222</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19199</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Patient Safety Research During Neonatal Care (R21) 
]]></Title>
<Purpose><![CDATA[This FOA encourages a wide range of collaborative research projects related to patient safety in the context of both routine as well as intensive newborn care. The FOA welcomes applications related to (but not limited to): the epidemiology of various domains of medical errors and consequent patient harm; assessing the factors at various levels that contribute to such errors; and intervention strategies at individual, systems, and institutional-levels to help reduce and eliminate medical errors in the context neonatal care. It is anticipated that knowledge gained from these projects will help develop strategies to deliver highest quality of healthcare to all newborn infants with utmost safety and effectiveness.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-227.html</GuideLink>
<RelDate>2011-06-09</RelDate>
<IntentDate>August 19, 2011, August 19, 2012, August 19, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011, September 19, 2012, September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-227.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-227</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19191</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Patient Safety Research during Neonatal Care (R03)]]></Title>
<Purpose><![CDATA[This FOA encourages a wide range of collaborative research projects related to patient safety in the context of both routine as well as intensive newborn care. The FOA welcomes proposals related to (but not limited to): the epidemiology of various domains of medical errors and consequent patient harm; assessing the factors at various levels that contribute to such errors; and intervention strategies at individual, systems, and institutional-levels to help reduce and eliminate medical errors in the context neonatal care. It is anticipated that knowledge gained from these projects will help develop strategies to deliver highest quality of healthcare to all newborn infants with utmost safety and effectiveness.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-226.html</GuideLink>
<RelDate>2011-06-09</RelDate>
<IntentDate>August 19, 2011, August 19, 2012, August 19, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011, September 19, 2012, September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-226.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-226</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19192</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Patient Safety Research During Neonatal Care (R01)]]></Title>
<Purpose><![CDATA[ This FOA encourages a wide range of collaborative research projects related to patient safety in the context of both routine as well as intensive newborn care. The FOA welcomes proposals related to (but not limited to): the epidemiology of various domains of medical errors and consequent patient harm; assessing the factors at various levels that contribute to such errors; and intervention strategies at individual, systems, and institutional-levels to help reduce and eliminate medical errors in the context neonatal care. It is anticipated that knowledge gained from these projects will help develop strategies to deliver highest quality of healthcare to all newborn infants with utmost safety and effectiveness.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-225.html</GuideLink>
<RelDate>2011-06-09</RelDate>
<IntentDate>August 19, 2011, August 19, 2012, August 19, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 19, 2011, September 19, 2012, September 19, 2013]]></AppReceiptDate>
<LARD>2013-09-19</LARD>
<FileName>PAR-11-225.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-225</DocNum>
<ExpirationDate>2013-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19211</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Limited Competition: Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research [IDeA-CTR][U54]
]]></Title>
<Purpose><![CDATA[To support the development of infrastructure and other resources required for the conduct of clinical and translational research in IDeA-eligible states.
]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-229.html</GuideLink>
<RelDate>2011-06-10</RelDate>
<IntentDate>August 30, 2011; August 30, 2012; August 30, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 27, 2011; September 27, 2012; September 27, 2013]]></AppReceiptDate>
<LARD>2013-09-27</LARD>
<FileName>PAR-11-229.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-229</DocNum>
<ExpirationDate>2013-09-28</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19220</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Clinical Trial Implementation Cooperative Agreement (U01) 
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) is to invite applications that propose implementation of investigator-initiated high-risk clinical trials. The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/.) Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (U01) Cooperative Agreement application. ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-234.html</GuideLink>
<RelDate>2011-06-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[September 13, 2011; January 13, 2012; May 14, 2012; September 13, 2012; January 14, 2013]]></AppReceiptDate>
<LARD>2013-01-14</LARD>
<FileName>PAR-11-234.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-234</DocNum>
<ExpirationDate>2013-01-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19221</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[NICHD Continuing Education Training Programs (T15)
]]></Title>
<Purpose><![CDATA[ The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites applications for grants to develop and conduct short-term continuing education programs to improve the knowledge and skills of a broad-based community of biomedical and behavioral researchers conducting research on reproductive, developmental, behavioral, social, and rehabilitative processes that determine the health and well-being of newborns, infants, children, adults, families, and populations, and to disseminate course materials and instructional experience to the scientific community. The program should include both didactic and hands-on experiences.  Programs focusing on uses of model organisms are also encouraged.      
 ]]></Purpose>
<RelNote/><ActivityCodes>T15</ActivityCodes>
<FA_DirectCosts>125000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-233.html</GuideLink>
<RelDate>2011-06-16</RelDate>
<IntentDate>30 days before application receipt date. </IntentDate>
<AppReceiptDate/><LARD>2014-09-07</LARD>
<FileName>PAR-11-233.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-233</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19223</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Epidemiology of Drug Abuse (R03)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), is intended to support research projects with the R03 mechanism to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups.  This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-232.html</GuideLink>
<RelDate>2011-06-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-232.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-232</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19224</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Epidemiology of Drug Abuse (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), is intended to support research projects with the R21 mechanism to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups.  This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner.    
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-231.html</GuideLink>
<RelDate>2011-06-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-231.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-231</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19225</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Epidemiology of Drug Abuse (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), is intended to support research projects with the R01 mechanism to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups.  This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-230.html</GuideLink>
<RelDate>2011-06-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-230.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-230</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19232</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Spatial Uncertainty: Data, Modeling, and Communication (R03)
]]></Title>
<Purpose><![CDATA[ The purpose of this funding opportunity announcement (FOA) is to support innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty.
 ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-240.html</GuideLink>
<RelDate>2011-06-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-240.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-240</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19233</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Spatial Uncertainty: Data, Modeling, and Communication (R21)]]></Title>
<Purpose><![CDATA[ The purpose of this funding opportunity announcement (FOA) is to support innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty.
 ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-239.html</GuideLink>
<RelDate>2011-06-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-239.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-239</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19234</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Spatial Uncertainty: Data, Modeling, and Communication (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-238.html</GuideLink>
<RelDate>2011-06-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-238.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-238</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19242</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Interventions for SIDS and Other Sleep Related Infant Deaths (R01) 
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to support research to improve the design and implementation, and effectiveness of preventive interventions for Sudden Infant Death Syndrome (SIDS) and unintentional injury infant deaths associated with the sleep environment.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-242.html</GuideLink>
<RelDate>2011-06-22</RelDate>
<IntentDate>August 13, 2011, August 13, 2012, August 13, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 13, 2011, September 13, 2012, September 13, 2013]]></AppReceiptDate>
<LARD>2013-09-13</LARD>
<FileName>PAR-11-242.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-242</DocNum>
<ExpirationDate>2013-09-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19244</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Limited Competition: Addressing Health Disparities in Maternal and Child Health through Community-Based Participatory Research (R03)
]]></Title>
<Purpose><![CDATA[The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), requests applications to implement developmental community-based participatory research (CBPR) projects planned and developed by recipients of the Phase I Academic-Community Partnerships Conference Series awards under PAR-08-106 and RFA-HD-06-019. This FOA provides support for community based participatory research (CBPR) projects that were identified and planned during the Phase I grant award. Only one CBPR project will be supported per grant award. The areas of emphasis include: infant mortality; sudden infant death syndrome; fibroid tumors; childhood, adolescent, and/or adult obesity; literacy; techniques for outreach and information dissemination; pediatric and maternal HIV/AIDS prevention; and violence prevention.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-241.html</GuideLink>
<RelDate>2011-06-22</RelDate>
<IntentDate>July 19, 2011</IntentDate>
<AppReceiptDate><![CDATA[August 19, 2011, August 19, 2012, August 19, 2013]]></AppReceiptDate>
<LARD>2013-08-19</LARD>
<FileName>PAR-11-241.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-241</DocNum>
<ExpirationDate>2013-08-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19258</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Effectiveness of Treatment for Oral Diseases in Medically Compromised Patients (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement encourages exploratory / developmental clinical research related to determining outcomes of prevention and treatment strategies for oral diseases in persons with medical conditions known to severely compromise oral health.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-12-007.html</GuideLink>
<RelDate>2011-06-28</RelDate>
<IntentDate>October 18, 2011; August 18, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 18, 2011 and September 18, 2012]]></AppReceiptDate>
<LARD>2012-09-18</LARD>
<FileName>RFA-DE-12-007.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DE-12-007</DocNum>
<ExpirationDate>2012-09-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19259</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Effectiveness of Treatment for Oral Diseases in Medically Compromised Patients (R01) 
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement encourages research related to determining outcomes of prevention and treatment strategies for oral diseases in persons with medical conditions known to severely compromise oral health.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-12-006.html</GuideLink>
<RelDate>2011-06-28</RelDate>
<IntentDate>October 18, 2011; August 18, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 18, 2011 and September 18, 2012]]></AppReceiptDate>
<LARD>2012-09-18</LARD>
<FileName>RFA-DE-12-006.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DE-12-006</DocNum>
<ExpirationDate>2012-09-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19277</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Effects of Secondhand Smoke on Cardiovascular and Pulmonary Disease Mechanisms (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute and National Institute of Environmental Health Sciences  National Institutes of Health, invites applications that propose to better characterize the dose-response relationship between secondhand smoke (SHS) exposure and the cardiovascular and pulmonary diseases by improving our understanding of the mechanisms by which SHS contributes to these diseases.  The recent Institute of Medicine (IOM) report on Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence serves as the basis for this initiative.  A wide range of research including animal and human laboratory studies, cohort and case control studies, and natural experiments resulting from home, workplace, and/or community changes in SHS exposure are consistent with this initiative.   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-244.html</GuideLink>
<RelDate>2011-07-07</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-244.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-244</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19280</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<Title><![CDATA[Obesity and Asthma: Awareness and Management (R01)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement issued by the National Institute of Nursing Research is to stimulate research to examine the interconnections of asthma and obesity.  The prevalences of both asthma and obesity have significantly risen in the past few decades.  Although the association between these 2 conditions has been found in many studies, the exact mechanisms for how this association arises are unresolved.  Because both of these conditions have their beginnings in early life, an aspect of the association between them that requires more understanding is their common exposures in early life. Studies that investigate the molecular pathways linking asthma and obesity are encouraged.  In addition, intervention studies targeting asthma or obesity and their effects on each one, and possible mechanisms of action are encouraged. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-245.html</GuideLink>
<RelDate>2011-07-07</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-245.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-245</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19286</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Translational Research in Pediatric and Obstetric Pharmacology (R21) ]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and/or in pregnant women and the developing fetus. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-248.html</GuideLink>
<RelDate>2011-07-12</RelDate>
<IntentDate>30 days prior to the applicable receipt date</IntentDate>
<AppReceiptDate><![CDATA[October 4, 2011, January 10, 2012, May 15, 2012, September 12, 2012, January 10, 2013, May 15, 2013]]></AppReceiptDate>
<LARD>2013-05-15</LARD>
<FileName>PAR-11-248.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-248</DocNum>
<ExpirationDate>2013-05-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19287</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Translational Research in Pediatric and Obstetric Pharmacology (R01) ]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and/or in pregnant women and the developing fetus. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-246.html</GuideLink>
<RelDate>2011-07-12</RelDate>
<IntentDate>30 days prior to the applicable receipt date</IntentDate>
<AppReceiptDate><![CDATA[October 4, 2011, January 10, 2012, May 15, 2012, September 12, 2012, January 10, 2013, May 15, 2013]]></AppReceiptDate>
<LARD>2013-05-15</LARD>
<FileName>PAR-11-246.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-246</DocNum>
<ExpirationDate>2013-05-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19290</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Translational Research in Pediatric and Obstetric Pharmacology (R03)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and/or in pregnant women and the developing fetus. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-247.html</GuideLink>
<RelDate>2011-07-12</RelDate>
<IntentDate>30 days prior to the applicable receipt date</IntentDate>
<AppReceiptDate><![CDATA[October 4, 2011, January 10, 2012, May 15, 2012, September 12, 2012, January 10, 2013, May 15, 2013]]></AppReceiptDate>
<LARD>2013-05-15</LARD>
<FileName>PAR-11-247.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-247</DocNum>
<ExpirationDate>2013-05-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19309</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Grant Award (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Research Program Grant (R21) applications from institutions/organizations that propose to study the ethical, legal and social implications (ELSI) of human genome research.  These applications should propose exploratory or novel studies that break new ground or extend previous discoveries toward new directions or applications.  Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-251.html</GuideLink>
<RelDate>2011-07-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-251.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-251</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19310</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Ethical Legal and Social Implications (ELSI) of Genomic Research Regular Research Program (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA, encourages Research Program Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-250.html</GuideLink>
<RelDate>2011-07-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-250.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-250</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19311</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research.  These applications should be for small, self-contained research projects.  Of particular interest are projects that propose focused legal, economic, philosophical or historical analyses of new or emerging issues.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-249.html</GuideLink>
<RelDate>2011-07-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-249.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-249</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19313</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to promote systems developmental biology. In the context of this FOA, systems developmental biology is defined as research focused on understanding how biological components work together to produce the complex biological phenomena encompassing embryonic development.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-257.html</GuideLink>
<RelDate>2011-07-18</RelDate>
<IntentDate>September 4, 2011, September 4, 2012, September 4, 2013</IntentDate>
<AppReceiptDate><![CDATA[October 4, 2011, October 4, 2012, October 4, 2013]]></AppReceiptDate>
<LARD>2013-10-04</LARD>
<FileName>PAR-11-257.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-257</DocNum>
<ExpirationDate>2013-10-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19318</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Gene-Environment Interplay in Substance Use Disorders (R03)]]></Title>
<Purpose><![CDATA[The National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism seek to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates.  Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field.  Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies.   ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-237.html</GuideLink>
<RelDate>2011-07-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-237.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-237</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19319</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Gene-Environment Interplay in Substance Use Disorders (R21)
 ]]></Title>
<Purpose><![CDATA[The National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism seek to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates.  Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field.  Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies.   ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-236.html</GuideLink>
<RelDate>2011-07-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-236.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-236</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19320</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Pregnancy in Women with Disabilities (R01)
]]></Title>
<Purpose><![CDATA[This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Nursing Research (NINR) encourages research project grants (R01) investigating the incidence, course, and outcomes of pregnancy among women with disabilities.  Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families.  Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-258.html</GuideLink>
<RelDate>2011-07-19</RelDate>
<IntentDate>30 days prior to the application due date(s).</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-258.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-258</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19321</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Pregnancy in Women with Disabilities (R21)
]]></Title>
<Purpose><![CDATA[This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Nursing Research, and the Office of Research on Women's Health  encourages exploratory/developmental research grant (R21) applications to investigate the incidence, course, and outcomes of pregnancy among women with disabilities.  Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families.  Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-259.html</GuideLink>
<RelDate>2011-07-19</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-259.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-259</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19229</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Gene-Environment Interplay in Substance Use Disorders (R01)]]></Title>
<Purpose><![CDATA[The National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism seek to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates.  Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field.  Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies.      
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-235.html</GuideLink>
<RelDate>2011-07-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-235.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-235</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19331</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Network Infrastructure Support for Emerging Areas of Research in the Basic Biology of Aging (R24) ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to provide infrastructure support to foster further development and integration in emerging interdisciplinary areas of research in basic biology of aging. This FOA will use the NIH Resource-Related Research Project (R24) mechanism to facilitate research networks that will advance specific scientific goals through meetings, conferences, small scale pilots, short term training opportunities (such as intensive workshops, summer institutes, or visiting scholar programs) and dissemination activities to encourage growth and development in these interdisciplinary areas. ]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-266.html</GuideLink>
<RelDate>2011-07-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-266.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-266</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19332</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Social and Behavioral Research on the Elderly in Disasters (R21)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute on Aging and the National Institute of Nursing Research encourages Exploratory/Developmental Research Project Grant (R21) applications from institutions or organizations that propose to conduct research in the behavioral and social sciences on the consequences of natural and man-made disasters for the health and well-being of the elderly, with an ultimate goal of preventing or mitigating harmful consequences.  Disasters include weather-related events, earthquakes, tsunamis; large-scale attacks on civilian populations, technological catastrophes, and pandemics.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-265.html</GuideLink>
<RelDate>2011-07-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-265.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-265</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19333</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Social and Behavioral Research on the Elderly in Disasters (R03)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute on Aging encourages Small Research Grant (R03) applications from institutions or organizations that propose to conduct research in the behavioral and social sciences on the consequences of natural and man-made disasters for the health and well-being of the elderly, with an ultimate goal of preventing or mitigating harmful consequences.  Disasters include weather-related events, earthquakes, large-scale attacks on civilian populations, technological catastrophes or perceived catastrophes, and pandemics. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-264.html</GuideLink>
<RelDate>2011-07-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-264.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-264</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19334</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Social and Behavioral Research on the Elderly in Disasters (R01)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute on Aging and the National Institute of Nursing Research encourages Research Project Grant (R01) applications from institutions or organizations that propose to conduct research in the behavioral and social sciences on the consequences of natural and man-made disasters for the health and well-being of the elderly, with an ultimate goal of preventing or mitigating harmful consequences.  Disasters include weather-related events, earthquakes, tsunamis, large-scale attacks on civilian populations, technological catastrophes, and pandemics.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-263.html</GuideLink>
<RelDate>2011-07-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-263.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-263</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19326</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Mechanistic Studies of Pain and Alcohol Dependence (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages applications that propose to conduct mechanistic studies on the relationship between alcohol drinking, alcohol dependence and pain. An association between chronic pain conditions and alcohol dependence has been revealed in numerous studies with episodes of alcohol abuse antedating chronic pain in some people and alcohol dependence emerging after the onset of chronic pain in others. Pain transmission and alcohols reinforcing effects share overlapping neural substrates giving rise to the possibility that chronic pain states significantly affect alcohol use patterns and promote the development of dependence and addiction. In addition, long term alcohol intoxication and alcohol dependence induce pain symptoms and may exacerbate chronic pain arising from other sources. The objective of this FOA is to understand genetic, pharmacological and learning mechanisms underlying the association between the propensity to drink alcohol and pain responses.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-268.html</GuideLink>
<RelDate>2011-07-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-268.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-268</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19327</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Mechanistic Studies of Pain and Alcohol Dependence (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages applications that propose to conduct mechanistic studies on the relationship between alcohol drinking, alcohol dependence and pain. An association between chronic pain conditions and alcohol dependence has been revealed in numerous studies with episodes of alcohol abuse antedating chronic pain in some people and alcohol dependence emerging after the onset of chronic pain in others. Pain transmission and alcohols reinforcing effects share overlapping neural substrates giving rise to the possibility that chronic pain states significantly affect alcohol use patterns and promote the development of dependence and addiction. In addition, long term alcohol intoxication and alcohol dependence induce pain symptoms and may exacerbate chronic pain arising from other sources. The objective of this FOA is to understand genetic, pharmacological and learning mechanisms underlying the association between the propensity to drink alcohol and pain responses.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-267.html</GuideLink>
<RelDate>2011-07-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-267.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-267</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19336</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<Title><![CDATA[Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the Fogarty International Center (FIC), and the National Institute of Allergy and Infectious Diseases (NIAID), encourages applications from eligible domestic and foreign institutions that propose to build capacity in their research administration infrastructures.  The Biomedical Biobehavioral Research Administration Capacity Development (BRAD) Program (G11) promotes the establishment of rigorous and externally supported biomedical and biobehavioral research and/or research-related training programs by providing support for strengthening institutional research administration infrastructures.]]></Purpose>
<RelNote/><ActivityCodes>G11</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-270.html</GuideLink>
<RelDate>2011-07-21</RelDate>
<IntentDate>August 23, 2011, June 30, 2012, June 29, 2013</IntentDate>
<AppReceiptDate><![CDATA[September 23, 2011, July 31, 2012, July 31, 2013]]></AppReceiptDate>
<LARD>2013-07-31</LARD>
<FileName>PAR-11-270.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-270</DocNum>
<ExpirationDate>2013-08-01</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19328</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[NIH Exploratory/Developmental Research Grant Program (Parent R21)
]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in categorical program areas. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-261.html</GuideLink>
<RelDate>2011-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-261.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-261</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19329</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[NIH Small Research Grant Program (Parent R03)]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) Investigator-Initiated Small Research Grant (R03) funding opportunity supports small research projects that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-262.html</GuideLink>
<RelDate>2011-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-262.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-262</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19330</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<Title><![CDATA[Research Project Grant (Parent R01)
]]></Title>
<Purpose><![CDATA[The Research Project Grant (R01) is an award made to an institution/organization to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in areas representing the specific interests and competencies of the investigator(s). The R01 research plan proposed by the applicant institution/organization must be related to the stated program interests of one or more of the NIH Institutes and Centers (ICs) based on descriptions of their programs.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-260.html</GuideLink>
<RelDate>2011-07-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-260.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-260</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19347</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[T2 Translational Research:  Research leading to new health care practices, community programs and policies affecting older persons (R21)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA)  encourages exploratory/developmental R21 research projects on translational research (T2) directed towards development of health care practices, community programs and policies, including monitoring and quality improvement for pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly.  For the purposes of this FOA, T2 translational research on aging is defined as research to gather information needed to develop or evaluate methods of translating results from clinical studies into everyday clinical practice and health decision making (e.g., adapting an efficacious intervention for application in clinical practice and evaluating its effectiveness in different clinical settings). Methods for T2 translational research include but are not limited to intervention studies, systematic reviews, meta analysis, outcomes research and implementation research. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-11-281.html</GuideLink>
<RelDate>2011-07-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAS-11-281.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-11-281</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19348</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[T1 Translational Research:  Novel interventions for prevention and treatment of age-related conditions (R21)
 ]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages exploratory/developmental R21 research projects to accelerate the pace of development of novel therapeutics involving biologics, pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly.   For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical findings towards the development of new strategies for prevention and treatment of age-related pathologies. For projects proposing basic research that is being conducted in animal models, the potential to treat a clinical age-related pathology must be clearly stated in the proposal.  Direct relevance of the data to a clinical aging condition must be established and clearly stated in the application. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-11-280.html</GuideLink>
<RelDate>2011-07-25</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAS-11-280.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-11-280</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19350</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R34)
]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative research. This FOA encourages research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-274.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-274.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-274</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19351</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R03)
 ]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative research. This FOA encourages research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need.

]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-272.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-272.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-272</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19352</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R01)
]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline NIMH's priority areas for innovative research. This FOA encourages research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need.

]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-271.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-271.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-271</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19353</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R34)
]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan  http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml, particularly objectives 1, 2, and 3 as adapted to HIV research.

]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-278.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-278.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-278</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19354</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R21)
]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml, particularly objectives 1, 2, and 3 as adapted to HIV research.

]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-277.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-277.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-277</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19355</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R03)
]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml, particularly objectives 1, 2, and 3 as adapted to HIV research.

]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-276.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-276.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-276</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19356</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R01)]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative intervention development research to advance HIV prevention and care. This FOA encourages research designed to (a) conduct tests of the efficacy of novel behavioral and/or integrated behavioral and biomedical interventions, (b) conduct basic behavioral and social science research that is needed to advance the development of innovative interventions, and (c) translate and operationalize the findings from these basic studies to develop interventions and assess their feasibility. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan  http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml, particularly objectives 1, 2, and 3 as adapted to HIV research.

]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-275.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-275.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-275</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19357</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R21) 
]]></Title>
<Purpose><![CDATA[The Division of AIDS Research (DAR) at the National Institute of Mental Health (NIMH) issues this Funding Opportunity Announcement (FOA) to outline priority areas for innovative research. This FOA encourages research designed to increase the impact of effective HIV/AIDS-related interventions for prevention and treatment. This FOA is informed by priority areas from the National HIV/AIDS Strategy, the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research, as well as the NIMH Strategic Plan (Objective 4): To strengthen the public health impact of NIMH-supported research. That is, through research, evaluation, and collaboration, to develop the capacity of NIMH to help close the gap between the development of new, research-tested interventions and their widespread use by those most in need.

]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-273.html</GuideLink>
<RelDate>2011-07-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PA-11-273.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-273</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19358</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[International Research Collaboration on Alcohol and Alcoholism (U01) 
 ]]></Title>
<Purpose><![CDATA[The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications for the purpose of fostering international collaborations between alcohol research investigators within the United States and investigators located at non-United States laboratories and performance sites for the mutual advancement of our understanding of alcohol problems and of clinical and public health approaches to their solutions. The program is intended to provide funds for research activities to be undertaken jointly between the U.S. and non-U.S. laboratory that expands the research direction of both the U.S. and non-U.S. laboratories in a collaborative manner.
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-282.html</GuideLink>
<RelDate>2011-07-27</RelDate>
<IntentDate>30 days before the standard submission dates</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-282.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-282</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19368</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<Title><![CDATA[Psychosocial/Behavioral Interventions and Services Research in Autism Spectrum Disorders (R34)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to facilitate exploratory research on psychosocial/behavioral treatments and innovative services research for autism spectrum disorders, including the development of instruments to evaluate the impact of interventions on core features of autism spectrum disorders, and comorbid symptomatology.It is intended to encourage research on: 1) the development and/or pilot testing of new or adapted interventions or instruments, 2) pilot testing novel interventions in preparation for larger efficacy trials, or 3) innovative services research directions that require preliminary testing or development, as well as to facilitate the program goal of enhancing autism research through the broad availability of data and resource infrastructure to further scientific advancement and public health benefits.]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-283.html</GuideLink>
<RelDate>2011-07-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-283.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-283</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19370</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement is to permit early peer review of the scientific rationale for a proposed clinical trial, and to facilitate the complete submission of a subsequent research grant application to support the full scale clinical trial.  The R34 planning grant mechanism is intended to provide time and support for an applicant to prepare, organize, and make oversight arrangements prior to consideration of an investigator-initiated application for a full clinical trial.  Activities supported by a planning grant could include development of a Manual of Procedures, creation of a Data Safety and Monitoring Board charter, development of data handling and statistical analysis plans, establishment of recruitment sites, preparation of preliminary submissions for regulatory approvals, development of training materials, and other tasks essential to a trial.  Following funding and successful completion of a planning grant, a clinical trial that is highly relevant to the institute's mission may be submitted to NIGMS as an R01 grant application.
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-287.html</GuideLink>
<RelDate>2011-08-01</RelDate>
<IntentDate>September 24, 2011, September 24, 2012, September 24, 2013</IntentDate>
<AppReceiptDate><![CDATA[October 24, 2011, October 24, 2012, October 24, 2013]]></AppReceiptDate>
<LARD>2013-10-24</LARD>
<FileName>PAR-11-287.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-287</DocNum>
<ExpirationDate>2013-10-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19372</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Centers of Biomedical Research Excellence (COBRE) (P20)]]></Title>
<Purpose><![CDATA[The National Center for Research Resources (NCRR) of the NIH invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes within Institutional Development Award (IDeA) eligible states. The objective of the COBRE initiative is to strengthen an institution's biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and to enhance the ability of investigators to compete independently for complementary National Institutes of Health (NIH) individual research grant or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH.
]]></Purpose>
<RelNote/><ActivityCodes>P20</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-286.html</GuideLink>
<RelDate>2011-08-01</RelDate>
<IntentDate>January 20, 2012, January 21, 2013, and January 21, 2014</IntentDate>
<AppReceiptDate><![CDATA[February 21, 2012, February 21, 2013, and February 21, 2014]]></AppReceiptDate>
<LARD>2014-02-21</LARD>
<FileName>PAR-11-286.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-286</DocNum>
<ExpirationDate>2014-02-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19378</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Health Promotion for Children With Physical Disabilities Through Physical Activity and Diet: Developing An Evidence Base (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Research Grant (R21) applications that will improve our understanding of how patterns of physical activity and dietary choice affect the health and fitness of children with physical disabilities.   

Proposed research should account for the functional limitations of children with disabilities and their nutritional needs, as well as the physiological, psychosocial, and environmental factors that play a role in determining the health of this population.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-284.html</GuideLink>
<RelDate>2011-08-02</RelDate>
<IntentDate>30 days prior to the applicable receipt date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-284.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-284</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19380</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Health Promotion for Children With Physical Disabilities Through Physical Activity and Diet: Developing An Evidence Base (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R01) applications that will improve our understanding of how patterns of physical activity and dietary choice affect the health and fitness of children with physical disabilities.   

Proposed research should account for the functional limitations of children with disabilities and their nutritional needs, as well as the physiological, psychosocial, and environmental factors that play a role in determining the health of this population.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-288.html</GuideLink>
<RelDate>2011-08-02</RelDate>
<IntentDate>30 days prior to the applicable receipt date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-288.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-288</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19381</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Institutional Career Development Award for Enhancing Research Capacity in Temporomandibular Joint Disorders and Orofacial Pain (K12)
]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to expand and strengthen the community of investigators engaged in research on temporomandibular joint disorders (TMJDs) and orofacial pain. An increase in the number of well-trained researchers is necessary to reach a critical mass of scientists with contemporary, multidisciplinary expertise who will be able to leverage recent advances in genetics, bio-engineering, and bio-behavioral research in order to enhance patient treatment and to advance scientific momentum in the field. The objectives of this FOA are to 1) increase the number of basic and clinical investigators who are trained in the sciences relevant to TMJD or orofacial pain research, 2) facilitate and improve the mentoring of this new group of scientists, 3) bring new scientific expertise to TMJD and orofacial pain research. ]]></Purpose>
<RelNote/><ActivityCodes>K12</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-289.html</GuideLink>
<RelDate>2011-08-03</RelDate>
<IntentDate>September 12, 2011, September 12, 2012, September 12, 2013</IntentDate>
<AppReceiptDate/><LARD>2013-10-12</LARD>
<FileName>PAR-11-289.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-289</DocNum>
<ExpirationDate>2013-10-13</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19382</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Educational Programs for Demography and Population Science, Family Planning and Contraception, and Reproductive Research (R25) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the NICHD, National Institutes of Health, encourages Research Education Project (R25) grant applications for educational activities related to Demography and Population Science, Family Planning and Contraception, and Reproductive Research. NICHD encourages applications for educational programs for interdisciplinary approaches, methodology, and the dissemination and use of existing datasets. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-292.html</GuideLink>
<RelDate>2011-08-03</RelDate>
<IntentDate>30 days prior to application due date(s)</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-292.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-292</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19383</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Aging Research Dissertation Awards to Increase Diversity (R36)
]]></Title>
<Purpose><![CDATA[The National Institute on Aging (NIA) announces the reissuance of Funding Opportunity Announcement (FOA) that provides dissertation awards in all areas of research within NIAs strategic priorities to increase diversity of the scientific research workforce engaged in research on aging and aging-related health conditions.
]]></Purpose>
<RelNote/><ActivityCodes>R36</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-291.html</GuideLink>
<RelDate>2011-08-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2013-01-07</LARD>
<FileName>PAR-11-291.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-291</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19394</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Cooperative Program in Translational Research Small Business Awards (U44) ]]></Title>
<Purpose><![CDATA[The goal of this funding opportunity announcement (FOA) is to support preclinical development and testing of new therapies for neurological disorders. The program will facilitate encouragementation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. Phase II and Fast-Track SBIR cooperative agreements are supported under the program. Phase I, as part of a Fast-Track, supports preliminary steps in the process for the preclinical development of therapeutics. To be eligible for Phase II support, either based on a previously successful Phase I or as part of a Fast-Track, projects must include therapeutic leads and in vivo proof of concept on efficacy. Phase II supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) can be submitted by the end of the project period. Phase II cannot support early-stage therapeutic discovery activities such as screening. The program scope excludes clinical research, basic research, and studies of disease mechanism. The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. This is a milestone-driven SBIR cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress.]]></Purpose>
<RelNote/><ActivityCodes>U44</ActivityCodes>
<FA_DirectCosts>1000000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-296.html</GuideLink>
<RelDate>2011-08-08</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-11-296.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-296</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19395</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Cooperative Program in Translational Research Multi-Component Research Projects (U54)]]></Title>
<Purpose><![CDATA[The goal of this funding opportunity announcement (FOA) is to support preclinical development and testing of new therapies for neurological disorders. The program will facilitateencouragement, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. To be eligible for support, projects must include therapeutic leads and in vivo proof of concept on efficacy. The program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as screening. The program also excludes clinical research, basic research, and studies of disease mechanism. The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress.]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-295.html</GuideLink>
<RelDate>2011-08-08</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-11-295.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-295</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19396</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Cooperative Program in Translational Research Single-Component Research Projects (U01)]]></Title>
<Purpose><![CDATA[The goal of this funding opportunity announcement (FOA) is to support preclinical development and testing of new therapies for neurological disorders. The program will facilitate encouragement , development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. To be eligible for support, projects must include therapeutic leads and in vivo proof of concept on efficacy. The program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as screening. The program also excludes clinical research, basic research, and studies of disease mechanism. The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress.]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-294.html</GuideLink>
<RelDate>2011-08-08</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-11-294.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-294</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19397</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Exploratory/Developmental Projects in Translational Research (R21)]]></Title>
<Purpose><![CDATA[The goal of this Funding Opportunity Announcement (FOA) is to support preliminary steps in the preclinical development of therapeutics for neurological disorders. Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA). The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. Clinical research, basic research, and studies of disease mechanism are outside program scope.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-293.html</GuideLink>
<RelDate>2011-08-08</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PAR-11-293.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-293</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19404</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Pilot studies in Pancreatic Cancer (R21)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), encourages the submission of Research Project Grant (R21) applications from institutions and organizations that propose to promote innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-297.html</GuideLink>
<RelDate>2011-08-09</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-11-297.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-297</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19405</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Pilot studies in Pancreatic Cancer (R03)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), encourages the submission of Small Research Grant (R03) applications from institutions and organizations that propose to promote innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-298.html</GuideLink>
<RelDate>2011-08-09</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-11-298.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-298</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19410</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Molecular and Cellular Substrates of Complex Brain Disorders (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages research grant applications from applicant organizations directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-299.html</GuideLink>
<RelDate>2011-08-10</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-299.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-299</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19411</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Molecular and Cellular Substrates of Complex Brain Disorders (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages research grant applications from applicant organizations directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-300.html</GuideLink>
<RelDate>2011-08-10</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-300.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-300</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19422</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[ORD]]></PartIC>
<Title><![CDATA[Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-301.html</GuideLink>
<RelDate>2011-08-11</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-301.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-301</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19423</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[ORD]]></PartIC>
<Title><![CDATA[Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R03)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development, testing and use of newly developed techniques superior to the ones currently used in the field.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-302.html</GuideLink>
<RelDate>2011-08-11</RelDate>
<IntentDate>30 days prior to the application due date(s) </IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-302.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-302</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19424</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[ORD]]></PartIC>
<Title><![CDATA[Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative. 

Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development and testing and use newly developed techniques superior to the ones currently used in the field.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-303.html</GuideLink>
<RelDate>2011-08-11</RelDate>
<IntentDate>30 days prior to application due date(s)</IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-303.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-303</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19425</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[ORD]]></PartIC>
<Title><![CDATA[Development of Appropriate Pediatric Formulations and Drug Delivery Systems SBIR (R43)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population.

The goal of this FOA is not to duplicate or compete with the private sector but to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems. ]]></Purpose>
<RelNote/><ActivityCodes>R43</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-304.html</GuideLink>
<RelDate>2011-08-11</RelDate>
<IntentDate>30 days before application receipt date(s)</IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-304.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-304</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19426</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[ORD]]></PartIC>
<Title><![CDATA[Development of Appropriate Pediatric Formulations and Drug Delivery Systems STTR (R41)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population.

The goal of this FOA is not to duplicate or compete with the private sector but to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems.]]></Purpose>
<RelNote/><ActivityCodes>R41</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-305.html</GuideLink>
<RelDate>2011-08-11</RelDate>
<IntentDate>30 days prior to application receipt dates(s)</IntentDate>
<AppReceiptDate><![CDATA[Multiple receipt dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-305.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-305</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19427</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[NIDDK Central Repositories Non-renewable Sample Access (X01)]]></Title>
<Purpose><![CDATA[The NIDDK Central Repositories house valuable samples and data from numerous major clinical studies. This FOA allows investigators to apply for access to non-renewable samples from one or more of these studies. Information about the samples available can be found at https://www.niddkrepository.org.   Applicants must provide information from the NIDDK Central Repositories documenting sample availability.
]]></Purpose>
<RelNote/><ActivityCodes>X01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-306.html</GuideLink>
<RelDate>2011-08-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[November 1, 2011; March 1, 2012; July 2, 2012; November 1, 2012; March 1, 2013; July 2, 2013; November 1, 2013; March 3, 2014; and July 2, 2014]]></AppReceiptDate>
<LARD>2014-07-02</LARD>
<FileName>PAR-11-306.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-306</DocNum>
<ExpirationDate>2014-07-03</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19428</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Discovery of Genetic Basis of Mendelian or Monogenic Heart, Lung, and Blood Disorders (X01)]]></Title>
<Purpose><![CDATA[The National Heart, Lung, and Blood Institute (NHLBI) invites applications to use the exome sequencing capacity of the Mendelian Disorders Genome Centers to carry out studies to investigate the genetic basis of Mendelian or monogenic disorders that significantly affect heart, lung, and blood (HLB) systems.
]]></Purpose>
<RelNote/><ActivityCodes>X01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-307.html</GuideLink>
<RelDate>2011-08-12</RelDate>
<IntentDate>September 19, 2011; April 16, 2012; April 15, 2013; and April 14, 2014</IntentDate>
<AppReceiptDate/><LARD>2014-05-14</LARD>
<FileName>PAR-11-307.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-307</DocNum>
<ExpirationDate>2014-05-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19429</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Secondary Analysis of Existing Alcohol Epidemiology Data (R01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism encourages R01 Research Grant applications for organizations/institutions that propose to conduct secondary analysis of existing data sets. NIAAA seeks to enhance the understanding of the patterns of alcohol consumption and the epidemiology of alcohol-related problems.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-308.html</GuideLink>
<RelDate>2011-08-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-308.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-308</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19430</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Secondary  Analysis of Existing Alcohol Epidemiology Data (R03)]]></Title>
<Purpose><![CDATA[ This funding opportunity announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism encourages R03 Small Grant applications for organizations/institutions that propose to conduct secondary analysis of existing data sets. NIAAA seeks to enhance the understanding of the patterns of alcohol consumption and the epidemiology of alcohol-related problems.
 ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-309.html</GuideLink>
<RelDate>2011-08-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-309.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-309</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19433</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Drug Abuse Prevention Intervention Research (R01)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage Research Project Grant (R01) applications from institutions/organizations that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C).   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-311.html</GuideLink>
<RelDate>2011-08-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-311.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-311</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19434</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Drug Abuse Prevention Intervention Research (R21)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage Exploratory/Developmental (R21) applications from institutions/organizations that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C). ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-312.html</GuideLink>
<RelDate>2011-08-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-312.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-312</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19435</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Drug Abuse Prevention Intervention Research (R03)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage Small Research Grant (R03) applications from institutions/organizations that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (e.g., mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C).  
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-313.html</GuideLink>
<RelDate>2011-08-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-313.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-313</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19438</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Systems Science and Health in the Behavioral and Social Sciences (R01) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the Office of Behavioral and Social Sciences Research (OBSSR) and the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of General Medical Sciences (NIGMS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) at the National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-314.html</GuideLink>
<RelDate>2011-08-17</RelDate>
<IntentDate>30 days prior to application receipt date.</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-314.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-314</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19439</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Systems Science and Health in the Behavioral and Social Sciences (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the Office of Behavioral and Social Sciences Research (OBSSR), and the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of General Medical Sciences (NIGMS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) at the National Institutes of Health, encourages Research Project Grant (R21) applications from institutions/organizations that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-315.html</GuideLink>
<RelDate>2011-08-17</RelDate>
<IntentDate>30 days prior to application receipt date.</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-315.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-315</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19449</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[FDA Small Scientific Conference Grant Program (R13)]]></Title>
<Purpose><![CDATA[To facilitate the provision of federal financial assistance in support of scientific conferences clearly aligned with the FDA mission.  Applicants must identify the FDA Office/Center best suited to support their proposed conference in the cover letter.  Failure to identify the relevant Office/Center will disqualify an application.  For more information about the FDA and its respective Offices/Centers, visit www.fda.gov. 
]]></Purpose>
<RelNote/><ActivityCodes>R13</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-310.html</GuideLink>
<RelDate>2011-08-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-07-15</LARD>
<FileName>PA-11-310.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-310</DocNum>
<ExpirationDate>2014-07-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19452</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Building a Genetic and Genomic Knowledge Base in Dental, Oral, and Craniofacial Diseases and Disorders (R01)]]></Title>
<Purpose><![CDATA[To encourage research into dental, oral, and craniofacial diseases and disorders for which there is evidence for genetic heritability but for which we do not have a strong understanding of the genetics/genomics of the disease or disorder. Applicable areas of investigation include identification of promising areas of the genome, and characterization and elucidation of the function(s) of genetic variants that affect disease risk in humans. The ultimate goal of these studies will be to drive development of effective diagnostic, therapeutic, and preventive approaches.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-317.html</GuideLink>
<RelDate>2011-08-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-317.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-317</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19459</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Behavioral and Social Genomics of Aging: Opportunities in the Health and Retirement Study (R01)]]></Title>
<Purpose><![CDATA[The Health and Retirement Study (HRS; see at http://hrsonline.isr.umich.edu/ ) is a longitudinal, nationally representative sample of the US population aged 50 years and older (plus spouses) with an oversample of African and Hispanic Americans and a total sample size of over 20,000). Using funds from the American Reinvestment and Recovery Act, the HRS is currently conducting genome-wide scans of DNA samples from approximately 20,000 participants, using the Illumina HumanOmni 2.5 Quad chip. It is anticipated that the genotype data for the first 13,000 subjects will be released to the public via dbGaP in the Fall of 2011, with data from the remaining participants to be released by the end of 2012. This FOA encourages applications taking advantage of the newly available genetic data to advance our understanding of how genetic, behavioral, and psychosocial factors affect the health and well-being of older Americans.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-318.html</GuideLink>
<RelDate>2011-08-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-318.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-318</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19473</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Single Cell Studies in Aging Research (R21)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute on Aging (NIA), National Institutes of Health, encourages grant applications from institutions/organizations that propose to develop research on single cell biology to enhance the understanding of the mechanisms of normal aging and of age-related diseases.  Applications using -omics technologies, imaging, optofluidic platforms, mass spectroscopy, whole genome sequencing, and other tools and technologies at the single cell level are encouraged since it is expected that the single cell approach will improve the determination of unique and biologically significant properties of tissues and organs during the aging process.

]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-321.html</GuideLink>
<RelDate>2011-08-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-321.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-321</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19474</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Single Cell Studies in Aging Research (R01)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute on Aging (NIA), National Institutes of Health, encourages grant applications from institutions/organizations that propose to develop research on single cell biology to enhance the understanding of the mechanisms of normal aging and of age-related diseases.  Applications using -omics technologies, imaging, optofluidic platforms, mass spectroscopy, whole genome sequencing, and other tools and technologies at the single cell level are encouraged since it is expected that the single cell approach will improve the determination of unique and biologically significant properties of tissues and organs during the aging process.

]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-320.html</GuideLink>
<RelDate>2011-08-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-320.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-320</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19475</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Scalable Assays for Unbiased In Vitro Analysis of Neurobiological Function (R21/R33)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages research grant applications from institutions/organizations to develop novel, robust analytical platforms using in vitro assays to reveal changes in neuronal and/or glial function.  The goal is to adapt state-of-the-art measures of basic cellular processes or molecular events that are key mediators of nervous system function with the intent to probe mechanisms and/or perturbations in an unbiased and efficient manner.  The novel assay platforms would provide opportunities to measure neurobiological endpoints and build a pipeline to be used in the context of target identification and drug discovery.
]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-319.html</GuideLink>
<RelDate>2011-08-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-319.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-319</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19491</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Biomarkers:  Bridging Pediatric and Adult Therapeutics (R01)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) invites applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy.  

]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-322.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-322.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-322</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19495</rowid>
<PrimaryIC><![CDATA[NIMHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Clinical Research Education and Career Development (CRECD) in Minority Institutions (R25)]]></Title>
<Purpose><![CDATA[The purpose of the Clinical Research Education and Career Development (CRECD) Program is to expand the national capability to improve diversity for research in the health sciences by developing the research workforce in clinical and translational sciences though providing grant support to minority institutions that offer doctorate degrees in the health professions or in a health-related science. These institutions historically have trained professionals from diverse backgrounds who provide health care to minority populations and are uniquely positioned to engage these populations in research and in the translation of research advances into culturally appropriate, measurable and sustained improvements in health outcomes. 

]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-325.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>October 2, 2011, October 2, 2012</IntentDate>
<AppReceiptDate><![CDATA[November 2, 2011, November 2, 2012]]></AppReceiptDate>
<LARD>2012-11-02</LARD>
<FileName>PAR-11-325.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-325</DocNum>
<ExpirationDate>2012-11-03</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19496</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Gamete Quality in Natural and Assisted Reproduction (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA), issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Environmental Health Sciences (NIEHS), and the Office of Dietary Supplements (ODS), is to encourage applications from the scientific community to support outstanding research in the area of female and male gamete quality.  For both natural and assisted reproduction, a focal point of the initiative is on the production, identification, and use of healthy gametes.  In this regard, the identification and validation of biomarkers that assess gamete quality is critical.  Additional areas of interest are the impact of nutrition, environmental exposures, disease states, and aging on oocyte and sperm quality. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-326.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-11-326.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-326</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19497</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Biomarkers:  Bridging Pediatric and Adult Therapeutics (R21)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) invites applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy. 

]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-324.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-324.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-324</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19498</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Biomarkers:  Bridging Pediatric and Adult Therapeutics (R03)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) invites applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-323.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-323.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-323</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19504</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Nursing Research (NINR) with participation from the National Heart, Lung, and Blood Institute (NHLBI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Center for Complementary and Alternative Medicine (NCCAM), and the Office of Behavioral and Social Sciences Research (OBSSR), is to encourage Exploratory/Developmental Research Grant Award (R21) applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18).  ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-329.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-329.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-329</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19505</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R03)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Nursing Research (NINR) with participation from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Behavioral and Social Sciences Research (OBSSR),  is to encourage Small Grant Program (R03) applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-328.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-328.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-328</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19506</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<Title><![CDATA[Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Nursing Research (NINR) with participation from the National Heart, Lung, and Blood Institute (NHLBI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Center for Complementary and Alternative Medicine (NCCAM), and the Office of Behavioral and Social Sciences Research (OBSSR), is to encourage Research Project Grant (R01) applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-327.html</GuideLink>
<RelDate>2011-09-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-327.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-327</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19501</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[mHealth Tools to Promote Effective PatientProvider Communication, Adherence to Treatment  and Self Management of Chronic Diseases In Underserved Populations (R21)
]]></Title>
<Purpose><![CDATA[The purpose of this initiative issued by the National Institute of Nursing Research (NINR) and the Office of Dietary Supplements is to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patientprovider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database.  mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-332.html</GuideLink>
<RelDate>2011-09-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-332.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-332</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19502</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[mHealth Tools to Promote Effective PatientProvider Communication, Adherence to Treatment  and Self Management of Chronic Diseases In Underserved Populations (R03)
]]></Title>
<Purpose><![CDATA[The purpose of this initiative issued by the National Institute of Nursing Research (NINR) and the Office of Dietary Supplements (ODS) is to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patientprovider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database.  mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-331.html</GuideLink>
<RelDate>2011-09-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-331.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-331</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19503</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[mHealth Tools to Promote Effective PatientProvider Communication, Adherence to Treatment  and Self Management of Chronic Diseases In Underserved Populations (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this initiative issued by the National Institute of Nursing Research (NINR) and the Office of Dietary Supplements (ODS) is to stimulate research utilizing Mobile Health (mHealth) tools aimed at the improvement of effective patientprovider communication, adherence to treatment and self-management of chronic diseases in underserved populations. With the rapid expansion of cellular networks and substantial advancements in Smartphone technologies, it is now possible - and affordable - to transmit patient data digitally from remote areas to specialists in urban areas, receive real-time feedback, and capture that consultation in a database.  mHealth tools, therefore, may facilitate more timely and effective patient-provider communication through education communication around goal setting, treatment reminders, feedback on patient progress and may improve health outcomes. This announcement encourages the development, testing and comparative effective analysis of interventions utilizing mHealth technologies in underserved populations.    ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-330.html</GuideLink>
<RelDate>2011-09-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-330.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-330</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19521</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<Title><![CDATA[Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages the translation of technologies for biomedical or behavioral research from academic and other non-small business research sectors to the marketplace. Small Business Concerns (SBCs) are encouraged to submit Small Business Innovation Research (SBIR) grant applications that propose to further develop, make more robust, and make more user-friendly such technologies in preparation for commercial dissemination. It is expected that this activity will require partnerships and close collaboration between the original developers of these technologies and SBCs, which may be accomplished in any of a number of ways, including the use of multiple principle investigators.  ]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-335.html</GuideLink>
<RelDate>2011-09-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-09-07</LARD>
<FileName>PA-11-335.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-335</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19524</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, encourages R01 research projects that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies against HIV, oral co-infections and oral opportunistic infections.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-334.html</GuideLink>
<RelDate>2011-09-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-334.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-334</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19525</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, encourages Exploratory/Developmental Research Grant applications that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies against HIV, oral co-infections and oral opportunistic infections. The R21 mechanism intends to support early stages of high risk-high impact research that may lead to breaking new ground or extending previous discoveries.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-333.html</GuideLink>
<RelDate>2011-09-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-333.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-333</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19518</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Social Neuroscience and Neuroeconomics of Aging (R01)
]]></Title>
<Purpose><![CDATA[The National Institute on Aging (NIA) issues this Funding Opportunity Announcement (FOA) with special review to stimulate interdisciplinary aging-relevant research in the social, affective and economic neurosciences. The NIA invites applications examining social, emotional and economic behaviors of relevance to aging, using approaches that examine mechanisms and processes at both (a) the social, behavioral or psychological (emotional, cognitive, motivational) level, and (b) the neurobiological or genetic level. Proposals are encouraged that have an overriding emphasis on economic, social or emotional processes and associated genetic or neurobiological processes. Applications should demonstrate either relevance for aging or for age differences or age-related changes in these processes.  Aging-relevant applications can address issues of importance to the well-being and health of either mid-life or older adults, and can include data spanning the entire life course.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-337.html</GuideLink>
<RelDate>2011-09-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 5, 2012, February 5, 2013, and February 5, 2014 for new applications; March 5, 2012, March 5, 2013 and March 5, 2014]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-337.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-337</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19519</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Social Neuroscience and Neuroeconomics of Aging (R21)]]></Title>
<Purpose><![CDATA[The National Institute on Aging (NIA) issues this Funding Opportunity  Announcement (FOA) with special review to stimulate interdisciplinary aging-relevant research in the social, affective and economic neurosciences. The NIA invites applications examining social, emotional and economic behaviors of relevance to aging, using approaches that examine mechanisms and processes at both (a) the social, behavioral or psychological (emotional, cognitive, motivational) level, and (b) the neurobiological or genetic level. Applications are encouraged that have an overriding emphasis on economic, social or emotional processes and associated genetic or neurobiological processes. Applications should demonstrate either relevance for aging or for age differences or age-related changes in these processes.  Aging-relevant applications can address issues of importance to the well-being and health of either mid-life or older adults, and can include data spanning the entire life course.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-336.html</GuideLink>
<RelDate>2011-09-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 16, 2012, February 16, 2013, and February 16, 2014 for new applications; March 16, 2012, March 16, 2013 and March 16, 2014]]></AppReceiptDate>
<LARD>2014-05-07</LARD>
<FileName>PAR-11-336.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-336</DocNum>
<ExpirationDate>2014-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19534</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Development of novel and emerging technologies for the accurate detection and diagnosis of polymicrobial infections in biomedical laboratory animal models (SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[There is a need to develop systems that are sensitive, selective, automated, and cost/size effective and capable of detection and identification of polymicrobial infections that may represent a threat to the survival of valuable biomedical animal resources or contribute confounding factors to research using these resources. This Funding Opportunity Announcement (FOA) seeks projects for rapid and sensitive detection of infectious agents as a key requirement for microbial identification in laboratory animal models. The diagnosis of polymicrobial infections has become increasingly important in enabling biological resource centers to meet the needs for establishing pathogen-free biological resources for current and future biomedical research needs. This funding opportunity announcement (FOA) encourages applications from small business concerns for Small Business Innovation Research (SBIR) projects that propose innovative research in the areas of detection and identification of infectious agents, including those involved in vertical transmission of diseases into embryos and larvae and development of required reagents and equipment. (See more information listed in Section I. Funding Opportunity Description). 
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-340.html</GuideLink>
<RelDate>2011-09-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-340.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-340</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19537</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Development of Novel and Emerging Technologies for the Accurate Detection and Diagnosis of Polymicrobial Infections in Biomedical Laboratory Animal Models (STTR [R41/R42]) 
]]></Title>
<Purpose><![CDATA[There is a need to develop systems that are sensitive, selective, automated, and cost/size effective and capable of detection and identification of polymicrobial infections that may represent a threat to the survival of valuable biomedical animal resources or contribute confounding factors to research using these resources. This Funding Opportunity Announcement (FOA) seeks projects for rapid and sensitive detection of infectious agents as a key requirement for microbial identification in laboratory animal models. The diagnosis of polymicrobial infections has become increasingly important in enabling biological resource centers to meet the needs for establishing pathogen-free biological resources for current and future biomedical research needs. This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Technology Transfer (STTR) projects that propose innovative research in the areas of detection and identification of infectious agents, including those involved in vertical transmission of diseases into embryos and larvae and development of required reagents and equipment. (See more information listed in Section I. Funding Opportunity Description).
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-341.html</GuideLink>
<RelDate>2011-09-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-09-07</LARD>
<FileName>PA-11-341.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-341</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19538</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Clinical Trial Implementation or Biomarker Clinical Evaluation Study Cooperative Agreement (U01)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, will support investigator-initiated Phase I, II, III or IV clinical trial cooperative agreement applications or biomarker evaluation studies that require prospective collection of clinical outcomes and clinical specimens.  All applicants must have received an NIDCR Clinical Trial Planning (R34) award to plan the proposed cooperative agreement study (see PAR-11-338 for information about NIDCR Clinical Trial or Biomarker Clinical Evaluation Study Planning Grants).  NIDCR may consider an exception. A unique application is required for each proposed study, and must include a final draft of the study protocol, a Manual of Procedures and other supporting materials such as the Investigators Brochure. These documents must meet all National Institutes of Health (NIH), Food and Drug Administration (FDA), and Office of Human Research Protections (OHRP) requirements. All awards will be made as cooperative agreements.]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-339.html</GuideLink>
<RelDate>2011-09-16</RelDate>
<IntentDate>30 days prior to receipt date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-11-339.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-339</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19539</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant (R34)]]></Title>
<Purpose><![CDATA[The NIDCR will support R34 grants for the planning and design of clinical trials or biomarker clinical evaluation studies. The R34 grant award will provide support for activities that include, but are not limited to: the establishment of the research team; the development of the clinical protocol and Clinical Investigators Brochure (or equivalent); the development of tools for data management, safety and operational oversight of the research; the definition of recruitment strategies; and all essential elements of the study such as a Manual of Procedures for the clinical trial or biomarker clinical evaluation study, or a draft of the manualized behavioral, community, or services intervention. (See Scope for more detail.) The Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant is not designed for the collection of preliminary data (clinical or pre-clinical), or the collection of prospective data to support the rationale for a clinical trial or study.
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-338.html</GuideLink>
<RelDate>2011-09-16</RelDate>
<IntentDate>Four weeks before standard due dates.</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-11-338.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-338</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19549</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NeuroNEXT Infrastructure Resource Access (X01)
]]></Title>
<Purpose><![CDATA[This FOA encourages proposals for biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices that may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III trial) in the treatment of neurologic disease. Proposals for drugs or biologics should provide compelling scientific evidence that the investigational agent proposed for study will reach/act upon the designated target or that its mechanism of action is such that it will be of benefit in ameliorating a specific aspect of the disease. 

]]></Purpose>
<RelNote/><ActivityCodes>X01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-344.html</GuideLink>
<RelDate>2011-09-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2014-10-21</LARD>
<FileName>PAR-11-344.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-344</DocNum>
<ExpirationDate>2014-10-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19550</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NeuroNEXT Clinical Trials (U01)]]></Title>
<Purpose><![CDATA[This FOA encourages applications for biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices that may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III trial) in the treatment of neurologic disease.  Applications for drugs or biologics should provide compelling scientific evidence that the investigational agent proposed for study will reach/act upon the designated target or that its mechanism of action is such that it will be of benefit in ameliorating a specific aspect of the disease. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol. Applicants do not need to be part of the existing NeuroNEXT infrastructure.  
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-343.html</GuideLink>
<RelDate>2011-09-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[December 2, 2011; April 2, 2012; August 2, 2012; December 3, 2012; April 2, 2013; August 2, 2013; December 2, 2013; April 2, 2014; August 1, 2014]]></AppReceiptDate>
<LARD>2014-08-01</LARD>
<FileName>PAR-11-343.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-343</DocNum>
<ExpirationDate>2014-08-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19557</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NeuroNEXT Small Business Innovation in Clinical Trials (U44)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices for neurological disorders which may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III clinical trial) in the treatment of neurologic disease.  The program will utilize the cooperative agreement mechanism to enable milestone-drive projects.  

]]></Purpose>
<RelNote/><ActivityCodes>U44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-345.html</GuideLink>
<RelDate>2011-09-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[December 2, 2011; April 2, 2012; August 2, 2012; December 3, 2012; April 2, 2013; August 2, 2013; December 2, 2013; April 2, 2014; August 1, 2014 ]]></AppReceiptDate>
<LARD>2014-08-01</LARD>
<FileName>PAR-11-345.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-345</DocNum>
<ExpirationDate>2014-08-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19558</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<Title><![CDATA[NINDS SBIR Technology Transfer (SBIR-TT [R43/R44])  
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for projects to transfer technology out of the NIH intramural research labs into the private sector.  If selected for SBIR funding, the SBC will be granted a royalty-free, non-exclusive internal research-use license for the term of and within the field of use of the SBIR award to technologies held by NIH with the intent that the SBC will develop the invention into a commercial product to benefit the public.   
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-347.html</GuideLink>
<RelDate>2011-09-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-11-347.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-347</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19559</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Interventions for Health Promotion and Disease Prevention in Native American Populations (R01) 
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations. NA populations are exposed to considerable risk factors that significantly increase their likelihood of chronic disease, substance abuse, mental illness, and HIV-infection. The intervention program should be culturally appropriate and promote the adoption of healthy lifestyles, improve behaviors and social conditions and/or improve environmental conditions related to chronic disease, the consumption of tobacco, alcohol and other drugs, mental illness or HIV-infection. The intervention program should be designed so that it could be sustained within the entire community within existing resources, and, if successful, disseminated in other Native American communities. The long-term goal of this FOA is to reduce mortality and morbidity in NA communities.  For the purposes of this FOA Native Americans include the following populations: Alaska Native, American Indian, and Native Hawaiian.  The term Native Hawaiian means any individual any of whose ancestors were natives, prior to 1778, of the area which now comprises the State of Hawaii.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-346.html</GuideLink>
<RelDate>2011-09-22</RelDate>
<IntentDate>April 15, 2012; April 15, 2013; April 15, 2014</IntentDate>
<AppReceiptDate><![CDATA[May 15, 2012; May 15, 2013; May 15, 2014 ]]></AppReceiptDate>
<LARD>2014-05-15</LARD>
<FileName>PAR-11-346.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-346</DocNum>
<ExpirationDate>2014-05-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19567</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3)
]]></Title>
<Purpose><![CDATA[This FOA invites applications for ancillary studies that use subjects enrolled in (or screened for participation in) the Type 1 Diabetes TrialNet clinical trials network.  Studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses.  This FOA is not intended to fund clinical trials with endpoints for clinical efficacy (including but not limited to C-peptide preservation). 
]]></Purpose>
<RelNote/><ActivityCodes>DP3</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-349.html</GuideLink>
<RelDate>2011-09-27</RelDate>
<IntentDate>November 7, 2011; May 7, 2012</IntentDate>
<AppReceiptDate><![CDATA[December 7, 2011 and June 7, 2012]]></AppReceiptDate>
<LARD>2012-06-07</LARD>
<FileName>PAR-11-349.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-349</DocNum>
<ExpirationDate>2012-06-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19566</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
]]></Title>
<Purpose><![CDATA[This FOA invites applications for ancillary studies using archived samples from selected type 1 diabetes clinical trials and studies.  Ancillary studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses.  
]]></Purpose>
<RelNote/><ActivityCodes>DP3</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-350.html</GuideLink>
<RelDate>2011-09-28</RelDate>
<IntentDate>November 7, 2011; May 7, 2012</IntentDate>
<AppReceiptDate><![CDATA[December 7, 2011 and June 7, 2012]]></AppReceiptDate>
<LARD>2012-06-07</LARD>
<FileName>PAR-11-350.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-350</DocNum>
<ExpirationDate>2012-06-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19573</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Short Courses on Mathematical, Statistical, and Computational Tools for Studying Biological Systems (R25)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of General Medical Sciences encourages applications for Research Education Grants (R25) from institutions and organizations to conduct workshops and short courses to improve integration of mathematical, statistical, and computational approaches into biological and/or behavioral research.  Support will be limited to activities that reach a wide audience of researchers.  The FOA is NOT intended for university courses or curriculum development.
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-11-351.html</GuideLink>
<RelDate>2011-09-30</RelDate>
<IntentDate>30 days before application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-11-351.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-11-351</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19575</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, is  to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney or urologic disease research. Studies should address important clinical and translational questions and are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of diagnosis, prevention, or treatment of kidney or urologic diseases.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-11-352.html</GuideLink>
<RelDate>2011-09-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-11-352.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-11-352</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19591</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<Title><![CDATA[Collaborations with National Centers for Biomedical Computing (R01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is for projects from individualinvestigators or small groups to collaborate with the NIH Common Fund for Medical Research National Centers for Biomedical Computing (NCBCs). For a description of the NCBCs see http://www.ncbcs.org/. The intention of the collaborating projects is to engage researchers across the nation in building an excellent biomedical computing environment, using the computational tools and biological and behavioral application drivers of the funded NCBCs as foundation stones.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-001.html</GuideLink>
<RelDate>2011-10-07</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-001.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-001</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19596</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[The NEI Mentored Clinical Scientist Development Program Award (K12)]]></Title>
<Purpose><![CDATA[The goal of this FOA is to expand and strengthen the community of investigators engaged in clinical vision research.  An increase in the number of well-trained clinical researchers is necessary to achieve a pool of scientists with contemporary, multidisciplinary expertise able to leverage recent advances in ocular genetics, therapeutics, bioengineering, and bio-behavioral research in order to enhance patient treatment and to increase scientific momentum in these fields.  The FOA is expected to increase the number and diversity of clinical investigators trained in the sciences relevant to clinical vision research; to facilitate the mentoring of this group of scientists; and to form a robust research community bringing new scientific expertise to address the Nation's biomedical, behavioral, and clinical research needs in vision research.  The FOA is expected to facilitate and support the career development of clinical vision scientists who have made a commitment to independent research careers.
]]></Purpose>
<RelNote/><ActivityCodes>K12</ActivityCodes>
<FA_DirectCosts>1125000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-002.html</GuideLink>
<RelDate>2011-10-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[May 14, 2012; 2013; and 2014]]></AppReceiptDate>
<LARD>2013-05-14</LARD>
<FileName>PAR-12-002.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-002</DocNum>
<ExpirationDate>2013-05-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19610</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<Title><![CDATA[Limited Competition: Framework Programs for Global Health Innovation (D43)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to provide support for the development of broadly interdisciplinary training programs in global health directed towards encouraging innovation in products, processes, and policies.  Trainees should be at the postdoctoral level or have attained a terminal degree in their fields.  Training projects should identify critical health needs in Low and Middle Income Countries (LMICs) that can be addressed through Innovation, and carry out the scientific research necessary to develop, validate, and test their concepts. To increase the translation of research findings into realized health benefits, project design should include considerations of implementation appropriate to low resource settings in LMICs, particularly regarding increased effectiveness, affordability, accessibility, ease of use or delivery, and/or scalability.  This FOA emphasizes hands-on, problem-solving, and collaborative approaches and allows U.S. and LMIC trainees to be trained together.  By engaging multiple entities within and among institutions, the proposed programs should also build institutional capacity for interdisciplinary training in global health, stimulate new collaborations, and increase the pipeline of researchers from a wide variety of fields who engage in global health research.
]]></Purpose>
<RelNote/><ActivityCodes>D43</ActivityCodes>
<FA_DirectCosts>350000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-003.html</GuideLink>
<RelDate>2011-10-14</RelDate>
<IntentDate>November 16, 2011, November 15, 2012</IntentDate>
<AppReceiptDate><![CDATA[December 15, 2011, December 14, 2012]]></AppReceiptDate>
<LARD>2012-12-14</LARD>
<FileName>PAR-12-003.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-003</DocNum>
<ExpirationDate>2012-12-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19623</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[National Cancer Institute Program Project (P01) Applications]]></Title>
<Purpose><![CDATA[With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated program project (P01) grants. Proposed program projects may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer treatment, cancer diagnosis, cancer prevention, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each Program Project application must consist of at least three component projects. The component projects must share a common central theme, focus, and/or overall objective.
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-005.html</GuideLink>
<RelDate>2011-10-21</RelDate>
<IntentDate>December 25, 2011</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-005.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-005</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19625</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22)]]></Title>
<Purpose><![CDATA[The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to provide highly-qualified dentists in NIH Intramural postdoctoral fellowship positions with an opportunity to receive further mentored research experience in the NIH Intramural program, and then to provide them with independent funding to facilitate the transition of their research programs as new investigators at extramural institutions. To achieve these objectives, the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators will support two phases of research: a mentored intramural phase of up to two years, and an independent extramural phase of up to three years. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardees research program as determined by an NIDCR progress review, which will include an evaluation of a research plan to be carried out at the extramural institution.
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-004.html</GuideLink>
<RelDate>2011-10-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-004.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-004</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19630</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Improving Access to Hearing Health Care (STTR) [R41/R42]
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose the development and translation of technologies to improve hearing healthcare outcomes. Responsive applications must seek to increase utilization of hearing health care technology by underserved patients and thus reduce health disparities. 
]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-12-005.html</GuideLink>
<RelDate>2011-10-26</RelDate>
<IntentDate>January 22, 2012; May 21, 2012; September 22, 2012; January 22, 2013; May 21, 2013; September 22, 2013</IntentDate>
<AppReceiptDate><![CDATA[February 22, 2012; June 21, 2012; October 22, 2012; February 22, 2013; June 21, 2013; October 22, 2013]]></AppReceiptDate>
<LARD>2013-10-22</LARD>
<FileName>RFA-DC-12-005.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DC-12-005</DocNum>
<ExpirationDate>2013-10-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19631</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Improving Access to Hearing Health Care (SBIR) [R43/R44]
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the development and translation of technologies to improve hearing healthcare outcomes. Responsive applications must seek to increase utilization of hearing health care technology by underserved patients and thus reduce health disparities.
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-12-004.html</GuideLink>
<RelDate>2011-10-26</RelDate>
<IntentDate>January 22, 2012; May 21, 2012; September 22, 2012; January 22, 2013; May 21, 2013; September 22, 2013</IntentDate>
<AppReceiptDate><![CDATA[February 22, 2012; June 21, 2012; October 22, 2012; February 22, 2013; June 21, 2013; October 22, 2013]]></AppReceiptDate>
<LARD>2013-10-22</LARD>
<FileName>RFA-DC-12-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DC-12-004</DocNum>
<ExpirationDate>2013-10-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19640</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<Title><![CDATA[Academic Research Enhancement Award (Parent R15)
]]></Title>
<Purpose><![CDATA[The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. AREA grants create opportunities for scientists and institutions, otherwise unlikely to participate extensively in NIH research programs, to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose students to meritorious research projects, and to strengthen the research environment of the applicant institution. ]]></Purpose>
<RelNote/><ActivityCodes>R15</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-006.html</GuideLink>
<RelDate>2011-11-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-006.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-006</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19654</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Innovative Pilot Studies of Novel Mechanism of Action Compounds for Treating Psychiatric Disorders (U01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage cooperative agreement applications to support experimental medicine-based first in human (FIH) and proof of concept (POC) studies of new mechanism of action, IND-ready candidate medications to treat mental disorders. The objective of the FOA is to accelerate the development of innovative pharmacological treatments through support of early phase human clinical testing.  FIH pharmacology studies should assess target engagement, pharmacological effects, safety, and tolerability of novel compounds in order to build a pipeline for initial POC or efficacy trials in patients. POC studies of novel compounds should use pharmacologically based dosing, with assessment of target engagement and evaluation of the impact of compounds on clinically relevant physiological systems as well as clinical indicators of effect. The overall objective is to facilitate rapid collection of data to "de-risk" novel mechanism of action or combination treatments and to attract private funding for further clinical and commercial development of candidate medications. Partnerships between academia and industry are strongly encouraged. 
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-007.html</GuideLink>
<RelDate>2011-11-07</RelDate>
<IntentDate>30 days prior to the application due date(s)</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-007.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-007</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19656</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Implications of the Economic Downturn for Health, Wealth, and Work at Older Ages (R01)]]></Title>
<Purpose><![CDATA[ This Funding Opportunity Announcement (FOA) invites research on the implications of exogenous shocks, such as those produced by the recent economic downturn, for health, economic circumstances, and planning throughout the life-cycle.
 ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-009.html</GuideLink>
<RelDate>2011-11-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-009.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-009</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19657</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Limited Competition: Revision(s) to the Dominantly Inherited Alzheimer Network (U19)
]]></Title>
<Purpose><![CDATA[ This funding opportunity announcement invites revision applications to the Dominantly Inherited Alzheimer Network (DIAN).  Revision applications may not request support beyond the project end date of the Parent award.
 ]]></Purpose>
<RelNote/><ActivityCodes>U19</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-008.html</GuideLink>
<RelDate>2011-11-08</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-12-008.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-008</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19665</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[HIV Incidence Assays with Improved Specificity (R01)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, encourages grant applications from institutions/ organizations that propose to develop improved HIV Incidence Assays with increased specificity and reliability for distinguishing incident from chronic HIV infections. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-012.html</GuideLink>
<RelDate>2011-11-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PA-12-012.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-012</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19675</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Alzheimer's Disease Drug Development Program (U01)
 ]]></Title>
<Purpose><![CDATA[The goal of this funding opportunity announcement (FOA) is to support pre-clinical development of new therapies aimed at modifying the behavioral symptoms in Alzheimer's disease (AD); or delaying the onset or slowing the progression of AD, mild cognitive impairment (MCI), or age-related cognitive decline. This program is specifically directed at projects focused on the optimization of therapeutic leads with demonstrated activity against an intended disease target. Projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the funding period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research and basic, mechanistic research. This is a milestone-driven cooperative agreement program involving participation of NIA program staff both in the development of the project plan and monitoring of research progress. ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-015.html</GuideLink>
<RelDate>2011-11-16</RelDate>
<IntentDate>January 5, 2012</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-015.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-015</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19676</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), encourages the submission of Exploratory/Developmental Research Project Grant (R21) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support pilot research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This FOA is not appropriate for molecular diagnostics discovery projects.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-014.html</GuideLink>
<RelDate>2011-11-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-014.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-014</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19677</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This FOA is not appropriate for molecular diagnostics discovery projects.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-013.html</GuideLink>
<RelDate>2011-11-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-013.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-013</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19679</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[NIA MSTEM:  Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) issued by the National Institute on Aging (NIA), NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education, encourages institutional Research Education Grant (R25) applications from institutions that propose creative and innovative research education programs to diversify the workforce in aging by (1) supporting undergraduate competency and completion in medicine, science, technology, engineering and mathematics ) ((MSTEM) to be referred to as NIA MSTEM fields henceforth),  as they relate to aging and, also, by (2) application and transition to graduate study that advances a cadre of students from diverse backgounds into NIA MSTEM  fields.   The interests of the NIA span biological, biomedical, behavioral, clinical and social sciences research across the lifespan with a focus on processes of aging through midlife and into old age. ]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>350000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-016.html</GuideLink>
<RelDate>2011-11-16</RelDate>
<IntentDate>December 25, 2011</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-016.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-016</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19680</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[NIDDK Mentored Research Scientist Development Award (K01)
]]></Title>
<Purpose><![CDATA[The purpose of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Mentored Research Scientist Development Award (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. The NIDDK invites K01 applications from advanced postdoctoral and/or recently appointed junior faculty (usually with a Ph.D. degree) in biomedical or behavioral sciences who are pursuing careers in research areas supported by the NIDDK. 
]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-020.html</GuideLink>
<RelDate>2011-11-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-020.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-020</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19688</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<Title><![CDATA[Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research (K26)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), using The Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research Award (K26) issued by NCRR, NIH, seeks to support established, outstanding scientists by providing protected time for mouse pathobiology research and comprehensive phenotyping of genetically modified mice as well as mentoring of junior investigators, thus relieving them of time-consuming institutional service obligations and administrative responsibilities.  ]]></Purpose>
<RelNote/><ActivityCodes>K26</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-021.html</GuideLink>
<RelDate>2011-11-17</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2015-01-07</LARD>
<FileName>PAR-12-021.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-021</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19694</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) seeks Research Project Grant (R01) applications that propose to use a common conceptual model to develop behavioral interventions to modify health behaviors and improve health outcomes in patients with comorbid chronic diseases and health conditions. Specifically, this FOA will support research in primary care that uses a multi-disease care management approach to behavioral interventions with high potential impact to improve patient-level health outcomes for individuals with three or more chronic health conditions. The proposed approach must modify behaviors using a common approach rather than administering a distinct intervention for each targeted behavior and/or condition. Diseases and health conditions can include, but are not limited to: mental health disorders (e.g., depression), diabetes, smoking, obesity, chronic pain, alcohol and substance abuse and dependence, chronic obstructive pulmonary disorder, cancer and hypertension.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-024.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-12-024.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-024</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19695</rowid>
<PrimaryIC><![CDATA[ORWH]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<Title><![CDATA[Myalgic Encephalomyelitis/Chronic Fatigue Syndrome:  Etiology, Diagnosis, Pathophysiology, and Treatment (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the Office of Research on Women's Health (ORWH) and co-sponsoring Institutes and Centers (ICs) of the National Institutes of Health (NIH) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in diverse groups and across the lifespan.  Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, the common mechanisms influencing the multiple body systems that are affected in ME/CFS are encouraged.  The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-033.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013; May 24, 2013; September 24, 2013; January 24, 2014; May 26, 2014; September 24, 2014</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-10-24</LARD>
<FileName>PAR-12-033.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-033</DocNum>
<ExpirationDate>2014-10-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19696</rowid>
<PrimaryIC><![CDATA[ORWH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R01) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the Office of Research on Women's Health (ORWH) and co-sponsoring Institutes and Centers (ICs) of the National Institutes of Health (NIH) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in diverse groups and across the lifespan.  Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, the common mechanisms influencing the multiple body systems that are affected in ME/CFS are encouraged.  The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers, innovative treatment modalities, and/or the modifiable risk and protective processes specifically targeted by preventive and/or treatment interventions.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-032.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013; May 24, 2013; September 24, 2013; January 24, 2014; May 26, 2014; September 24, 2014 </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-10-24</LARD>
<FileName>PAR-12-032.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-032</DocNum>
<ExpirationDate>2014-10-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19697</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03)]]></Title>
<Purpose><![CDATA[The objective of this Funding Opportunity Announcement (FOA) is to encourage research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-029.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-029.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-029</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19698</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21)
]]></Title>
<Purpose><![CDATA[The objective of this Funding Opportunity Announcement (FOA) is to encourage research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-030.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-030.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-030</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19699</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01)]]></Title>
<Purpose><![CDATA[The objective of this Funding Opportunity Announcement (FOA) is to encourage research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-031.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-031.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-031</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19700</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Effects of Adolescent Binge Drinking on Brain Development (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), encourages Exploratory/Developmental Research Grant (R21) applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-028.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-028.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-028</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19701</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Effects of adolescent binge drinking on brain development (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), encourages Research Project Grant (R01) applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-027.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-027.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-027</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19702</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol impairment of immune function, host defense and tissue homeostasis (R01)]]></Title>
<Purpose><![CDATA[Susceptibility to infection and organ damage are the two most common causes of alcohol-related morbidity and mortality. These consequences of alcohol abuse are closely associated with profound impairment of the host innate and adaptive immune systems. The mechanisms of these immune alterations and their link with alcohol-related medical problems are, in most cases, poorly understood. The goal of this FOA is to attract applications on basic and translational research: 1) to identify how alcohol alters immune function; 2) to establish functional links between immune alterations and alcohol related infections and organ damage; and 3) to develop means for mitigating immune impairment with the goal of alleviating alcohol-induced pathology. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-025.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-025.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-025</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19703</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol impairment of immune function, host defense and tissue homeostasis (R21) ]]></Title>
<Purpose><![CDATA[Susceptibility to infection and organ damage are the two most common causes of alcohol-related morbidity and mortality. These consequences of alcohol abuse are closely associated with profound impairment of the host innate and adaptive immune systems. The mechanisms of these immune alterations and their link with alcohol-related medical problems are, in most cases, poorly understood. The goal of this FOA is to attract applications on basic and translational research: 1) to identify how alcohol alters immune function; 2) to establish functional links between immune alterations and alcohol related infections and organ damage; and 3) to develop means for mitigating immune impairment with the goal of alleviating alcohol-induced pathology. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-026.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2015-01-07</LARD>
<FileName>PA-12-026.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-026</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19686</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Practical Interventions to Improve Medication Adherence in Primary Care (R21)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is being issued by the NIH Adherence Network through the Office of Behavioral and Social Sciences Research (OBSSR), with participation from  the National Eye Institute (NEI), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute on Deafness and Other Communication Disorders (NIDCD), the National Institute of Mental Health (NIMH), the National Institute of Nursing Research (NINR) and the National Center for Complementary and Alternative Medicine (NCCAM). This FOA encourages Exploratory/Developmental Research Project Grant (R21) applications for research and development of novel, practical interventions to improve adherence to medication. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-023.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-12-023.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-023</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19687</rowid>
<PrimaryIC><![CDATA[OBSSR]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Practical Interventions to Improve Medication Adherence in Primary Care (R01) 
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is being issued by the NIH Adherence Network through the Office of Behavioral and Social Sciences Research (OBSSR), with participation from the National Cancer Institute (NCI), the National Eye Institute (NEI), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging (NIA), the National Institute on Deafness and Other Communication Disorders (NIDCD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Mental Health (NIMH), the National Institute of Nursing Research (NINR), and the National Center for Complementary and Alternative Medicine (NCCAM). This FOA seeks Research Project Grant (R01) applications that propose practical interventions to improve adherence to medication. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-022.html</GuideLink>
<RelDate>2011-11-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-01-07</LARD>
<FileName>PA-12-022.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-022</DocNum>
<ExpirationDate>2014-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19707</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Developmental Mechanisms of Human Structural Birth Defects (P01)]]></Title>
<Purpose><![CDATA[The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Office of Dietary Supplements (ODS), National Institutes of Health (NIH) encourages innovative, multidisciplinary, interactive, and synergistic program project (P01) grant applications from institutes/organizations that propose to integrate basic, translational, and clinical approaches to understanding the developmental biology and genetic basis of congenital structural human malformations.  To contain costs, each P01 will consist of only three component projects and associated cores.  At least one project must propose basic research in an animal model system and at least one project must be clinical or translational in nature.  The component projects must share a common central theme, focus, or objective on a specific developmental structural malformation or class of anomalies that is genotypically, mechanistically, biologically, or phenotypically analogous or homologous in both animal models and humans.
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-034.html</GuideLink>
<RelDate>2011-11-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-034.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-034</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19711</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<Title><![CDATA[Mechanisms Mediating Osteoarthritis in Aging (R01)
]]></Title>
<Purpose><![CDATA[The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases invite applications that are intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms mediating osteoarthritic progression.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-019.html</GuideLink>
<RelDate>2011-11-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-019.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-019</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19681</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<Title><![CDATA[Mechanisms Mediating Osteoarthritis in Aging (R21)
]]></Title>
<Purpose><![CDATA[The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases invite applications intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms mediating osteoarthritic progression.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-018.html</GuideLink>
<RelDate>2011-11-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-018.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-018</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19723</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Small Grants Program for Cancer Epidemiology (R03)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), encourages the submission of Small Research Grant (R03) applications for research on cancer etiology and epidemiology. The overarching goal of this FOA is to provide support for pilot projects, testing of new techniques, secondary analyses of existing data, development and validation of measurement methods, linkage of genetic polymorphisms with other variables related to cancer risk, and development of innovative projects for more comprehensive research in cancer etiology and epidemiology.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-039.html</GuideLink>
<RelDate>2011-11-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 19, 2012; July 17, 2012; November 19, 2012; March 19, 2013; July 23, 2013; November 19, 2013; March 18, 2014; July 22, 2014; November 18, 2014]]></AppReceiptDate>
<LARD>2014-11-18</LARD>
<FileName>PAR-12-039.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-039</DocNum>
<ExpirationDate>2014-11-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19724</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NCEZID]]></PartIC>
<Title><![CDATA[Research to Advance Vaccine Safety (R21)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-038.html</GuideLink>
<RelDate>2011-11-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-038.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-038</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19725</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NCEZID]]></PartIC>
<Title><![CDATA[Research to Advance Vaccine Safety (R01)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-037.html</GuideLink>
<RelDate>2011-11-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-037.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-037</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19727</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Investigations on Primary Immunodeficiency Diseases (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity is intended to support innovative investigations in primary immunodeficiency diseases.  Of particular interest are the detection of primary immunodeficiency diseases, the identification of the molecular basis of these diseases, and the design and pre-clinical development of innovative therapies for these diseases. Clinical trials will not be supported by this FOA.  Studies using samples obtained from humans and studies on animal models are encouraged.  Investigators who have not received independent NIH funding in this field are encouraged to apply.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-036.html</GuideLink>
<RelDate>2011-11-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-036.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-036</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19732</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[International Research Collaboration on Drug Abuse and Addiction Research (R03) 
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (PA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs scientific priority areas. While the priorities will change from year to year, in FY12 priority areas include: linkages between HIV/AIDS and drug abuse, and prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders).
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-042.html</GuideLink>
<RelDate>2011-11-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-042.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-042</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19733</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[International Research Collaboration on Drug Abuse and Addiction Research (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (PA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should have relevance to the mission of NIDA and where feasible should address NIDAs scientific priority areas. While the priorities will change from year to year, in FY12 priority areas include: linkages between HIV/AIDS and drug abuse, and prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders).
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-041.html</GuideLink>
<RelDate>2011-11-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-041.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-041</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19734</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[International Research Collaboration on Drug Abuse and Addiction Research (R01) 
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (PA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should  have relevance to the mission of NIDA and where feasible should address NIDAs scientific priority areas. While the priorities will change from year to year, in FY12 priority areas include: linkages between HIV/AIDS and drug abuse, and prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders).
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-040.html</GuideLink>
<RelDate>2011-11-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-040.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-040</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19738</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[NIAMS Small Grant Program For New Investigators (R03)]]></Title>
<Purpose><![CDATA[The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is seeking small grant (R03) applications to stimulate and facilitate the entry of promising new investigators into research on arthritis and musculoskeletal and skin diseases and injuries. This FOA will provide support for pilot research that is likely to lead to a subsequent individual research project grant (R01). Clinical trials of any phase will not be supported by this FOA.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>25000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-045.html</GuideLink>
<RelDate>2011-11-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[March 20, 2012; July 20, 2012; November 20, 2012; March 20, 2013; July 19, 2013; November 20, 2013; March 20, 2014; July 21, 2014; and November 20, 2014]]></AppReceiptDate>
<LARD>2014-11-20</LARD>
<FileName>PAR-12-045.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-045</DocNum>
<ExpirationDate>2014-11-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19748</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Prevention and Treatment of Obesity, Diabetes, and Chronic Kidney Disease in Military Populations (R01)]]></Title>
<Purpose><![CDATA[The goal of this FOA is to encourage Research Project Grant (R01) applications on prevention and treatment of obesity, diabetes, and chronic kidney disease in military personnel (active duty and retired) and their families.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-048.html</GuideLink>
<RelDate>2011-12-01</RelDate>
<IntentDate>January 14, 2012; May 14, 2012; September 15, 2012; January 14, 2013; May 14, 2013; September 11, 2013; January 14, 2014; May 13, 2014; September, 2014</IntentDate>
<AppReceiptDate><![CDATA[February 14, 2012; June 14, 2012; October 15, 2012; February 14, 2013; June 14, 2013; October 11, 2013; February 14, 2014; June 13, 2014; October 15, 2014]]></AppReceiptDate>
<LARD>2014-10-15</LARD>
<FileName>PAR-12-048.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-048</DocNum>
<ExpirationDate>2014-10-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19749</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[NIDDK Education Program Grants (R25)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages Research Education (R25) grant applications from applicant organizations that propose to create educational opportunities for undergraduate students, graduate students, and postdoctoral fellows in areas of biomedical or behavioral research of particular interest to the NIDDK, while fostering the career development of these students and fellows.  The structure of the educational opportunity can include an intensive summer research program, a curriculum-based program or a combination of both experiences.  The NIDDK is especially interested in attracting students and postdoctoral fellows from scientific disciplines underrepresented in disease-oriented biomedical research, such as engineering, informatics, computer science, and computational sciences, to encourage them to apply their expertise to research relevant to diabetes and other endocrine and metabolic diseases; digestive and liver diseases; nutrition; obesity research and prevention; and kidney, urologic and hematologic diseases.]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-047.html</GuideLink>
<RelDate>2011-12-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-047.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-047</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19752</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Cancer Education Grants Program (R25)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to support innovative educational efforts that would help to reduce cancer incidence, morbidity, and mortality, and that would improve the quality of life of cancer patients. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-049.html</GuideLink>
<RelDate>2011-12-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-049.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-049</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19754</rowid>
<PrimaryIC><![CDATA[Roadmap]]></PrimaryIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[OSC]]></PartIC>
<Title><![CDATA[Regional Comprehensive Metabolomics Resource Cores (RCMRC) (U24)]]></Title>
<Purpose><![CDATA[This FOA invites cooperative agreement applications to establish Regional Comprehensive Metablomics Resource Cores (RCMRC) to increase the national capacity for utilizing metabolomics in biomedical research.To facilitate the biological and clinical application of metabolomics, technology service cores, pilot/feasibility projects, training activities, and outreach activities will be supported.]]></Purpose>
<RelNote/><ActivityCodes>U24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-016.html</GuideLink>
<RelDate>2011-12-02</RelDate>
<IntentDate>January 13, 2012; January 15, 2013</IntentDate>
<AppReceiptDate><![CDATA[February 15, 2012; February 15, 2013]]></AppReceiptDate>
<LARD>2013-02-15</LARD>
<FileName>RFA-RM-11-016.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-RM-11-016</DocNum>
<ExpirationDate>2013-02-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19739</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44])]]></Title>
<Purpose><![CDATA[To encourage new or renewal Small Business Innovation Research (SBIR) grant applications focused on specific product development activities for radiological/nuclear medical countermeasures leading to Investigational New Drug (IND) or Investigational Device Exemption (IDE) submission packages to the U.S. Food and Drug Administration.  
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-044.html</GuideLink>
<RelDate>2011-12-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-044.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-044</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19767</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Ancillary Studies in Clinical Trials (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites research grant applications to conduct time-sensitive ancillary studies related to heart, lung, and blood diseases and sleep disorders in conjunction with ongoing clinical trials and other large clinical studies supported by NIH or non-NIH entities. The program establishes an accelerated review/award process to support the crucial time frame in which these ancillary studies must be performed. Time-sensitive ancillary studies include those that require active longitudinal data collection and thus need to begin recruiting subjects as close as possible to the start of the parent study. The ancillary study can address any research questions related to the mission of NHLBI for which the parent study can provide participants, infrastructure, and data. The parent studies most often will be a clinical trial, but also can be an observational study or registry that can provide a sufficient cohort of well-characterized patients. Each ancillary study application must demonstrate the time-sensitive nature of the application and must explicitly address why an expedited review is essential to its feasibility. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-003.html</GuideLink>
<RelDate>2011-12-07</RelDate>
<IntentDate>April 24, 2012; August 24, 2012; December 24, 2012</IntentDate>
<AppReceiptDate><![CDATA[May 24, 2012; September 24, 2012; January 24, 2013]]></AppReceiptDate>
<LARD>2013-01-24</LARD>
<FileName>RFA-HL-13-003.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-003</DocNum>
<ExpirationDate>2013-01-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19772</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Advanced Neural Prosthetics Research and Development (U01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and pilot clinical studies for neural prosthetics. The program will utilize the cooperative agreement mechanism to enable support for milestone-driven projects for the development and demonstration of clinically-useful neural prosthetic devices. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for clinical study, and proof-of-concept or pilot clinical studies.   
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>1000000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-053.html</GuideLink>
<RelDate>2011-12-08</RelDate>
<IntentDate>One month prior to application due date.</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-053.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-053</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19773</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[Advanced Neural Prosthetics Research and Development (SBIR [U44])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to pursue translational and pilot clinical studies for neural prosthetics. The program will utilize the cooperative agreement mechanism to enable support for milestone-driven projects for the development and demonstration of clinically-useful neural prosthetic devices. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for clinical study, and proof-of-concept or pilot clinical studies. ]]></Purpose>
<RelNote/><ActivityCodes>U44</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-054.html</GuideLink>
<RelDate>2011-12-08</RelDate>
<IntentDate>One month prior to application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-054.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-054</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19775</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Limited Competition: Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54)]]></Title>
<Purpose><![CDATA[The National Cancer Institute (NCI) invites cooperative agreement (U54) applications for the implementation of Comprehensive Partnerships between institutions serving communities with cancer health disparities and NCI-designated Cancer Centers (or groups of Centers). The purpose of this limited competition funding opportunity announcement (FOA) is to foster and support intensive collaborations among investigators at institutions that serve communities with cancer health disparities in order to develop stronger national cancer programs aimed at understanding the reasons behind the significant cancer disparities and related impacts on these populations. This FOA is intended for: (1) supporting active Comprehensive Partnerships under the U54 mechanism; and (2) elevating the most promising partnerships currently in the planning phase (U56 awards) to the comprehensive status.
]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-055.html</GuideLink>
<RelDate>2011-12-09</RelDate>
<IntentDate>December 27, 2011; December 28, 2012; December 28, 2013</IntentDate>
<AppReceiptDate><![CDATA[January 27, 2012; January 28, 2013, January 28, 2014]]></AppReceiptDate>
<LARD>2014-01-28</LARD>
<FileName>PAR-12-055.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-055</DocNum>
<ExpirationDate>2014-01-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19779</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Enhancing Developmental Biology Research at Undergraduate Institutions Academic Research Enhancement Award (R15)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages grant applications to strengthen the developmental biology research environment at educational institutions that provide baccalaureate or advanced degrees, but that have not been major recipients of NIH support. In addition, this FOA attempts to foster the development of novel or underutilized experimental model systems, and to motivate students through exposure to and participation in research projects designed to study fundamental processes underlying normal development. 
]]></Purpose>
<RelNote/><ActivityCodes>R15</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-057.html</GuideLink>
<RelDate>2011-12-12</RelDate>
<IntentDate>30 days before application due date</IntentDate>
<AppReceiptDate><![CDATA[September 10, 2012, September 10, 2013, September 10, 2014]]></AppReceiptDate>
<LARD>2014-09-10</LARD>
<FileName>PAR-12-057.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-057</DocNum>
<ExpirationDate>2014-09-11</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19784</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<Title><![CDATA[Solicitation of Validated Hits for the Discovery of in vivo Chemical Probes (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes. It is expected that applicants will have in hand the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. 

Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms.  Emphasis will be placed on assays that provide new insight into important disease targets and processes..
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-060.html</GuideLink>
<RelDate>2011-12-13</RelDate>
<IntentDate>30 days prior to the anticipated application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-12-060.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-060</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19785</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<Title><![CDATA[Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages investigators to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement HTS-ready assays for the discovery and development of small molecule chemical probes.

Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms.  Emphasis will be placed on assays that provide new insight into important disease targets and processes. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-059.html</GuideLink>
<RelDate>2011-12-13</RelDate>
<IntentDate>30 days prior to the anticipated application due date. </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-12-059.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-059</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19786</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages investigators to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement HTS-ready assays for the discovery and development of small molecule chemical probes.

Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms.  Emphasis will be placed on assays that provide new insight into important disease targets and processes..
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-058.html</GuideLink>
<RelDate>2011-12-13</RelDate>
<IntentDate>30 days prior to the anticipated application due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2014-09-07</LARD>
<FileName>PAR-12-058.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-058</DocNum>
<ExpirationDate>2014-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19797</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<Title><![CDATA[Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research encourages R01 applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-061.html</GuideLink>
<RelDate>2011-12-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-061.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-061</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19756</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[NCI Mentored Research Scientist Development Award to Promote Diversity (K01) ]]></Title>
<Purpose><![CDATA[The purpose of the NCI Mentored Research Scientist Development Award (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Awards are not renewable and they are not transferable from one principal investigator (PI) to another. The Diversity Training Branch (DTB) of the Center to Reduce Cancer Health Disparities (CRCHD), at the National Cancer Institute (NCI), invites career development award applications (K01) from individuals representative of groups that have been shown to be underrepresented in health-related science, who have been recipients of an NIH Research Supplement to Promote Diversity Award, any Ruth L. Kirschstein National Research Service Award (individual F31/F32 or institutional T32), or can demonstrate that they have been supported in a mentored capacity within any research grant equivalent to an NIH peer-reviewed research grant (e.g., American Cancer Society [ACS] research grant).  Candidates with clinical degrees (e.g., MD) may wish to consider the NCI Mentored Clinical Scientist Award to Promote Diversity Award (K08) and candidates interested in patient-oriented research may wish to consider the NCI Mentored Patient-Oriented Research to Promote Diversity Award (K23) as more appropriate alternatives relative to their stage of development and career goals. 
]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-050.html</GuideLink>
<RelDate>2011-12-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-050.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-050</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19757</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)]]></Title>
<Purpose><![CDATA[The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented cancer research[POR]. The NCI's Diversity Training Branch (DTB) and the Center to Reduce Cancer Health Disparities (CRCHD) announce the availability of the "Mentored Patient-Oriented Research Award to Promote Diversity" for career development of individuals with a health professional doctoral degree from groups currently underrepresented on a national level in the biomedical, clinical, behavioral, and social sciences. The NCI recognizes a unique and compelling need to promote diversity in the patient-oriented research workforce. 
]]></Purpose>
<RelNote/><ActivityCodes>K23</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-052.html</GuideLink>
<RelDate>2011-12-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-052.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-052</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19762</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08)]]></Title>
<Purpose><![CDATA[The primary purpose of the NCI Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. This NCI-sponsored K08 award is specifically designed to promote career development of clinical scientists from diverse backgrounds that have been shown to be underrepresented in health-related science and for those who are committed to a career in  basic biomedical, behavioral or translational cancer research, including research on cancer health disparities. 
]]></Purpose>
<RelNote/><ActivityCodes>K08</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-051.html</GuideLink>
<RelDate>2011-12-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-051.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-051</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19803</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Partnerships for Development of Therapeutics and Diagnostics for Biodefense (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), invites research applications for projects that support preclinical development of lead candidate therapeutics or diagnostics against NIAID Category A, B, or C priority agents. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>750000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-017.html</GuideLink>
<RelDate>2011-12-16</RelDate>
<IntentDate>April 24, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-05-24</LARD>
<FileName>RFA-AI-12-017.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-017</DocNum>
<ExpirationDate>2012-05-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19806</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[The NCI Transition Career Development Award to Promote Diversity (K22)]]></Title>
<Purpose><![CDATA[The purpose of the National Cancer Institute (NCI) Career Transition Award (K22) is to help ensure that a diverse pool of highly trained scientists are available in adequate numbers and in appropriate research areas to address the nation's biomedical, behavioral, and clinical research needs. The Diversity Training Branch (DTB), the Center to Reduce Cancer Health Disparities (CRCHD) (http://crchd.cancer.gov/) invites applications from recipients of the NCI Mentored Career Development Award to Promote Diversity, or from advanced postdoctoral and/or newly independent research scientists representative of groups that are underrepresented in biomedical, behavioral, clinical, and/or social sciences (see Section III, Eligible Individuals). This award will provide "protected time" for recipients to develop and receive support for their initial cancer research program. In addition, this award can provide a two-year mentored experience in NCI intramural programs for interested individuals. 
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-062.html</GuideLink>
<RelDate>2011-12-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-062.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-062</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19808</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Research Dissemination and Implementation Grants (R18)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to support dissemination and implementation studies to 1) develop innovative approaches to translating efficacious treatments and effective prevention modalities for heart, lung, and blood diseases and sleep disorders to the clinic, community, and/or other real-world settings; 2) test the effectiveness, sustainability, determinants, and cost-effectiveness of these approaches in real-world settings; and 3) examine the effectiveness of interventions as they are disseminated and implemented in real-world settings to reduce risk factors for and enhance prevention and treatment of heart, lung, and blood diseases and sleep disorders.]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-063.html</GuideLink>
<RelDate>2011-12-16</RelDate>
<IntentDate>30 days before the application due date. </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-05-07</LARD>
<FileName>PAR-12-063.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-063</DocNum>
<ExpirationDate>2013-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19810</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies through technical/analytical validation in an appropriate cancer-relevant biological system or context. An emerging technology is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits projects where proof-of-principle of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a major impact in a broad area of cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation as non-responsive and will not be reviewed. 

]]></Purpose>
<RelNote/><ActivityCodes>R33</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-003.html</GuideLink>
<RelDate>2011-12-21</RelDate>
<IntentDate>January 23, 2012, April 21, 2012, August 18, 2012</IntentDate>
<AppReceiptDate><![CDATA[February 23, 2012; May 21, 2012; September 18, 2012]]></AppReceiptDate>
<LARD>2012-09-18</LARD>
<FileName>RFA-CA-12-003.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-CA-12-003</DocNum>
<ExpirationDate>2012-09-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19811</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Innovative and Early-Stage Development of Emerging Technologies in Biospecimen Science (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing technically innovative feasibility studies focused on early stage development of technologies that address issues related to pre-analytical variations in the collection, processing, handling, and storage of cancer-relevant biospecimens or their derivatives. The overall goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or samples derived from those biospecimens for downstream molecular analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to potentially accelerate and/or enhance research in cancer biology, prevention, diagnosis, treatment, epidemiology, and cancer health disparities, by reducing pre-analytical variations that affect biospecimen and/or sample quality. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). 

]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-004.html</GuideLink>
<RelDate>2011-12-21</RelDate>
<IntentDate>January 23, 2012; April 21, 2012; August 18, 2012</IntentDate>
<AppReceiptDate><![CDATA[February 23, 2012; May 21, 2012; September 18, 2012]]></AppReceiptDate>
<LARD>2012-09-18</LARD>
<FileName>RFA-CA-12-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-CA-12-004</DocNum>
<ExpirationDate>2012-09-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19812</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Early-Stage Innovative Technology Development for Cancer Research (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing exploratory research projects focused on the inception and development of early stage, highly innovative, technologies or emerging technologies with significant transformative potential that has not yet been explored in a cancer-relevant use. An emerging technology is defined (for the purpose of this FOA) as one that has passed the initial developmental stage, but has not yet been evaluated within the context of a cancer-relevant intended use and requires significant modification for the proposed application. The emphasis of this FOA is on technologies with a high degree of technical innovation with the potential to significantly affect and transform investigations exploring the molecular and cellular bases of cancer. If successful, these technologies would accelerate and/or enhance research in the areas of cancer biology, prevention, diagnosis and treatment, control, epidemiology, and/or cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be based on molecular and/or cellular characterizations of cancer.

]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-002.html</GuideLink>
<RelDate>2011-12-21</RelDate>
<IntentDate>January 23, 2012, April 21, 2012, August 18, 2012</IntentDate>
<AppReceiptDate><![CDATA[February 23, 2012; May 21, 2012; September 18, 2012]]></AppReceiptDate>
<LARD>2012-09-18</LARD>
<FileName>RFA-CA-12-002.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-CA-12-002</DocNum>
<ExpirationDate>2012-09-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19814</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[NCI Established Investigator Award in Cancer Prevention and Control (K05)]]></Title>
<Purpose><![CDATA[The purpose of the NCI Established Investigator Award in Cancer Prevention and Control (K05) is to provide protected time to senior investigators with exceptional mentoring records and sustained, high levels of research productivity in cancer prevention, cancer control, or the behavioral or population sciences to devote to research and mentoring.
]]></Purpose>
<RelNote/><ActivityCodes>K05</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-065.html</GuideLink>
<RelDate>2011-12-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-065.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-065</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19815</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing technically innovative feasibility studies focused on the advanced development and validation of cancer-relevant technologies that address issues related to pre-analytical variations in the collection, processing, handling, and storage of biospecimens or their derivatives. The overall goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or their derived samples for downstream molecular analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. This FOA solicits R33 applications; this mechanism is suitable for projects where proof-of-principle of the proposed technology or methodology has already been established and supportive preliminary data are available. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation as non-responsive and will not be reviewed.]]></Purpose>
<RelNote/><ActivityCodes>R33</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-005.html</GuideLink>
<RelDate>2011-12-21</RelDate>
<IntentDate>January 23, 2012, April 21, 2012, August 18, 2012</IntentDate>
<AppReceiptDate><![CDATA[February 23, 2012; May 21, 2012; September 18, 2012]]></AppReceiptDate>
<LARD>2012-09-18</LARD>
<FileName>RFA-CA-12-005.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-CA-12-005</DocNum>
<ExpirationDate>2012-09-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19817</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Network and Infrastructure Support for Development of Interdisciplinary Aging Research (R24)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to provide network and infrastructure support to foster development of novel interdisciplinary research approaches on important topics in aging research. This FOA will use the NIH Resource-Related Research Project (R24) mechanism to facilitate research networks that will advance specific scientific goals through activities such as meetings, conferences, small scale pilots, short term training opportunities, and visiting scholar programs, and dissemination activities to encourage growth and development in these interdisciplinary areas.
]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-064.html</GuideLink>
<RelDate>2011-12-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-064.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-064</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19826</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Imaging - Science Track Award for Research Transition (I/START) [R03]
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) issued by the National Institute on Drug Abuse encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-066.html</GuideLink>
<RelDate>2011-12-21</RelDate>
<IntentDate>30 days prior to the application due date</IntentDate>
<AppReceiptDate/><LARD>2015-01-07</LARD>
<FileName>PAR-12-066.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-066</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19831</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Limited Competition: Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71) 
]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage institutions in low-and middle-income countries (LMIC) to submit an application for a planning grant under the Fogarty HIV Research Training Program.  This program supports research training that will strengthen the HIV research capacity of institutions in low-and middle-income countries (LMIC).  The planning grant application must propose a plan to develop the components necessary for an application for a research training program to submit in response to D43 FOA (PAR-12-068 for D43 FOA). In developing an application for a planning grant, applicants need to be familiar with the objectives and special requirements of the research training program as defined in the D43 FOA.  
]]></Purpose>
<RelNote/><ActivityCodes>D71</ActivityCodes>
<FA_DirectCosts>28000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-070.html</GuideLink>
<RelDate>2011-12-22</RelDate>
<IntentDate>June 24, 2012, June 24, 2013, June 24, 2014 </IntentDate>
<AppReceiptDate><![CDATA[July 24, 2012, July 24, 2013, July 24, 2014]]></AppReceiptDate>
<LARD>2014-07-24</LARD>
<FileName>PAR-12-070.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-070</DocNum>
<ExpirationDate>2014-07-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19833</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D43)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage applications for research training programs to strengthen the HIV research capacity at low- and middle-income country (LMIC) institutions. Each application should propose a training program that will build or strengthen research capacity in an applicant-defined HIV-related scientific topic at an identified LMIC institution. 

Current AITRP and Phase II ICOHRTA AIDS TB award institutions are not eligible to submit applications under this FOA until the last year of their current AITRP or Phase II ICOHRTA AIDS TB project period.

U.S. Institutions must have on-going HIV research collaborations with the LMIC institution named in their application to be eligible to apply.]]></Purpose>
<RelNote/><ActivityCodes>D43</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-068.html</GuideLink>
<RelDate>2011-12-22</RelDate>
<IntentDate>June 24, 2012, June 24, 2013, June 24, 2014 </IntentDate>
<AppReceiptDate><![CDATA[July 24, 2012, July 24, 2013, July 24, 2014]]></AppReceiptDate>
<LARD>2014-07-24</LARD>
<FileName>PAR-12-068.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-068</DocNum>
<ExpirationDate>2014-07-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19834</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)]]></Title>
<Purpose><![CDATA[The purpose of the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) is to support the career development of junior investigators with research or health professional doctoral degrees who want to become cancer-focused academic researchers in cancer prevention, cancer control, or the behavioral or population sciences. 
]]></Purpose>
<RelNote/><ActivityCodes>K07</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-067.html</GuideLink>
<RelDate>2011-12-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-067.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-067</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19835</rowid>
<PrimaryIC><![CDATA[FIC]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Training Programs for Critical HIV Research Infrastructure for Low- and Middle-Income Country Institutions (G11) ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage U.S. institutions with research collaborations at low-and middle-income country (LMIC) institutions to submit applications for training programs to strengthen the leadership and expertise in selected critical research infrastructure areas at their collaborating LMIC institutions.  This FOA can support training related to technical expertise, administration and financial management in support of:

]]></Purpose>
<RelNote/><ActivityCodes>G11</ActivityCodes>
<FA_DirectCosts>92000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-069.html</GuideLink>
<RelDate>2011-12-22</RelDate>
<IntentDate>June 24, 2012, June 24, 2013, June 24, 2014 </IntentDate>
<AppReceiptDate><![CDATA[July 24, 2012, July 24, 2013, July 24, 2014]]></AppReceiptDate>
<LARD>2014-07-24</LARD>
<FileName>PAR-12-069.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-069</DocNum>
<ExpirationDate>2014-07-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19728</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Small Grants for Behavioral Research in Cancer Control (R03)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the NCI, invites investigator-initiated Small Research Grant (R03) applications for research projects that can be carried out in a short period of time with limited resources in behavioral research in cancer prevention and control. This FOA is designed to enhance basic and applied behavioral sciences research in the context of cancer control, with a secondary goal of attracting new investigators to the field from a variety of biomedical, behavioral and public health disciplines. Proposed research projects would include pilot or feasibility studies, secondary analyses of existing data, and meta-analyses particularly in the areas of: (1) basic biobehavioral and psychological services, (2) behavioral genetics, (3) cancer survivorship and bereavement, (4) health behaviors, (5) health communication and informatics, (6) health disparities, (7) processes of cancer care including delivery and utilization, and (8) tobacco control. ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-035.html</GuideLink>
<RelDate>2011-12-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[February 17, 2012; June 19, 2012; October 18, 2012]]></AppReceiptDate>
<LARD>2012-10-18</LARD>
<FileName>PAR-12-035.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-035</DocNum>
<ExpirationDate>2012-10-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19837</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Mental Health (NIMH), seeks to support collaborative preliminary intervention studies to evaluate the feasibility, tolerability, acceptability and safety of novel mechanism drug candidates, promising investigational new drugs (INDs), or novel psychosocial strategies for the treatment of mental disorders and for obtaining the preliminary data needed as a pre-requisite to larger-scale (efficacy or effectiveness) intervention or services studies. This FOA should be used when at least two but no more than three sites from different Institutions/Organizations are needed to complete the study. The collaborating studies should be organized in order to increase sample size, accelerate recruitment, and/or increase sample diversity and representation. For a linked set of collaborative R34s, each site shall have its own Program Director/Principal Investigator and provide for a mechanism for cross-site coordination, quality control, database management, statistical analysis, and reporting. 
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-071.html</GuideLink>
<RelDate>2012-01-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-071.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-071</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19840</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54)]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to announce the re-competition of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (SCCPIR).  The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) provides funding for a limited number of research centers in the reproductive sciences.  These centers provide an arena for multidisciplinary interactions between basic and clinical scientists interested in establishing high quality translational research programs in the area of reproductive health and infertility.  The centers also serve as a national resource for the training and career development of new scientists electing to pursue careers conducting translational research in high priority areas of reproduction and infertility.  Finally, center investigators are expected to participate in important community outreach and education efforts to increase awareness and convey the importance and implications of their research activities to the general public.
]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-13-005.html</GuideLink>
<RelDate>2012-01-04</RelDate>
<IntentDate>May 27, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-27</LARD>
<FileName>RFA-HD-13-005.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HD-13-005</DocNum>
<ExpirationDate>2012-06-28</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19849</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Minor Use Minor Species Development of Drugs; Research Project Grant (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions/organizations that propose to develop, or support the development of, new animal drugs intended for minor use in major species or intended for use in minor species.  Only new animal drug products that have been designated in accordance with the provisions of section 573 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR Part 516 are eligible for grants.  FDA is authorized to provide grants for designated new animal drugs to assist in defraying the costs of qualified safety and effectiveness testing.  This FOA relates to grants to assist in defraying the costs of qualified safety and effectiveness testing when a grant will either result in, or substantially contribute to, approval or conditional approval of a designated MUMS drug for a designated intended use.  Applicants must include an explanation of how the proposed study will help gain product approval or conditional approval in the applications Background and Significance section.  All funded studies are subject to the requirements of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 331 et seq.), regulations issued under it, and applicable Department of Health and Human Services (HHS) statutes and regulations.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-003.html</GuideLink>
<RelDate>2012-01-06</RelDate>
<IntentDate>February 17, 2012; July 20, 2012; December 07, 2012; July 26, 2013; December 06, 2013; July 18, 2014; December 05, 2014</IntentDate>
<AppReceiptDate/><LARD>2014-12-05</LARD>
<FileName>RFA-FD-12-003.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-003</DocNum>
<ExpirationDate>2014-12-06</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19861</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Competing Renewal Awards of SBIR Phase II (Phase IIB) Grants (SBIR [R44])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects requiring approval from a Federal regulatory agency. The FOA aims to facilitate the transition of previously funded SBIR Phase II projects to the commercialization stage by promoting partnerships between NIHs SBIR awardees and third-party investors and/or strategic partners. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all SBIR Phase II applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will equal or exceed the NINDS funds being requested throughout the SBIR Phase IIB project period.   ]]></Purpose>
<RelNote/><ActivityCodes>R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-077.html</GuideLink>
<RelDate>2012-01-11</RelDate>
<IntentDate>One month prior to application due date</IntentDate>
<AppReceiptDate><![CDATA[August 5, 2012 and August 5, 2013
AIDS Date: September 7, 2012 and September 7, 2013]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-12-077.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-077</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19862</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Competing Renewal Awards of STTR Phase II (Phase IIB) Grants (STTR [R42])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA)  encourages Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects requiring approval from a Federal regulatory agency. The FOA aims to facilitate the transition of previously funded STTR Phase II projects to the commercialization stage by promoting partnerships between NIHs STTR awardees and third-party investors and/or strategic partners. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all STTR Phase II applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NINDS funds being requested throughout the STTR Phase IIB project period.  ]]></Purpose>
<RelNote/><ActivityCodes>R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-076.html</GuideLink>
<RelDate>2012-01-11</RelDate>
<IntentDate>One month prior to application due date</IntentDate>
<AppReceiptDate><![CDATA[August 5, 2012 and August 5, 2013; 
AIDS Date: September 7, 2012 and September 7, 2013 ]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-12-076.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-076</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19863</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Competing Renewal Awards of SBIR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (SBIR [R44])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support exploratory clinical trials for projects that were previously funded by NIH SBIR Phase II awards. The trials must focus on products related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS) and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies.  Since conducting the clinical trials needed for commercialization may be capital-intensive, the FOA aims to facilitate the transition of SBIR Phase II projects to the commercialization stage by promoting partnerships between NIHs SBIR awardees and third-party investors and/or strategic partners. ]]></Purpose>
<RelNote/><ActivityCodes>R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-075.html</GuideLink>
<RelDate>2012-01-11</RelDate>
<IntentDate>One month prior to application due date</IntentDate>
<AppReceiptDate><![CDATA[August 5, 2012 and August 5, 2013
AIDS: September 7, 2012 and September 7, 2013]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-12-075.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-075</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19864</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Competing Renewal Awards of STTR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (STTR [R42])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that seek additional funding to support exploratory clinical trials for projects that were previously funded by NIH STTR Phase II awards. The trials must focus on products related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS) and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies.  Since conducting the clinical trials needed for commercialization may be capital-intensive, the FOA aims to facilitate the transition of STTR Phase II projects to the commercialization stage by promoting partnerships between NIHs STTR awardees and third-party investors and/or strategic partners. ]]></Purpose>
<RelNote/><ActivityCodes>R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-074.html</GuideLink>
<RelDate>2012-01-11</RelDate>
<IntentDate>One month prior to application due date</IntentDate>
<AppReceiptDate><![CDATA[August 5, 2012 and August 5, 2013
AIDS: September 7, 2012 and September 7, 2013 ]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-12-074.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-074</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19865</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Exploratory Clinical Trials for Small Business (SBIR [R44])]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS).  The trials must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics as well as surgical, behavioral or rehabilitation therapies. Only Phase II and Fast-Track applications are supported under this program. Phase I applications are only accepted as part of a Fast-track application. 
]]></Purpose>
<RelNote/><ActivityCodes>R44</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-073.html</GuideLink>
<RelDate>2012-01-11</RelDate>
<IntentDate>One month prior to application due date </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-073.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-073</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19866</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Exploratory Clinical Trials for Small Business (STTR [R42])]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS).  The trials must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics as well as surgical, behavioral or rehabilitation therapies. Only Phase II and Fast-Track applications are supported under this program. Phase I applications are only accepted as part of a Fast-track application. 
]]></Purpose>
<RelNote/><ActivityCodes>R42</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-072.html</GuideLink>
<RelDate>2012-01-11</RelDate>
<IntentDate>One month prior to application due date </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-072.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-072</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19870</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Biodemography of Aging (R03)]]></Title>
<Purpose><![CDATA[Biodemography, the integration of demographic and biological theory and methods, provides an innovative tool for understanding the impact of aging on health and longevity.  This FOA encourageapplications for research combining demographic and life-science approaches for expanding the current understanding of aging/senescence, frailty and mortality.  Applications should include evolutionary and life history theories as a framework for investigating individual and population-level factors that underlie changes in lifespan and healthy life expectancy, including sex and population differentials in late-life frailty and mortality.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-080.html</GuideLink>
<RelDate>2012-01-13</RelDate>
<IntentDate>February 13, 2012, February 1, 2013, February 3, 2014 </IntentDate>
<AppReceiptDate><![CDATA[March 13, 2012, March 1, 2013, March 3, 2014]]></AppReceiptDate>
<LARD>2014-03-03</LARD>
<FileName>PAR-12-080.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-080</DocNum>
<ExpirationDate>2014-03-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19871</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Biodemography of Aging (R21)]]></Title>
<Purpose><![CDATA[Biodemography, the integration of demographic and biological theory and methods, provides an innovative tool for understanding the impact of aging on health and longevity.  This FOA encourageapplications for research combining demographic and life-science approaches for expanding the current understanding of aging/senescence, frailty and mortality.  Applications should include evolutionary and life history theories as a framework for investigating individual and population-level factors that underlie changes in lifespan and healthy life expectancy, including sex and population differentials in late-life frailty and mortality. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-079.html</GuideLink>
<RelDate>2012-01-13</RelDate>
<IntentDate>February 13, 2012, February 1, 2013, February 3, 2014</IntentDate>
<AppReceiptDate><![CDATA[March 13, 2012, March 1, 2013, March 3, 2014]]></AppReceiptDate>
<LARD>2014-03-03</LARD>
<FileName>PAR-12-079.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-079</DocNum>
<ExpirationDate>2014-03-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19872</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Biodemography of Aging (R01)]]></Title>
<Purpose><![CDATA[Biodemography, the integration of demographic and biological theory and methods, provides an innovative tool for understanding the impact of aging on health and longevity.  This FOA encourageapplications for research combining demographic and life-science approaches for expanding the current understanding of aging/senescence, frailty and mortality.  Applications should include evolutionary and life history theories as a framework for investigating individual and population-level factors that underlie changes in lifespan and healthy life expectancy, including sex and population differentials in late-life frailty and mortality.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-078.html</GuideLink>
<RelDate>2012-01-13</RelDate>
<IntentDate>February 13, 2012, February 1, 2013, February 3, 2014</IntentDate>
<AppReceiptDate><![CDATA[March 13, 2012, March 1, 2013, March 3, 2014]]></AppReceiptDate>
<LARD>2014-03-03</LARD>
<FileName>PAR-12-078.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-078</DocNum>
<ExpirationDate>2014-03-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19875</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1) ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage submission of applications for the Leadership Group for a Clinical Research Network on Antibacterial Resistance.  The Leadership Group (LG) will have overall responsibility for designing, prioritizing, implementing and managing the networks clinical research agenda to address antibacterial resistance (AR) scientific priorities.  Applications for the LG must include an overview component and three functional components: a Leadership and Operations Center (LOC), a Laboratory Center (LC) and a Statistics and Data Management Center (SDMC).  
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-019.html</GuideLink>
<RelDate>2012-01-13</RelDate>
<IntentDate>May 2, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-01</LARD>
<FileName>RFA-AI-12-019.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-019</DocNum>
<ExpirationDate>2012-06-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19877</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R21)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN). The majority of acquired peripheral neuropathy research has focused on diabetic and inherited diseases; this FOA intends to stimulate neuroscience researchers to apply their expertise from studying these other neuropathies to the injuries incurred by cancer treatments. More data is necessary to understand the mechanisms of neuronal damage and to identify the targets instrumental to CIPN initiation and maintenance. Preclinical research that focuses not only on peripheral neuropathic pain but also on neurosensory symptoms such as paresthesias and peripheral anesthesias is invited. The ultimate goal of this FOA is to lead to a molecular understanding of CIPN that allows for the rational development of interventions that will treat or prevention CIPN. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-083.html</GuideLink>
<RelDate>2012-01-17</RelDate>
<IntentDate>May 16, 2012</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-083.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-083</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19878</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN). The majority of acquired peripheral neuropathy research has focused on diabetic and inherited diseases; this FOA intends to stimulate neuroscience researchers to apply their expertise from studying these other neuropathies to the injuries incurred by cancer treatments. More data is necessary to understand the mechanisms of neuronal damage and to identify the targets instrumental to CIPN initiation and maintenance. Preclinical research that focuses not only on peripheral neuropathic pain but also on neurosensory symptoms such as paresthesias and peripheral anesthesias is invited. The ultimate goal of this FOA is to lead to a molecular understanding of CIPN that allows for the rational development of interventions that will treat or prevention CIPN. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-082.html</GuideLink>
<RelDate>2012-01-17</RelDate>
<IntentDate>May 5, 2012</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-082.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-082</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19888</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Targeting Inflammation and Immune Activation in HIV Disease (U01)]]></Title>
<Purpose><![CDATA[This FOA solicits applications that propose small proof-of-concept clinical trials, with concurrent intensive laboratory studies, designed to evaluate the effect of an intervention on chronic immune activation or persistent inflammation in HIV-infected individuals who are taking effective antiretroviral therapy. The intervention must have a known mechanism of action. The goal of this initiative is to identify specific mechanisms or pathways that can be targeted to prevent or reverse persistent immune activation in HIV-infected individuals.  
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-007.html</GuideLink>
<RelDate>2012-01-20</RelDate>
<IntentDate>June 13, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-13</LARD>
<FileName>RFA-AI-12-007.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-007</DocNum>
<ExpirationDate>2012-07-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19899</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32)]]></Title>
<Purpose><![CDATA[The Jointly Sponsored NIH Predoctoral Training Program in the Neurosciences supports broad and fundamental research training in the neurosciences via institutional NRSA research training grants (T32) at domestic institutions of higher education. Trainees appointed to this training grant are financially supported for either one or two years, during the first 2 years of their graduate research training. The primary objective is to prepare individuals for careers in neuroscience that have a significant impact on the health-related research needs of the Nation.
]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-084.html</GuideLink>
<RelDate>2012-01-24</RelDate>
<IntentDate>April 25, 2012, April 25, 2013, April 25, 2014 </IntentDate>
<AppReceiptDate><![CDATA[May 25, 2012, May 25, 2013, and May 25, 2014]]></AppReceiptDate>
<LARD>2014-05-25</LARD>
<FileName>PAR-12-084.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-084</DocNum>
<ExpirationDate>2014-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19911</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Nutrition Obesity Research Centers (P30)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, invites grant applications from institutions/organizations that propose to establish core centers that are part of an integrated program of nutrition and/or obesity-research. The Nutrition Obesity Research Center (NORC) program is based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner.  Each proposed NORC must be organized around central themes that reflect the nutrition and/or obesity research focus of the center members.
]]></Purpose>
<RelNote/><ActivityCodes>P30</ActivityCodes>
<FA_DirectCosts>750000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-004.html</GuideLink>
<RelDate>2012-01-26</RelDate>
<IntentDate>May 29, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-29</LARD>
<FileName>RFA-DK-12-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DK-12-004</DocNum>
<ExpirationDate>2012-06-30</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19914</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Competing Revisions for Macromolecular Interactions in Cells (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to diversify and extend the scope and capabilities of currently funded NIGMS R01 and R37 projects for studies on macromolecular interactions and their relationship to function in cells.  This FOA solicits competitive revisions (formerly called "competing supplements") of currently funded NIGMS grants specializing in the analysis of molecular systems and mechanisms in live organelles, cells, tissues, or organisms.  Applicants may increase their budgets to extend the scientific scope of their projects or to add new approaches that enhance their capabilities for research on macromolecular interactions in cells.  Collaboration is not a requirement of this initiative, but applicants may request support for collaboration (including subcontracts) with investigators who have complementary expertise  Support for access of modestly funded laboratories to experimental approaches and research objectives that are otherwise financially out of reach is one priority of this FOA. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>80000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-13-003.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>February 26, 2012, September 18, 2012</IntentDate>
<AppReceiptDate><![CDATA[March 26, 2012, October 18, 2012]]></AppReceiptDate>
<LARD>2012-10-18</LARD>
<FileName>RFA-GM-13-003.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-GM-13-003</DocNum>
<ExpirationDate>2012-10-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19915</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Leadership Group for a Clinical Research Network on Vaccines to Prevent HIV infection (UM1) 
]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to solicit applications for the Leadership Group for a Clinical Research Network on Vaccines to Prevent HIV Infection.  The Leadership Group (LG) will have overall responsibility for developing, implementing and adapting the networks clinical research agenda to address NIAIDs HIV/AIDS scientific priorities described below (Part 2, Section I, #3). Applications for the LG must be comprised of three separate linked UM1 applications: a Leadership and Operations Center (LOC), a Laboratory Center (LC) and a Statistical and Data Management Center (SDMC).
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-012.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>August 28, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-28</LARD>
<FileName>RFA-AI-12-012.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-012</DocNum>
<ExpirationDate>2012-09-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19916</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Leadership Group for a Clinical Research Network on Integrated Strategies to Prevent HIV Infection (UM1)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to solicit applications for the Leadership Group for a Clinical Research Network on Integrated Strategies to Prevent HIV Infection. The Leadership Group (LG) will have overall responsibility for developing, implementing and adapting the networks clinical research agenda to address NIAIDs HIV/AIDS scientific priorities described below (Part 2, Section I, #3). Applications for the LG must be comprised of three separate linked UM1 applications: a Leadership and Operations Center (LOC), a Laboratory Center (LC) and a Statistical and Data Management Center (SDMC).
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-011.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>August 28, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-28</LARD>
<FileName>RFA-AI-12-011.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-011</DocNum>
<ExpirationDate>2012-09-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19917</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Leadership Group for a Clinical Research Network on Microbicides to Prevent HIV Infection (UM1)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to solicit applications for the Leadership Group for a Clinical Research Network on Microbicides to Prevent HIV Infection.  The Leadership Group (LG) will have overall responsibility for developing, implementing and adapting the networks clinical research agenda to address NIAIDs HIV/AIDS scientific priorities described below (Part 2, Section I, #3). Applications for the LG must be comprised of three separate linked UM1 applications: a Leadership and Operations Center (LOC), a Laboratory Center (LC) and a Statistical and Data Management Center (SDMC).
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-008.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>August 28, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-28</LARD>
<FileName>RFA-AI-12-008.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-008</DocNum>
<ExpirationDate>2012-09-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19918</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Leadership Group for a Clinical Research Network on Therapeutics for HIV/AIDS and HIV-associated Infections in Adults (UM1)
 ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage applications for the Leadership Group for a Clinical Research Network on Therapeutics for HIV/AIDS and HIV-associated Infections in Adults.   The Leadership Group (LG) will have overall responsibility for developing, implementing and adapting the networks clinical research agenda to address NIAIDs HIV/AIDS scientific priorities described below (Part 2, Section I, #3). Applications for the LG must be comprised of three separate linked UM1 applications: a Leadership and Operations Center (LOC), a Laboratory Center (LC) and a Statistical and Data Management Center (SDMC).
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-004.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>August 28, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-28</LARD>
<FileName>RFA-AI-12-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-004</DocNum>
<ExpirationDate>2012-09-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19919</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Leadership Group for a Clinical Research Network on HIV/AIDS and HIV-associated Infections in Pediatric and Maternal Populations (UM1)  ]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to solicit applications for the Leadership Group for a Clinical Research Network on HIV/AIDS and HIV-associated Infections in Pediatric and Maternal Populations.  The Leadership Group (LG) will have overall responsibility for developing, implementing and adapting the networks clinical research agenda to address NIAIDs HIV/AIDS scientific priorities described below (Part 2, Section I, #3). Applications for the LG must be comprised of three separate linked UM1 applications: a Leadership and Operations Center (LOC), a Laboratory Center (LC) and a Statistical and Data Management Center (SDMC).
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-001.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>August 28, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-28</LARD>
<FileName>RFA-AI-12-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-001</DocNum>
<ExpirationDate>2012-09-29</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19926</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Cutting-Edge Basic Research Awards (CEBRA) (R21)
]]></Title>
<Purpose><![CDATA[The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them. It supports research that is high-risk and potentially high-impact that is underrepresented or not included in NIDA's current portfolio. The proposed research should: (1) test a highly novel and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would have a substantial impact on current thinking; and/or (2) develop or adapt innovative techniques or methods for addiction research, or that have promising future applicability to drug abuse research.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>125000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-086.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[August 20, 2012; December 20, 2012; August 20, 2013, December 20, 2013, August 20, 2014, and December 19, 2014 ]]></AppReceiptDate>
<LARD>2014-12-19</LARD>
<FileName>PAR-12-086.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-086</DocNum>
<ExpirationDate>2014-12-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19898</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<Title><![CDATA[NIBIB Research Education Programs for Residents and Clinical Fellows (R25)]]></Title>
<Purpose><![CDATA[This FOA  encouragesResearch Education Grant (R25) applications from institutions/organizations that propose to support the development and/or implementation of programs that relate to the research education and training of residents and clinical fellows to foster their careers as clinician-scientists. The PD(s)/PI(s) (see below) must have a faculty appointment in a Department of Radiology and the participants in this research education program must be residents and clinical fellows in programs including, but not limited to, cardiology, neurology, orthopaedics, ophthalmology, radiology, or surgery (see Eligible Individuals). The NIH recognizes a unique and compelling need to promote diversity in the biomedical, behavioral, clinical and social sciences research workforce. ]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-085.html</GuideLink>
<RelDate>2012-01-27</RelDate>
<IntentDate>April 23, 2012; April 23, 2013; April 23, 2014</IntentDate>
<AppReceiptDate><![CDATA[May 23, 2012; May 23, 2013; May 23, 2014]]></AppReceiptDate>
<LARD>2014-05-23</LARD>
<FileName>PAR-12-085.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-085</DocNum>
<ExpirationDate>2014-05-24</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19929</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[New Technologies for Viral Hepatitis SBIR (R43/R44)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to respond to the Combating the Silent Epidemic of Viral Hepatitis: U.S. Department of Health and Human Services Action Plan for the Prevention, Care and Treatment of Viral Hepatitis (Viral Hepatitis Action Plan) which was released on May 12, 2011 (http://www.hhs.gov/ash/initiatives/hepatitis/).  SBCs are encouraged to propose SBIR grant applications to develop resources, research tools, instrumentations, biomarkers, devices, drugs or new and innovative approaches to diagnosis, monitoring, management, treatment and prevention of viral hepatitis and viral hepatitis associated liver disease.    
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-090.html</GuideLink>
<RelDate>2012-01-31</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-090.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-090</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19930</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[New Technologies for Viral Hepatitis STTR (R41/R42) 
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) that propose to respond to the Combating the Silent Epidemic of Viral Hepatitis: U.S. Department of Health and Human Services Action Plan for the Prevention, Care and Treatment of Viral Hepatitis (Viral Hepatitis Action Plan) which was released on May 12, 2011 (http://www.hhs.gov/ash/initiatives/hepatitis/).  SBCs are encouraged to propose STTR grant applications to develop resources, research tools, instrumentations, biomarkers, devices, drugs or new and innovative approaches to diagnosis, monitoring, management, treatment and prevention of viral hepatitis and viral hepatitis associated liver disease. ]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-091.html</GuideLink>
<RelDate>2012-01-31</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-091.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-091</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19932</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[PHS 2012-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2012-2 SBIR/STTR Program Descriptions and Research Topics for NIH.)]]></Purpose>
<RelNote/><ActivityCodes>R41,R42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-089.html</GuideLink>
<RelDate>2012-01-31</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-12-089.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-089</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19933</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[ACF]]></PartIC>
<PartIC><![CDATA[CGH]]></PartIC>
<PartIC><![CDATA[FDA]]></PartIC>
<PartIC><![CDATA[NCCDPHP]]></PartIC>
<PartIC><![CDATA[NCHHSTP]]></PartIC>
<PartIC><![CDATA[NCIPC]]></PartIC>
<PartIC><![CDATA[NCIRD]]></PartIC>
<PartIC><![CDATA[NIOSH]]></PartIC>
<Title><![CDATA[PHS 2012-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the Administration for Children and Families (ACF) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH, CDC, FDA or ACF awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2012-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, FDA and ACF  
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-088.html</GuideLink>
<RelDate>2012-01-31</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>PA-12-088.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-088</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19934</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[HIV Vaccine Research and Design (HIVRAD) Program (P01)]]></Title>
<Purpose><![CDATA[Support of multi-component, multi-disciplinary projects that address important scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included.
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-087.html</GuideLink>
<RelDate>2012-01-31</RelDate>
<IntentDate>May 13, 2012; May 13, 2013; May 13, 2014</IntentDate>
<AppReceiptDate><![CDATA[June 13, 2012; June 13, 2013; June 13, 2014 ]]></AppReceiptDate>
<LARD>2014-06-13</LARD>
<FileName>PAR-12-087.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-087</DocNum>
<ExpirationDate>2014-06-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19938</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Partnerships for Development of Vaccine Technologies (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), invites research applications for projects focused on preclinical development of candidate technologies (including adjuvants) that would improve vaccine effectiveness and/or simplify vaccine delivery to patient populations during a natural outbreak of an infectious disease or following the intentional release of an infectious agent. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-014.html</GuideLink>
<RelDate>2012-02-01</RelDate>
<IntentDate>May 26, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-26</LARD>
<FileName>RFA-AI-12-014.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-014</DocNum>
<ExpirationDate>2012-06-27</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19942</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)
]]></Title>
<Purpose><![CDATA[Through this Funding Opportunity Announcement (FOA), the Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB), at the National Cancer Institute (NCI), invite grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies, development and testing of new methodologies, secondary data analyses, and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research and to provide resources for those investigators that may need additional support on their path to successfully compete for R01 funding in basic mechanistic research in understanding cancer health disparities. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-094.html</GuideLink>
<RelDate>2012-02-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[June 20, 2012; November 20, 2012; June 20, 2013; November 20, 2013; June 20, 2014; November 20, 2014]]></AppReceiptDate>
<LARD>2014-11-20</LARD>
<FileName>PAR-12-094.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-094</DocNum>
<ExpirationDate>2014-11-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19943</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Biomedical and Behavioral Research Innovations to Ensure Equity (BRITE) in Maternal and Child Health (R15)
]]></Title>
<Purpose><![CDATA[The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) seeks to increase the diversity of the pool of researchers involved in health equity research related to NICHD mission areas including infant mortality; Sudden Infant Death Syndrome (SIDS); child, adolescent, and/or adult obesity; uterine fibroids; pediatric and maternal HIV/AIDS prevention; violence prevention; health literacy; and outreach and information dissemination.

]]></Purpose>
<RelNote/><ActivityCodes>R15</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-093.html</GuideLink>
<RelDate>2012-02-02</RelDate>
<IntentDate>30 days before applicable receipt date.</IntentDate>
<AppReceiptDate><![CDATA[April 3, 2012, October 11, 2012, October 11, 2013]]></AppReceiptDate>
<LARD>2013-10-11</LARD>
<FileName>PAR-12-093.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-093</DocNum>
<ExpirationDate>2013-10-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19944</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Basic Cancer Research in Cancer Health Disparities (U01)]]></Title>
<Purpose><![CDATA[Through this Funding Opportunity Announcement (FOA), the Center to Reduce Cancer Health Disparities (CRCHD), the Division of Cancer Biology (DCB) and Division of Cancer Prevention (DCP), at the National Cancer Institute (NCI), encourage grant applications from investigators interested in conducting basic, mechanistic research into the biologic/genetic causes of cancer health disparities. These cooperative agreement research awards (U01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, and may include the development and testing of new methodologies and models, secondary data analyses, and mechanistic studies of identified biological factors associated with cancer disparities, including those related to basic research in prevention strategies.  This FOA is also designed to aid and facilitate the development of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can develop resources and tools, such as biospecimens, cell lines and methods that are necessary to conduct basic research in cancer health disparities. 
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-095.html</GuideLink>
<RelDate>2012-02-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[June 20, 2012; November 20, 2012; June 20, 2013; November 20, 2013; June 20, 2014; November 20, 2014 ]]></AppReceiptDate>
<LARD>2014-11-20</LARD>
<FileName>PAR-12-095.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-095</DocNum>
<ExpirationDate>2014-11-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19945</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB) of the National Cancer Institute (NCI), invites applications by investigators from diverse backgrounds underrepresented in basic and biomedical cancer research. The NIH recognizes a unique and compelling need to promote diversity in the NIH-funded research workforce. The purpose of this FOA is to improve the diversity of the NCI-funded research workforce by supporting and recruiting eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from socially, culturally, economically, or educationally disadvantaged backgrounds that have recently and demonstrably inhibited their ability to pursue a career in health-related research. This funding opportunity will also provide a bridge to investigators that have completed their research training and may need extra time to develop a research project grant application.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-096.html</GuideLink>
<RelDate>2012-02-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[June 20, 2012; November 20, 2012; June 20, 2013; November 20, 2013; June 20, 2014; November 20 2014]]></AppReceiptDate>
<LARD>2014-11-20</LARD>
<FileName>PAR-12-096.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-096</DocNum>
<ExpirationDate>2014-11-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19949</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[Ancillary Studies in PREDICT-HD (U01)
]]></Title>
<Purpose><![CDATA[The National Institute of Neurological Disorders and Stroke (NINDS) invites applications for ancillary studies that will further our understanding of the unique clinical and biomarker signatures of premanifest or prodromal Huntington's disease (HD) through coordination with the NINDS-funded Neurobiological Predictors of Huntington's Disease (PREDICT-HD) study. The PREDICT-HD study is an international 32-site observational study of persons at-risk for HD, and includes clinical and biospecimen resources from 800 premanifest HD participants and 200 healthy control subjects.  Extensive clinical data including UHDRS motor examination, cognitive and neuropsychiatric assessments, and structural MRI imaging have been collected over a ten-year time frame, with a subset of these data accessible through the dbGaP website http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000222.v1.p1.  

]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-097.html</GuideLink>
<RelDate>2012-02-03</RelDate>
<IntentDate>One month prior to application due date.</IntentDate>
<AppReceiptDate><![CDATA[April 25, 2012; August 14, 2012; December 11, 2012; April 12, 2013; August 14, 2013; December 11, 2013; April 11, 2014]]></AppReceiptDate>
<LARD>2014-04-11</LARD>
<FileName>PAR-12-097.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-097</DocNum>
<ExpirationDate>2014-04-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19950</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Grand Challenges in Global Mental Health: Integrating Mental Health into Chronic Disease Care Provision in Low- and Middle-Income Countries (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) seeks research project grant (R01) applications that promote the establishment of an evidence base on contextually relevant, cost-effective integrated care interventions for the treatment of patients with co-morbid mental and chronic physical illnesses in low- and middle-income countries (LMICs). Specifically, this FOA will support research that builds on existing chronic disease care and treatment platforms to incorporate management of mental illness, employs a multi-disease care management approach with potentially high impact for improving patient- and system-level outcomes (e.g., patient morbidity and functioning; improved diagnosis of mental illness among patients with chronic medical illnesses; decreased cost to the health care system; improved care coordination), and establishes feasible methods for multi-disease management in LMICs. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>350000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-040.html</GuideLink>
<RelDate>2012-02-03</RelDate>
<IntentDate>May 20, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-20</LARD>
<FileName>RFA-MH-13-040.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MH-13-040</DocNum>
<ExpirationDate>2012-06-21</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19953</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) solicits applications for Phased Innovation (R21/R33) research projects to conduct rigorous, objective services research to monitor and examine changes in drug use prevention, addiction treatment, and associated HIV and viral hepatitis services, that may occur as a result of healthcare reform.  This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition of up to four years of expanded research support (R33 phase). The total project period for an application submitted in response to this FOA may not exceed five years.  
]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-001.html</GuideLink>
<RelDate>2012-02-06</RelDate>
<IntentDate>July 22, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-08-22</LARD>
<FileName>RFA-DA-13-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DA-13-001</DocNum>
<ExpirationDate>2012-08-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19959</rowid>
<PrimaryIC><![CDATA[NEI]]></PrimaryIC>
<Title><![CDATA[Stem Cell Approaches to Developing New Therapies for Ocular Diseases (R01)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to encourage the submission of applications proposing to use human stem cells to develop methods for generating replacement cells and transplantation techniques for the treatment of ocular diseases and disorders.  Studies may include elucidating the mechanisms required to direct stem cell differentiation into specialized ocular cell lineages. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-EY-12-001.html</GuideLink>
<RelDate>2012-02-07</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-07-02</LARD>
<FileName>RFA-EY-12-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-EY-12-001</DocNum>
<ExpirationDate>2012-07-03</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19970</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Development of Measures to Determine Successful Hearing Health Care Outcomes (R01)]]></Title>
<Purpose><![CDATA[The goal of this FOA is to encourage Research Project Grant (R01) applications that seek to identify the variables contributing to successful hearing health care outcomes in adults with hearing loss, and to develop and evaluate clinical measures of those variables.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-101.html</GuideLink>
<RelDate>2012-02-09</RelDate>
<IntentDate>September 3, 2012, May 3, 2013, January 3, 2014</IntentDate>
<AppReceiptDate><![CDATA[October 3, 2012, June 3, 2013, February 3, 2014, by 5:00 PM local time of applicant organization.]]></AppReceiptDate>
<LARD>2014-02-03</LARD>
<FileName>PAR-12-101.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-101</DocNum>
<ExpirationDate>2014-02-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19973</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Academic-Community Partnership Conference Series (R13)]]></Title>
<Purpose><![CDATA[The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages Research Conference Grant (R13) applications to conduct health disparities-related meetings, workshops, and symposia. The purpose of the Academic-Community Partnership Conference Series is to bring together academic institutions/organizations and community organizations to identify opportunities for addressing health disparities through the use of Community-Based Participatory Research (CBPR). The objectives of meetings conducted as part of this award will be to: (1) establish and/or enhance academic-community partnerships; (2) identify community-driven research priorities, and (3) develop long-term collaborative CBPR research agendas. Thus, it is expected these partnerships will lead to grant applications for the support of CBPR projects designed to meet identified community needs. The areas of focus for these partnerships may include one or more of the following community-health issues: infant mortality; Sudden Infant Death Syndrome (SIDS); fibroid tumors; childhood, adolescent, and/or adult obesity; health literacy; techniques for outreach and information dissemination; pediatric and maternal HIV/AIDS prevention; and violence prevention.]]></Purpose>
<RelNote/><ActivityCodes>R13</ActivityCodes>
<FA_DirectCosts>30000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-102.html</GuideLink>
<RelDate>2012-02-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[pril 10, 2012, October 17, 2012, October 17, 2013]]></AppReceiptDate>
<LARD>2013-10-17</LARD>
<FileName>PAR-12-102.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-102</DocNum>
<ExpirationDate>2013-10-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19967</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<PartIC><![CDATA[OSC]]></PartIC>
<Title><![CDATA[Administrative Supplements to Existing NIH Grants and Cooperative Agreements(Parent Admin Supp)]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) hereby notify Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.Applications for administrative supplements are considered prior approval requests (as described in Section 8.1.2.11 of the NIH Grants Policy Statement) and will be routed directly to the Grants Management Officer of the parent award.


Although requests for administrative supplements may be submitted through this FOA, there is no guarantee that funds are available from the awarding IC or for any specific grant. All applicants are encouraged to discuss potential requests with the awarding IC. Additionally, prior to submission, applicants must review the awarding IC's web site to ensure they meet the IC's requirements.A list of those web sites is available at http://grants.nih.gov/grants/guide/admin_supp/index.htm. ]]></Purpose>
<RelNote/><ActivityCodes>333</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-100.html</GuideLink>
<RelDate>2012-02-13</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Due dates may vary by awarding IC.  See the awarding IC web site for any applicable Application Due Dates. ]]></AppReceiptDate>
<LARD>2013-01-30</LARD>
<FileName>PA-12-100.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-100</DocNum>
<ExpirationDate>2013-01-31</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19939</rowid>
<PrimaryIC><![CDATA[NIMHD]]></PrimaryIC>
<Title><![CDATA[NIMHD Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01)
]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is issued by the National Institute on Minority Health and Health Disparities (NIMHD) to solicit innovative grant applications on:

1. Biological and genetic research to explore disease mechanisms or pathways that influence health outcomes in minority and health disparity populations.

2. Clinical and translational research linking basic science discovery with effective treatment or clinical practice.

The overall goal of this initiative is to enhance our understanding of fundamental biological mechanisms involved in disease conditions and develop therapies or interventions that can directly or demonstrably contribute to the elimination of health disparities. 

Biological, genetic, clinical and translational research projects investigating the etiology, physiology, genetic risk factors, molecular pathways, gene-environmental interactions, pharmacogenomic and personalized medicine in health disparity populations are particularly encouraged.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-12-004.html</GuideLink>
<RelDate>2012-02-14</RelDate>
<IntentDate>May 11, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-11</LARD>
<FileName>RFA-MD-12-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MD-12-004</DocNum>
<ExpirationDate>2012-06-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19982</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Mental Health Research Dissertation Grant to Increase Diversity (R36)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA), issued by the National Institute of Mental Health (NIMH), is to increase the diversity of the mental health research workforce by providing dissertation awards in all areas of research within the strategic priorities of the NIMH to individuals from diverse backgrounds underrepresented in mental health research to support the completion of the doctoral research project. 
]]></Purpose>
<RelNote/><ActivityCodes>R36</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-103.html</GuideLink>
<RelDate>2012-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[April 23, 2012, August 22, 2012, December 21, 2012, April 22, 2013, August 22, 2013, December 23, 2013, April 22, 2014, August 22, 2014, December 22, 2014]]></AppReceiptDate>
<LARD>2014-12-22</LARD>
<FileName>PAR-12-103.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-103</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19983</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Mucosal Environment and HIV Prevention (MEHP) (R01)]]></Title>
<Purpose><![CDATA[The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, encourages grant applications from institutions/organizations that address the long term goal and objectives of increasing the safety and efficacy of non-vaccine biomedical prevention, such as microbicides and PrEP, through a better understanding of their interactions with the tissue micro- and macro-environments of the genital (male and female) and gastrointestinal mucosa. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-106.html</GuideLink>
<RelDate>2012-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-106.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-106</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19984</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Functional Glycomics in HIV Vaccine Design (R01)]]></Title>
<Purpose><![CDATA[Glycans play key roles in the transmission, antigenicity, and immunogenicity of the HIV-1 envelope protein. Glycans also modulate the immune response, playing an essential role in both innate and adaptive immunity. The purpose of this Funding Opportunity Announcement (FOA)  is to stimulate and foster multi-disciplinary investigator- initiated collaborative research to 1) investigate structural and conformational features of glycosylation that may lead to novel HIV vaccine design approaches, and 2) to elucidate the impact of differential glycosylation on the quality of the immune response to HIV. Ultimately, the discovery of a safe, effective, prophylactic vaccine that provides long-term protection from HIV infection may depend on novel approaches that incorporate new knowledge of the key role glycans play in the elicitation and maturation of broadly neutralizing antibodies and effector immune responses. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-105.html</GuideLink>
<RelDate>2012-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-105.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-105</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19985</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Enhancing Cellular Immunity in the Female Reproductive Tract (R01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the discovery of mechanisms that mediate the induction and maintenance of effective antigen-specific CD8+ memory T cells in the female reproductive tract (FRT). The ultimate goal is to develop the knowledge base needed to facilitate the development of future vaccines that generate effective and persistent T lymphocyte responses against infection by HIV and other mucosal pathogens in the FRT. This program is not intended to support evaluation of mucosal vaccines or therapies, or research primarily focused on pathogens.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-104.html</GuideLink>
<RelDate>2012-02-14</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-104.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-104</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19986</rowid>
<PrimaryIC><![CDATA[NIMHD]]></PrimaryIC>
<Title><![CDATA[ NIMHD Social, Behavioral, Health Services, and Policy Research on Minority Health and Health Disparities (R01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative social, behavioral, health services, and policy research that can directly and demonstrably contribute to the elimination of health disparities. Projects may involve primary data collection or secondary analysis of existing datasets. Projects that examine understudied health conditions; examine the effectiveness of interventions, services, or policies for multiple health disparity populations; and/or directly measure the impact of project activities on levels of health disparities are particularly encouraged.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-12-003.html</GuideLink>
<RelDate>2012-02-14</RelDate>
<IntentDate>May 4, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-04</LARD>
<FileName>RFA-MD-12-003.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MD-12-003</DocNum>
<ExpirationDate>2012-06-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19988</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Delivering Therapeutics to Residual Active HIV Reservoirs (R01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement is to encourage new ideas for eliminating cellular reservoirs of HIV that continue to actively produce virus in tissue compartments despite suppression of plasma viremia with antiretroviral therapy. New approaches to delivering antiretrovirals or other anti-HIV agents to these tissues or to specific cell types are needed to block virus production, limit inflammation, and facilitate clearance of these reservoir cells. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-107.html</GuideLink>
<RelDate>2012-02-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-107.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-107</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19989</rowid>
<PrimaryIC><![CDATA[Roadmap]]></PrimaryIC>
<Title><![CDATA[Assays for High Throughput Screening (HTS) to Discover Chemical Probes in the Molecular Libraries Probe Production Centers Network (MLPCN) (X01)]]></Title>
<Purpose><![CDATA[The purpose is to encourage the investigators to form collaborations with the Molecular Libraries Probe Production Centers Network (MLPCN) to implement HTS-ready assays for the discovery and development of small molecule chemical probes.

Through this program, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms.  Emphasis will be placed on assays that provide new insight into important disease targets and processes. 
]]></Purpose>
<RelNote/><ActivityCodes>X01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-108.html</GuideLink>
<RelDate>2012-02-16</RelDate>
<IntentDate>March 16, 2012; July 16, 2012</IntentDate>
<AppReceiptDate><![CDATA[April 16, 2012; August 15, 2012]]></AppReceiptDate>
<LARD>2012-08-15</LARD>
<FileName>PAR-12-108.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-108</DocNum>
<ExpirationDate>2012-08-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19991</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Targeting Persistent HIV Reservoirs (TaPHIR) (R21/R33)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to stimulate the development of innovative tools and strategies for curing HIV infection. HIV establishes latent infection in long-lived cells that form a reservoir of virus that persists in infected individuals even after years of treatment with highly active antiretroviral therapy (HAART). Curing HIV infection requires innovative strategies to identify and eliminate these reservoir cells. The task is especially difficult given the lack of HIV protein expression during latency and the low frequency of latently infected cells during treatment. Novel approaches are therefore sought to efficiently monitor and specifically target reservoirs of latently infected cells to facilitate the testing of strategies to cure HIV infection in vivo.   
]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-109.html</GuideLink>
<RelDate>2012-02-17</RelDate>
<IntentDate>March 25, 2012; March 25, 2013; and March 25, 2014 </IntentDate>
<AppReceiptDate><![CDATA[April 25, 2012; April 25, 2013, and April 25, 2014]]></AppReceiptDate>
<LARD>2014-04-25</LARD>
<FileName>PAR-12-109.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-109</DocNum>
<ExpirationDate>2014-04-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19992</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Eradication of HIV-1 from CNS Reservoirs: Implications for Therapeutics (R21)]]></Title>
<Purpose><![CDATA[The National Institute of Mental Health (NIMH) and the National Institute of Neurological Disorders and Stroke (NINDS) invite novel research grant applications to address the problem of HIV-1 persistence focused solely on the central nervous system (CNS) of HIV-infected persons treated with Highly Active Anti-Retroviral Therapy (HAART).  This Funding Opportunity Announcement (FOA) will support highly innovative research in five areas:  (1) basic research to identify and characterize CNS-based cellular reservoirs of HIV-1 for individuals on HAART; (2) basic research to determine the mechanisms involved in the temporal establishment, maintenance, and resurgence of CNS-based HIV-1 reservoirs in relationship to the effects and timing of HAART, viral expression, and viral evolution within the brain; (3) development of physiologically relevant animal models and CNS-based cellular assays that recapitulate HIV-1 persistence and latency in the presence of effective HAART; (4) drug screening of potential agents which traverse the blood-brain barrier and eliminate latent or other sources of residual virus in the CNS; and (5) design of therapeutic strategies aimed at eradication of HIV-1 from the CNS.  Applications ranging from basic to translational research in domestic and international settings are of interest.  Multidisciplinary research teams are encouraged but not required. ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-031.html</GuideLink>
<RelDate>2012-02-17</RelDate>
<IntentDate>August 12, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-12</LARD>
<FileName>RFA-MH-13-031.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MH-13-031</DocNum>
<ExpirationDate>2012-09-13</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19993</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Eradication of HIV-1 from CNS Reservoirs: Implications for Therapeutics (R01)
]]></Title>
<Purpose><![CDATA[The National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS), and National Institute of Allergy and Infectious Disease (NIAID) invite research grant applications to address the problem of HIV-1 persistence focused solely on the central nervous system (CNS) of HIV-infected persons treated with Highly Active Anti-Retroviral Therapy (HAART).  This Funding Opportunity Announcement (FOA) will support innovative research in five areas:  (1) basic research to identify and characterize CNS-based cellular reservoirs of HIV-1 for individuals on HAART; (2) basic research to determine the mechanisms involved in the temporal establishment, maintenance, and resurgence of CNS-based HIV-1 reservoirs in relationship to the effects and timing of HAART, viral expression, and viral evolution within the brain;  (3) development of physiologically relevant animal models and CNS-based cellular assays that recapitulate HIV-1 persistence and latency in the presence of effective HAART; (4) drug screening of potential agents which traverse the blood-brain barrier and eliminate latent or other sources of residual virus in the CNS; and (5) design of therapeutic strategies aimed at eradication of HIV-1 from the CNS.  Applications ranging from basic to translational research in domestic and international settings are of interest. Multidisciplinary research teams are encouraged but not required. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-030.html</GuideLink>
<RelDate>2012-02-17</RelDate>
<IntentDate>August 12, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-12</LARD>
<FileName>RFA-MH-13-030.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MH-13-030</DocNum>
<ExpirationDate>2012-09-13</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>19997</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44) ]]></Title>
<Purpose><![CDATA[The purpose of the NHLBI SBIR Phase IIB Bridge Award is to facilitate and accelerate the capital-intensive steps that are required to transition SBIR Phase II projects to the commercialization stage by promoting partnerships between SBIR Phase II awardees and third-party investors and/or strategic partners. Applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NHLBI funds being requested throughout the Phase IIB Bridge Award project period. Projects proposed in response to this FOA must relate to the NHLBI mission and require eventual Federal regulatory approval/clearance. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. ]]></Purpose>
<RelNote/><ActivityCodes>R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-016.html</GuideLink>
<RelDate>2012-02-17</RelDate>
<IntentDate>May 19, 2012; May 19, 2013; May 19, 2014</IntentDate>
<AppReceiptDate><![CDATA[June 19, 2012; June 19, 2013; June 19, 2014]]></AppReceiptDate>
<LARD>2014-06-19</LARD>
<FileName>RFA-HL-13-016.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-016</DocNum>
<ExpirationDate>2014-06-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20003</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<Title><![CDATA[NIH Blueprint for Neuroscience Research Grand Challenge: Discovering Novel Drugs for Disorders of the Nervous System (U01) ]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) announces a unique opportunity for investigators working with small molecule compounds to gain access to a robust virtual pharma network to discover neurotherapeutic drugs. Successful applicants to this FOA will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug discovery services that are not typically available to the academic research community. Funding will be provided through a U01 cooperative agreement mechanism to conduct biological testing of compound analogs in disease assays and models in the investigators laboratory. No-cost drug discovery services will also be provided, including medicinal chemistry optimization, IND-directed pharmacology and toxicology, and Phase I clinical testing. Researchers in possession of disease assays and small molecule compounds that show promise for treating nervous system and psychiatric disorders, but that are not yet suitable for clinical testing, are strongly encouraged to apply.   ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-13-003.html</GuideLink>
<RelDate>2012-02-21</RelDate>
<IntentDate>September 8, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-10-08</LARD>
<FileName>RFA-NS-13-003.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-NS-13-003</DocNum>
<ExpirationDate>2012-10-09</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20005</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Getting from Genes to Function in Lung Disease (R01)]]></Title>
<Purpose><![CDATA[This FOA encourages applications that propose to characterize the function of gene(s) and their associated variants identified by genome-wide association studies (GWAS) or other genetic approaches to be involved in lung diseases.  Studies should use integrated approaches across scientific disciplines to determine the pathobiological function of these genes.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-110.html</GuideLink>
<RelDate>2012-02-22</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-09-07</LARD>
<FileName>PA-12-110.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-110</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20006</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Limited Competition for the Continuation of the Clinical Centers for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4)]]></Title>
<Purpose><![CDATA[This Limited Competition Funding Opportunity Announcement (FOA) invites applications from the Principal Investigators of the six current Clinical Centers (CCs) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study of type 1 diabetes (T1D) etiology.  The TEDDY study involves the rigorous investigation of TEDDY subjects, including data and samples, for the identification of infectious agents, dietary factors, or other environmental factors associated with onset of T1D and/or T1D associated autoimmune markers.  The six current CCs have been involved in study design and data and biosample acquisition since the inception of the TEDDY consortium.  The CCs have recruited participants and followed the subjects over the past 10 years. This FOA is a one-time solicitation to support the CCs to allow them to continue to retain, follow clinically, and collect biosamples from TEDDY subjects for an additional 5 years.
]]></Purpose>
<RelNote/><ActivityCodes>UC4</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-504.html</GuideLink>
<RelDate>2012-02-22</RelDate>
<IntentDate>June 17, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-17</LARD>
<FileName>RFA-DK-12-504.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DK-12-504</DocNum>
<ExpirationDate>2012-07-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20013</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Research on the Health of LGBTI Populations (R21)
]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of various population groups and improve the effectiveness of health interventions and services for individuals within those groups.  High priority is placed on research on populations that appear to have distinctive health risk profiles but have received insufficient attention from investigators.  This Funding Opportunity Announcement (FOA) highlights a particular community:  lesbian, gay, bisexual, transgender, intersex, and related populations (designated here as LGBTI populations).  Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.  
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-113.html</GuideLink>
<RelDate>2012-02-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-113.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-113</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20014</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<Title><![CDATA[Research on the Health of LGBTI Populations [R03]
]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of various population groups and improve the effectiveness of health interventions and services for individuals within those groups.  High priority is placed on research on populations that appear to have distinctive health risk profiles but have received insufficient attention from investigators.  This Funding Opportunity Announcement (FOA) highlights a particular community:  lesbian, gay, bisexual, transgender, intersex, and related populations (designated here as LGBTI populations).  Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.  
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-112.html</GuideLink>
<RelDate>2012-02-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-112.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-112</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20015</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<PartIC><![CDATA[OBSSR]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Research on the Health of LGBTI Populations [R01]]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of various population groups and improve the effectiveness of health interventions and services for individuals within those groups.  High priority is placed on research on populations that appear to have distinctive health risk profiles but have received insufficient attention from investigators.  This Funding Opportunity Announcement (FOA) highlights a particular community:  lesbian, gay, bisexual, transgender, intersex, and related populations (designated here as LGBTI populations).  Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-111.html</GuideLink>
<RelDate>2012-02-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-111.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-111</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20017</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[Infrastructure Development Program in Patient-Centered Outcomes Research (PCOR) (R24)]]></Title>
<Purpose><![CDATA[Purpose.  This FOA solicits Resource-Related Research Projects (R24) grant applications from organizations that propose to improve health outcomes by developing and disseminating evidence-based information to patients, clinicians, policy makers, and health care administrators, responding to their expressed needs about which clinical and health system design interventions are most effective for which patients under specific circumstances. 
Mechanism of Support. This FOA will use the AHRQ Resource-Related Research Projects (R24) grant mechanism. 
Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.  Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.  
]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-114.html</GuideLink>
<RelDate>2012-02-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[June 19, 2012, December 19, 2012, December 19, 2013, December 19, 2014]]></AppReceiptDate>
<LARD>2014-12-19</LARD>
<FileName>PA-12-114.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-114</DocNum>
<ExpirationDate>2014-12-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20033</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Collaborations for Macromolecular Interactions in Cells (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to establish inter-disciplinary collaborative projects to advance studies of macromolecular interactions and their relationship to function in cells.  These collaborations are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems.  Grantees may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology;  (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening);  (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, superresolution light microscopy);  (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-13-004.html</GuideLink>
<RelDate>2012-03-01</RelDate>
<IntentDate>May 14, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-14</LARD>
<FileName>RFA-GM-13-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-GM-13-004</DocNum>
<ExpirationDate>2012-06-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20034</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[Research Networks for Macromolecular Interactions in Cells (U54)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to establish inter-disciplinary collaborative research networks to advance studies of macromolecular interactions and their relationship to function in cells.  These networks are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems.  Invetigators may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology;  (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening);  (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, superresolution light microscopy);  (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. ]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-13-005.html</GuideLink>
<RelDate>2012-03-01</RelDate>
<IntentDate>May 14, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-14</LARD>
<FileName>RFA-GM-13-005.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-GM-13-005</DocNum>
<ExpirationDate>2012-06-15</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20035</rowid>
<PrimaryIC><![CDATA[AHRQ]]></PrimaryIC>
<Title><![CDATA[AHRQ Mentored Career Enhancement Award in Patient Centered Outcomes Research (PCOR) for Mid-Career and Senior Investigators (K18)]]></Title>
<Purpose><![CDATA[Section 6301(b) of the Patient Protection and Affordable Care Act , Public Law 111-148 (the Affordable Care Act), enacted Section 937(e) of the Public Health Services Act authorizing AHRQ to establish a grant program that provides for the training of researchers in comparative effectiveness methods and states that, at a minimum, such training shall be in methods that meet the methodological standards adopted [by PCORI] under 1181(d)(9) of the Social Security Act.  AHRQ is also authorized to sponsor health services research career development programs under section 902(b) of the Public Health Service Act.  This FOA addresses the Affordable Care Acts provision authorizing AHRQ to support the training of researchers in comparative clinical effectiveness research.  AHRQ encourages submission of applications from minority serving institutions. ]]></Purpose>
<RelNote/><ActivityCodes>K18</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-115.html</GuideLink>
<RelDate>2012-03-01</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[May 2, 2012, December 18, 2012, December 18, 2013, December 18, 2014]]></AppReceiptDate>
<LARD>2014-12-18</LARD>
<FileName>PAR-12-115.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-115</DocNum>
<ExpirationDate>2014-12-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20040</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Harnessing Advanced Health Technologies to Drive Mental Health Improvement (R34)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to test the innovative use of existing technologies to significantly improve access to and quality of mental health care, and to propose the collection and use of actionable mental health information to improve outcomes of people with mental disorders. ]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-061.html</GuideLink>
<RelDate>2012-03-02</RelDate>
<IntentDate>May 22, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-22</LARD>
<FileName>RFA-MH-13-061.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MH-13-061</DocNum>
<ExpirationDate>2012-06-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20041</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Harnessing Advanced Health Technologies to Drive Mental Health Improvement (R01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to test the innovative use of existing technologies to significantly improve access to and quality of mental health care, and to propose the collection and use of actionable mental health information to improve outcomes of people with mental disorders.]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-060.html</GuideLink>
<RelDate>2012-03-02</RelDate>
<IntentDate>May 22, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-22</LARD>
<FileName>RFA-MH-13-060.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MH-13-060</DocNum>
<ExpirationDate>2012-06-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20065</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Innovative Food Defense Program (R18)]]></Title>
<Purpose><![CDATA[The Innovative Food Defense Program (IFDP) grants are designed to generate food defense tools and resources that are easily replicated and can complement, aid in the development of, or improve State, local, Tribal and territorial (SLTT)food defense programs. The known overlap between food safety (unintentional contamination) and food defense (intentional contamination) is extensive and the pool of resources available is often the same.As the Food Safety Modernization Act recognizes the evolution of the relationship between food safety and food defense, it is critical that these programs be integrated to the maximum extent possible in order to ensure the most efficient use of resources, as well as to optimize response to an incident or event.]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-116.html</GuideLink>
<RelDate>2012-03-09</RelDate>
<IntentDate/><AppReceiptDate><![CDATA[June 15, 2012, 2013, 2014, by 5:00 PM local time of applicant organization.]]></AppReceiptDate>
<LARD>2014-06-15</LARD>
<FileName>PAR-12-116.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-116</DocNum>
<ExpirationDate>2014-06-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20068</rowid>
<PrimaryIC><![CDATA[NIBIB]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<Title><![CDATA[Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes.Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them.Responsive grant applications must involve a formal collaboration with a healthcare provider or other healthcare organization serving a health disparity population during Phase I and Phase II.]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-EB-12-001.html</GuideLink>
<RelDate>2012-03-09</RelDate>
<IntentDate>April 21, 2012, August 21, 2012</IntentDate>
<AppReceiptDate><![CDATA[May 21, 2012, September 21, 2012, by 5:00 PM local time of applicant organization.
September 7, 2012, January 7, 2013, by 5:00 PM local time of applicant organization. ]]></AppReceiptDate>
<LARD>2013-01-07</LARD>
<FileName>RFA-EB-12-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-EB-12-001</DocNum>
<ExpirationDate>2013-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20077</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[The NCI Transition Career Development Award (K22)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent. 
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-121.html</GuideLink>
<RelDate>2012-03-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PAR-12-121.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-121</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20080</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03)]]></Title>
<Purpose><![CDATA[The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary data analyses of existing oral or craniofacial database resources, or to develop needed statistical methodology for analyzing oral and craniofacial data using existing oral or craniofacial databases. The R03 grant mechanism supports research specifically limited in time and amount for studies in categorical program areas.]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-120.html</GuideLink>
<RelDate>2012-03-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PAR-12-120.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-120</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20081</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Partnerships for Interventions to Treat Chronic, Persistent and Latent Infections (R21/R33)]]></Title>
<Purpose><![CDATA[This FOA seeks to stimulate basic and early-stage translational research focused on development of novel intervention strategies to clear persistent, chronic or latent infectious agents from the host. Responsive applications will define and address a therapeutic need specific to a targeted pathogen.  ]]></Purpose>
<RelNote/><ActivityCodes>R21/R33</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-020.html</GuideLink>
<RelDate>2012-03-15</RelDate>
<IntentDate>June 13, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-13</LARD>
<FileName>RFA-AI-12-020.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-020</DocNum>
<ExpirationDate>2012-07-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20085</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34)]]></Title>
<Purpose><![CDATA[The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting robust, well-designed, and well-executed clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between NIDCD project collaborator and investigator for a planning grant for phase III clinical trials of definitive efficacy. NIDCD Phase III Clinical Trials in Communication Disorders (U01) applications are accepted only from successful NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) awardees, unless NIDCD program staff agrees to accept a phase III clinical trial application from an investigator who has not used an NIDCD clinical trial planning grant first. The NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) is used to gather information and prepare a Manual of Procedures (MOP) (see http://www.nidcd.nih.gov/research/clinicaltrials for an example of a complete, detailed MOP).  NIDCD Phase III Clinical Trials in Communication Disorders (U01) (PAR-12-123) applications must include a complete detailed MOP in the appendix.       
]]></Purpose>
<RelNote/><ActivityCodes>U34</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-124.html</GuideLink>
<RelDate>2012-03-16</RelDate>
<IntentDate>30 days  before planned submission date. </IntentDate>
<AppReceiptDate><![CDATA[June 4, 2012; October 4, 2012; February 4, 2013; June 4, 2013; October 4, 2013,February 4, 2014; June 4, 2014; October 3, 2014; February 4, 2015]]></AppReceiptDate>
<LARD>2015-02-04</LARD>
<FileName>PAR-12-124.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-124</DocNum>
<ExpirationDate>2015-02-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20086</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01)]]></Title>
<Purpose><![CDATA[The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting robust, well-designed, and well-executed clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between NIDCD project collaborator and investigator to support phase I and II clinical trials of preliminary efficacy and phase III clinical trials of definitive efficacy.  Phase III clinical trial applications must include a complete detailed Manual of Procedures (MOP) in the appendix (see http://www.nidcd.nih.gov/research/clinicaltrials for an example of a complete, detailed MOP). The NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) (PAR-12-124) may be used to gather information and prepare the MOP.  ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-123.html</GuideLink>
<RelDate>2012-03-16</RelDate>
<IntentDate>30 days before planned submission date.  </IntentDate>
<AppReceiptDate><![CDATA[June 4, 2012; October 4, 2012; February 4, 2013; June 4, 2013; October 4, 2013,February 4, 2014; June 4, 2014; October 3, 2014; February 4, 2015 ]]></AppReceiptDate>
<LARD>2015-02-04</LARD>
<FileName>PAR-12-123.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-123</DocNum>
<ExpirationDate>2015-02-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20089</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the Office of Dietary Supplements (ODS) encourages R21 applications that propose to conduct secondary analysis of existing data sets relevant to diabetes and endocrine and metabolic diseases; digestive diseases and nutrition, including obesity and eating disorders; and kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-125.html</GuideLink>
<RelDate>2012-03-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-125.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-125</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20098</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and preliminary research on (1) organizational and/or systems-level interventions that may optimize access, utilization, delivery, quality, and/or cost of treatment services for drug, tobacco, or alcohol abuse or dependence through the use of evidence-based practices; (2) organizational and/or systems-specific adaptations to existing evidence-based practices necessary to facilitate their implementation in these new contexts; and (3) novel service delivery models to be pilot tested in preparation for larger-scale effectiveness trials.  This R34 award mechanism provides resources for assessing the feasibility, acceptability, utility, and sustainability of novel approaches to service delivery for drug, tobacco, or alcohol abuse or dependence, with the ultimate goal of facilitating the uptake of scientifically-supported clinical practices.  This FOA supports pilot and preliminary research on service delivery models, and organizational or systems-level interventions.  This FOA will not support developmental or efficacy studies for novel preventive interventions or clinical therapies, nor will it support efficacy studies on the adaptation of existing interventions for new client populations.  
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-130.html</GuideLink>
<RelDate>2012-03-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2015-05-07</LARD>
<FileName>PA-12-130.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-130</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20099</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourages Small Grant (R03) applications on health services and economic research to improve the quality of prevention, treatment, and recovery support services for drug, alcohol and tobacco abuse.  Such research projects might emphasize any of the following subjects: (1) clinical quality improvement; (2) organization and delivery of services; (3) implementation research; (4) economic and cost studies; or (5) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug, alcohol, and tobacco prevention, treatment, and recovery services. ]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>50000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-129.html</GuideLink>
<RelDate>2012-03-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-129.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-129</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20100</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourages Exploratory/Developmental (R21) grant applications on health services and economic research to improve the quality of prevention, treatment, and recovery support services for drug, alcohol and tobacco abuse.  Such research projects might emphasize any of the following subjects: (1) clinical quality improvement; (2) organization and delivery of services; (3) implementation research; (4) economic and cost studies; or (5) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug, alcohol, and tobacco prevention, treatment, and recovery services.   
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-128.html</GuideLink>
<RelDate>2012-03-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-128.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-128</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20101</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourages Research Project Grant (R01) applications on health services and economic research to improve the quality of prevention, treatment, and recovery support services for drug, alcohol and tobacco abuse.  Such research projects might emphasize any of the following subjects: (1) clinical quality improvement; (2) organization and delivery of services; (3) implementation research; (4) economic and cost studies; or (5) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug, alcohol, and tobacco prevention, treatment, and recovery services.   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-127.html</GuideLink>
<RelDate>2012-03-19</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-127.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-127</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20106</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) will support basic and translational studies aimed at understanding the mechanisms of itch sensation and developing methods to modulate and control itch sensation in disease and rehabilitation.  The purpose is to accelerate discovery in this nascent field and to apply new knowledge to improve human conditions relevant to the NIAMS mission.  This FOA intends to support a broad range of investigations using animal and human models, with an emphasis on multidisciplinary collaboration for rapid bench-to-bedside exchange of information and therapy development. This FOA is not intended to support applications proposing clinical trials.  ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-131.html</GuideLink>
<RelDate>2012-03-19</RelDate>
<IntentDate>30 days before due date </IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-131.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-131</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20107</rowid>
<PrimaryIC><![CDATA[NIAMS]]></PrimaryIC>
<Title><![CDATA[Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) will support basic and translational studies aimed at understanding the mechanisms of itch sensation and developing methods to modulate and control itch sensation in disease and rehabilitation.  The purpose is to accelerate discovery in this nascent field and to apply new knowledge to improve human conditions relevant to the NIAMS mission.  This FOA intends to support a broad range of investigations using animal and human models, with an emphasis on multidisciplinary collaboration for rapid bench-to-bedside exchange of information and therapy development.  This FOA is not intended to support applications proposing clinical trials.
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-132.html</GuideLink>
<RelDate>2012-03-20</RelDate>
<IntentDate>30 days before due date</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-132.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-132</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20113</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Translational Research at the Aging/Cancer Interface (TRACI) (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-136.html</GuideLink>
<RelDate>2012-03-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-136.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-136</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20114</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Translational Research at the Aging/Cancer Interface (TRACI) (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) encourages translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population.  
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-135.html</GuideLink>
<RelDate>2012-03-21</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-135.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-135</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20119</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Cardiovascular Risk Reduction in Underserved Rural Communities (R01)
]]></Title>
<Purpose><![CDATA[The overall objective is to build the evidence base and accelerate the implementation and translation of evidence- or practice-based interventions into practice in rural communities.  To accomplish this objective, NHLBI invites applications that will plan and execute well-designed controlled trials that maximize the opportunities available in rural communities to reduce cardiovascular disease risk factors. The long-term goal is to foster sustainable interventions and scientific research that will lead to reduced cardiovascular morbidity and mortality in high-risk rural populations. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-013.html</GuideLink>
<RelDate>2012-03-21</RelDate>
<IntentDate>December 11, 2012</IntentDate>
<AppReceiptDate/><LARD>2013-01-11</LARD>
<FileName>RFA-HL-13-013.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-013</DocNum>
<ExpirationDate>2013-01-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20109</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
]]></Title>
<Purpose><![CDATA[NIDA grant-funded research programs aiming to develop medications for the treatment of Substance Use Disorders (SUDs) are often hindered by a lack of both human and financial resources.  Drug development is a long process that requires teams of people with a wide range of individual skill sets.  Consequently, individual grantees with the skills to get through the preclinical stages of drug development often fail to transition their project through the clinic and into the market place.  Grantees frequently lack both real world experience of the drug development process and the financial resources to advance a medication to the market place in the necessary timeframe.  The purpose of this Funding Opportunity Announcement (FOA) is to help support these efforts to meet these objectives by leveraging the strengths of two or more organizations toward a common goal of medications development.  ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>2000000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-12-122.html</GuideLink>
<RelDate>2012-03-21</RelDate>
<IntentDate>07/07/2012, 11/07/2012, 06/17/2013, 11/04/2013, 02/24/2014, 11/04/2014 </IntentDate>
<AppReceiptDate><![CDATA[08/07/2012, 12/07/2012, 07/17/2013, 12/04/2013, 03/24/2014, 12/04/2014]]></AppReceiptDate>
<LARD>2014-12-04</LARD>
<FileName>PAS-12-122.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-12-122</DocNum>
<ExpirationDate>2014-12-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20120</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[NHLBI Career Transition Award (K22)]]></Title>
<Purpose><![CDATA[The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows with an opportunity to receive mentored research experience in the NHLBI Division of Intramural Research and then to provide them with funding to facilitate the transition of their research programs as new investigators to extramural institutions. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research: a mentored intramural phase (two years) and an extramural phase (three years), for a total of five years of combined support. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardees research program as determined by an NHLBI progress review, which will include an evaluation of a research plan to be carried out at the extramural institution. 
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-137.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PAR-12-137.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-137</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20124</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[NHLBI Systems Biology Collaborations (R01)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose collaborative systems biology research projects by multi-disciplinary teams to advance our understanding of normal physiology and perturbations associated with heart, lung, blood, and sleep (HLBS) diseases and disorders. Multi-disciplinary expertise across experimental and computational domains is required, and the multi-PI mechanism is allowed, as integration across these domains is a critical element of the proposed research plan.  ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-138.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>August 14, 2012; December 14, 2012; August 13, 2013; December 13, 2013; August 15, 2014; December 13, 2014</IntentDate>
<AppReceiptDate><![CDATA[September 14, 2012; January 14, 2013; September 13, 2013; January 13, 2014; September 15, 2014; January 13, 2015]]></AppReceiptDate>
<LARD>2015-01-13</LARD>
<FileName>PAR-12-138.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-138</DocNum>
<ExpirationDate>2015-01-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20125</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<Title><![CDATA[Child Health Research Career Development Award (CHRCDA) Program [K12]]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) issued by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, invites applications for institutional research career development (K12) programs from applicant organizations that propose to support a national program of mentored institutional career development programs for junior faculty investigators who have recently completed postgraduate clinical training in a subspecialty area of Pediatrics, and are committed to launching an independent research career. The program provides supervised research training to assist the transition into productive physician scientists. ]]></Purpose>
<RelNote/><ActivityCodes>K12</ActivityCodes>
<FA_DirectCosts>400000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-13-011.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>May 27, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-27</LARD>
<FileName>RFA-HD-13-011.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HD-13-011</DocNum>
<ExpirationDate>2012-06-28</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20126</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R21)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) issued by the National Institute of Nursing Research (NINR) and the National Institute of Environmental Health Sciences (NIEHS) is to encourage interdisciplinary research aimed at promoting health, limiting symptoms and disease, and reducing health disparities in children and older adults living or spending time in non-traditional settings. These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases including lower respiratory diseases, chronic obstructive pulmonary disease, and cardiovascular diseases. Risk identification and symptom management include prevention and behavior changes and actions to maintain health and prevent disease with an emphasis on the individual, family, and community which will advance nursing science. For purposes of this FOA, non-traditional settings, for children and older adults, include, but are not limited to places such as community centers, pre-school and non-traditional school environments (e.g., churches, daycare, home-based schools, dormitories, and alternative schools), child and older adult foster care facilities, older adult day care facilities, half-way homes,  assisted living and long-term care facilities.  ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-134.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2016-01-07</LARD>
<FileName>PA-12-134.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-134</DocNum>
<ExpirationDate>2016-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20127</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Pilot and Feasibility Clinical Research Studies in Digestive Diseases and Nutrition (R21)
]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Cancer Institute, and the Office of Dietary Supplements (ODS) of the National Institutes of Health encourages pilot and feasibility clinical and epidemiological research studies of new therapies or means of health promotion and prevention of digestive and liver diseases and nutritional disorders associated with digestive and liver diseases. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-139.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-139.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-139</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20128</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence and For Substance Abusing Populations with HIV (R34)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) encourages Clinical Trial Planning Grant (R34) applications to develop, pilot test and determine the feasibility of technology tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on: (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services.
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-118.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-118.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-118</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20129</rowid>
<PrimaryIC><![CDATA[NIOSH]]></PrimaryIC>
<Title><![CDATA[Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
]]></Title>
<Purpose><![CDATA[The purpose of this announcement is to support research projects and epidemiologic studies to help answer critical questions about physical and mental health conditions related to the September 2001 terrorist attacks including: biomarkers of exposures or health outcomes; epidemiologic studies; exposure-response relationships; improvements in diagnosis and treatment; patterns of illness (age, gender, etc.); risk factors for disease; and other research studies on WTC-related health conditions or emerging conditions. 
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-126.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>April 20, 2012, September 24, 2012, September 24, 2013; September 24, 2014</IntentDate>
<AppReceiptDate><![CDATA[May 21, 2012, October 24, 2012, October 24, 2013, October 24, 2014]]></AppReceiptDate>
<LARD>2014-10-24</LARD>
<FileName>PAR-12-126.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-126</DocNum>
<ExpirationDate>2014-10-25</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20108</rowid>
<PrimaryIC><![CDATA[NINR]]></PrimaryIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<Title><![CDATA[Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R01)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) issued by the National Institute of Nursing Research (NINR) and the National Institute of Environmental Health Sciences (NIEHS) is to encourage interdisciplinary research aimed at promoting health, limiting symptoms and disease, and reducing health disparities in children and older adults living or spending time in non-traditional settings. These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases including lower respiratory diseases, chronic obstructive pulmonary disease, and cardiovascular diseases. Risk identification and symptom management include prevention and behavior changes and actions to maintain health and prevent disease with an emphasis on the individual, family, and community which will advance nursing science. For purposes of this FOA, non-traditional settings, for children and older adults, include, but are not limited to places such as community centers, pre-school and non-traditional school environments (e.g., churches, daycare, home-based schools, dormitories, and alternative schools), child and older adult foster care facilities, older adult day care facilities, half-way homes,  assisted living and long-term care facilities.     
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-133.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2016-01-07</LARD>
<FileName>PA-12-133.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-133</DocNum>
<ExpirationDate>2016-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20072</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01) ]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) encourages Research Project Grant (R01) applications to test the utility and implementation of technological tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-117.html</GuideLink>
<RelDate>2012-03-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-117.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-117</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20130</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), encourages innovative multidisciplinary research projects that will advance our mechanistic understanding of microflora influences on Gastro-Intestinal (GI) carcinogenesis. This FOA seeks applications that leverage and integrate information from large, meta-omic data sets to guide studies that identify critical microbial activities that can be mechanistically linked to GI carcinogenesis. Applicants may draw from existing large data sets, and may also propose to generate appropriate new data, including but not limited to data from both gene and protein analysis, such as DNA sequence and copy number, post-translational modifications, secreted signals, and protein-protein interaction data between host factors and individual microbial species, or  communities of microbes. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-140.html</GuideLink>
<RelDate>2012-03-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[July 2, 2012; November 1, 2012; March 4, 2013; July 2, 2013; November 1, 2013; March 4, 2014 ]]></AppReceiptDate>
<LARD>2014-03-04</LARD>
<FileName>PAR-12-140.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-140</DocNum>
<ExpirationDate>2014-03-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20110</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Limited Competition: Data Coordinating Center for Cardiothoracic Surgical Trials Network (CTSN) (U01)]]></Title>
<Purpose><![CDATA[The purpose of this limited Funding Opportunity Announcement (FOA) is to invite applications to support the Data Coordinating Center (DCC) for the Cardiothoracic Surgical Trials Network (CTSN).  A separate FOA (RFA-HL-13-017) seeks applications for Network Core Clinical Centers.  

The goal of the CTSN is to evaluate surgical interventions and related management approaches to improve the treatment of cardiovascular disease and conditions in adult patients.  The DCC provides administrative and statistical support to maintain an infrastructure to develop, coordinate, and conduct multiple collaborative surgical trials designed to improve cardiovascular outcomes and optimize post-operative neurological function.  
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-022.html</GuideLink>
<RelDate>2012-03-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-06-13</LARD>
<FileName>RFA-HL-13-022.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-022</DocNum>
<ExpirationDate>2012-06-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20135</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<PartIC><![CDATA[ICRH]]></PartIC>
<Title><![CDATA[Core Clinical Centers for the Cardiothoracic Surgical Trials Network, CTSN (UM1)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to request applications for participation as a Core Clinical Center in a continuation of the Cardiothoracic Surgical Trials Network (CTSN).  Highly innovative approaches to patient recruitment and retention for challenging cardiothoracic (CT) surgical trials, as well as a strong track record of prior trial performance, are sought.  A separate solicitation (RFA-HL-13-022) seeks applications for a network Data Coordinating Center.]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-017.html</GuideLink>
<RelDate>2012-03-28</RelDate>
<IntentDate>May 13, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-13</LARD>
<FileName>RFA-HL-13-017.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-017</DocNum>
<ExpirationDate>2012-06-14</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20137</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Toward an Improved Understanding of HDL Function (R01)]]></Title>
<Purpose><![CDATA[This FOA encourages grant applications that propose to develop, validate, and standardize assays to measure HDL function and biomarkers for HDL function and to identify new pathways and potential HDL targets in the relationship to HDL function. Innovative methods to determine HDL functional properties such as in vivo reverse cholesterol transport (RCT), anti-oxidant, anti-inflammatory, and antithrombotic activities, and biomarkers for HDL function are encouraged. Projects that will explore HDL novel functional pathways and therapeutics related to HDL function are also encouraged.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-143.html</GuideLink>
<RelDate>2012-03-28</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-09-07</LARD>
<FileName>PA-12-143.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-143</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20140</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)
]]></Title>
<Purpose><![CDATA[The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-145.html</GuideLink>
<RelDate>2012-03-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PAR-12-145.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-145</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20141</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[NCI Small Grants Program for Cancer Research (NCI Omnibus R03)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), of the National Institutes of Health (NIH) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-144.html</GuideLink>
<RelDate>2012-03-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PAR-12-144.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-144</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20142</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Mechanisms of Alcohol-associated Cancers (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Cancer Institute (NCI) invites applications from researchers with broad ranges of expertise to study the mechanisms by which alcohol increases cancer risk.

Alcohol has been classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC).  Target sites for alcohol-related carcinogenesis include the oral cavity, pharynx, esophagus, larynx, breast, liver, and colon.  A better understanding of the molecular basis by which alcohol increases cancer risk could lead to improved therapeutic approaches and preventative strategies and would provide guidance on safe levels of alcohol consumption.  The goal of this program announcement is to stimulate a broad range of research into the mechanisms by which alcohol contributes to carcinogenesis. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-147.html</GuideLink>
<RelDate>2012-03-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PA-12-147.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-147</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20143</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<Title><![CDATA[Mechanisms of Alcohol-associated Cancers (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Cancer Institute (NCI) invites applications from researchers with broad ranges of expertise to study the mechanisms by which alcohol increases cancer risk.

Alcohol has been classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC).  Target sites for alcohol-related carcinogenesis include the oral cavity, pharynx, esophagus, larynx, breast, liver, and colon.  A better understanding of the molecular basis by which alcohol increases cancer risk could lead to improved therapeutic approaches and preventative strategies and would provide guidance on safe levels of alcohol consumption.  The goal of this program announcement is to stimulate a broad range of research into the mechanisms by which alcohol contributes to carcinogenesis. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-146.html</GuideLink>
<RelDate>2012-03-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PA-12-146.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-146</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20132</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Research on Emergency Medical Services for Children (EMSC) [R21]]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) is designed to improve the quality and quantity of research related to emergency medical services for children (EMSC), with the goal of reducing morbidity and mortality in children through improved care delivery. This FOA invites the submission of innovative R21 applications dealing with exploratory and developmental aspects of research included under the term EMSC: prevention research to reduce the need for emergency care; clinical research to ensure that children receive high-quality and appropriate medical, nursing and mental health care in an emergency; health systems research, from pre-hospital care, to the emergency department, to in-patient care and return to the community; models to improve service and cost efficiency in pediatric emergency care; and methodological studies to improve the quality of research conducted.   ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-142.html</GuideLink>
<RelDate>2012-03-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-142.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-142</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20133</rowid>
<PrimaryIC><![CDATA[NICHD]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Research on Emergency Medical Services for Children (EMSC) [R01]
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) is designed to improve the quality and quantity of research related to emergency medical services for children (EMSC), with the goal of reducing morbidity and mortality in children through improved care delivery. This FOA invites the submission of applications dealing with the following areas of research included under the term EMSC: prevention research to reduce the need for emergency care; clinical research to ensure that children receive high-quality and appropriate medical, nursing and mental health care in an emergency; health systems research, from pre-hospital care, to the emergency department, to in-patient care and return to the community; models to improve service and cost efficiency in pediatric emergency care; and methodological studies to improve the quality of research conducted.    
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-141.html</GuideLink>
<RelDate>2012-03-29</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-141.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-141</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20144</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Senior Scientist Research Award (K05)
]]></Title>
<Purpose><![CDATA[The purpose of the Senior Scientist Research (K05) is intended to provide protected time for outstanding senior scientists who have demonstrated a sustained high level of productivity conducting biomedical research relevant to the scientific mission of the appropriate institute to focus on their research and to provide mentoring of new investigators.  ]]></Purpose>
<RelNote/><ActivityCodes>K05</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-148.html</GuideLink>
<RelDate>2012-03-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-148.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-148</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20145</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<Title><![CDATA[A Data Resource for Analyzing Blood and Marrow Transplants (Limited Competition U24)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcment (FOA) is to continue the support for the Center for International Blood and Marrow Transplant Research (CIBMTR). This database resource collects consecutive outcomes data from transplant centers worldwide and makes them accessible to transplant investigators, patients, and healthcare policy makers. In addition, the CIBMTR provides quality data to transplant researchers for observational research studies on patients who had blood and marrow transplants. 
]]></Purpose>
<RelNote/><ActivityCodes>U24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-503.html</GuideLink>
<RelDate>2012-03-30</RelDate>
<IntentDate>May 11, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-11</LARD>
<FileName>RFA-CA-12-503.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-CA-12-503</DocNum>
<ExpirationDate>2012-06-12</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20147</rowid>
<PrimaryIC><![CDATA[NCCAM]]></PrimaryIC>
<Title><![CDATA[Centers of Excellence for Research on CAM (P01)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) is issued by the National Center for Complementary and Alternative Medicine (NCCAM) to enable submission of applications that propose to conduct research that is of high-priority to NCCAM that requires synergistic collaboration between outstanding scientists, and the synthesis of multiple research approaches by multi-disciplinary research teams. The CERC mechanism is designed to support research in which the funding of three or four synergistic, highly meritorious projects as a group offers significant scientific advantages over support of the same projects as individual research grants.  Each CERC must consist, throughout the duration of the award, of three or four research projects, focused on basic, mechanistic, and/or translational research questions relevant to the research priorities described in the current NCCAM Strategic Plan.
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-151.html</GuideLink>
<RelDate>2012-03-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[September 25, 2012, 2013, 2014; AIDS: January 7, 2013, 2014,2015
]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PAR-12-151.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-151</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20149</rowid>
<PrimaryIC><![CDATA[NCI]]></PrimaryIC>
<Title><![CDATA[Cancer Target Discovery and Development (CTDD) Network (U01)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) and the Cancer Target Discovery and Development (CTDD) initiative is to promote innovative research on high throughput approaches to the discovery and characterization of new cancer targets and their modulators. Projects resulting from this FOA are expected to bridge the gap between the enormous volumes of data generated by the comprehensive molecular characterizations of many cancer subtypes and the ability to use these data for the development of human cancer therapeutics and associated response markers. Applicants must propose research projects focused on high-throughput identification and/or characterization of potential targets for cancer therapy, and/or the identification of small molecules that modulate validated cancer targets. Proposed projects are expected to combine in-depth mining of large-scale genomic data, systems biology analyses and/or experimental approaches to provide initial characterization of functional significance.]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-006.html</GuideLink>
<RelDate>2012-03-30</RelDate>
<IntentDate>May 21, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-21</LARD>
<FileName>RFA-CA-12-006.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-CA-12-006</DocNum>
<ExpirationDate>2012-06-22</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20150</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Genomic Medicine Pilot Demonstration Projects Coordinating Center (U01)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support a Coordinating Center (CC) to serve as a centralized resource to facilitate and support a consortium of collaborative genomic medicine pilot Demonstration Projects designed to demonstrate the feasibility of, and develop methods for, incorporating an individual patients genomic findings into his or her clinical care. 
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-007.html</GuideLink>
<RelDate>2012-04-03</RelDate>
<IntentDate>June 19, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-19</LARD>
<FileName>RFA-HG-12-007.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-12-007</DocNum>
<ExpirationDate>2012-07-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20156</rowid>
<PrimaryIC><![CDATA[NIDCD]]></PrimaryIC>
<Title><![CDATA[Development of a Vestibular Neural Prosthesis (R01)]]></Title>
<Purpose><![CDATA[The National Institute on Deafness and Other Communication Disorders (NIDCD) solicits grant applications that advance the development of a vestibular neural prosthesis towards studies in human subjects. Responsive applications must employ electrical stimulation of the vestibular nerve to diminish sensory impairments arising from damage or disease to the vestibular endorgans. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-13-001.html</GuideLink>
<RelDate>2012-04-03</RelDate>
<IntentDate>September 4, 2012; January 4 2013; May 4, 2013; September 4, 2013</IntentDate>
<AppReceiptDate><![CDATA[October 4, 2012; February 4 2013; June 4, 2013; October 4, 2013]]></AppReceiptDate>
<LARD>2013-10-04</LARD>
<FileName>RFA-DC-13-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DC-13-001</DocNum>
<ExpirationDate>2013-10-05</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20157</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Genomic Medicine Pilot Demonstration Projects (U01)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to support a consortium of collaborative genomic medicine pilot Demonstration Projects designed to demonstrate the feasibility of, and develop methods for, incorporating an individual patients genomic findings into his or her clinical care. 
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-006.html</GuideLink>
<RelDate>2012-04-03</RelDate>
<IntentDate>June 19, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-19</LARD>
<FileName>RFA-HG-12-006.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-12-006</DocNum>
<ExpirationDate>2012-07-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20158</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01)]]></Title>
<Purpose><![CDATA[The NINDS recognizes the unique and compelling need to promote diversity in participation in neuroscience research and expects these efforts to diversify the neuroscience research workforce to lead to the recruitment of the most talented researchers from all groups. The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research is to provide junior faculty support and protected time (up to three years) for an intensive, supervised career development experience in neuroscience research.  The goal of the NINDS K01 is to diversify the pool of independent neuroscience research investigators and to enhance the probability of success in obtaining independent NIH or other independent research support. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty position at the time of award. 

]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-152.html</GuideLink>
<RelDate>2012-04-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PAR-12-152.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-152</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20159</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Limited Competition: NHLBI Research Centers at Minority Serving Institutions - Phase II (P50)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI) is a limited competition to solicit applications from investigators funded under Phase I of the NHLBI Research Centers at Minority-Serving Institutions program. http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-11-019.html  The purpose is to establish research centers to augment and strengthen research capabilities and resources in biomedical and behavioral research related to heart, lung, and blood diseases and disorders, with  the ultimate goal to increase diversity in the biomedical and behavioral research enterprise.  The program is intended to occur in two phases:  Phase I (the recruitment/retention phase and establishment of the External Advisory Board, 2 years) and Phase II (the development of the research program and research operations, 5 years).  This FOA is intended to support Phase II only, and is dependent upon the success from Phase I.  ]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-011.html</GuideLink>
<RelDate>2012-04-04</RelDate>
<IntentDate>May 13, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-13</LARD>
<FileName>RFA-HL-13-011.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-011</DocNum>
<ExpirationDate>2012-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20161</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[U.S.-China Program for Biomedical Collaborative Research (R01)]]></Title>
<Purpose><![CDATA[The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and applied research between United States (U.S.)-based researchers and Chinese researchers in the areas of allergy, immunology, and infectious diseases including HIV/AIDS and its co-morbidities and co-infections, cancer, mental health, Parkinsons disease (PD), and stroke. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-021.html</GuideLink>
<RelDate>2012-04-04</RelDate>
<IntentDate>August 18, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-18</LARD>
<FileName>RFA-AI-12-021.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-021</DocNum>
<ExpirationDate>2012-09-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20162</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement encourages applications using community-engaged research methods to investigate the potential health risks of environmental exposures of concern to the community and to implement an environmental public health action plan based on research findings.  The overall goal is to support changes to prevent or reduce exposure to harmful environmental exposures and improve the health of a community.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-153.html</GuideLink>
<RelDate>2012-04-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PA-12-153.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-153</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20163</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<PartIC><![CDATA[NCER]]></PartIC>
<Title><![CDATA[Children's Environmental Health and Disease Prevention Research Centers (P01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by NIEHS and EPA encourages grant applications to support a transdisciplinary program of basic and applied research to examine the effects of environmental factors on childrens health and well-being. Research conducted through the Centers should include substantive areas of science in childrens health while incorporating innovative technologies and approaches and links to the environment. The revised program encourages strong links between disciplines in the basic, applied, clinical and public health sciences to prevent disease and promote health in all children.
]]></Purpose>
<RelNote/><ActivityCodes>P01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-12-001.html</GuideLink>
<RelDate>2012-04-05</RelDate>
<IntentDate>June 17, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-17</LARD>
<FileName>RFA-ES-12-001.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-ES-12-001</DocNum>
<ExpirationDate>2012-07-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20164</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25)]]></Title>
<Purpose><![CDATA[The National Heart, Lung, and Blood Institute, National Institutes of Health invites Research Education (R25) applications to promote diversity in undergraduate and health professional participant populations by providing short-term research education support to stimulate career development in cardiovascular, pulmonary, hematologic, and sleep disorders research.  The overall goal of the program is to provide research opportunities for individuals from backgrounds underrepresented in biomedical science, including individuals from disadvantaged backgrounds, individuals from underrepresented racial and ethnic groups, and individuals with disabilities that will significantly contribute to a diverse research workforce in the future.  The research opportunities should be of sufficient depth to enable the participants, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of research, and help prepare participants interested in research to pursue competitive fellowships, or other research training or career development awards.]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-020.html</GuideLink>
<RelDate>2012-04-05</RelDate>
<IntentDate>June 9, 2012; January 7, 2013; January 7, 2014</IntentDate>
<AppReceiptDate><![CDATA[July 9, 2012; February 7, 2013; February 7, 2014]]></AppReceiptDate>
<LARD>2014-02-07</LARD>
<FileName>RFA-HL-13-020.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-020</DocNum>
<ExpirationDate>2014-02-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20168</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Limited Competition: Revisions to Existing NIMH-Supported Cooperative Agreement Awards (U01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites revision applications from current NIMH-supported cooperative agreements (U01 awards).  
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-154.html</GuideLink>
<RelDate>2012-04-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-12-154.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-154</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20154</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp)
]]></Title>
<Purpose><![CDATA[The Office of Research on Womens Health (ORWH), participating Institutes and Centers (ICs) of the National Institutes of Health (NIH), and the Office of Dietary Supplements (ODS) announce the continuation of the program for administrative supplements to research grants to support individuals with high potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances. The purpose of these supplements is to encourage such individuals to re-enter research careers within the missions of all the program areas of NIH. This program will provide administrative supplements to existing NIH research grants for the purpose of supporting full-time or part-time research by these individuals to update their existing research skills and knowledge.
]]></Purpose>
<RelNote/><ActivityCodes>DP1,DP2,DP3,DP4,DP5,G12,P01,P20,P30,P40,P41,P50,P51,P60,R01,R18,R24,R34,R37,R41,R42,R43,R44,RC1,RC2,RC3,RC4,U01,U10,U18,U19,U34,U41,U42,U54,UM1,UP5</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-150.html</GuideLink>
<RelDate>2012-04-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-29</LARD>
<FileName>PA-12-150.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-150</DocNum>
<ExpirationDate>2015-09-30</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20155</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[FIC]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIEHS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<Title><![CDATA[Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
]]></Title>
<Purpose><![CDATA[The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds are available for administrative supplements to improve the diversity of the research workforce by supporting and recruiting students, postdoctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project. 
]]></Purpose>
<RelNote/><ActivityCodes>333,DP1,DP2,DP3,DP4,DP5,G12,K99/R00,P01,P20,P30,P40,P41,P50,P60,R01,R03,R15,R18,R21,R24,R34,R37,R41,R42,R43,R44,RC1,RC2,RC3,RC4,SC1,SC2,SC3,U01,U10,U18,U19,U34,U41,U42,U54,UM1,UP5</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-149.html</GuideLink>
<RelDate>2012-04-06</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-29</LARD>
<FileName>PA-12-149.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-149</DocNum>
<ExpirationDate>2015-09-30</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20170</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[NIAID Career Transition Award (K22)
]]></Title>
<Purpose><![CDATA[The purpose of the NIAID Research Scholar Development Award (RSDA) program is to increase and maintain a strong cohort of new and talented NIH-supported independent investigators that will address the health needs of the Nation. The NIAID RSDA is specifically designed to facilitate the transition from a postdoctoral research position to an independent research position.  
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-156.html</GuideLink>
<RelDate>2012-04-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PAR-12-156.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-156</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20171</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Integrative Omics Data Analysis for Discovery in Lung Diseases (R01)]]></Title>
<Purpose><![CDATA[The National Heart, Lung, and Blood Institute (NHLBI) invites applications to: (1) generate systems-level models of pulmonary pathobiology through integrative analyses of existing omics (e.g., genomics, transcriptomics, proteomics, metabolomics) data; and (2) experimentally test novel predictions of these models using human tissues/cells and/or mammalian animal models. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-155.html</GuideLink>
<RelDate>2012-04-10</RelDate>
<IntentDate>May 19, 2012; May 19, 2013; May 19, 2014</IntentDate>
<AppReceiptDate><![CDATA[June 19, 2012; June 19, 2013; June 19, 2014]]></AppReceiptDate>
<LARD>2014-06-19</LARD>
<FileName>PAR-12-155.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-155</DocNum>
<ExpirationDate>2014-06-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20177</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Pilot and Feasibility Clinical Research Grants in Diabetes, and Endocrine and Metabolic Diseases (R21)
]]></Title>
<Purpose><![CDATA[This FOA, issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, encourages pilot and feasibility clinical and behavioral studies related to the prevention or treatment of diabetes and endocrine and genetic metabolic diseases. The Pilot and Feasibility Clinical Research Grants Program is for exploratory, short-term clinical studies, so that new ideas may be investigated without stringent requirements for preliminary data. The short-term studies should focus on research questions that are likely to have high clinical impact. Studies can include testing a new prevention strategy, a new intervention or a unique combination of therapies. A high priority is the use of such studies to help stimulate the translation of promising research developments from the laboratory into clinical practice in the treatment or prevention of diabetes, endocrine diseases and genetic metabolic diseases, including cystic fibrosis. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-157.html</GuideLink>
<RelDate>2012-04-10</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-157.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-157</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20178</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<Title><![CDATA[Clinical Trials Units for NIAID Networks (UM1)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to solicit applications for Clinical Trials Units (CTUs) for NIAID clinical research networks focused on the following six research areas:  1) Adult HIV therapeutic strategies, including HIV cure, noninfectious comorbidities, and the infectious comorbidities of hepatitis and tuberculosis; 2) strategies to address HIV and HIV-associated infections in pediatric and maternal populations; 3) integrated HIV prevention strategies; 4) microbicide strategies to prevent HIV infections; 5) vaccines to prevent HIV infections; and 6) strategies to address antibacterial resistance.
]]></Purpose>
<RelNote/><ActivityCodes>UM1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-018.html</GuideLink>
<RelDate>2012-04-10</RelDate>
<IntentDate>December 29, 2012</IntentDate>
<AppReceiptDate/><LARD>2013-01-29</LARD>
<FileName>RFA-AI-12-018.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-AI-12-018</DocNum>
<ExpirationDate>2013-01-30</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20179</rowid>
<PrimaryIC><![CDATA[NIDCR]]></PrimaryIC>
<Title><![CDATA[Administrative Supplements for Collaborative Science: Opportunities for Existing NIDCR Grants and Cooperative Agreements (Admin Supp)]]></Title>
<Purpose><![CDATA[The NIDCR announces the availability of funds for Administrative Supplements to NIDCR-funded research projects. These funds are intended to enhance ongoing research by enabling NIDCR-funded researchers to form new collaborations that were not anticipated at the time of submission, review and funding of the NIDCR parent grant. These collaborative activities must be within the scope of the approved aims of the parent award and are expected to provide novel scientific approaches to the research plan for the NIDCR grantee and collaborators. Collaborations that bring together ideas, theories, methods and approaches from disparate scientific disciplines are particularly encouraged, as are those involving individuals from groups that are currently underrepresented in the biomedical and biobehavioral sciences.]]></Purpose>
<RelNote/><ActivityCodes>333,P01,R01,R15,R37,U01,U54</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-159.html</GuideLink>
<RelDate>2012-04-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[June 11, 2012; January 30, 2013; May 30, 2013; January 30, 2014; May 30, 2014]]></AppReceiptDate>
<LARD>2014-05-30</LARD>
<FileName>PA-12-159.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-159</DocNum>
<ExpirationDate>2014-06-01</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20180</rowid>
<PrimaryIC><![CDATA[NLM]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NIDCD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<Title><![CDATA[NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp)]]></Title>
<Purpose><![CDATA[The National Library of Medicine, in conjunction with NIH Institutes and Centers (ICs) named above, announces an Administrative Supplement opportunity available to eligible NIH awardees with active R01 grants and, in some cases, with active P01, P30, P50 and U01 grants (see details below).   

These administrative supplements provide funds to supported research and center grants in order to enhance the storage, organization, management and use of electronic research data through the involvement of informationists, also known as in-context information specialists.  ]]></Purpose>
<RelNote/><ActivityCodes>333,P01,P30,P50,R01,U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-158.html</GuideLink>
<RelDate>2012-04-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-06-05</LARD>
<FileName>PA-12-158.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-158</DocNum>
<ExpirationDate>2012-06-06</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20181</rowid>
<PrimaryIC><![CDATA[NCCAM]]></PrimaryIC>
<Title><![CDATA[Collaborative Activities to Promote Research on Integrative Approaches to Symptom Management in Military Populations (Administrative Supplement)]]></Title>
<Purpose><![CDATA[The National Center for Complementary and Alternative Medicine (NCCAM) announces the availability of one-year administrative supplements for NCCAM-funded grantees to stimulate collaborations for research on integrative approaches to pain and symptom management in military populations. The proposed activities must be within the scope of the peer-reviewed activities specified within the NIH parent award. ]]></Purpose>
<RelNote/><ActivityCodes>333,P01,R01,R34,U01,U19</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-160.html</GuideLink>
<RelDate>2012-04-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-06-15</LARD>
<FileName>PA-12-160.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-160</DocNum>
<ExpirationDate>2012-06-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20182</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Exploratory Centers of Excellence in ELSI Research (CEER) (P20)]]></Title>
<Purpose><![CDATA[The National Human Genome Research Institute (NHGRI) is soliciting grant applications for the support of Exploratory Centers (P20) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). Exploratory Centers will support expanding or modifying existing resources at an institution for the purpose of developing a Specialized Center (P50) CEER application. The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information.  CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities.  In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate.  ]]></Purpose>
<RelNote/><ActivityCodes>P20</ActivityCodes>
<FA_DirectCosts>175000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-012.html</GuideLink>
<RelDate>2012-04-12</RelDate>
<IntentDate>June 19, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-19</LARD>
<FileName>RFA-HG-12-012.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-12-012</DocNum>
<ExpirationDate>2012-07-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20183</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Specialized Centers of Excellence in ELSI Research (CEER) (P50)]]></Title>
<Purpose><![CDATA[The National Human Genome Research Institute (NHGRI) is soliciting grant applications for the support of Specialized Centers (P50) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs).  The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information.  CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities.  In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate.  Finally, CEERs will be responsible for contributing to training the next generation of ELSI researchers, with particular emphasis on training researchers from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds.
]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>750000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-005.html</GuideLink>
<RelDate>2012-04-12</RelDate>
<IntentDate>June 19, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-19</LARD>
<FileName>RFA-HG-12-005.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-12-005</DocNum>
<ExpirationDate>2012-07-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20185</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Basic Research on HIV Persistence (R21)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to increase our understanding of persistent HIV-1 infection in patients under highly active anti-retroviral therapy (HAART). Support would be through soliciting Exploratory/Developmental Grant (R21) applications for hypothesis-driven basic research in HIV/AIDS that is focused on directly achieving this aim. The emphasis of this initiative is on the development of new ideas and approaches in HIV-1 persistence including model and assay development that may directly inform future studies on the design of therapeutic strategies to achieve long term remission without treatment or a complete eradication of residual virus and complete cure for HIV infection and AIDS.   
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-162.html</GuideLink>
<RelDate>2012-04-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-162.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-162</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20186</rowid>
<PrimaryIC><![CDATA[NIAID]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Basic Research on HIV Persistence (R01) 
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to increase our understanding of persistent HIV-1 infection in patients under highly active anti-retroviral therapy (HAART). Support would be through soliciting Research Project Grant (R01) applications for hypothesis-driven basic research in HIV/AIDS that is focused on directly achieving this aim. The emphasis of this initiative is on the development of new ideas and approaches in HIV-1 persistence including model and assay development that may directly inform future studies on the design of therapeutic strategies to achieve long term remission without treatment or a complete eradication of residual virus and complete cure for HIV infection and AIDS. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-161.html</GuideLink>
<RelDate>2012-04-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-01-07</LARD>
<FileName>PA-12-161.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-161</DocNum>
<ExpirationDate>2015-01-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20187</rowid>
<PrimaryIC><![CDATA[NINDS]]></PrimaryIC>
<Title><![CDATA[NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22)
]]></Title>
<Purpose><![CDATA[The NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity issued by the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), is designed to increase the number of highly trained early career investigators from diverse backgrounds underrepresented in neuroscience research.  Faculty from diverse backgrounds  represent only 5% of the tenure-stream neuroscience faculty (2009 Survey Report Neuroscience Departments and Programs).  This opportunity provides individuals from diverse backgrounds  with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position.  Individuals from diverse backgrounds underrepresented in neuroscience research are eligible for support under this award if they have doctoral research degrees (Ph.D., P.h.D./M.D. or equivalent) and between 2 and 5 years of postdoctoral research experience at the time of application. ]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-163.html</GuideLink>
<RelDate>2012-04-12</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PAR-12-163.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-163</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20195</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHGRI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIA]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Limited Competition:  Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (U01)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to seek revision applications to cooperative agreements that are supporting networks or consortia of researchers who conduct or will be interested in conducting research in the following areas:

The effectiveness of current human subjects protections and the development of tools and methods to examine evolving, evidence-based approaches to improve human subjects protections. 

The feasibility, costs, benefits, and impacts of requiring consent for research on deidentified human specimens and data using novel models of consent, e.g., notification, opt-out, opt-in, broad consent. ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-12-166.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-05-25</LARD>
<FileName>PAS-12-166.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-12-166</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20196</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<Title><![CDATA[Limited Competition:  Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to seek revision applications to cooperative agreements that are supporting networks or consortia of researchers who conduct or will be interested in conducting research in the following areas:

The effectiveness of current human subjects protections and the development of tools and methods to examine evolving, evidence-based approaches to improve human subjects protections. 

The feasibility, costs, benefits, and impacts of requiring consent for research on deidentified human specimens and data using novel models of consent, e.g., notification, opt-out, opt-in, broad consent.
]]></Purpose>
<RelNote/><ActivityCodes>UL1</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-12-167.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-05-25</LARD>
<FileName>PAS-12-167.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-12-167</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20197</rowid>
<PrimaryIC><![CDATA[NCATS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIMHD]]></PartIC>
<Title><![CDATA[Limited Competition:  Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (U24)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to seek revision applications to cooperative agreements that are supporting networks or consortia of researchers who conduct or will be interested in conducting research in the following areas:

The effectiveness of current human subjects protections and the development of tools and methods to examine evolving, evidence-based approaches to improve human subjects protections. 

The feasibility, costs, benefits, and impacts of requiring consent for research on deidentified human specimens and data using novel models of consent, e.g., notification, opt-out, opt-in, broad consent.
]]></Purpose>
<RelNote/><ActivityCodes>U24</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-12-165.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-05-25</LARD>
<FileName>PAS-12-165.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-12-165</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20198</rowid>
<PrimaryIC><![CDATA[NCATS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Limited Competition:  Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (U10)
]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to seek revision applications to cooperative agreements that are supporting networks or consortia of researchers who conduct or will be interested in conducting research in the following areas:

The effectiveness of current human subjects protections and the development of tools and methods to examine evolving, evidence-based approaches to improve human subjects protections. 

The feasibility, costs, benefits, and impacts of requiring consent for research on deidentified human specimens and data using novel models of consent, e.g., notification, opt-out, opt-in, broad consent.
]]></Purpose>
<RelNote/><ActivityCodes>U10</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-12-168.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-05-25</LARD>
<FileName>PAS-12-168.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-12-168</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20200</rowid>
<PrimaryIC><![CDATA[ORIP]]></PrimaryIC>
<PartIC><![CDATA[NEI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<Title><![CDATA[Research Resource for Human Organs and Tissues (U42)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is for the support of a Research Resource for Human Organs and Tissues for the continued availability of human tissues and organs to biomedical researchers in the United States previously funded under the auspices of RFA-RR-07-006 (http://grants.nih.gov/grants/guide/rfa-files/rfa-rr-07-006.html ). The research resource is expected to facilitate procurement, preservation, and distribution of human tissue and organs to qualified biomedical researchers.
]]></Purpose>
<RelNote/><ActivityCodes>U42</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-12-002.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-10-23</LARD>
<FileName>RFA-OD-12-002.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-OD-12-002</DocNum>
<ExpirationDate>2012-10-24</ExpirationDate>
<DocStatus>Processing</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20201</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<Title><![CDATA[Clinical Sequencing Exploratory Research Coordinating Center (U01)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement is to provide centralized support and coordination for the studies and investigators funded under the the Clinical Sequencing Exploratory Research (CSER) program (RFA-HG-10-017 and RFA-HG-12-009), who will explore, within an active clinical setting, the application of genomic sequence data to the care of patients, as well as the studies and investigators in the Return of Results (RoR) Consortium, which encompasses elements of the CSER program and studies supported under the Ethical, Legal, and Social Implications program RFA-HG-11-003 and RFA-HG-11-004.
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>800000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-008.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>June 26, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-26</LARD>
<FileName>RFA-HG-12-008.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-12-008</DocNum>
<ExpirationDate>2012-07-27</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20202</rowid>
<PrimaryIC><![CDATA[NHGRI]]></PrimaryIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<Title><![CDATA[Clinical Sequencing Exploratory Research (U01)]]></Title>
<Purpose><![CDATA[The NHGRI and NIDA seek grant applications to explore, within an active clinical setting, the application of genomic sequence data to the care of patients.  Our understanding of human genetic variation and its association with disease risk and with individual response to treatment continues to expand rapidly.  Simultaneously, a revolution has occurred in genomic sequencing technologies, making it technically and economically feasible to consider the application and utilization of genomic sequence data in clinical care.  Applications submitted in response to this FOA will address critical questions about the application of genomic sequencing to clinical care of individual patients, from generation of genomic sequence data, to interpretation and translation of the data for the physician, to communication to the patient, including an examination of the ethical, legal and psychosocial implications of bringing broad genomic data into the clinic. ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>1500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-12-009.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>June 26, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-26</LARD>
<FileName>RFA-HG-12-009.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HG-12-009</DocNum>
<ExpirationDate>2012-07-27</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20203</rowid>
<PrimaryIC><![CDATA[NCATS]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIBIB]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NLM]]></PartIC>
<Title><![CDATA[Limited Competition:  Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (U54)]]></Title>
<Purpose><![CDATA[The purpose of this FOA is to seek revision applications to cooperative agreements that are supporting networks or consortia of researchers who conduct or will be interested in conducting research in the following areas:

The effectiveness of current human subjects protections and the development of tools and methods to examine evolving, evidence-based approaches to improve human subjects protections. 

The feasibility, costs, benefits, and impacts of requiring consent for research on deidentified human specimens and data using novel models of consent, e.g., notification, opt-out, opt-in, broad consent.
]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAS-12-169.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-05-25</LARD>
<FileName>PAS-12-169.html</FileName>
<DocType>PAS</DocType>
<DocNum>PAS-12-169</DocNum>
<ExpirationDate>2012-05-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20204</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[ National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50)]]></Title>
<Purpose><![CDATA[The National Institute on Aging invites Revision applications (formerly called competing supplements) to ongoing NIA-supported Alzheimer's Disease Centers (P50) in order to expand the scope of the existing award. Revision applications should include proposal of a new core or project. Revision applications may not request support beyond the end date of the Parent P50 award.
]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-170.html</GuideLink>
<RelDate>2012-04-20</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-170.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-170</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20206</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<Title><![CDATA[Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34)]]></Title>
<Purpose><![CDATA[This FOA for R34 applications seeks to support: (a) pilot and/or feasibility testing of new, revised, or adapted preventive intervention approaches targeting the initiation of drug and alcohol use, the progression to abuse or dependence, and the acquisition or transmission of HIV infection among diverse populations and settings; and (b) pre-trial feasibility testing for prevention services and systems research. This R34 mechanism does not support the development of intervention protocols, manuals, or the standardization of protocols. It is expected that research conducted via this R34 mechanism will consist of early stage efficacy, effectiveness or services research that will provide intervention pilot and/or feasibility data that is a pre-requisite for submitting larger drug or alcohol abuse and/or drug- or alcohol-related HIV prevention intervention studies.  
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>225000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-171.html</GuideLink>
<RelDate>2012-04-23</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-05-07</LARD>
<FileName>PA-12-171.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-171</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20207</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<Title><![CDATA[Multidisciplinary Studies of HIV/AIDS and Aging (R21)]]></Title>
<Purpose><![CDATA[This FOA invites applications proposing to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.  
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-174.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[August 7, 2012; December 7, 2012; April 9, 2013; August 7, 2013; December 6, 2013; April 9, 2014; August 7, 2014; December 9, 2014; April 7, 2015]]></AppReceiptDate>
<LARD>2015-04-07</LARD>
<FileName>PAR-12-174.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-174</DocNum>
<ExpirationDate>2015-04-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20208</rowid>
<PrimaryIC><![CDATA[NIMHD]]></PrimaryIC>
<Title><![CDATA[NIMHD Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities: Planning Phase (R24)]]></Title>
<Purpose><![CDATA[The National Institute on Minority Health and Health Disparities (NIMHD) invites applications for this Funding Opportunity Announcement (FOA) to plan the development of effective interventions using community based participatory research (CBPR) approaches.  Support will be provided to develop and strengthen partnerships between researchers and health disparity communities to plan and pilot interventions for a disease or condition to reduce health disparities.
]]></Purpose>
<RelNote/><ActivityCodes>R24</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-12-006.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>May 27, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-27</LARD>
<FileName>RFA-MD-12-006.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-MD-12-006</DocNum>
<ExpirationDate>2012-06-28</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20209</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Pre-Application for the FY13 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02)]]></Title>
<Purpose><![CDATA[The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers.  The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative.  The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others. The research proposed must be in an area described in the Trans  NIH Plan for HIV-Related Research http://www.oar.nih.gov/strategicplan/.  ]]></Purpose>
<RelNote/><ActivityCodes>X02</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-164.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-10-03</LARD>
<FileName>PAR-12-164.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-164</DocNum>
<ExpirationDate>2012-10-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20210</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[NINDS]]></PartIC>
<PartIC><![CDATA[NINR]]></PartIC>
<Title><![CDATA[Multidisciplinary Studies of HIV/AIDS and Aging (R01)]]></Title>
<Purpose><![CDATA[This FOA invites applications proposing to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.  
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-175.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[August 7, 2012; December 7, 2012; April 9, 2013; August 7, 2013; December 6, 2013; April 9, 2014; August 7, 2014; December 9, 2014; April 7, 2015 ]]></AppReceiptDate>
<LARD>2015-04-07</LARD>
<FileName>PAR-12-175.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-175</DocNum>
<ExpirationDate>2015-04-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20211</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Multidisciplinary Studies of HIV/AIDS and Aging (R03)]]></Title>
<Purpose><![CDATA[This FOA invites applications proposing to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.  
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>100000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-176.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[August 7, 2012; December 7, 2012; April 9, 2013; August 7, 2013; December 6, 2013; April 9, 2014; August 7, 2014; December 9, 2014; April 7, 2015]]></AppReceiptDate>
<LARD>2015-04-07</LARD>
<FileName>PAR-12-176.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-176</DocNum>
<ExpirationDate>2015-04-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20212</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Translational Research to Improve Obesity and Diabetes Outcomes (R18)]]></Title>
<Purpose><![CDATA[The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages NIH Research Demonstration and Dissemination Project grant (R18) applications from institutions/ organizations to test practical, sustainable, acceptable, and cost efficient adaptations of efficacious strategies or approaches prevent and treat diabetes and/or obesity. Research must target the prevention or reversal of obesity, prevention of type 2 diabetes, improved care of type 1 and type 2 diabetes, or the prevention or delay of the complications of these conditions. The approaches tested should have the potential to be widely disseminated to clinical practice, individuals and communities at risk. 
]]></Purpose>
<RelNote/><ActivityCodes>R18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-172.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[July 2, 2012 , November 1, 2012 , March 1, 2013, July 1, 2013, November 1, 2013, March 3, 2014, July 1, 2014, November 3, 2014, March 2, 2015 ]]></AppReceiptDate>
<LARD>2015-03-02</LARD>
<FileName>PAR-12-172.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-172</DocNum>
<ExpirationDate>2015-03-03</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20213</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<Title><![CDATA[Planning Grants for Translational Research to Improve Obesity and Diabetes Outcomes (R34)]]></Title>
<Purpose><![CDATA[The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Mental Health (NIMH) encourage NIH Clinical Trial Planning Grant Program grant (R34) applications from institutions/ organizations to develop and pilot test practical, sustainable, acceptable, and cost efficient adaptations of efficacious strategies or approaches prevent and treat diabetes and/or obesity. Research must target the prevention or reversal of obesity, prevention of type 2 diabetes, improved care of type 1 and type 2 diabetes, or the prevention or delay of the complications of these conditions. NIMH encourages research focused on people with severe mental illness (SMI), whose risk for obesity and type 2 diabetes is twice that of the general population. The approaches tested should have the potential to be widely disseminated to clinical practice, individuals and communities at risk.
]]></Purpose>
<RelNote/><ActivityCodes>R34</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-173.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[July 2, 2012 , November 1, 2012 , March 1, 2013, July 1, 2013, November 1, 2013, March 3, 2014, July 1, 2014, November 3, 2014,  March 2, 2015 ]]></AppReceiptDate>
<LARD>2015-03-02</LARD>
<FileName>PAR-12-173.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-173</DocNum>
<ExpirationDate>2015-03-03</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20199</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[FY13 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1)]]></Title>
<Purpose><![CDATA[The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers.  The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative.  The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others. The research proposed must be in an area described in the Trans  NIH Plan for HIV-Related Research http://www.oar.nih.gov/strategicplan/. ]]></Purpose>
<RelNote/><ActivityCodes>DP1</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-002.html</GuideLink>
<RelDate>2012-04-24</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2013-01-17</LARD>
<FileName>RFA-DA-13-002.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DA-13-002</DocNum>
<ExpirationDate>2013-01-18</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20215</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol Abuse, Sleep Disorders and Circadian Rhythms (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), encourages Research Project Grant (R01) applications proposing to conduct mechanistic studies in humans and animal models on the relationships between alcohol abuse, circadian rhythms and sleep disorders.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-177.html</GuideLink>
<RelDate>2012-04-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2015-05-07</LARD>
<FileName>PA-12-177.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-177</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20216</rowid>
<PrimaryIC><![CDATA[NIAAA]]></PrimaryIC>
<Title><![CDATA[Alcohol Abuse, Sleep Disorders and Circadian Rhythms (R21)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), encourages Exploratory/Developmental Research Grant (R21) applications proposing to conduct mechanistic studies in humans and animal models on the relationships between alcohol abuse, circadian rhythms and sleep disorders.]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>275000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-178.html</GuideLink>
<RelDate>2012-04-26</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2015-05-07</LARD>
<FileName>PA-12-178.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-178</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20217</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products (U01)]]></Title>
<Purpose><![CDATA[The goal of this proposal is to develop a computational fluid dynamics (CFD) model of orally inhaled drug products that can account for drug product characteristics (aerodynamic particle size distribution, APSD) and physiological parameters (breathing pattern and airway geometry) on total and regional deposition in the lungs. Specifically, the CFD model will be capable of predicting highly localized deposition of pharmaceutically relevant polydisperse aerosols from metered dose inhalers (MDIs) and dry powder inhalers (DPIs). The results obtained in this study will be used in developing a linked CFD-compartment model that can predict the effects of lung deposition on safety (systemic exposure) and efficacy (local delivery) for locally acting orally inhaled drugs.

]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-019.html</GuideLink>
<RelDate>2012-04-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-05-31</LARD>
<FileName>RFA-FD-12-019.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-019</DocNum>
<ExpirationDate>2012-06-01</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20218</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability (U01)]]></Title>
<Purpose><![CDATA[The purpose of this project is to study the effect of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.  Formulations having the same active and inactive ingredients in the same concentrations may still exhibit differences in physicochemical properties due to differences in the manufacturing process.  Key physicochemical properties which impact clearance, distribution, and drug release will be investigated.

]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>400000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-020.html</GuideLink>
<RelDate>2012-04-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-06-22</LARD>
<FileName>RFA-FD-12-020.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-020</DocNum>
<ExpirationDate>2012-06-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20219</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Pharmacokinetics Studies of Tacrolimus in Transplant Patients (U01)
]]></Title>
<Purpose><![CDATA[The goal of this proposal is to compare the pharmacokinetics of two sources of generic tacrolimus capsules to Prograf in stable transplant patients.  Patients will be switched between both brand and generic and generic and brand.   The outcome of this study can help address the public concerns regarding the quality of generic tacrolimus and improve review practices of generic tacrolimus if necessary.   
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-021.html</GuideLink>
<RelDate>2012-04-27</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-05-31</LARD>
<FileName>RFA-FD-12-021.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-021</DocNum>
<ExpirationDate>2012-06-01</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20221</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[CDER Strategic Communication Outreach (U18)
]]></Title>
<Purpose><![CDATA[Reaching out to inform the American people is part of the mission of FDAs Center for Drug Evaluation and Research (CDER) to promote and protect the public health.  Communication about the risk and benefits, safety and effectiveness of human drug products to the public can be complex and challenging.  As such, CDERs Office of Communications (OCOMM) wants to leverage its communication efforts and collaborate with public outreach groups about its key initiatives and issues. 

]]></Purpose>
<RelNote/><ActivityCodes>U18</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-023.html</GuideLink>
<RelDate>2012-04-30</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-06-15</LARD>
<FileName>RFA-FD-12-023.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-023</DocNum>
<ExpirationDate>2012-06-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20229</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[ODS]]></PartIC>
<Title><![CDATA[Exploratory/Developmental Clinical Research Grants in Obesity (R21)]]></Title>
<Purpose><![CDATA[This FOA issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the National Heart, Lung and Blood Institute (NHLBI); the National Cancer Institute (NCI); the National Center for Complementary and Alternative Medicine (NCCAM), Office of Dietary Supplements (ODS), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD of the National Institutes of Health (NIH), encourages research grant applications from institutions/organizations that propose to conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program. 
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-179.html</GuideLink>
<RelDate>2012-05-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2015-05-07</LARD>
<FileName>PA-12-179.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-179</DocNum>
<ExpirationDate>2015-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20230</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Mentored Career Award for Faculty at Institutions That Promote Diversity (K01)]]></Title>
<Purpose><![CDATA[The NIH recognizes a unique and compelling need to promote diversity in the biomedical, behavioral, clinical and social sciences research workforce. The NIH expects efforts to diversify the workforce to lead to the recruitment of the most talented researchers from all groups, to improve the quality of the educational and training environment, to balance and broaden the perspective in setting research priorities, to improve the ability to recruit subjects from minority and other health disparity populations into clinical research protocols, and to improve the Nations capacity to address and eliminate health disparities.]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-018.html</GuideLink>
<RelDate>2012-05-02</RelDate>
<IntentDate>June 9, 2012; January 7, 2013; January 7, 2014</IntentDate>
<AppReceiptDate><![CDATA[July 9, 2012; February 7, 2013; February 7, 2014]]></AppReceiptDate>
<LARD>2014-02-07</LARD>
<FileName>RFA-HL-13-018.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-018</DocNum>
<ExpirationDate>2014-02-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20231</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Promoting Organ and Tissue Donation Among Diverse Populations (R01)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), invites investigators to apply for a grant to develop hypothesis-driven educational programs to increase the number of both living and deceased donor organs and tissue donated for transplantation from minority and other health disparity populations. This FOA intends to stimulate investigators to develop  effective culturally sensitive educational and behavioral interventions to improve the attitudes, beliefs and behaviors towards organ and tissue transplantation, as well as the need for organ transplantation, among minority and other health disparity populations. The grant will provide support for the development and testing of educational and behavioral programs in  minority and other health disparity populations to enhance their understanding of the need, risks and benefits of organ and tissue donation, and ultimately to increase the number of minority and other health disparity populations participating in living and deceased organ donation. 
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>150000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-006.html</GuideLink>
<RelDate>2012-05-02</RelDate>
<IntentDate>June 3, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-03</LARD>
<FileName>RFA-DK-12-006.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DK-12-006</DocNum>
<ExpirationDate>2012-07-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20232</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Food Protection Rapid Response Team and Program Infrastructure Improvement Implementation Project (U18)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) is being issued to announce the availability of up to three (3) cooperative agreements to be awarded under a Limited Competition.

These cooperative agreements are intended to develop, implement, and sustain replicable models of an all-hazards food and foodborne illness Rapid Response Team (RRT) concept within the national integrated food safety system.

]]></Purpose>
<RelNote/><ActivityCodes>U18</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-014.html</GuideLink>
<RelDate>2012-05-02</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-07-06</LARD>
<FileName>RFA-FD-12-014.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-014</DocNum>
<ExpirationDate>2012-07-07</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20233</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Rapid Assessment Post-Impact of Disaster  (R03)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research in the aftermath of disasters and mass casualty events. Potential applicants are strongly encouraged to contact NIMH Program Staff before submitting a RAPID application to determine whether or not the proposed work meets the guidelines of this program, whether requested RAPID funding is likely to be available, and whether the idea should be considered for initial submission as a fully developed, non-expedited application via a regular/parent FOA. RAPID grants described in this FOA may be used to facilitate initial research for investigators who intend to follow up with a full research application, using the preliminary time sensitive data from a RAPID grant as the basis for their subsequent application.  
]]></Purpose>
<RelNote/><ActivityCodes>R03</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-180.html</GuideLink>
<RelDate>2012-05-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Applications should be submitted within approximately six weeks of the identified disaster event.]]></AppReceiptDate>
<LARD>2015-10-03</LARD>
<FileName>PAR-12-180.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-180</DocNum>
<ExpirationDate>2015-10-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20234</rowid>
<PrimaryIC><![CDATA[NIMH]]></PrimaryIC>
<Title><![CDATA[Rapid Assessment Post-Impact of Disaster (R21)
]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research in the aftermath of disasters and mass casualty events. Potential applicants are strongly encouraged to contact NIMH Program Staff before submitting a RAPID application to determine whether or not the proposed work meets the guidelines of this program, whether requested RAPID funding is likely to be available, and whether the idea should be considered for initial submission as a fully developed, non-expedited application via a regular/parent FOA. RAPID grants descried in this FOA may be used to facilitate initial research for investigators who intend to follow up with a full research application, using the preliminary time sensitive data from a RAPID grant as the basis for their subsequent application.  
]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-181.html</GuideLink>
<RelDate>2012-05-03</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Applications should be submitted within approximately six weeks of the identified disaster event. 
]]></AppReceiptDate>
<LARD>2015-10-03</LARD>
<FileName>PAR-12-181.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-181</DocNum>
<ExpirationDate>2015-10-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20236</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Food Protection Rapid Response Teams (U18)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) is being issued to announce the availability of up to five cooperative agreements to be awarded under a Limited Competition. These cooperative agreements are intended to develop, implement, and sustain an all-hazards food emergency Rapid Response Team (RRT) concept, encompassing both food and feed protection programs, within the national integrated food safety system. Preparing for and effectively responding to foodborne outbreaks, documenting results in a transparent manner, and identifying potential preventive practices are all significant elements of an effective RRT. Implementing the RRT concept facilitates long-term improvements to the national food safety system by strengthening intra-agency and interagency collaboration, both to improve effectiveness of multiagency responses and to build programs on nationally shared best practices and tools. This will be accomplished through the provision of funding for program improvement and will require extensive cooperation and coordination with critical state agencies, FDA District Offices, and other FDA program offices. Effective leveraging of resources and harmonization of efforts will also require collaboration with relevant initiatives, including those of federal partners (e.g., the Centers for Disease Control and Prevention (CDC)), national initiatives and associations, and State and local partners. 
]]></Purpose>
<RelNote/><ActivityCodes>U18</ActivityCodes>
<FA_DirectCosts>300000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-013.html</GuideLink>
<RelDate>2012-05-03</RelDate>
<IntentDate>May 23, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-06</LARD>
<FileName>RFA-FD-12-013.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-013</DocNum>
<ExpirationDate>2012-07-07</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20244</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[T32 Training Program for Institutions That Promote Diversity (T32)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to increase the participation of individuals from diverse backgrounds underrepresented in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum. The NHLBIs T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training at non-research intensive institutions with an institutional mission focused on serving minority and other health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, hematologic, and sleep disorders. The NHLBIs T32 Training Program for Institutions That Promote Diversity is designed to expand the capability for biomedical research by providing grant support to institutions that have developed successful programs that promote diversity and that offer doctoral degrees in the health professions or in health-related sciences. These institutions are uniquely positioned to engage minority and other health disparity populations in research and translation of research advances that impact health outcomes, as well as provide health care for these populations]]></Purpose>
<RelNote/><ActivityCodes>T32</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-021.html</GuideLink>
<RelDate>2012-05-04</RelDate>
<IntentDate>June 9, 2012; January 7, 2013; January 7, 2014</IntentDate>
<AppReceiptDate><![CDATA[July 9, 2012; February 7, 2013; February 7, 2014]]></AppReceiptDate>
<LARD>2014-02-07</LARD>
<FileName>RFA-HL-13-021.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-021</DocNum>
<ExpirationDate>2014-02-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20245</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[FDA FERN Microbiological Cooperative Agreement Continuation Program (U18)]]></Title>
<Purpose><![CDATA[The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from institutions/ organizations for inclusion into FDA's FERN Microbiology Cooperative Agreement Program. The FERN cooperative agreements are intended to target state, local, and tribal FERN labs to provide increased sample analyses in the event of food outbreaks or other large-scale food emergency events requiring surge capacity testing of implicated food samples.  These samples could involve foods and/or environmental samples related to foods, and will be collected by Federal, State, or local agencies. Selected labs with existing sample collection capabilities may be tasked with sample collection activities in support of this program. Numbers of samples and scheduling of samples will be done by the FERN National Program Office (NPO) in coordination with State/Local lab authorities.  Federal or State surveillance assignments will also be a source of samples for lab analysis. The FDA estimates that the analysis of 500 samples per year would be optimal.

]]></Purpose>
<RelNote/><ActivityCodes>U18</ActivityCodes>
<FA_DirectCosts>250000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-018.html</GuideLink>
<RelDate>2012-05-04</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-07-01</LARD>
<FileName>RFA-FD-12-018.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-018</DocNum>
<ExpirationDate>2012-07-02</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20247</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<PartIC><![CDATA[NCATS]]></PartIC>
<PartIC><![CDATA[NCCAM]]></PartIC>
<PartIC><![CDATA[NCI]]></PartIC>
<PartIC><![CDATA[NHLBI]]></PartIC>
<PartIC><![CDATA[NIAAA]]></PartIC>
<PartIC><![CDATA[NIAID]]></PartIC>
<PartIC><![CDATA[NIAMS]]></PartIC>
<PartIC><![CDATA[NIDA]]></PartIC>
<PartIC><![CDATA[NIDCR]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<PartIC><![CDATA[NIGMS]]></PartIC>
<PartIC><![CDATA[NIMH]]></PartIC>
<PartIC><![CDATA[ORWH]]></PartIC>
<Title><![CDATA[Native American Research Centers for Health (NARCH)
]]></Title>
<Purpose><![CDATA[The purpose of this funding opportunity announcement (FOA) is to encourage grant applications for new or continued Native American Research Centers for Health (NARCH). The NARCH program supports opportunities for conducting research and research training to meet the needs of American Indian/Alaska Native (AI/AN) communities. This FOA is issued by the National Institute of General Medical Sciences in conjunction with the other Institutes/Centers of the National Institutes of Health (NIH) and the Indian Health Service (IHS).]]></Purpose>
<RelNote/><ActivityCodes>S06</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-182.html</GuideLink>
<RelDate>2012-05-08</RelDate>
<IntentDate>June 10, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-10</LARD>
<FileName>PAR-12-182.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-182</DocNum>
<ExpirationDate>2012-07-11</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20250</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[Mentored Career Development Award to Promote Faculty Diversity/Re-Entry in Biomedical Research (K01)]]></Title>
<Purpose><![CDATA[The NIH recognizes a unique and compelling need to promote diversity and re-entry in the biomedical, behavioral, clinical, and social sciences research workforce. The NIH expects efforts to diversify the workforce to lead to the recruitment of the most talented researchers from all groups, to improve the quality of the educational and training environment, to balance and broaden the perspective in setting research priorities, to improve the ability to recruit subjects from  minority and other health disparity populations into clinical research protocols, and to improve the Nations capacity to address and eliminate health disparities. There is also a need to ensure a pathway for re-entry into academics for these individuals who, because of these interruptions, may have unique perspectives on problem solving, adaptability to new situations, and ability to bring innovative insights into the academic research environment that can make a significant contribution to the scientific workforce.]]></Purpose>
<RelNote/><ActivityCodes>K01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-019.html</GuideLink>
<RelDate>2012-05-09</RelDate>
<IntentDate>June 9, 2012; January 7, 2013; January 7, 2014</IntentDate>
<AppReceiptDate><![CDATA[July 9, 2012; February 7, 2013; February 7, 2014]]></AppReceiptDate>
<LARD>2014-02-07</LARD>
<FileName>RFA-HL-13-019.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-019</DocNum>
<ExpirationDate>2014-02-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20251</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<Title><![CDATA[SBIR E-learning for HAZMAT and Emergency Response (SBIR [R43/R44]) ]]></Title>
<Purpose><![CDATA[This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Advanced Technology Training (ATT) Products for the health and safety training of hazardous materials (HAZMAT) workers, emergency responders, and skilled support personnel.  These products would complement the goals and objectives of the Worker Education and Training Program (WETP).  The major objective of the NIEHS/WETP is to prevent work related harm by assisting in the training of workers in how best to protect themselves and their communities from exposure to hazardous materials.  There is a need to ensure that learning and training technologies are further developed, field tested and applied to real world situations.  It is the intent of this FOA to support the development of emerging technologies to improve worker preparedness through training and education enhancements and methodologies, and to support e-collaboration, e-teaching, and e-learning in safety and health training for workers engaged in hazardous materials response.  The financial support for this initiative comes directly from NIEHS Worker Education and Training Branch SBIR funds.  This FOA is for SBIR applications only.   
]]></Purpose>
<RelNote/><ActivityCodes>R43,R44</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-12-005.html</GuideLink>
<RelDate>2012-05-09</RelDate>
<IntentDate>June 27, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-27</LARD>
<FileName>RFA-ES-12-005.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-ES-12-005</DocNum>
<ExpirationDate>2012-07-28</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20256</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<Title><![CDATA[Role of Environmental Chemical Exposures in the Development of Obesity, Type 2 Diabetes and Metabolic Syndrome (R21)
]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA), issued by the National Institute of Environmental Health Sciences (NIEHS), encourages grant applications to understand the role of environmental chemical exposures in the development of obesity, type 2 diabetes and/or metabolic syndrome. Applications must link an environmental exposure to the increased incidence of weight gain, type 2 diabetes and aspects of metabolic syndrome in animal models or human studies. While any exposure window is acceptable it is anticipated that the most sensitive time for exposures to affect the disease outcomes will be during development e.g., in utero and/or neonatal or early childhood. For human studies developmental exposures (in utero and early childhood) should be linked to early biomarkers of disease onset. Animal studies should focus on identifying new environmental chemicals that alter weight gain, insulin sensitivity and glucose tolerance and altered lipid metabolism indicative of obesity, type 2 diabetes and/or metabolic syndrome.   ]]></Purpose>
<RelNote/><ActivityCodes>R21</ActivityCodes>
<FA_DirectCosts>200000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-184.html</GuideLink>
<RelDate>2012-05-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PA-12-184.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-184</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20257</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<PartIC><![CDATA[NICHD]]></PartIC>
<PartIC><![CDATA[NIDDK]]></PartIC>
<Title><![CDATA[Role of Environmental Chemical Exposures in the Development of Obesity, Type 2 Diabetes and Metabolic Syndrome (R01)
]]></Title>
<Purpose><![CDATA[The Funding Opportunity Announcement, issued by the National Institute of Environmental Health Sciences (NIEHS), encourages grant applications to understand the role of environmental chemical exposures in the development of obesity, type 2 diabetes and/or metabolic syndrome. Applications must link an environmental exposure to the increased incidence of weight gain, glucose tolerance/insulin sensitivity and aspects of metabolic syndrome in animal models or human studies. While any exposure window is acceptable it is anticipated that the most sensitive time for exposures to affect the disease outcomes will be during development e.g. in utero and/or neonatal or early childhood. For human studies developmental exposures (in utero and early childhood) should be linked to early biomarkers of disease onset. Animal studies should focus on identifying environmental chemicals that alter endpoints indicative of affecting disease development and the site and mechanism(s) of the effects that lead to the increased disease incidence.   
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-185.html</GuideLink>
<RelDate>2012-05-11</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2015-09-07</LARD>
<FileName>PA-12-185.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-185</DocNum>
<ExpirationDate>2015-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20259</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01)]]></Title>
<Purpose><![CDATA[The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications to test the hypothesis that reductions in illicit drug use are associated with improved health outcomes in patients. This FOA will support both prospective and retrospective studies, which may include, but not limited to, identification and characterization of beneficial health outcomes that are associated with reduced levels of drug use. Such studies may focus on identification and or validation of strategies, methods, and tools (including biomarkers) that can assess the salutary consequences resulting from reduced use of a particular illicit drug. These objectives may be achieved either by developing new or validating currently available methodologies that will monitor a health outcome associated with changes in use of a particular illicit drug. Further, identifying health outcomes associated with changes in drug use will stimulate translational research by providing additional measures of health effects linked to drug abuse, and may also be useful in evaluating the efficacy of new therapeutic agents for treating substance use disorders (SUDs). The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs.  ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>500000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-007.html</GuideLink>
<RelDate>2012-05-11</RelDate>
<IntentDate>July 22, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-08-22</LARD>
<FileName>RFA-DA-13-007.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DA-13-007</DocNum>
<ExpirationDate>2012-08-23</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20258</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[National Institute on Aging Analysis of Alzheimer's Disease Genome Sequencing Project Data [U19]]]></Title>
<Purpose><![CDATA[The National Institute on Aging invites applications specific to the analysis of whole exome and genome sequencing data provided by the National Human Genome Research Institute Large-Scale Sequencing Program for the Alzheimer's disease research community.]]></Purpose>
<RelNote/><ActivityCodes>U19</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-183.html</GuideLink>
<RelDate>2012-05-14</RelDate>
<IntentDate>July 8, 2012</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2013-09-07</LARD>
<FileName>PAR-12-183.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-183</DocNum>
<ExpirationDate>2013-09-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20267</rowid>
<PrimaryIC><![CDATA[NIDA]]></PrimaryIC>
<Title><![CDATA[Synthesis and Preclinical Evaluation of Medications to Treat Substance Use Disorders (SUDs) (R01)]]></Title>
<Purpose><![CDATA[The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications to support the synthesis and preclinical evaluation of new molecular entities as potential treatments for Substance Use Disorders (SUDs).  Responsive applications may include synthesis, identification, optimization and preclinical efficacy and/or safety assessment of lead compounds.  Applications must provide timelines and decision-trees with go/no-go criteria to advance or discontinue testing a compound.  Possible new molecular entities include, but are not limited to, small molecules, enzymes, antibodies, and vaccines. The goal is to identify candidate compounds and advance them towards Investigational New Drug (IND) submission. ]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-004.html</GuideLink>
<RelDate>2012-05-15</RelDate>
<IntentDate>July 15, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-08-15</LARD>
<FileName>RFA-DA-13-004.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DA-13-004</DocNum>
<ExpirationDate>2012-08-16</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20268</rowid>
<PrimaryIC><![CDATA[FDA]]></PrimaryIC>
<Title><![CDATA[Enhancing post-market surveillance through developing registries for medical device epidemiology (U01)]]></Title>
<Purpose><![CDATA[(1) To develop registries and consortia in key medical device areas to implement new registry methodologies that strategically broaden the scope of the US and international postmarket surveillance system, and

(2) To address identified gaps in the current postmarket surveillance system by developing new methodologies for registry data collection and linkage, or by adapting known methodologies to medical devices, and 

(3) To develop novel methodology that allows for use of the registry data collection infrastructure to serve multiple purposes including postmarket surveillance, device tracking through Unique Device Identifiers (UDI), prospective embedded studies, quality improvement, and other uses.
]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>125000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-028.html</GuideLink>
<RelDate>2012-05-15</RelDate>
<IntentDate>June 1, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-06-25</LARD>
<FileName>RFA-FD-12-028.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-FD-12-028</DocNum>
<ExpirationDate>2012-06-26</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20269</rowid>
<PrimaryIC><![CDATA[NIA]]></PrimaryIC>
<Title><![CDATA[Macroeconomic Aspects of Population Aging (R01)]]></Title>
<Purpose><![CDATA[This Funding Opportunity Announcement (FOA) invites research on the macroeconomics of aging - the impact of population aging on the macroeconomy and in turn how macroeconomic factors impact health and well-being.
]]></Purpose>
<RelNote/><ActivityCodes>R01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-186.html</GuideLink>
<RelDate>2012-05-15</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[October 3, 2012; October 3, 2013; October 3, 2014]]></AppReceiptDate>
<LARD>2014-10-03</LARD>
<FileName>PAR-12-186.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-186</DocNum>
<ExpirationDate>2014-10-04</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20270</rowid>
<PrimaryIC><![CDATA[NIGMS]]></PrimaryIC>
<Title><![CDATA[NIGMS National Centers for Systems Biology (P50)]]></Title>
<Purpose><![CDATA[The National Institute of General Medical Sciences (NIGMS) invites grant applications from institutions/organizations proposing to establish Centers of Excellence in Systems Biology.  The goal of this initiative is to promote pioneering research, research training, education, and outreach programs focused on systems-level inquiries of biomedical phenomena within the NIGMS mission.  The description of the NIGMS mission can be found on the website, www.nigms.nih.gov]]></Purpose>
<RelNote/><ActivityCodes>P50</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PAR-12-187.html</GuideLink>
<RelDate>2012-05-16</RelDate>
<IntentDate>September 23, 2012; September 23, 2013; September 23, 2014</IntentDate>
<AppReceiptDate><![CDATA[October 23, 2012; October 23, 2013; October 23, 2014]]></AppReceiptDate>
<LARD>2014-10-23</LARD>
<FileName>PAR-12-187.html</FileName>
<DocType>PAR</DocType>
<DocNum>PAR-12-187</DocNum>
<ExpirationDate>2014-10-24</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20271</rowid>
<PrimaryIC><![CDATA[NIEHS]]></PrimaryIC>
<Title><![CDATA[Transition to Independent Environmental Health Research (TIEHR) Career Development Award  (K22)]]></Title>
<Purpose><![CDATA[The Transitions to Independent Environmental Health Research (TIEHR) Career Development Award is a 3-year bridge scholar development program for newly independent faculty who intend to pursue careers focused on environmental health sciences research.  At the conclusion of the career development period the candidates are expected to demonstrate they can successfully compete for research funding in the environmental health sciences..
]]></Purpose>
<RelNote/><ActivityCodes>K22</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/pa-files/PA-12-188.html</GuideLink>
<RelDate>2012-05-16</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate><![CDATA[Multiple dates, see announcement.]]></AppReceiptDate>
<LARD>2017-05-07</LARD>
<FileName>PA-12-188.html</FileName>
<DocType>PA</DocType>
<DocNum>PA-12-188</DocNum>
<ExpirationDate>2017-05-08</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20272</rowid>
<PrimaryIC><![CDATA[NHLBI]]></PrimaryIC>
<Title><![CDATA[The NIH Centers for Accelerated Innovations (U54)]]></Title>
<Purpose><![CDATA[The NIH Centers for Accelerated Innovations (NCAI) will develop Centers that (1) solicit and select promising emerging technologies, such as therapeutics (e.g., drugs, biologics), preventatives, diagnostics, devices, tools, etc. and (2) facilitate their translation to commercialized products that improve patient care and enhance health. The NCAI will nurture the development of high priority early-stage technologies within the NHLBIs mission in a manner consistent with business case development and regulatory requirements by providing (1) funding for product definition studies (e.g. feasibility studies, prototype development, or proof-of-concept studies), (2) unified and coordinated access to expertise in areas required for early technology development, including scientific, regulatory, reimbursement, business, legal, and project management, and (3) training and hands-on experience in entrepreneurism.  Establishing public-private partnerships and providing non-federal funds will be critical for success.    ]]></Purpose>
<RelNote/><ActivityCodes>U54</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-008.html</GuideLink>
<RelDate>2012-05-17</RelDate>
<IntentDate>August 19, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-09-19</LARD>
<FileName>RFA-HL-13-008.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-HL-13-008</DocNum>
<ExpirationDate>2012-09-20</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20274</rowid>
<PrimaryIC><![CDATA[NIH]]></PrimaryIC>
<PartIC><![CDATA[ORIP]]></PartIC>
<Title><![CDATA[Research Education Program for Laboratory Animal Medicine Veterinarians (R25)]]></Title>
<Purpose><![CDATA[This funding opportunity announcement issued by the Office of Research Infrastructure Programs (ORIP), Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), Officer of the Director, NIH, solicits Research Education Grant (R25) applications to provide research education for veterinarians interested in pursuing a career in Laboratory Animal Medicine (LAM). The objective is to prepare veterinarians to be competent and proficient in the field of Laboratory Animal Medicine in support of biomedical investigations with emphasis on performing collaborative research, and development and maintenance of animal models in support of translational research activities. 
]]></Purpose>
<RelNote/><ActivityCodes>R25</ActivityCodes>
<FA_DirectCosts>112000</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-12-006.html</GuideLink>
<RelDate>2012-05-18</RelDate>
<IntentDate>Not Applicable</IntentDate>
<AppReceiptDate/><LARD>2012-07-18</LARD>
<FileName>RFA-OD-12-006.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-OD-12-006</DocNum>
<ExpirationDate>2012-07-19</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>

<GuideDocs>
<rowid>20279</rowid>
<PrimaryIC><![CDATA[NIDDK]]></PrimaryIC>
<Title><![CDATA[Limited Competition for the Continuation of the Halt-Polycystic Kidney Disease Trials Data Coordinating Center (DCC) (U01)]]></Title>
<Purpose><![CDATA[The purpose of this limited competition is to extend the activities of the Data Coordinating Center (DCC) during the final two years of patient follow-up of the two ongoing HALT-Polycystic Kidney Disease (PKD) clinical trials.  The extension will insure the statistical power and significance of the study outcomes.  The HALT-PKD Trials are comprised of two studies (A & B) that are both fully enrolled.  HALT-PKD Study A is evaluating the impact of renin-angiotensin-aldosterone system (RAAS) blockade on progression of disease in 548 hypertensive PKD patients with estimated glomerular filtration rate (GFR)  60ml/min/1.73 m2. The primary endpoint of the study is the percent change in total kidney volume, as measured by magnetic resonance imaging (MRI) over time.  HALT-PKD Study B is evaluating the impact of RAAS blockade on progression of disease in 472 hypertensive PKD patients with estimated GFR 30-60 ml/min/1.73 m2. The primary endpoint of Study B is a composite endpoint of time to the 50% reduction of baseline estimated GFR, ESRD (initiation of dialysis or preemptive transplant), or death.   ]]></Purpose>
<RelNote/><ActivityCodes>U01</ActivityCodes>
<FA_DirectCosts>none</FA_DirectCosts>
<GuideLink>http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-505.html</GuideLink>
<RelDate>2012-05-18</RelDate>
<IntentDate>June 30, 2012</IntentDate>
<AppReceiptDate/><LARD>2012-07-30</LARD>
<FileName>RFA-DK-12-505.html</FileName>
<DocType>RFA</DocType>
<DocNum>RFA-DK-12-505</DocNum>
<ExpirationDate>2012-07-31</ExpirationDate>
<DocStatus>Published</DocStatus>
</GuideDocs>
</dataroot>

